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ABSTRACT 
Network-guided genome-wide studies reveal a complex genetic 
architecture of warfarin resistance in the Norway rat (Rattus 
norvegicus) 
by 
Shuwei Li 
 A fundamental challenge in evolutionary biology and medical genetic research is 
to connect the phenotype (a disease in humans or an adaptive trait in animals or plants) 
with the genotype. Using a classical example of an adaptive trait with a strong Mendelian 
genetic basis - warfarin resistance in the Norway rat (Rattus norvegicus), my dissertation 
tests the main hypothesis that speculated ‘simple’ adaptive trait has a more complex 
genetic architecture.  
 Warfarin is an anticoagulant rodenticide used since the 1950s, and also is a widely 
prescribed blood-thinning drug in human. As a rodenticide, warfarin has initially been 
very effective. However, resistant rodents have evolved quickly and Vkorc1 (vitamin K 
epoxide reductase complex subunit 1) is the known resistance gene. As a popular drug, 
warfarin has a narrow therapeutic window with several genes VKORC1, CYP2C9, 
CYP4F2 established as biomarkers predicting warfarin dose in humans, suggesting a 
complex genetic architecture of warfarin resistance in rodents.  
 In my thesis I performed network-guided genomic association studies 
(NetGWAS) and gene expression analysis to identify candidate genes involved in 
warfarin resistance based on a sample of ~600 wild rats from 19 populations in Germany.  
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 My thesis work revealed that the resistance mutation in Vkorc1 likely is under 
balancing selection and was recently introduced to the rat population in our study area.  
 A key innovation of my thesis is adopting a NetGWAS approach to prioritize true 
associations and conducting co-expression network analysis to detect expression changes 
related to warfarin. My work shows that additional candidate genes are connected to the 
vitamin K pathway of which Vkorc1 is an essential component. While the validation of 
identified genes remains a challenge, the value of my thesis for future investigation is 
shown: one candidate gene Calu (Calumenin) is associated with warfarin resistance in 
multiple populations and is an essential part of the vitamin K cycle. Finally, my thesis 
briefly examines the genetics underlying a newly postulated cost of resistance, arterial 
calcification.  
 This dissertation provides us an innovative framework in which we learned the 
genetic architecture of an adaptive trait in multiple dimensions: nucleotide or expression 
variation, genomic distribution and gene-gene interactions.  
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Chapter 1 
Introduction 
What is life? In the last paragraph of the book On the Origin of Species by 
Means of Natural Selection, Darwin said: “life is which evolves” (Darwin 1859). 150 
years later, J. Craig Venter described it in another way: “life is a software system and 
DNA is the genetic code”. As suggested by Jerry A. Coyne and others, what Darwin 
really told us in his book is not the origin of species but the origin of adaptation 
(Coyne 2009). Now with better knowledge and more advanced tools in hand, Dr. 
Ventor’s definition urges us to understand what exactly happened during the 
adaptation process, i.e. what is the precise nature and role of changes in DNA that 
affect evolving systems. Since Darwin emphasized that “many slight differences” are 
the source of variation for selection to act upon, generations of scientists have been 
examining the question of “what is the genetic basis of adaptation” (Orr 2005; Hurst 
2009; Wang et al. 2011; Radwan and Babik 2012; Axelsson et al. 2013; Linnen et al. 
2013).  
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Interestingly, this search for general answers that explain adaptive trait 
evolution in natural populations of animals and plants parallels to the search for 
answers regarding the genetics underlying disease in humans. The enduring effort in 
medical genetic research to identify genes and pathways, and genetic mechanisms 
that explain disease has been a powerful driver of molecular tools and theoretical 
innovation, and recently, genomic tools and genome-wide association analyses (Lucia 
A. et al. ; Risch and Merikangas 1996; Consortium 2005; Schadt et al. 2005; 
Consortium 2007; Purcell et al. 2007; Gilad, Rifkin, and Pritchard 2008; Slatkin 
2008; Takeuchi et al. 2009; Barabasi, Gulbahce, and Loscalzo 2011; Liu et al. 2011; 
Stranger, Stahl, and Raj 2011; Li et al. 2012).  
1.1. Background 
“We know little about the genetic basis of adaptation” (Orr and Irving 1997). 
Is the adaptation built from a few genes of large effect or many genes each of small 
effects? Does adaptation occur from de novo mutation or standing variation? What is 
the mode of selection on the mutant alleles and are these recessive, dominant, or over-
dominant? New technologies have been developed and considerable progress has 
been made with regard to technological and theoretical developments; but we still 
know little about the genetic basis of adaptive traits in natural populations of animals 
and plants, and with the advent of genome-wide perspectives and data we are faced 
with as many new opportunities as we are faced with new challenges. For instance, 
we now are able to examine how does selection shape the genome as a whole? If 
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multiple selective events are discovered we might wonder whether these are part of a 
single selective event affecting multiple loci of if each selected site is under its own 
selective pressure? In this context selection is broadly defined, but potentially might 
need to be viewed in a refined fashion, such as selection on driver mutations initially 
leading to an adaptation which are followed by mutations enhancing the trait and 
mutations compensating for fitness costs associated with driver mutations. From a 
genome-wide perspective we can pose the general question whether adaptation occurs 
at the levels of amino acid sequences or at the level of gene expression? A key 
question underlying my thesis is whether the potentially complex genetic architecture 
of adaptive traits as such is simpler once we adopt a gene-gene interaction network 
perspective. In other words, perceived complexity in terms of the number of genes 
involved might be reduced to single of few pathways. Within such pathways a 
challenge would be to distinguish genes that directly interact with selective agents 
from genes that are compensating for any fitness costs.  
Understanding the genetic basis of adaptation requires us to bridge the gap 
between genotype and phenotype. As defined by Wilhelm Johannsen in 1911, the 
“genotype is an organism’s heredity and phenotype is what that heredity produces.” 
(Johannsen 1911). Bridging the gap between genotype and phenotype requires the 
identification of genetic variations that contribute to the phenotypic trait. Moreover, it 
requires testing for the strength, mode and timing of selection for each variant. A 
novel research direction in this context involves the exploration of any gene-gene 
interactions and functional relationships among variants. In Figure 1.1 I summarize 
some of the steps involved in contemporary and future studies with aim to bridge the 
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genotype and phenotype gap. First, genes and other variants responsible associated 
with a phenotype are isolated by genome wide association analyses of based on other 
mapping strategies. The trait or disease of interest might be determined by one 
primary gene or be complex in its architecture. Note, however, that based on my 
thesis work I propose that adaptation in nature may not seem to progress by simple 
genetics; instead, simple genetics progress towards complex genetics over time 
through recruitment of new mutations and standing variants to either enhance the 
trait, buffer the trait, or compensate for a cost of the main driving mutations.  
 
Figure 1.1 – Linking the genotype with the phenotype by examining nucleotide 
variation and experssion changes with a network perspective as genes or proteins are 
interacted with each other in pathways and networks.  
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Genome wide variation and association studies (GWAS), as well as analyses 
of gene expression have revealed a wealth and diversity of genomic variation, and 
clearly have shown that mutations on DNA sequences frequently result in altered 
protein structures and gene expression patterns to the effect that these affect function 
(Figure 1.1). Moreover, systems biological perspectives and tools applied to genomic 
data clearly revealed that genes are not working in isolation, but the genome should 
be viewed as a network connecting subnetworks (pathways), and connections (edges) 
in the network can be encoded in numerous ways, including as gene expression 
changes or protein-protein binding, just to mention a few. Thus, if we zoom out from 
the resolution at single genes, individual pathways, to the thousands of interacting 
genes, it becomes clear that for function to be maintained individual components need 
to interact properly, or are well buffered to change. Moreover, the disruption caused 
by new mutations, often of dramatic effect such as the Y139C mutation (Y to C 
amino-acid change at position 139 of the protein) in Vkorc1 that I study, can be 
anticipated by examining genetic networks (Rost et al. 2004). In addition, this 
network perspective raises questions regarding a simplistic view of single selective 
events under study in natural populations. For instance, even an initially single gene 
response could result in cascade effects in the network, and thus, result in what 
appears as multiple selective events. If these selective events are detected and 
interpreted in isolation the importance of selection on the genome would appear 
inflated, as single events result in numerous responses at the genome level. For these, 
and many other reasons, adopting a network perspective is needed to more effectively 
explore the fundamental questions concerning the genetic basis for adaptation.  
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In my thesis I study a presumably very simple model system: warfarin 
resistance in wild rats (Rattus norvegicus). The rationale to study such a presumably 
simple and unusual pesticide resistance system is to illustrate that even in such system 
complexity is found. This should provide guidance to studies of natural study systems 
that obviously are more complex. Results of my work suggest that the current state-
of-the art of interpreting genomic data collected on wild populations appears to result 
in misleading conclusions in that a mere tabulation of genomic regions under 
selection only is a small part of studies that aim to understand the genetics of 
adaptation.   
Warfarin (a derivative of 4-hydroxycoumarin) was introduced in the 1950s as 
an anticoagulant rodenticide. It works by blocking the vitamin K 2,3-epoxide 
reductase complex (VKOR) of the vitamin K cycle, and subsequently impairing the 
vitamin K-dependent gamma-carboxylation system and the following activation of 
blood coagulation factors, and, as a presumably unnecessary side effect, should 
reduce the activities of vitamin K-dependent proteins not involved in blood 
coagulation (c.f. Appendix 8, Figure 5.2) (Presnell and Stafford 2002; Stafford 2005). 
Thus, susceptible rodents succumb to internal hemorrhage after ingestion of the 
poison and the ‘blood-thinning’ effect of warfarin made the substance extremely 
useful as a rodenticide. In addition, it was quickly realized that this blood thinning 
effect could be taken advantage of by turning warfarin into a drug to prevent heart 
attack, stroke or thrombosis in human (Gage et al. 2003; Geisen et al. 2005).                    
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While my thesis is mainly concerned with the evolutionary genetics of 
adaptive evolution of a trait, my thesis has important implications to the biomedical 
sciences also. Specifically, although warfarin has been widely prescribed as a drug for 
about 60 years, it remains a difficult drug to manage because of its narrow therapeutic 
range, wide dosage variation, and serious side effects if dosed inappropriately. The 
optimal dosage varies dramatically within and between human patients owing to 
genetics, diet, drug-drug interactions, and other environmental factors (Kamali 2006). 
It is thus a challenge to determine a safe yet effective dose of warfarin for individual 
patients that prevents thrombosis while avoiding bleeding risks (Takeuchi et al. 
2009). In humans, several mutations in the genes VKORC1 (encodes VKOR), 
CYP2C9 (cytochrome P450, family 2, subfamily C, polypeptide 9; encodes enzyme 
metabolize the S-enantiomer of warfarin), and CYP4F2 (cytochrome P450, family 4, 
subfamily F, polypeptide 2; vitamin K1 oxidase) affect the physiological response to 
warfarin drug treatment, and thus, presently these are established as the only 
biomarkers predicting warfarin dosage (Li et al. 2004; Rost et al. 2004; McDonald et 
al. 2009; Pautas et al. 2009; Takeuchi et al. 2009). Other candidate genes such as 
GGCX (Gamma-glutamyl carboxylase) and EPHX1 (Epoxide hydrolase 1, 
microsomal) were reported, but with controversial results obtained during different 
studies (Wadelius et al. 2005; Cha et al. 2007; Wadelius et al. 2007; Pautas et al. 
2009). Nonetheless, incorporating genetic information greatly improved the warfarin 
dosage estimation, therby averting an estimated 85,000 serious bleeding cases and 
17,000 strokes annually. Genetically informed warfarin dosing has dramatically 
reduced health care costs (~ 1 billion annually, source: AEI-Brookings joint center for 
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regulatory studies). Now genetic forecasting of warfarin dose is actively studied and 
practiced (IWPC ; Wadelius et al. 2009; Pavani et al. 2012; UI-Health 2012). Even 
though warfarin has become a poster child for the future of personalized medicine my 
thesis shows that warfarin dosing in this application area would benefit from an even 
more comprehensive understanding of the genetic underlying physiological responses 
to warfarin. Such searches for additional genes are complicated in humans and 
potentially could be more effectively done in our study system of free-ranging rats 
that have been inadvertently selected for decades to resist the poison. In this system 
we would expect that any variant and gene that enhances the fitness of rats 
theoretically had a chance of fixation of 2Nes, as opposed to 1/Ne in human 
populations where warfarin response is not a selected trait. Interesting, my thesis 
results indicate that drift plays a larger role in the study system that was anticipated at 
the onset of the study, however. 
As the first generation rodenticide, warfarin was initially a highly effective 
tool to control rats (Endler 1985; Gillespie 1991; Kohn, Pelz, and Wayne 2000). 
However, resistance to warfarin has evolved within a mere ~10-15 years after its 
introduction in the 1950s. Warfarin resistant rats have been found, first in Scotland 
(1958) and subsequently at the Wales-Anglo border (1960), Denmark (1962), Holland 
(1966) and Germany (1967) (Boyle 1960; Lund 1964; Jackson and Kaukeinen 1972; 
population and agriculture 1986). Now resistant rats have been found in many 
locations dispersed across the globe, with much of resistance yet to be discovered 
because systematic surveys rarely being conducted (Figure 1.2).  
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Figure 1.2 – Distribution of warfarin resistance for Norway rats (R. norvegicus) 
around the world. Map is generated in GIS (Geographic Information Systems).  
Resistance to warfarin was speculated to have simple genetic basis (Greaves 
and Ayres 1969; Wallace and MacSwiney 1979). It is currently accepted that Vkorc1 
is the major gene that causes warfarin resistance in rodents (Kohn and Pelz 1999; 
Kohn and Pelz 2000; Li et al. 2004; Rost et al. 2004; Pelz et al. 2005). The best-
documented case where resistance by Vkorc1 is conferred is by a Y->C substitution at 
position 139 of VKORC1 that decreases warfarin binding affinity (Kohn, Pelz, and 
Wayne 2003; Rost et al. 2004; Rost et al. 2009). This Y139C mutation occurs in our 
study area in Germany. The vertebrate homologues to Vkorc1 gene are found in 
arthropods, plants, bacteria and archaea (Goodstadt and Ponting 2004), suggesting the 
gene is involved in pathways and physiological/developmental processes other that 
blood coagulation.  
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1.2. Rationale 
Norway rats in our study area in Germany have experienced decades of strong 
selection with the rodenticide warfarin. While it is commonly thought that at least 
three genes (VKORC1, CYP2C9 and CYP4F2) are associated with warfarin dosage 
variance in human, and Vkorc1 in rats, a main question of my thesis is whether the 
strong and persistent selection with warfarin has selected for additional genes in the 
rat genome (Figure 1.3). If this main working assumption of the thesis is met then the 
fundamental question studied is whether these genes are clustered in terms of function 
and pathways in a gene-gene interaction network. If this hypothesis was true then the 
main contribution of the thesis, in terms of evolutionary theory, would be i) that even 
simple genetic adaptations mentioned in evolutionary textbooks and literature might 
in fact more commonly be more complex. ii) Complexity of adaptive traits should be 
interpreted not with regard to the number of genes involved alone, but also within the 
context of the number of pathways involved.  
Moreover, as I discuss in detail in Chapter 2, the Y139C resistance mutation 
imposes fitness costs (reduced growth rate and arterial calcification, etc.) to rats. Thus 
it is interesting to explore the existence of other genes with potentially compensatory 
mutations that have become a part of the genetics of warfarin resistance.  
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Figure 1.3 – Rationale of thesis. Several genes VKORC1, CYP2C9, CYP4F2 are 
established as biomarkers predicting warfarin dose in humans. We expect to detect 
additional genes other than Vkorc1 related to warfarin resistance in rodents which 
have experienced strong selection. 
1.3. Overview of methods  
In this dissertation project, I performed a network-guided genomic study 
utilizing innovative computational and statistical tools to search for genetic variants 
associated with warfarin resistance, and to investigate these variants in terms of 
selection and in terms of gene-gene interactions that they might mediate or affect.  
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The first focus is on the known resistance gene Vkorc1. While it is commonly 
assumed that the warfarin resistance trait is under balancing selection as mediated by 
overdominance, this has not been confirmed by any population genetic analysis of the 
resistance gene Vkorc1. Interestingly, patterns of linked microsatellite variation 
indicated directional selection rather than balancing selection at the locus (Kohn, 
Pelz, and Wayne 2000). Thus, the first sets of methods used include SNP typing at 
Vkorc1 and linked sites and population genetic analyses. Forward time simulations 
are used to distinguish competing hypotheses regarding timing, strength, and mode of 
selection at Vkorc1 consistent with the observed patterns.   
In the following I switch from a gene-centric perspective to a genome-wide 
perspective. Notably, in our laboratory the candidate gene-centric perspective has 
been applied to the two other obvious candidate genes of the cytochrome 450 types. 
To learn the overall genetic architecture underlying warfarin resistance the rat 
genome is searched for SNPs associated with resistance. This is done on an 
Affymetrix SNP typing platform in collaboration with genome centers. Identified 
variants and the haplotypes they are located on are examined selection and undergo 
functional annotations. Designed to identify genetic variations associated with 
complex diseases and traits, genome wide association studies (GWAS) have gained 
tremendous attention (Lucia A. et al.). I detected significant SNPs by measuring 
association strength as Bayes Factors during Bayesian association analyses. However, 
this traditional GWAS approach detected candidate variants individually and 
independently, resulting in large lists of candidate genes, many of which likely to be 
false positive owing to linkage to functional sites, and GWAS did not account for 
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interesting gene-gene interactions as part of the significance assessments (Cordell 
2009). Hence we expanded the traditional GWAS to Network-guided GWAS 
(NetGWAS) by evaluating the significance of association of genes with the trait in 
the context of their location in gene-gene interaction networks.  Thus, trait relevant 
genes are prioritized. A key innovation of this thesis is the implementation of a 
modified Google’s PageRank algorithm to conduct these analyses (Page et al. 1999). 
The larger set of candidate genes is analyzed with population genomic tools, and 
forward time simulations are used to test null models predicting the randomly 
expected number of genes underlying the trait as explained by drift (and chance) 
alone. The thesis addresses another novel challenge neglected in data-driven 
molecular population genetics analyses, which is to detect selection on sets of 
interacting genes and within the frameworks of genetic network. 
The ability to conduct analyses of gene expression added an important 
“intermediate level” that might help filling the genotype and phenotype gap, and on 
occasion is referred to as the closest proxy for a phenotype that is a target of selection 
(Ellegren et al. 2012). Some variations, like the resistance mutation on Vkorc1 gene, 
change the protein structure (Kohn, Pelz, and Wayne 2003; Rost et al. 2009). Some 
variants, on the other hand, might alter the gene expression, such as the mutations in 
the promoter region of the lactase gene underlying the adaptation of humans to milk 
consumption (Tishkoff et al. 2007). Previous studies have reported few genes with 
differential expression patterns on small custom arrays that are associated with 
rodenticide resistance (Markussen et al. 2008a; Markussen et al. 2008b).  Here the 
Affymetrix platform was used to obtain genome-wide expression profiles for wild 
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rats kept in the laboratory of collaborators testing these for resistance status. Such 
testing involves the injection of rats with low doses of warfarin. Thus, we assay gene 
expression for resistant and susceptible rats induced and non-induced with warfarin. 
These data are used to search for associations between gene expression and the 
resistance trait, as well as to construct co-expression networks. In this thesis the SNP 
association results and gene expression results are combined for a more 
comprehensive view of the genetics underlying warfarin resistance, and while 
considering candidate genes.  Methods employed include an analysis of population 
structure to account for stratification. Finally, I collected further genotype data for 
larger population samples for top candidate genes to better understand the population 
genetics of these genes, including the effects of selection and drift. 
1.4. Outline of the Dissertation 
After an introductory Chapter 1 thesis Chapter 2 focuses on a population 
genetic analysis of the Vkorc1 gene and linked polymrophisms in a wild-derived 
population NW and a non-resistant population LH. We connected genotype, 
phenotype and fitness by analyzing the association of the Y139C underlying SNP and 
evaluated various models of selection n the gene and haplotype it is located on. Three 
fundamental questions are examined in Chapter 2. The strength and mode of selection 
at Vkorc1 are analyzed and the age of the mutation is estimated.  
Chapter 3 is concerned with a network-guided GWAS (NetGWAS) on a 10k 
rat SNP array on which a wild-derived population, NW, and a non-resistant 
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population, LH, were assayed with aim to detect associations of SNPs with warfarin 
resistance (SNP array I). I combined the gene-gene interaction (GGI) network 
information with the gene-trait association measures based on a modified Google’s 
PageRank algorithm (Page et al. 1999; Morrison et al. 2005). Gene ranks are given to 
prioritize warfarin related genes followed by functional annotation analyses based on 
the Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes 
(KEGG) pathway information (Ogata et al. 1999; Consortium 2008). Population 
genomic analyses were performed between the resistant and non-resistant 
populations, including tests for extended haplotypes and linkage disequilibrium (LD). 
Chapter 4 describes the work involved to find genes that display association of 
their expression with the resistance phenotype under various experimental variables 
(induction with warfarin, gender, and warfarin resistance genotype at Vkorc1). Co-
expression networks are built based on the microarray data collected from the same 
wild-derived populations, NW and LH, which were used in Chapter 3. A stunning 
600 genes that were correlated with warfarin treatment and resistance phenotype 
emerged, which clearly was unexpected given that warfarin was supposed to be a 
pathway-specific drug and poison. This observation was critically evaluated and in 
chapter 3 it is shown that linkage of many polymorphic variants underlying 
expression polymorphisms in wild rats must be linked to the causal sites under 
selection, and genetic hitchhiking and neutral haplotype structure cased these to 
magnify the gene expression response to warfarin. Network analyses in functional 
terms were crucial steps in the identification of candidate genes, identifying 21 
clusters. Although the known resistance non-synonymous mutation underlying 
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Y139C is not known to modify the expression of Vkorc1 gene, the surrounding genes 
exhibited signals of warfarin related expression variations and formed a detectable 
cluster. This finding showed the promises of other clusters to form false-positive 
associations by random chance (linkage). Results from chapter 2 were used to refine 
the analyses of gene expression by mapping SNP array data onto the annotated gene 
expression data. This reduced the number of subnetworks to 7. Finally, by eQTL 
mapping (expression quantitative trait loci) we increased our knowledge about the 
architecture of gene regulation (Gilad, Rifkin, and Pritchard 2008). 
In Chapter 5, we performed the network-guided genomic association study 
(NetGWAS) of the rat 10k SNP array data in multiple additional wild populations 
(SNP array II). We used population structure analysis of ~ 600 rats to select 46 
samples suitable for the SNP array experiment (SNP array II) in that they are part of 
the same (non-stratified) clusters identified. For discovery and validation purposes, 
genes with multiple supporting evidences from all chapters were reported at the top of 
this candidate gene list. For one candidate gene, Calu, the association was validated 
in a sample of ~600 rats. 
In Chapter 6 some key implications of this thesis are discussed and future 
work on this specific study system are provided, as well as some general 
recommendations for the genomic study of the genetic architecture underlying 
adaptive traits (Figure 1.4).  
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1.5. Contribution of the Dissertation 
This dissertation built a framework for understanding the genetic basis of 
warfarin resistance (Figure 1.4), which utilized genomic platforms, bioinformatics, 
and population genetics to test the main hypothesis that even adaptive traits once 
thought to be simple in their genetics have a more complex genetic architecture. In 
this framework, we first tested selection at the genetic level for the known resistance 
gene Vkorc1, which would serve as an example for decoding signals of selective 
sweep (Chapter 2).  
 
Figure 1.4 –Overview of workflow and major methological steps and innovations.  
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In addition to Vkorc1, I identified other candidate genes related to warfarin 
using network-guided genomic analyses based on variation data (SNP array) (Chapter 
3) and microarray expression data (Chapter 4). Beyond the conventional GWAS and 
expression analysis of identifying candidate genes along the genome, we incorporated 
the information of gene interactions, which facilitated the candidate gene 
identification, and revealed relationships among multiple genes. The candidate gene 
list would be of interest to the study of warfarin therapy and genetic forecasting of 
dose in personalized medication. In this dissertation, not only we learned the genetic 
architecture of warfarin resistance, I also constructed a gene interaction network map 
for multiple candidate genes to understand their functional relevance, which can 
hardly be learned in traditional GWAS and expression analysis. 
It connects evolutionary biology and medical genetic research, and has 
important implication in public health and agriculture. The developed algorithms and 
tools would be generally applied to other systems in cancer or disease genetic 
research.  A key prediction of the thesis is that knowledge, or inferences, of gene 
interactions enable a systematic dissection of the genetics of adaptive traits, as I 
predict that a significant fraction of additional genes involved in warfarin resistance 
can be connected to the main resistance gene in terms of function. 
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Chapter 2 
Balancing selection on an overdominant de 
novo Vkorc1-Y139C mutation in warfarin 
resistant Norway rat populations 
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Abstract 
Field studies conducted in the 1977 have revealed that warfarin rodenticide 
resistance in Norway rats (Rattus novergicus) is an example of an overdominant 
mutation under balancing selection. However, the selection mode at the locus has not 
been studied with molecular population genetics; except that in the early 2000s 
analyses of microsatellite marker polymorphisms in free-living rat populations 
revealed the position of the resistance gene in form of localized and elevated levels of 
linkage disequilibrium, reduced polymorphisms, and genetic differentiation between 
populations of different resistance levels. These studies all pre-dated the time of the 
molecular identification of the warfarin resistance gene; now known to be encoded by 
a vitamin K epoxide reducatse subcomponent 1 (Vkorc1).  Moreover, specific 
mutations in Vkorc1 have now been shown to confer resistance during in vivo and in 
vitro studies. Foremost a mutation altering a Y at position 139 of the amino-acid 
sequence to a C is known to encode resistance to warfarin and to some of its 
derivatives, including bromadiolone and difeancoum. Here we conduct an analysis of 
single-nucleotide polymorphism (SNP) variation in Norway rats from Germany 
where the Y139C mutation is highly prevalent (>70%). From SNP typing on time-
series samples of rats we estimate the selection coefficient at Vkorc1 as s = 0.3. In 
conjunction with forward time simulations we show that observed patterns of 
polymorphism are consistent with the over-dominance model. We dated the mutation 
‘age’ by comparing models of selective sweeps associated with de novo mutations 
with a starting frequency of 1/Ne with models of sweeps associated standing variants 
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of varying starting frequencies. We found evidence for a de novo origin of Y139C in 
Vkorc1 in our study area, which could be interpreted as a de novo mutation that 
occurred or the arrival of an Y139C migrant rats in the area. During simulations we 
identified the setting of initial allele frequencies of neutral sites affect expected 
genetic variation patterns in a crucial fashion. Warfarin resistance in the Norway rat, 
as mediated by an Y139C mutation in Vkorc1, thus is confirmed as an example of an 
overdominant mutation under balancing selection. 
2.1. Introduction 
A fundamental challenge in evolutionary biology is to understand the genetic 
basis of adaptation.  Amongst the many crucial steps involved in the dissection of 
adaptive traits is the identification of the genes and specific variants mapping within 
or around them that contribute to the trait (Barrett and Hoekstra 2011). Moroever, 
documentation of the relative adaptive contribution of the variants is as essential as 
documenting the adaptive value of the trait (Barrett and Hoekstra 2011).  
Theoretical and molecular population genetic approaches thus have been 
developed that aid the detection and characterization of genes and specific variants in 
terms of their contributions to adaptation. Specifically, positive selection usually 
drives beneficial alleles from low to high frequency, or as it is generally modeled, to 
fixation (Pritchard and Di Rienzo 2010). The process affects physically linked neutral 
sites in that these rise in frequency alongside the selected site, and the region around a 
selected site will be ‘swept’ clean of genetic polymorphism. Thus, selected regions 
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can be detected in form of reduced genetic variation and extended linkage 
disequilibrium structure (Kim and Stephan 2003; Kim and Nielsen 2004; Stephan, 
Song, and Langley 2006). This effect, termed ‘selective sweep’ by ‘genetic 
hitchhiking’ (Smith and Haigh 1974) needs to be tested rigorous ly against neutral 
models that consider genetic drift, recombination and population structure.  
However, while the approach has been applied to map the warfarin resistance 
gene by using patterns of polymorphism at neutral microsatellite loci (Kohn, Pelz, 
and Wayne 2000), the results were ambiguous in terms of the details regarding the 
selective regime that caused the observed patterns. In addition, at the time the 
resistance gene was not known and genome sequences and genomic tools to assay 
variation were unavailable, and thus, the study, results and analyses conducted at that 
time were necessarily limited when compared to the current state-of-the–art such 
analyses. In fact, previous analysis of microsatellite data appeared to contradict the 
expectations in that directional selection, rather than balancing selection on an 
overdominant warfarin resistance variant, could explain the observed patterns of 
variation (Kohn, Pelz, and Wayne 2000). In addition and crucially, unlike in 2000 the 
warfarin resistance gene is now known ((Li et al. 2004; Rost et al. 2004; Pelz et al. 
2005); see below) such that the analyses can be targeted at the known variants in the 
gene and the directly adjacent neutral sites.  
Warfarin works by inhibiting the activity of the vitamin K 2,3-epoxide 
reductase complex (VKOR) encoded Vkorc1, and subsequently impairing the vitamin 
K-dependent g-carboxylation system, which is essential for the activation of blood 
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coagulation factors and other vitamin K-dependent proteins (c.f. Appendix 8, Figure 
5.2) (Presnell and Stafford 2002; Stafford 2005). Thus susceptible rats ingesting the 
poison succumb due to internal hemorrhaging while both homozygous resistant and 
heterozygous rats are resistant to the rodenticide.  
As the first-generation rodent poison used since 1950s, warfarin (a derivative 
of 4-hydroxycoumarin) has imposed intense selection pressure on rat (Rattus 
norvegicus) populations (Hans-Joachim, Detlef, and Gerhard 1995; Kohn, Pelz, and 
Wayne 2000). However, a mere 8-10 years later, resistance towards warfarin has 
become prevalent in Germany (1967) and other European coutries (Boyle 1960; Lund 
1964; population and agriculture 1986). The molecular basis for this resistance has 
been identified as the Y139C mutation in Vkorc1 (vitamin K epoxide reductase 
complex, subunit 1) (Rost et al. 2004; Pelz et al. 2005). The Y->C amino acid change 
at position 139 (A to G mutation in Vkorc1 exon 3) leads to a ~ 42% reduction of the 
basal in vitro VKOR activity but protects VKOR activity in the presence of warfarin 
at ~ 20%, which appears to be sufficient to maintain blood coagulation at levels that 
do not impair fitness (Pelz et al. 2005; Rost et al. 2009). The Y139C mutation has 
spread through a vast geographic area in northwestern Germany in response to 
warfarin and other anticoagulants (Kohn, Pelz, and Wayne 2000; Kohn, Pelz, and 
Wayne 2003)). In this resistance area the resistance phenotype was determined for 
hundreds of rats by using a blood clotting response (BCR) test (Kohn, Pelz, and 
Wayne 2003). 
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However, according to the classical literature (Partridge 1979; Partridge 1980) 
a pleiotropic fitness cost in form of impaired blood coagulation is imposed on the 
homozygous resistant genotype. Recently, additional evidence has been collected 
showing that homozygous resistant rats display a more complex set of traits that 
likely are detrimental under intense competition in the wild. First, it has been 
recognized that resistant rats have reduced VKOR enzyme activity (Pelz et al. 2005; 
Rost et al. 2009) and higher requirement for vitamin K to maintain normal blood-
clotting function in the absence of warfarin (Partridge 1979; Markussen et al. 2003). 
This results in the homozygous resistant rats having longer blood clotting times 
(Jacob et al. 2012). Second, in a Vkorc1 mutant laboratory strain where Y139C has 
been introgressed experimentally a reduction in offspring numbers was reported 
(Jacob et al. 2012). Third, reduced growth rate have been observed in resistant rats 
from Welsh (Smith, Townsend, and Smith 1991) but the opposite was reported also 
(Smith et al. 1993). Vitamin K deficiency is expected to result in lower activities of 
vitamin K dependent proteins, notable here Matrix Gla protein (MGP), which is a 
vascular calcification inhibitor (Danziger 2008; Kohn, Price, and Pelz 2008).  
Warfarin resistance has been a classical example of an adaptive overdominant 
locus under balancing selection since its initial discoveries (Greaves et al. 1977). For 
the warfarin resistance locus in wild rats early estimations of the relative fitness ratios 
based on the sampling of rats during fieldwork provided a fitness model for the three 
phenotypic classes and genotypes (Table 2.1). However, this classical textbook 
example for an overdominant locus has not been revisited with state-of-the art 
molecular population genetics and rigorous computer simulations. 
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Table 2.1 – Fitness models at the warfarin resistance locus 
Genotype  S/S S/R R/R 
Fitness model 1-s 1-ds 1-t 
No selection 1 1 1 
Recessive 1-s 1-s 1 
Codominance 1-s 1-1/2s 1 Directional selection 
Dominance 1-s (0.70) 
1 
(1.00) 
1 
(1.00) 
Over-dominance 1-s (0.70) 
1 
(1.00) 
1-t 
(0.90) Balancing selection 
(Greaves et al. 1977) 0.68 1.00 0.37 
Penetrance model 0.07 0.95 0.98 
 
S - wild type susceptible allele, R - resistance allele (Y139C).  
s - selection coefficient for S/S genotype.  
t - fitness cost of R/R.  
d - dominance parameter.  
Values in the parentheses denote the fitness ratio estimated by our study; the estimation from 
Greaves et al. is shown separately (Greaves et al. 1977). 
The penetrance model for the resistance mutation in Vkorc1 gene is calculated and averaged 
across populations (see methods). 
 
Warfarin resistance appeared rapidly after the introduction of warfarin as a 
rodenticide in the 1950s. This raises the question of broad evolutionary biological 
relevance whether adaptive variants often are selected from pre-existing standing 
genetic variants rather than by selection on de novo mutations. Theory predicts that 
selection on the former class of variants results in narrower valleys of reduced 
polymorphism when compared to such valleys associated with new beneficial 
mutations (Figure 3 in Barrett et al.) (Barrett and Schluter 2008). This is explained by 
the expectation that standing variations have longer histories preceding selection 
during which recombination and recurrent mutation add polymorphism at linked 
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neutral sites. In other words, adaptive standing variants are associated with different 
haplotypes as opposed to one haplotype (Barrett and Schluter 2008). Others have 
speculated that resistance has evolved from de novo mutation (Pelz et al. 2005) or 
from standing variation (Barrett and Schluter 2008).  
Here we use molecular population genetic (single nucleotide polymorphisms, 
SNPs) data collected in a large sample of wild-caught rats for which the resistance 
phenotype and the Vkorc1 genotypes are known (Kohn, Pelz, and Wayne 2000; 
Kohn, Pelz, and Wayne 2003). We formally analyze the mode, timing and strength of 
selection on warfarin resistance as mediated by Y139C in Vkorc1. 
2.2. Methods and Materials 
2.2.1. Sampling 
We chose 29 rats of a larger population of wild rats where warfarin and 
bromadiolone resistance segregates (designated as NW sample) that were maintained 
in the laboratory by Hans-Joachim Pelz at the Federal Research Institute for 
Cultivated Plants, Julius Kuehn Institute (JKI), in Muenster, Germany.  These rats 
were caught in the wild from a highly resistant population in northwestern Germany 
near Muenster, Germany, and located within a vast geographic region in northwestern 
Germany where resistance is highly prevalent. From this resistance area we 
previously obtained samples of wild rats from 35 farms during a three years’ project 
investigating the resistance to rodenticides including warfarin (Kohn, Pelz, and 
Wayne 2000; Kohn, Pelz, and Wayne 2003). Here, based on DNA quality of these we 
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included 728 rats from this previous study for further analyses. Furthermore, we 
chose 12 non-resistant rats from a fully susceptible population (designated as sample 
LH) sampled previously about 300 km away from the resistant area (Kohn, Pelz, and 
Wayne 2000).  
In the resistant area, populations with sample sizes > 10 were kept for further 
analysis; resulting in a sample of 668 rats collected on 17 farms (Appendix 1). Of 
these 14 populations were exposed to warfarin and later treated with other 
anticoagulants rodenticides. We used the abbreviation names for 5 populations (WU-
pop24, KB-pop11, TH-pop23&16, SP-pop20, LH-pop4f) as mentioned in a previous 
study (Kohn, Pelz, and Wayne 2000). We labeled other populations by their farm 
numbers adopted from a previous study that utilized these samples (Kohn, Pelz, and 
Wayne 2003).  
Resistance to rodenticides was physiologically determined with a blood 
clotting response (BCR) test (Kohn, Pelz, and Wayne 2000; Kohn, Pelz, and Wayne 
2003) and were available for 599 of the 668 rats. The resistance level, R%, for each 
population is calculated using the number of resistant individuals divided by the 
number of samples with resistance phenotype assigned. Note that heterozygous rats 
(R/S) and homozygous rats (R/R) are resistant.  
Our data have a temporal dimension in that careful monitoring in the field 
documented the incidence of resistance frequencies during controlled field 
experimentations where populations were sampled before and after treatments with 
the anticoagulants in the field from 1996 to 1998. Thus, we were able to take 
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advantage of time-series samples to estimate the selection coefficient on Vkorc1 
Y139C, as we have collected the genotypes at Vkorc1 for rats in this study (see 
below). 
2.2.2. Phylogeny of the resistance gene Vkorc1 
Pseudogenes of Vkorc1 exist in mammalian genomes, and thus, we examined 
the currently annotated Vkorc1 of the rat in a phylogenetic framework to establish 
orthology to the human gene and to characterize briefly the pseudogenes that occur in 
the rat genome. We constructed the phylogenetic tree of the known resistance gene 
Vkorc1 (vitamin K epoxide reductase complex, subunit 1) and its paralog Vkorc1l1 
(Vkorc1-like protein 1) among 6 species: human (Homo sapiens), rat (Rattus 
norvegicus), mouse (Mus musculus), dog (Canis lupus familiaris), Cattle (Bos 
taurus), Fugu (Takifugu rubripes) (Figure 2.1). Multiple sequence alignments of 
genomic sequences were conducted in ClustalW 2.0.10 at default settings (Larkin et 
al. 2007). Phylogenetic trees of nucleotide and protein sequences were estimated 
using Bayesian inference (BI) with fugu as outgroup. The Bayesian phylogenetic 
trees were estimated using the MrBayes 3.1.2 program (Ronquist and Huelsenbeck 
2003) with two simultaneous Markov Chain Monte Carlo (MCMC) chains run for 
1,000,000 generations and sample frequency of every 100 generations with burn-in = 
2,500. The Generalized Time Reversible evolutionary model (GTR; Nst=6) was 
applied. 
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2.2.3. Genotype data of Vkorc1 and the surrounding region 
The Y139C mutation on the Vkorc1 gene has been identified as the main 
mutation that confers warfarin resistance in Norway rats from the study area (Pelz et 
al. 2005). We genotyped all samples from the NW population and 691 samples from 
19 other populations by using High Resolution Melting (HRM) SNP analysis 
(Wittwer et al. 2003). The Type-it HRM PCR Kit was purchased from QIAGEN 
(http://www.qiagen.com, a provider of sample and assay technologies). The primers 
covering the identified SNP underlying Y139C targeted with HRM genotyping 
(Appendix 2) were designed in Primer3 (http://frodo.wi.mit.edu/primer3, access May 
2011). For each sample, 0.65 ul genomic DNA was added to reaction volume of 10 
ul, which includes 5 ul HRM PCR Master Mix, 2.95 ul RNase-free water and 1.4 ul 
primer Mix.  
HRM analyses were conducted on the Rotor-Gene Q (QIAGEN’s real-time 
PCR cycler), with an initial PCR activation of 95°C for 5 min, followed by 40 cycles 
of denaturation at 95°C for 10 seconds, annealing and extension at 55°C for 30 
seconds; the following HRM were performed in a temperature range from 75°C-90°C 
with 0.1°C increments at each step. The genotypes for each rat sample were identified 
with the threshold set at a ‘confidence percentage’ > 85% (White, Hall, and Cross 
2007) in the HRM analysis that compared with 9 reference samples with the Vkorc1 
genotypes (GG, GA, AA) as determined by DNA Sanger sequencing. 
For the samples of LH (non-resistant population) and NW (wild-derived 
laboratory resistant rats), the genotype data of 100 SNPs flanking Vkorc1 (from 172 
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Mb to 202 Mb on chromosome 1) were collected. Eighty of these SNPs were assayed 
on the Affymetrix Rat 10k SNP array platform.  We refer to these SNPs by their 
assay ID provided along with the Affymetrix array and preceded by a ‘S’ (Appendix 
3). Data on 19 SNPs that map within 2 Mb of Vkorc1 for LH and NW rats were 
obtained by PCR amplification and Sanger sequencing in our laboratory 
(unpublished).  These SNPs were named by their gene names and their physical 
position on Chromosome 1. 
2.2.4. Genotype-phenotype association test 
Although there is a broad consensus that Vkorc1 is a main resistance factor, 
surprisingly, this has not been tested formally yet at the level of populations using 
association studies accounting for various factors confounding association analyses. 
Amongst these are population structure and sample stratification, and the effect of 
genetic hitching on false positive association of linked neutral sites.  We computed 
genetic association of the Y139C mutation in Vkorc1 with the warfarin resistance 
phenotype as determined by BCR test for rats from 14 natural populations (Cochran-
Mantel-Haenszel tests controlling for sex; Table 2.3).  Tests were done as 
implemented in PLINK v1.07 (Purcell et al. 2007).  
For the NW population association tests using PLINK v1.07 
(http://pngu.mgh.harvard.edu/purcell/plink/) were run for all 100 SNPs, including 
those SNPs that map within the ~30 Mb 5’ and 3’ flanking regions of Vkorc1 (Purcell 
et al. 2007). Association tests were run assuming a simple allelic model with 1 
degree-of-freedom. To control for the effect of sex the CMH (Cochran–Mantel–
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Haenszel) test was applied. Raw P-values and P-values adjusted using Holm’s (1979) 
step-down multiple correction method were calculated (Appendix 3). The Bonferroni 
correction method were similar to those obtained by using Holm’s correction (not 
shown). We plotted the –log10 of the P-values along the 30 Mb region on 
chromosome 1 that carries the Y139C mutation in Vkorc1 (Figure 2.2A). 
2.2.5. Imputation-based association test between genotype and phenotype 
In addition to traditional association tests we implemented an imputation-
based Bayesian regression association method implemented in the software package 
BimBam (Scheet and Stephens 2006; Servin and Stephens 2007; Guan and Stephens 
2008). Using the prior D2 from (Servin and Stephens 2007) we computed Bayes 
Factors (BF), which measure the strength of association, and at the same time 
obtained P-values by 1,000 random permutations. By definition, the BF for the null 
hypothesis of no association between SNP and trait value, H0, is set as 1.  Within this 
framework a log10 (BF) of 2 indicates that the marker-trait association is 100 times 
more likely under the prior model than under H0. For each SNP we computed three 
BFs each assuming an additive model (BF1), a dominance model (BF2), and an over-
dominance model (BF3). We conducted these calculations by adjusting the values of 
the parameters σa (additive effect) and σd (dominance effect). BF1 was calculated 
under additive model by averaging over σa = 0.1, 0.2, 0.4 and σd = σa /4 as previously 
was suggested (Servin and Stephens 2007; Stephens and Balding 2009). BF2 was 
calculated by averaging over σa = 0.1, 0.2, 0.4 and σd  = σa to increase the weight on 
the dominance model. In addition, considering the over-dominance model, we 
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computed BF3 using σa = 0.45, σd = 0.55. The log10 values obtained for the BFs and 
the corresponding P-values are shown in Figure 2.2A (c.f. Appendix 3). 
Furthermore, we calculated the posterior probabilities of association (PPA) to 
evaluate how many SNPs are truly associated with the phenotype (Stephens and 
Balding 2009). We used a prior distribution of up to 2 causal SNPs and gave weights 
to the ratios 2/1/0 to 1-SNP, 2-SNP and >2-SNP models to calculate the PPA by 
averaging over the 30 Mb region, but also BY ANALYZING each SNP 
SEPARATELY or BY AVERAGING OVER each 2-SNP pair. Models containing 
the same number of causal SNPs were assumed as equal priors that were weighted by 
€ 
n
l
 
 
 
 
 
 ; where n is the number of SNPs mapping and assayed in the region (here 100) 
and l denotes the number of causal SNPs. We plotted the marginal PPA for each SNP 
in the region using the statistical software package R to assess whether there is any 
significance evidence (PPA > 0.5) for causal SNPs other than Y139C Vkorc1 (Figure 
2.3). 
2.2.6. Linkage disequilibrium (LD) around Vkorc1  
For the non-resistant population LH and resistant NW rats, linkage 
disequilibrium (LD) in the 30 Mb region was calculated in PLINK (Purcell et al. 2007) 
using the measure of r-square for phased data, which represents the statistical 
correlation of allele frequencies at any two loci. A heat map of LD (r-square) matrix 
for the NW population (Figure 2.2A) and the LH population (Figure 2.2B) were 
plotted across the 30 Mb region using R.   
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2.2.7. Estimation of the selection coefficient at Vkorc1  
To quantify the selection coefficient on the Y139C mutation in Vkorc1 we 
jointly estimated s and the effective population size Ne for Vkorc1 based on time-
series sampling data of allele frequencies using an expanded hidden Markov model 
(HMM) (Bollback, York, and Nielsen 2008). This method assumed that the change of 
allele frequency was primarily driven by selection on a co-dominant locus; i.e. 
assuming s heterozygotes and 2s for homozygotes.  
For each population, we binned the samples into several time-points based on 
the sampling time and the rodenticides treatment. Data points with only one rat 
sample per time point were removed from the analysis. Populations were exposed to 
warfarin first and subsequently were exposed to a second-generation anticoagulant 
bromadiolone (and select populations were exposed to difenacoum and/or 
brodifacoum). However, here we only considered the first set of data points where 
populations were sampled prior to warfarin use for rodent control and then after the 
exposure to warfarin. The Y139C allele frequencies prior and after warfarin exposure 
are provided in Table 2.3. 
With the assumption of 3 months a generation (Adams and Boice 1983), the 
numerical HMM integration was performed for s ranging from -0.5 to 5, and Ne 
ranging from 100 to 100,000, with a grid size >= 500 as recommended. We used a 
grid size of 1,000. The maximum likelihood estimates converged towards Ne = 103. 
Thus, we performed the profile likelihood analysis for the parameter settings s = -1 to 
1 and Ne=1,000, to s for each population separately. Corresponding 95% confidence 
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intervals for s were estimated based on the chi-square distribution. Assuming 
Ne=10,000, we obtained similar estimates of s (not shown). For some populations we 
were unable to estimate s because no samples with the Vkorc1 mutation were 
available at the end of sampling period (Table 2.3). It is known that both the Y139C 
heterozygote and homozygote genotypes are warfarin resistant, i.e. the mutation is 
penetrance (Table 2.1) (Pelz et al. 2005; Kohn, Price, and Pelz 2008). Hence, the 
fitness values for the susceptible homozygote, the Y139Y/C heterozygote and the 
Y139C homozygote are set as 1, 1 + s and 1 + 2s, respectively, to reflect co-
dominance. Consequently, s of homozygous susceptible rats (S/S) was corrected by 1 
- 1 / (1 + 2s). The average s calculated across populations was then calculated (Table 
2.3) and used in our forward population genetic simulations (see below).  
2.2.8. Population genetic analysis 
2.2.8.1. Recombination rate 
We estimated the recombination rate using PHASE 2.1.1 (Stephens and Li 
2003; Crawford et al. 2004) for the Vkorc1 gene flanking region, i.e. based on 
polymorphism data collected for 100 SNPs mapping between chromosome locations 
172 Mb and 202 Mb on rat chromosome 1. The analysis was done for the sample 
taken from population LH (non-resistant) a sample taken from population NW. The 
parameter settings underlying this analysis of recombination were as follows: Number 
of iterations=100; thinning interval=1; burn-in=100. The default recombination model 
was adopted and analyzed assuming a prior of the population recombination rate rho 
= 4Nec = 2.4×10-5 (Jensen-Seaman et al. 2004)).  Using the default prior of 
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recombination rate as rho = 4×10-4 yielded similar results (not shown). As 
recommended, for each input file, we ran the algorithm implemented in the PHASE 
software 5 times to select results with the highest value for the goodness of fit 
estimation. Each final run was set to be 10 times longer than other iterations to obtain 
a better estimation of the recombination rate. We calculated the median of rho and the 
median of varying factor lamda (the rate between locus i-1 and locus i exceeds the 
background rate given in the first column of the recombination estimation file) for 
each SNP interval (distance between two SNPs). The recombination rate associated 
with each SNP interval was calculated as rho x lamda, and the average recombination 
rate was obtained for Ne = 1,000. We estimated r = 0.002 per megabase for the sample 
taken from the susceptible population LH, and in our simulations and analyses was 
taken as the background recombination rate and not confounded by the effect of 
selection on polymorphism (e.g. by reducing Ne).   
As described in detail below, we conducted forward time population genetic 
simulations for ideal populations and assuming sets of population variation 
parameters, such as allele frequencies prior to selection, assuming a constant 
recombination rate r = 0.006 per megabase per generation as estimated for Norway 
rats laboratory strain to show a general trend (Jensen-Seaman et al. 2004). For the 
forward simulations that were run using parameter setting, again, e.g. allele 
frequencies prior to warfarin selection, taken from the empirical data as taken from 
the susceptible population LH and the recombination rate r = 0.002 per megabase as 
estimated from these empirical allele frequency data to compare with the observation 
data.  
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2.2.8.2. Vkorc1 haplotype structure  
To infer which allele of each Vkorc1-linked SNP initially was associated with 
Y139C when the mutation was selected first we used the haplotype reconstruction 
software PHASE 2.1.1, which implements a Bayesian statistical approach and EM 
(Expectation Maximization) algorithm (Stephens, Smith, and Donnelly 2001; 
Stephens and Scheet 2005).  We inferred the haplotypes for pairs of SNPs; one linked 
SNP and the SNP underlying the Y139C mutation in Vkorc1. We allowed a 
recombination model with a suggested recombination rate 0.00001 as prior, and 
performed the permutation of case-control (resistant and non-resistant) test to increase 
the inferring power. As above, we ran PHASE 5 times with each final run 10 times 
longer to estimate the likely haplotypes. The probability of any linked SNP allele to 
be on the same haplotype as the SNP underlying Y139C was deduced from the 
inferred haplotype frequencies; i.e. the most commonly inferred haplotypes were 
taken as those representing the original haplotype the introduced Y139C mediated 
resistance in the population. 
2.2.8.3. Allele frequencies of Vkorc1 and linked sites 
For each rat the time point of sampling was recorded such that for our sample 
it is known whether any rat was sampled before warfarin rodenticide application to 
the population or thereafter. Thus, the allele frequency of the resistance mutation 
Y139C in Vkorc1 gene could be computed for these time points in each of the 19 
natural populations of rats that underwent experimental rodent control with warfarin. 
The allele frequencies prior and after warfarin treatments are shown in Table 2.3. The 
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allele frequency change over time is shown for 7 populations where high resistance 
levels (R% > 80%) were encountered (Figure 2.4); populations with low R% were not 
shown since they may not be in the comparable stage or level of evolutionary history 
in terms of warfain selection. The sample taken from the NW population consisted 
out of 20 resistant and 9 non-resistant rats (Appendix 1), which were derived from 
wild rats sampled from a highly resistant population with estimated resistance 
frequency of ~90% as estimated in the field. To recover the population statistics of 
the original (unsampled) population, we performed the permutation of NW samples 
according to three resistant levels: 85%, 90% and 95% respectively and calculated the 
average allele frequency and other population parameters for the NW population. For 
further analysis, we used the population statistics obtained through the permutations 
obtained from re-sampling form a population with a resistance frequency of 90%. 
Inferred haplotype frequencies were used to calculate the allele frequency of 
the SNP alleles that prior to warfarin selection were on the same haplotype as the 
resistance mutation. These inferences were done based on the data collected for the 
non-resistant population LH and the resistant population NW (recorded in Appendix 
3).  
2.2.8.4. Polymorphism measures 
 We calculated two polymorphism measures at each SNP in each population 
for both the empirical and simulated data (see below):  
 
 38 
 
Nucleotide diversity θπ was estimated using: 
 Equation 2.1 – Nucleotide diversity. 
where ni is the count of allele i at each SNP in the population, and  
(Hohenlohe et al. 2010). 
Observed heterozygosity Hobs was obtained by calculating the proportion of 
individuals with heterozygote genotypes at each SNP. Averages for both statistics 
were calculated across SNPs. 
2.2.9. Fitness model definitions at Vkorc1 and forward-time simulations 
Forward time simulations were done using Python scripts (provided upon 
request) designed to implement algorithms provided by the environment of SimuPOP 
(Peng and Kimmel 2005; Peng, Amos, and Kimmel 2007). Two types of simulations 
are distinguished throughout. First, simulations starting from simplified population 
samples where, e.g. we set starting allele frequencies. We refer to the as simulations 
based on assumed data. Second, we ran simulations starting from allele frequencies 
taken from the observed data prior to selection, which we chose from the susceptible 
population LH. We refer to these as simulations based on empirical data. We assumed 
1,000 diploid individuals in each simulated population but similar results were 
obtained with a population size of 10,000 (data not shown). For each forward-time 
simulation we ran 1,000 replicates, and the distributions of results were used to 
generate later statistical summaries including averages and confidence levels.  
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Furthermore, we assumed random mating and an estimated recombination 
rate: r = 6 × 10-3 per megabase per generation for simulations that starting with 
assumed allele frequencies to show the general trend. We assumed r = 2 × 10-3 per 
megabase per generation for the simulations that built on the empirical data for 
comparing with observed genetic variation in empirical data (Jensen-Seaman et al. 
2004).  
We simulated the beginning of selection with warfarin in 1950s (generation 0). 
We could consider 45 years from 1953 (the first time warfarin was used in Europe) to 
1998 (the end of our sampling date), which corresponds to ~31 years with the 
knowledge that warfarin resistant rats have been noticed first in Germany in 1967 
(population and agriculture 1986). These time periods ALL corresponded to at most 
200 generations when assuming 4 generations a year, and to at least 93 generations 
when assuming 3 generations a year (Adams and Boice 1983). In practice, 200 
generation was used for our simulations of hypothetical populations to show the 
general trend until 200 generations; 150 generations were used for simulation done 
based on empirical data as the middle point between 100 and 200 generations (Table 
2.2).  
Table 2.2 – Simulation settings. 
Simulation 
Type N 
Time 
frame SNPs Simulation Models 
Fitness model 
Dominance 
& New  
Overdominance 
& New  
Assumed 
data  
103 
 
200 
gens 
301 sites across 30 Mb 
region (0.1 Mb density) 
& equal initial allelefreq 
M
ut
at
io
n 
ag
e 
Dominance 
& Standing 
Overdominance 
& Standing 
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Neutral 
Fitness model 
Dominance 
& New  
Overdominance 
& New  
Empirical 
data 
103 
 
150 
gens 
100 SNPs across 30 Mb 
around Vkorc1 with 
initial allelefreq from LH 
(nonresistant) 
M
ut
at
io
n 
ag
e 
Dominance 
& Standing 
Overdominance 
& Standing 
 
N: population size. Fitness model (c.f. Table 2.1). 
2.2.9.1. Simulation based on assumed data 
We structured the data such that 301 neutral SNP sites were evenly distributed 
along a 30 Mb region on chromosome 1 (density = 0.1 Mb), with the 151th SNP 
localized I the center and under selection. We assigned the same initial allele 
frequency to the alleles at each SNPs to range from 0.1 to 0.9.  
2.2.9.2. Simulations based on empirical data 
Following the structure of our observed data we consider 100 SNPs located in 
a 30 Mb region flanking Vkorc1 on both sides. Their initial allele frequencies were set 
according to the values observed in the fully susceptible population LH population.  
2.2.9.3. Standing variation or new mutation 
We considered two scenarios that differ in terms of the origin of the Y139C 
mutation. First, we assume that the allele is a de novo mutation starting with 
frequency 1/2Ne in generation one. 
Second we consider a scenario where the Y139C mutation pre-dated the 
application of warfarin, and thus was present in the population at some frequency 
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higher than 1/2Ne at generation one. We attempted to simulate this scenario using a 
few additional pieces of information available for Norway rats and their colonization 
history of Europe. It is believed that R. norvegicus colonized Europe ~1716-1796 
(Pelz et al. 2005). We use the simplified time window spanning the years from 1750s-
1950s, which correspond to 600-800 generations in rats assuming 3-4 generations per 
year. We then simulated the situation that the Y139C mutation occurred about 250 
years ago de novo, i.e. we assume that the mutation was not present in the founding 
populations of rats that came from Asia, but instead, that the mutation is 
comparatively recent but pre-dates the introduction of warfarin. We assumed this 
scenario such that a reasonably wide range of standing allele frequencies can be 
generated. Evolution then was simulated to occur from generations -700 to generation 
zero under the neutral model and then under selection since the use of warfarin in 
1950s (generation zero). Selection was model considering the various models and 
parameter settings for directional selection and balancing selection. 
Specifically, the fitness model under selection is described as the first row in 
Table 2.1. There, S represents the wild type allele of the SNP under selection, and R 
represents the mutation. The selection coefficient s is set to act to select against non-
resistant rats, and t is the fitness cost that the Y139C mutation incurs on the 
homozygous mutant genotype. Here we only considered the dominance and over-
dominance models since rats with both genotypes S/R and R/R are resistant to 
warfarin (Penetrance model in Table 2.1) (Pelz et al. 2005; Kohn, Price, and Pelz 
2008). Finally, drift only was simulated and compared to the observed results in both 
the populations LH (all susceptible) and NW (~90% resistance frequency).  
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The selection coefficient s = 0.3 has been estimated as described above based 
on the time-series sampling of rats. In the directional selection model, both the S/R 
and R/R genotypes have a fitness value of 1 assigned to them. Under a balancing 
selection model we estimated the fitness cost t of the R/R genotype by solving the 
equation PR = s / (s + t) (c.f. page 217 in (Hartl and Clark 2007) for t; where PR is the 
equilibrium allele frequency of the mutated allele. With a PR ~ 0.75 estimated from 
the empirical data at Vkorc1 accross our natural populations (Figure 2.4) and s = 0.3 
(Table 2.3), we obtain t = 0.1 as the fitness cost for the mutant homozygotes (R/R). 
Finally, the combination of the above two scenarios describing the evolution 
of resistance by a new mutation or from standing variation, and the 2 fitness models 
describing directional selection on a dominant mutation or balancing selection on a 
overdominant mutation, yielded a 2 x 2 table (Table 2.2).  
2.2.9.4. Statistics from simulations 
We obtained several population genetic statistics from the simulations and 
compared them with the empirical data: 
For each generation and for each SNP we tabulated the allele frequencies of 
the allele (by inference or as per simulation settings, see above) that initially was 
linked to the mutation in Vkorc1 on the same haplotype, and we tabulated R2 and D’ 
measuring LD between the selected SNP and linked neutral SNPs. 
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At the final generation we tabulated genotype frequencies, observed 
heterozygosities, and the frequencies of the haplotypes where the mutation in Vkorc1 
and the linked allele at SNPs remained on the same haplotype. 
The genotype-phenotype association test was conducted after sampling 35 
cases and 15 controls from a simulated 1,000 individuals. The penetrance model for 
the resistance mutation in Vkorc1 was estimated by calculating the proportion of 
individuals carrying the genotype SS, SR and RR that are resistant to warfarin in the 
population. The averaged penetrance values across population NW and all other 
populations are given in Table 2.1. 
2.2.9.5. Simulations considering a range of selection coefficients 
We performed simulations where directional selection acts on a de novo 
mutation. The selection coefficients we examined are 0.01, 0.05, 0.1, 0.2, 0.3 and 0.5, 
and the populations evolved for 2000, 1000, 400, 300, 200 generations, respectively, 
when they reached fixation of the beneficial allele. After fixation of the beneficial 
alleles we tabulated and plotted the allele frequencies along the chromosome to 
evaluate the expected size of the region affected by the selective sweeps under 
various scenarios and settings. 
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2.3. Results 
2.3.1. Description of resistant and non-resistant populations 
This chapter focused on one non-resistant (LH) and one resistant (NW) 
population. The population NW assayed on the SNP array is derived from wild rats 
(Rattus norvegicus) were trapped from a highly resistant area in the northwestern 
Germany and then kept in the lab for about 12-17 months allowing breeding (Kohn, 
Pelz, and Wayne 2000; Kohn, Pelz, and Wayne 2003; Kohn, Price, and Pelz 2008). 
From this population, termed NW population, 20 resistant and 9 non-resistant rats 
were assayed for SNP variation on the Affymetrix SNP arrays. To infer the original 
population features (i.e. assuming most of the population was not sampled) we 
permuted the NW population by shuffling samples according to a 90% resistance 
level (the estimated resistance frequency of the total population as per personal 
communication with Hans-Joachim Pelz, at the Federal Research Institute for 
Cultivated Plants, Julius Kuehn Institute (JKI), in Muenster, Germany). When we 
considered other resistance levels (85%-95%) results were similar (not shown). From 
population LH (located about 300km away from the resistant area) we assayed 12 
non-resistant rats.  
In addition, we also studied 668 rats from 17 natural populations from the 
resistant area (Appendix 1). 14 populations were exposed to warfarin as well as other 
anticoagulant rodenticides. Warfarin has been used as a rodenticide in the field since 
1950s (Hans-Joachim, Detlef, and Gerhard 1995; Kohn, Pelz, and Wayne 2000). 
Samples of rats trapped in the field between 1996-1999 were sampled at different 
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time points, including time points that pre-dated the application of warfarin in these 
populations and at time points that post-dated the application of warfarin (Pelz, 
Hänisch2, and Lauenstein 1995; Kohn, Pelz, and Wayne 2000; Kohn, Pelz, and 
Wayne 2003). Notable, this is not to imply that these populations were exposed to 
warfarin for the first time, but were exposed to warfarin by our field studies for the 
first time. The sample sizes obtained from these populations ranged from N=19 to 73.  
2.3.2. The rat ortholog of human biomarker Vkorc1 is associated with 
warfarin resistance 
Vkorc1 gene causes warfarin resistance in rodents (Pelz et al. 2005; Rost et al. 
2009), and in humans VKORC1 is known to be the primary target of warfarin. 
Polymorphisms in VKORC1 can be used to make drug dosage predictions (Rost et al. 
2004; McDonald et al. 2009; Pautas et al. 2009; Takeuchi et al. 2009). The rat gene 
Vkorc1l1 (Vkorc1-like protein 1) is paralogous to Vkorc1 (Rost et al. 2004). To learn 
the evolutionary relationships of these genes and to ascertain that we study the only 
functional Vkorc1 in the rat genome we constructed a phylogenetic tree based on 
nucleotide gene sequence and amino acid sequence in 6 species, namely human 
(Homo sapiens), rat (Rattus norvegicus), mouse (Mus musculus), dog (Canis lupus 
familiaris), cattle (Bos taurus), and fugu (Takifugu rubripes) as outgroup (Figure 2.1).  
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Figure 2.1 – Phylogenic relationships among Vkorc1 and Vkorc1l1. A. DNA sequence 
phylogeny. B. Amino acid phylogeny. Bootstrap values are shown besides nodes. 
Scale bars indicate nucleotide and amino acid substitutions per site. Phylogenetic 
trees were estimated using Bayesian inference (BI) with two simultaneous Markov 
Chain Monte Carlo (MCMC) chains run for 1,000,000 generations and sampling of 
trees with a frequency of 1 every 100 generations with burn-in = 2,500. Hsa: human 
(Homo sapiens); Rno: rat (Rattus norvegicus); Mmu: mouse (Mus musculus), Cfa: 
dog (Canis lupus familiaris); Bta: cattle (Bos taurus); Tru: fugu (Takifugu rubripes). 
The human VKORC1 (4101 bp, 163 aa), grouped with two pseudogenes: 
VKORC1P1 (chromosome X) and VKORC1P2 (chromosome 1). It is the ortholog of 
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the rodent Vkorc1 (2521 bp, 161 aa). It might be interesting to explore the potential 
function of pseudogenes in expression regulation (Long and Zhang 2012). Human 
Vkorc1l1 is 81,543 bp, much longer than Vkorc1 in terms of nucleotide sequence; but 
with 176 aa the pseudogene has an amino-acid sequence similar in length to Vkorc1. 
Rat Vkorc1l1 also produce a 176 aa sequence but its nucleotide sequence length spans 
46,299 bp. The complete history of gene duplication events remains ambiguous as the 
phylogeny based on the nucleotide sequences and based on amino-acid sequences 
differ (Figure 2.1). Nevertheless, the main intention here was to validate orthology 
between the well-studied human gene and the rat gene.  
Numerous lines of investigations have identified Vkorc1 as a major genetic 
factor underlying warfarin resistance in rodents as well as in humans. However, 
curiously, none of the studies have rigoriosly tested for association in wild rodent 
populations while controlling for demographics and genetic hitchhiking. In particular, 
previous studies tested for association in highly resistant rat populations where the 
extended haplotype due to hitchhiking leads to association between markers and 
resistance over vast genomic distances (Kohn, Pelz, and Wayne 2000).  
Here we tested for association between the resistance phenotype as 
determined by the BCR tests and the Y139C mutation, as well as 100 SNPs that map 
onto rat chromosome 1. For the population NW we find that Vkorc1 is strongly 
associated with warfarin resistance (P-value = 1 × 10-6) (Table 2.3). We also collected 
the genotype data of the Y139C mutation in Vkorc1 gene and tested their genotype-
phenotype associations in other 14 wild populations that range in resistance 
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frequencies from high to low. As shown in Table 2.3, Vkorc1 is significantly (P-value 
< 0.05) associated with warfarin resistance in most (11 of 14) populations. Thus, here 
we reconfirmed that Y139C in Vkorc1 gene is a major resistance factor underlying 
resistance.  
2.3.3. Characterization of the selective sweep at Vkorc1 
As suggested by a previous study (Kohn, Pelz, and Wayne 2000), we 
performed the association tests cross 30 Mb around Vkorc1 (from 172 – 202 Mb on 
Chromosome 1). We observed association due to genetic hitchhiking of numerous 
linked SNPs with resistance and the Y139C mutation in population NW (Figure 
2.2A). In fact, 40% SNPs within the region are significantly associated with the 
warfarin resistant/susceptible phenotypes. We computed three Bayes Factors (BF1-3) 
to measure the association strength of each SNP based on an imputation-based 
Bayesian approach (Servin and Stephens 2007) assuming either additive (BF1), 
dominance (BF2) and over-dominance (BF3). Vkorc1 gene has the highest BF under 
the over-dominance model (log10BF3 = 8.235) (Figure 2.2A). Other than Vkorc1, no 
other SNP in the region has a log10BFs > 3, which suggests overdominance model has 
relatively strong power for detecting association of Vkorc1 variant. 43% of the SNPs 
in the region have P-values < 0.05 for BF3, contrasting with 18% SNPs with P-values 
< 0.05 for BF3 on the whole Chromosome 1. 
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Figure 2.2 – Marker-trait association and linkage disequilibrium (LD) along rat 
chromosome 1. (A) Results are shown for the highly resistant (~90% warfarin 
resistance frequency) population NW. (B) The LD block of the same region for the 
non-resistant LH population. 
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Figure 2.3 – The posterior probability of Bayesian association analysis along rat 
chromosome 1 using SNP data collected for population NW.  
We evaluated a model statistically that posits that in the region for which we 
collected SNP data there is only on causal SNP underlying the resistance trait. To 
accomplish this we computed the posterior probability of association (PPA) for each 
SNP with the resistance trait and summarized the marginal PPA for models that 
describe association between the trait and one SNP only (1-SNP) and two SNPs (2-
SNP). Our assumption was that it is unlikely that numerous, i.e. more than 2 SNPs, 
are located in this region under study. As shown in Figure 2.3, the SNP 
underlyignY139C located in Vkorc1 has the highest marginal PPA of 0.98 and thus, is 
supported as the only causal SNP associated with the phenotype in the 30 Mb region 
studied. 
Another classical feature of selective sweeps is that these cause an excess of 
linkage disequilibrium (LD) spanning a longer than expected chromosomal region, or 
LD blocks (Kim and Nielsen 2004). Here for the population NW population we 
observed that a LD block with high r-square values (>= 0.4) is supported for rat 
chromosome 1 positions 185-189 Mb, including the region where Vkorc1 maps 
(Figure 2.2A). In contrast, in the fully susceptible population LH we found no support 
for a big LD block (Figure 2.2B).  
For example, a SNP located in the gene Ppapdc1a (Ppapdc1a_188589203) is 
in significant LD with Vkorc1 (squared r = 0.5) even though the sites are separated by 
a distance of ~ 1.4 Mb; Ld over such a distance is not expected under neutrality in the 
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absence of selection as we determined by forward-time simulations. Notably, whether 
we computed LD for our sample of rats available from the population NW, or for the 
sample of rats simulated by permutation of samples from population NW, significant 
LD blocks were found to flank Vkorc1. 
2.3.4. Estimation of the selection coefficient on Vkorc1 
We took advantage of the fact that we had samples available from different 
time points spanning 3 years in 14 natural populations. Notably, we had samples 
available from populations where rats were trapped prior to warfarin rodenticide 
treatment were collected and thereafter. Thus, across these time-series samples we 
were able to jointly estimate the selection coefficient s on Vkorc1 as well as the 
effective population size Ne. Based on maximum likelihood analysis Ne was estimated 
as ~1,000. Notable, for the remaining analyses described the effect of Ne on s was 
small, at least as long as Ne was between 1,000 and 10,000 (Table 2.3).  
When we considered all rat populations sampled the averaged selection 
coefficient against rodenticide susceptible rats was estimated as 0.347. However, this 
would include treatments with second-generation anticoagulants such as 
bromadiolone and difenacoum thought to be more toxic than warfarin. If we restrict 
our analyses to warfarin treatment only, i.e. only consider samples collected prior and 
after warfarin treatment (which in the field studies preceded treatments with 
bromadiolone and difenacoum), we estimated an average selection coefficient of 
~0.295. Thus for the subsequent simulations and analyses we used s = 0.3 in our 
fitness models.  
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The frequencies of the mutant allele in Vkorc1 decreased from 0.75-0.82 to 
0.71-0.75 in three populations (populations 10, 12, 17) during the sampling period. 
Thus, the estimated selection coefficients in these populations appeared to be negative 
(Table 2.3). However, under a balancing selection model on an overdominant 
mutation this pattern is expected, as we discuss below.  
Table 2.3 – Estimation of selection coefficient s on the Y139C mutation in Vkorc1.  
PopID N R% Assoc (P-value) 
s 
(Ne=103) 
s 
(Ne=104) 
Initial 
frequency 
End 
frequency Poisons 
4f(LH) 13 0% - - - 0 0 No 
11(KB) 70 83% 2e-4 0.310 0.273 0.68 0.73 W 
21(SP) 23 33% 0.273 - - 0.08 0 W 
23(TH) 56 10% 0.001 0.254 0.273 0.07 0.17 W 
5 20 74% 0.004 0.254 0.255 0.39 0.44 W 
13 42 64% 2e-5 0.254 0.273 0.13 0.5 W 
14 19 44% 0.001 0.401 0.428 0.18 0.5 W 
12 25 95% 0.012 -0.033 -0.033 0.77 0.75 W+D 
10 42 95% 0.170 -0.266 -0.263 0.82 0.73 W+D 
4 52 94% 0.008 0.254 0.267 0.55 0.73 W+D 
24(WU) 73 93% 9e-5 0.187 0.150 0.68 0.75 W+D 
19 56 65% 3e-8 0.310 0.341 0.36 0.58 W+D 
17 53 86% 1e-6 -0.033 -0.033 0.75 0.71 W+B 
20 27 62% 3e-4 0.794 0.798 0.35 0.75 W+B 
6 24 96% 0.103 0.545 0.481 0.85 1 W+B+D 
28 37 86% 0.028 0.254 0.273 0.52 0.67 W+B+D 
Average 40 69% - 0.347 0.346 0.46 0.55 - 
 
PopID: population ID and name abbreviation for 5 populations as in (Kohn, Pelz, and Wayne 
2000). 
N: the sample size in each population named by the farm number.  
R%: the proportion of resistant rats in each population (the warfarin resistant level) 
Assoc(P-value): the significance P-values of the genotype-phenotype association (CMH) 
tests.  
s: corrected selection coefficient estimated assuming Ne = 103 and 104. ‘-’ indicates s could 
not be estimated. 
The allele frequencies of the Y139C mutation in Vkorc1 at the beginning and the end of 
sampling period are provided. 
Poisons: rat populations were exposed to different rodenticides, including warfarin (W), 
brodifacoum (B), coumatetralyl (C) and difenacoum (D) (c.f. Chapter 6). 
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LH population was not included for calculating average values of populations from the 
resistant area. 
2.3.5. Allele frequencies of Vkorc1 and linked sites 
The frequency of the beneficial Y139C allele is expected to increase rapidly 
after warfarin selection.  This is what we observed for the Y139C mutation in natural 
populations (Table 2.3). However, fixation of this adaptive mutation was not 
observed despite of the strong selection pressure; only in pop6 did the allele 
frequency of the Vkorc1 resistance mutation increase from 0.85 to fixation after 
exposure to warfarin and the other two more potent second-generation anticoagulants 
difenacoum and brodifacoum (Table 2.3). 
In contrast, and in general, we observed that allele frequencies at the end of 
the sampling periods (after warfarin treatment) approached 0.70-0.75 in 7 populations 
where resistance was prevalent (R% > 80%), and ~ 0.5 in 4 populations with 
intermediate resistance levels (population 5, 13, 14 and 19), and < 0.2 in 2 
populations (TH and SP) with low resistance levels (R% < 33%) (Table 2.3). Thus, 
casual inspection of these results of allele frequency measurements suggests that the 
resistance trait cannot reach fixation. Similarily, the frequency of the beneficial allele 
decreases from 0.77 to 0.75 in Pop12, from 0.82 to 0.73 in Pop10 and from 0.75 to 
0.71 in Pop17 (Figure 2.4). This pattern further suggests that the resistance allele 
approach an equilibrium frequency of ~ 0.75 in wild rats, which reminds us of the 
allele frequency change dynamics under balancing selection (Hartl and Clark 2007). 
Finally, the average mutant allele frequency in the highly resistant population NW 
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samples was estimated as 0.64, again, suggesting that the majority of resistance 
alleles are found in the heterozygote state. 
 
Figure 2.4 – Temporal allele frequency change of the Vkorc1 Y139C variant in 7 
natural populations of rats with resistance levels R% > 80%. 
Our inferences of the haplotype frequencies at the onset of selection and their 
subsequent inferred change in frequency were consistent with the adaptive value of 
the Y139C bearing haplotype. Specifically, the allele frequencies of the neutral sites, 
which were initially linked to the beneficial mutation, increased. This was evident by 
comparing inferred haplotypes and neutral linked SNP allele frequencies collected 
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from the non-resistant population LH and the highly resistant population NW 
(Appendix 3). 
2.3.6. Estimated recombination rates 
We estimated the recombination rates in the regions flanking Vkorc1 in the 
fully warfarin susceptible population LH and in the highly resistant population NW. 
Compared to a previous estimate of r = 0.006/Mb (Jensen-Seaman et al. 2004), the 
recombination rate estimated from LH population was found to be lower, ~0.002/mb. 
The former is used for the simulation of hypothetical population to show a general 
trend of genetic variation pattern, and the latter from LH is plugged in the empirical 
simulation for the comparison with the observation from empirical data (c.f. forward-
time simulation section). The recombination rate based on NW samples is even lower, 
about 0.0006/Mb, which is expected after selection and might also be due to the 
potential haplotype structure in this population. 
2.3.7. Forward time simulations 
To assess whether the abundance change of the beneficial allele and the linked 
neutral alleles are due to genetic drift or are driven by selection, we performed 
forward-time simulation under neutral model and selection models. As shown in 
Table 2.1, without selection, the fitness values of genotype S/S, S/R and R/R are 
equally 1. Here, S represents the wild type nonresistant allele, and R represents the 
Y139C mutation in Vkorc1 gene. If under warfarin selection, the non-resistant 
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genotype S/S has lower fitness (1 – s) and the selection coefficient s, as previously 
estimated, is ~ 0.3. 
Moreover, we conducted simulations under two selection models to evaluate 
whether the beneficial mutation is not yet fixed under directional selection because it 
should not be fixed in this time scale since warfarin selection was introduced in the 
1950s, or whether the lack of fixation is better explained by a balancing selection 
mode (Table 2.1). Under directional selection, we considered the dominance model 
with respect to warfarin resistance, in which both S/R and R/R genotype have 
fitnesses of 1 and the non-resistant genotype S/S has a fitness of 1 - s (~0.7). Under 
balancing selection on an over-dominant mutation the heterozygote genotype S/R has 
the highest fitness 1, S/S has the fitness of 1 - s ~ 0.7, and the homozygote mutant 
genotype R/R has lower fitness than S/R due to the fitness costs (Greaves et al. 1977; 
Smith, Townsend, and Smith 1991; Kohn, Price, and Pelz 2008), represented by 1 - t. 
Here we estimated t by the equation PR = s / (s + t). With the equilibrium allele 
frequency of the beneficial mutation PR ~ 0.75 (Figure 2.4) and s = 0.3, t is estimated 
here as 0.1. 
Here we further consider the question whether warfarin resistance has evolved 
by selection on a de novo mutation to Y139C in our study area or has evolved by 
selection on a standing variant that pre-dated the introduction of warfarin selection. , 
We simulated two scenarios to distinguish the two models.  
To model the case of selection on standing variation we considered a scenario 
where the mutation leading to Y139C occurred on one allele ~700 generations ago; 
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i.e. before selection with warfarin selection but roughly corresponding to the time 
when R.norvegicus colonized Europe ~1716-1786 (Pelz et al. 2005). After evolving 
neutrally from generation -700 to generation zero selection with warfarin was added 
to the model. Generation zero thus was assumed to coincide with the 1950s when 
warfarin was introduced, which corresponds to about 100-200 generations (Adams 
and Boice 1983). We performed the simulations based on assumed allele frequency 
data across the 30 Mb region with spatially equally distributed SNPs each with the 
same initial minor and major allele frequencies. This simulation was done to explore 
differences between selective sweeps under the competing models.  
To more quantitatively approximate expected values for allele frequencies and 
the chromosomal extent over which the selective sweep region can be seen we 
performed simulations that are based on the observed allele frequencies and actual 
chromosomal map locations of 100 SNPs linked to Vkorc1, again, with the initial 
allele frequencies obtained from the non-resistant population LH 150 generations ago 
(the generation when warfarin selection was introduced first). In sum, in both 
simulations we considered the alternative models of selection on new mutations 
versus standing variants, as well as the competing models describing directional 
selection versus balancing selection. 
2.3.7.1. Balancing selection on an overdominant mutation Y139C 
Patterns of allele frequency changes of the adaptive Y139C allele were 
examined by plotting the allele frequency change over time for the beneficial allele 
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under dominance and over-dominance models assuming the mutation arose as a new 
mutation or from selection on a standing variant (Figure 2.5).  
 
Figure 2.5 – Simulated allele frequency change of the Y139C mutation in Vkorc1 
under four selection models. (A) Dominance and new mutation model; (B) Over-
dominance and new mutation model; (C) Dominance and standing variation model; 
(D) Over-dominance and standing variation model. 
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Patterns of allele frequency changes of the adaptive Y139C allele were 
examined by plotting the allele frequency change over time for the beneficial allele 
under dominance and over-dominance models assuming the mutation arose as a new 
mutation or from selection on a standing variant (Figure 2.5). Assuming selection on 
a new mutation under directional selection we observed that the Y139C allele 
frequency has already reached 0.9 under strong selection (e.g. selection coefficient = 
0.3) as early as 100 generations (~ 25 to 33 years) after the introduction of warfarin 
selection (Figure 2.5A).  
Under balancing selection, the frequency stays at the equilibrium frequency of 
~0.75 after 100 generations (Figure 2.5B). Empirically observed Y139C allele 
frequencies were  ~0.64 in the NW population and ~0.7-0.75 in most natural 
populations at then end of our sampling period (~150 – 200 generations after 
introduction of warfarin selection) (Figure 2.4). Thus, simulations of balancing 
selection more closely approximate the observed data. Notably, whetehr we simulated 
balancing selection on a new mutation or on a standing variant we would draw the 
same conclusion (Figure 2.5C and D). In addition, we demonstrated that the observed 
Y139C allele frequency could hardly be obtained under a neutral model (Figure 2.6).  
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Figure 2.6 – Simulated allele frequency change under a neutral model (A – Y139C 
mutation and B – flanking region). 
In the above analyses we considered the allele frequency change at Y139C. In 
the following we examine the allele frequency changes at SNPs that map in the 
flanking region of Vkorc1. In Figure 2.7 we plot the allele frequency change pattern 
across a 30 Mb region over 200 generations under warfarin selection. For the purpose 
of learning the different patterns among 4 models (see above), we performed the 
simulations with initial allele frequencies set to be 0.5 at each SNP. Simulations of 
directional selection on a new mutation revealed that the alleles linked to the 
beneficial allele have been driven to near fixation after 200 generations. In contrast, 
simulations of balancing selection on a new mutation resulted in an approach towards 
equilibrium frequencies for linked alleles. Directional selection can be distinguished 
from balancing selection as the former left a stronger signal than the latter. 
Specifically, under directional selection linked neutral alleles more rapidly increased 
in frequencies and the selective sweep region is longer (Figure 2.7A and B).  
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To examine results of simulations of selection on standing variants we plotted 
the allele frequency changes since the adaptive allele arose at -700 generations, and 
since it has been selected starting at generation 0. The comparison of results of 
simulations of directional selection with results obtained from simulations of 
balancing selection on a standing variant revealed also that under the former model 
allele frequencies more rapidly rise to high frequencies and the size of the selective 
sweep window is bigger (Figure 2.7C and D). 
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Figure 2.7 – Hypothetical simulation of allele frequency change of a sweep region 
across 30 Mb. A-D as in Figure 2.5 legend. 
With the initial allele frequencies set as in the control population LH, the 
empirical simulation told a similar story as did the hypothetical simulations, where 
we started the simulations based on assumed allele frequencies as opposed to 
empirically observed allele frequencies in the susceptible population LH (Figure 2.8).  
Specifically, we observed that both at the selected Y139C sites directional 
selection had a stronger impact on the linked neutral alleles also. We separately 
plotted the simulated allele frequencies for the final generation across the 30 Mb 
segment on chromosome 1 against the observed allele frequencies from population 
NW. The observations (gray wall) are most similar to the simulation results under the 
balancing selection model (Figure 2.8E). Besides, we showed that the observed 
pattern cannot be obtained under the neutral model, in which the allele frequencies of 
the whole region would merely be under drift (Figure 2.6B). 
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Figure 2.8 – Empirical simulation of allele frequency change. A-D as in Figure 2.5 
legend. (E) The allele frequencies of the last generation across 30 Mb along the 
chromosome 1 under four models compared to observed data. The middle black 
vertical line indicates the position of Vkorc1. 
2.3.7.2. Linked allele frequency dynamics support the Y139C mutation as 
a new mutation 
It has been predicted that a selective sweep associated with selection on a 
standing variant is less pronounced in terms of reduction of heterozygosity and 
chromosomal distance over which this occurs than would be a selective sweep on a 
new mutation (Barrett and Schluter 2008).  Our simulation results supported this 
theoretical prediction when we simulated these models under settings tailored to 
describe the evolution of warfarin resistance in rats in our study area (Figure 2.7 and 
Figure 2.8). When we simulated selection on a new mutation, we observed that most 
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SNPs in the 30 Mb region display strong hitchhiking dynamics.  However, if we 
model selection on a standing variant that has already existed in the population for a 
long time before selection with warfarin (usually even greater than the -700 
generations we simulated here), only a small region will display genetic hitchhiking 
dynamics. As expected, the precise outcomes depend on recombination rates assumed. 
Results of simulations confirm the expectation that selection on standing variants will 
affect more than one haplotype, and thus, even during the hitchhiking process 
recombination can occur, thereby resulting in more subtle drops of polymorphism and 
a smaller window affected by genetic hitchhiking.  
An important finding during our simulations was that the initial frequency at 
SNPs linked to a pre-existing Vkorc1 Y139C allele prior to selection matters. As an 
extreme case we a time prior to the use of warfarin and we consider an infinite 
population undergoing random mating. At this time the soon-to-be advantageous 
allele (Y139C) and flanking neutral alleles are in linkage equilibrium. Once the pre-
existing beneficial allele will be selected the sweep signals in the flanking region 
would be strongly dependent on the minor and major allele frequencies at the linked 
neutral alleles, as these would be dragged along with probabilities that reflect initial 
frequencies, and these will not change after selection is introduced into the system 
(Figure 2.9C and D). 
 67 
 
 
Figure 2.9 – Hypothetical simulation (under extreme scenarios without linkage 
disequilibrium before selection) of a sweep region across 30 Mb. A-D as in Figure 2.5 
legend. 
Thus, we expect that the longer the history of the Y139C adaptive allele has 
been prior to the introduction of warfarin selection the expected sweep effect on the 
flanking region once warfarin was introduced will be inversely related to the ‘age’ of 
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the Y139C mutation. To model this effect here we considered an age of Y139C as -
700 generations and as -100 generations (selection starts at generation 0). We 
observed that this small difference in age is already discernible; the selection on the 
Y139C mutation of age -100 generations resulted in a stronger sweep signal than 
selection on the older standing variant of age -700 generations (Figure 2.10). 
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Figure 2.10 – Hypothetical simulation (considering -100 and -700 generations of the 
resistance mutation age before selection) of a sweep region across 30 Mb. 
In Figure 2.8E, we plotted the observed SNP allele frequencies in the resistant 
population NW along the 30 Mb region as well as the SNP allele frequencies 
simulated under four selection models. The observations are most similar to the 
simulation results obtained under a model describing a new over-dominant mutation 
under balancing selection. Assuming a low recombination rate r = 0.002 during the 
simulations based on the observed allele frequencies in population LH genetic 
hitchhiking is only seen for SNPs that map within 3-4 Mb of the selected Y139C, 
both when we modeled balancing selection on a new variant and selection on a 
standing variant. But even for these SNPs nearby Y139C the relative increase in allele 
frequency was not enough to compare to the observed frequencies when we simulated 
selection on a standing Y139C variant. For example, the allele frequency of the 
linked SNP Ppapdc1a_188589203, which maps 1.4 Mb away from Vkorc1, increased 
from 0.09 in population LH to 0.71 in population NW that experienced warfarin 
selection (Appendix 3). This observation is much higher than the simulated frequency 
of ~0.55 from standing variation, but is in close agreement when simulating selection 
on a new variant, which reached ~0.70. Similarly, the window size affected by 
hitchhiking differed between when simulating selection on new and standing variants 
increase and the former results more closely resembled those observed (almost 30 Mb 
vs. ~ 2-4 Mb)  (Figure 2.7 and Figure 2.8).  
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2.3.7.3. Reduced linked polymorphism supports Y139C as a new 
overdominant mutation under balancing selection 
Selective sweeps are charccterized by local reductions of genetic 
polymorphism (Barrett and Schluter 2008). Both the size and shape of the sweep 
region contain information about the mode of selection and the age of the mutation. 
Here we compare simulated results and observed results for the polymorphism 
measures nucleotide diversity θπ (equivalent to the expected heterozygosity) and 
observed heterozygosity Hobs. 
As predicted by Figure 3 in (Barrett and Schluter 2008), under directional 
selection, the valley of reduced nucleotide diversity resulting from directional 
selection on standing variation is narrower than the valley resulting from selection on 
a new mutation (Figure 2.11A and B). We expanded these predictions by considering 
a balancing selection model also. We observed that the region of reduced 
polymorphism shaped by balancing selection on a standing variant is much shallower 
and narrower than those resulting from directional selection. The model describing 
directional selection on standing variation (blue line) has a narrower valley than the 
simulations of balancing selection on a new mutation (green line) when the entire 30 
Mb-spanning region was considered (Figure 2.11A and B).  
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Figure 2.11  – Valley of reduced polymorphism. Nucleotide diversity of Vkorc1 
sweep region under (A) hypothetical simulation and empirical simulation: (B) 30 Mb 
sweep region and (C) the middle 4 Mb region. Observed heterozygosity: (D) 
hypothetical simulation and empirical simulation: (E) 30 Mb sweep region and (F) the 
middle 4 Mb region. 
A more detailed analysis of 4 Mb region that directly flanks Vkorc1 on both 
the 5’ and 3’ ends revealed even more pronounced such differences. Specifically, 
while the simulations of directional selection on a standing Y139C variant resulted in 
a valley of reduced linked polymorphisms, the simulations of balancing selection on a 
new Y139C mutation under balancing selection resulted in a valley of reduced 
polymorphisms also, but with a small peak of high polymorphisms at its center and 
where Y139C maps (Figure 2.11C; Table 2.1). Thus, the observed levels of 
nucleotide diversity (black line) are consistent with the simulated results describing 
balancing selection on a new mutation (Figure 2.11B and C). 
The other measure of polymorphism Hobs supported the above conclusions 
(Figure 2.11D-F).  
2.3.7.4. Patterns of linkage disequilibrium support Y139C as a new 
mutation 
As described in Figure 2.2A and Figure 2.2B, an excess of linkage 
disequilibrium was observed surrounding Vkorc1 in NW population, which suggested 
a recent footprint left by selection. As an example, we plotted the change of LD 
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between Vkorc1 and the SNP Ppapdc1a_188589203 over generations under different 
models (Figure 2.12). Usually, the LD measure of D is the statistical covariance of 
haplotype genotypes, and r-square represents the square of statistical correlation 
coefficient (LaFramboise 2009). The best agreement with the observed r-square value 
0.5 is the new mutation under over-dominance model, which supported our 
conclusion. 
 
Figure 2.12  – simulated LD (between the Vkorc1 and a neutral SNP) change over 
time (empirical simulation). A-D as in Figure 2.5 legend. 
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And assuming this model, we could roughly estimate the mutation occurrence 
time. Given the observed r-square value 0.5, the mutation would be occurred about 
100 generations ago (Figure 2.12). From the end of our sampling year 1998, this 
estimation corresponded to 1965 – 1973, which is consistent with the early reported 
resistance rats in Germany at 1967 (population and agriculture 1986). 
2.3.7.5. The effects of initial allele frequencies on sweep pattern? 
Neutral SNPs with different initial allele frequencies will respond differently 
to the “dragging strength” of selection. This is a somewhat surprising finding in this 
work and hasn’t been paid enough attention before. Sweep seems to have larger 
effects on neutral alleles with low frequency than high frequency. Although in 
general, the beneficial mutation has higher chance to occur on the chromosome that 
the neutral alleles have high frequencies. And this is what we observed after inferring 
the neutral alleles linked to the adaptive mutation in Vkorc1. Examining the initial 
allele frequencies at the SNPs that are linked to the beneficial allele we observed that 
only 17% of these have allele frequencies < 0.5 in population LH. In contrast, in NW 
population most SNPs that are linked to the adaptive mutation have high frequencies; 
with 64% of these displaying major allele frequencies of  >= 0.7. 
Here, we observed that neutral SNPs with an initially low frequency tend to 
increase rapidly by genetic hitchhiking. For example, the SNP Ppapdc1a_188589203 
has the initial frequency of 0.09 in the susceptible population LH, but increased to 
0.71 in the highly resistant population NW. In contrast, its neighboring SNP 
Ppapdc1a_188589271 with an initial frequency of 0.23 only increased to 0.52 after 
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selection. Such differences in the initial frequencies also affected LD. The r-square 
value between the low frequency SNP Ppapdc1a_188589203 and Vkorc1 is 0.5, 
which is much higher than the r-square between its neighboring high frequency SNP 
Ppapdc1a_188589271and Vkorc1 (r-square = 0.25). The general patterns followed 
these examples.  Specifically, we examined the allele frequencies at SNPS at the last 
generation with regard to the different initial frequencies chosen for the simulations 
(0.1-0.9), while modeling balancing selection on a new overdominant Y139C 
mutation, by plotting the allele frequency itself (Figure 2.13A) and the allele 
frequency changes (delta allele frequency; which we calculated as observed allele 
frequency minus the initial frequency, Figure 2.13B). We observed that linked neutral 
allele frequencies increase much more rapidly for alleles with low initial frequencies. 
 
A. 
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B. 
 
Figure 2.13 – The effect of different initial allele frequencies on selective sweep 
pattern (hypothetical simulation). (A) Allele frequency after selection and (B) delta 
allele frequency: allele frequency after selection minus before selection. 
Different settings of the intitial SNP frequencies affected profoundly affected 
expected patterns of LD. We plotted r-square between SNPs linked to Y139C across 
the 30 Mb region from generation 0 to generation 150, with the initial allele 
frequencies set as observed in the susceptible population LH (empirical simulation, 
Figure 2.14 and Figure 2.15). Generally speaking, LD decreased with distance from 
the selected locus. However, closely linked SNPs with different initial allele 
frequencies exhibited big difference in LD. Specifically, we observed several small 
LD peaks amongst what otherwise resembled a plateau of low to intermediate LD. 
We attribute these to those few SNPs where the initial frequency of the alleles linked 
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on the same haplotype of Y139C was low. 
 
Figure 2.14 – LD (between the adaptive variant and surrounding sites) change over 
time across 30 Mb sweep region (empirical simulation, backside view). A-D as in 
Figure 2.5 legend. 
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Figure 2.15 – LD (between the adaptive variant and surrounding sites) change over 
time across 30 Mb sweep region (empirical simulation, frontside view). A-D as in 
Figure 2.5 legend. 
2.3.7.6. How long the sweep spans? 
Consistent with previous studies (Kohn, Pelz, and Wayne 2000) our 
simulations revealed a region on chromosome 1 that is affected by the selective 
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sweep associated with warfarin selection on Y139C that spans ~30 Mb when we 
modeled balancing selection on an overdominant locus with s = 0.3 (Figure 2.8, 
Figure 2.11, Figure 2.15). To generally estimate chromosomal region affected by a 
selective sweep under various selection intensities, we conducted the simulations 
based upon assumed (set) prior allele frequencies with a recombination rate of 0.006 
Mb estimated from the laboratory rat strain. We simulated the models describing 
selection on a new mutation under directional selection with s chosen to vary between 
0.01 and 0.50. Balancing selection affects a narrower region as indicated in Figure 2.7. 
Here we only show the directional selection case for future reference purpose, as it is 
the commonly assumed model in most genetic analysis. 
As expected based on theory, weaker selection strengths require longer times 
to drive the new adaptive mutation to high frequency. However, it is indicated that for 
s >= 0.3, 200 generations are enough for increasing to increase an adaptive mutation 
almost to fixation; if we assume s = 0.1, it requires 400 generations. For s = 0.05 and 
0.01, we found that 1,000 and 2,000 generations are needed for an adaptive mutation 
to reach fixation, respectively. 
Clearly the assumed selection coefficient is of importance in any system under 
selection. Here we plotted the allele frequencies across the whole 30 Mb region 
assuming a hypothetical adaptive allele has reached fixation under different selection 
pressures (s = 0.01, 0.05, 0.1, 0.2, 0.3 and 0.5). As indicated in Figure 2.16, when s = 
0.01, only a small region (within 2 Mb) will be affected; whereas when s = 0.5, the 
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sweep region is even greater than 30 Mb. This prediction with varying selection 
coefficients would be considered as a reference in future search for sweep regions. 
 
Figure 2.16  – The effect of different selection strength on selective sweep pattern 
(hypothetical simulation). Simulation is performed under directional selection to 
provide reference for further studies as directional selection is the most commonly 
assumed model. 
2.3.7.7. Association between Vkorc1 and warfarin resistance cannot be 
obtained randomly based on simulation 
The penetrance of the Y139C mutation in Vkorc1 has been estimated based on 
the proportions of resistant rats with each of the resistance genotypes from an analysis 
of the resistant population NW and the other natural populations available for study 
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(Table 2.1). About 93% rats with the SS genotype were susceptible to warfarin. In 
contrasts, >95% rats with the SR or RR genotypes were warfarin resistant. This near 
complete penetrance with regard to warfarin is used in our simulations and 
corresponds to previous such estimates of penetrance (Kohn, Pelz, and Wayne 2000). 
Notably, the penetrance of Vkorc1 Y139C with regard to bromadiolone and 
difenacoum poison resistance is much lower and closely resembles co-dominance 
(Kohn, Pelz, and Wayne 2000). 
Our analysis of the observed data showed that the Y139C Vkorc1 SNP under 
balancing selection is significantly associated with the resistance phenotype (P-value 
in 1,000 replicates < 4×10-5). We could not replicate this result when we simulated 
the neutral process (P-value in 1,000 replicates = 0.05). Even when we simulated 
directional selection on Y139C we could not re-capitulate this level of significance of 
association between Y139C and the warfarin resistance trait as measured using the 
BCR method. In fact, since under a directional selection model the beneficial allele is 
almost fixed the association tests returned non-significant P-value (1,000 replicates) 
of  > 0.1, as the observed resistance frequency (and considering penetrance) was 
much below fixation (~0.7). 
2.4. Discussion 
“Evolutionary adaptation is a special and onerous concept that should not be 
used unnecessarily, and an effect should not be called a function unless it is clearly 
produced by design and not by chance.” 
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      George C. Williams, 1966. 
As pointed out by Barrett et al. in 2011, great progress has been made in 
identifying trait-related genes, but less is known about the details of the selection 
regime (Barrett and Hoekstra 2011). By examining the details of a specific selective 
sweep it is not only possible to identify the “adaptive” variations, but furthermore, to 
test for these generally unknown details of the selection regime.  
Prominent examples that first documented to possibility to detect “adaptive” 
variations via genome scans for selective sweep signals included the early efforts to 
map the warfarin resistance locus (Kohn, Pelz, and Wayne 2000) and adaptive 
mutations in Drosophila (Harr, Kauer, and Schlötterer 2002).  Other such examples 
have followed, and these include the identification of beneficial alleles associated 
with lactase tolerance in humans (Tishkoff et al. 2007) and genes that conferred 
insecticide resistance in Drosophila (Cyp6g1) (Kohn, Pelz, and Wayne 2000; 
Schlenke and Begun 2004; Tishkoff et al. 2007).  
Despite these successes, the designation of “adaptive” in many cases is 
premature and the underlying selective mechanisms are unknown. Specifically, 
factors that shaped the selective sweep, such as the selection strength, the fitness 
model and mutation age (relative to environmental changes), generally have not been 
explicitly considered.  
Here by testing the genotype-phenotype association of the known warfarin 
resistance gene Vkorc1 and by investigating the genetic variation surrounding the 
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gene we connected genotype, phenotype and fitness; as it is required to fully 
document the role of an adaptive allele underlying an adaptive trait (Barrett and 
Hoekstra 2011). In particular we employed rigorous forward-time computer 
simulations (Kim and Stephan 2002; Peng, Amos, and Kimmel 2007; Servin and 
Stephens 2007; Carvajal-Rodriguez 2008; Hoban, Bertorelle, and Gaggiotti 2012) to 
distinguish among several scenarios that could have promoted the evolution of 
warfarin resitance in the Norway rat. Such forward-time simulations have critical 
advantages over backward (coalescent based) simulations in predicting outcomes, 
testing hypothesis and evaluating statistical approaches (Hudson 2002; Peng, Amos, 
and Kimmel 2007; Carvajal-Rodriguez 2008; Kim and Wiehe 2009).  
In this study, we took advantage of the forward-time population simulation 
computational environment simuPOP (Peng and Kimmel 2005) to compare 
competing hypotheses that could explain the evolution of warfarin resistance as 
mediated by the Y139C mutation in Vkorc1. Although the Y139C mutation in Vkorc1 
cannot explain all the aspects of resistance, it has been identified as the primary 
resistance factor that promoted the spread of warfarin resistance in our study area in 
Germany (Pelz et al. 2005). The comparison between simulated results under 
different models and the empirical data supported a model positing balancing 
selection model and a new or young overdominant Y139C warfarin resistance 
mutation in Norway rat populations that we study in Germany.  
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2.4.1. Selection strength and fitness models 
Measurements of selection intensities and relative fitness ratios done during 
field work in the 1970s established warfarin resistance in the Norway rat as a now 
classical example of balancing selection on an overdominant mutation (Greaves et al. 
1977). In the age of genome scanning and population genomics, and with the 
knowledge of the warfarin resistance gene in hand these predictions can be tested at a 
more rigorous level. In addition, our work consists of field work over many years, 
with the sampling of rats from prior and after warfarin selection, and genome-scale 
SNP diversity data. Thus, we can combine field data and molecular data to estimate 
crucial parameters, unlike most other methods that infer selection coefficients based 
on the genetic diversity data around presumably adaptive sites of unknown adaptive 
significance (Kim and Stephan 2003; Barrett and Hoekstra 2011).  
Specifically, with genetic polymorphism data in hand for rats that were 
sampled at multiple time points during a three-year field experiment, we were able to 
jointly estimate the selection coefficient and the population size using Bollback et 
al.’s maximum likelihood approach (Bollback, York, and Nielsen 2008). 
Our estimation of the selection coefficient of 0.3 for the wild type 
homozygous rats under warfarin selection is similar to previous calculations of 0.32 
(1-0.68, c.f. Table 2.1) (Greaves et al. 1977). This supports the value of filed work 
and the monitoring of phenotype frequencies in the field, but also lend credentials to 
molecular population genetic studies estimating s in the absence of any field data.  
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And the following simulation with selection coefficient of 0.3 in the fitness 
model is in concert with our observation. The selection coefficient of ~0.3 estimated 
for the warfarin resistant rat populations from our study area in Germany is high, 
above that estimated for most natural populations: for example, s estimated against 
the wild type genotype in human populations where malaria is common is ~0.1 (Hartl 
and Clark 2007) and s for alleles promoting lactase tolerance are ~0.04-0.097 (Barrett 
and Hoekstra 2011). The selection coefficients estimated for the two genes associated 
with coat color variation after horse domestication are about 0.0007 (Agouti) and 
0.0019 (Mc1r) (Ludwig et al. 2009). Selection on coat color variants in beach mice 
are ~0.07-0.21 (Barrett and Hoekstra 2011). Thus, our study system is somewhat 
extreme in terms of the selection regime. However, our main aim to study this system 
in more depth is to establish a study system that can be used to more deeply 
investigate the genetics of adaptation. Notably, the study system was amongst the first 
to illustrate the power of population genomic screens to identify and localize adaptive 
variants in natural populations.   
For the resistant heterozygotes and homozygotes, the observed allele 
frequency change patterns, and the simulations, supported a model that posits 
balancing selection on an overdominant variant. The fitness cost parameter t 
associated with the warfarin resistant homozygote was estimated as t = 0.1 using the 
‘known’ selection coefficient of ~0.3 and the equilibrium frequency of the adaptive 
Y139C allele frequency of 0.75 (Table 2.1). This estimate is much smaller than the 
previous estimate of 0.63 (1-0.37, c.f. Table 2.1; (Greaves et al. 1977)). However, the 
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observed allele frequency at Y139C and the reduced levels of linked polymorphism 
agree well with the simulation results we obtained by adopting t = 0.1.  
The fitness cost of the resistant mutation has been studied for years and it may 
involve multiple pathways.  Accumulated researches reported high requirements of 
Vitamin K, blood clotting disorder and aorta mineralization in resistant rats 
(Markussen et al. 2003; Kohn, Price, and Pelz 2008). Recent experiment 
demonstrated that at vitamin K deficiency, blood clotting time increased in 
homozygous resistant rats, but only a little in heterozygous males, not in 
heterozygous females or wild-type rats (Jacob et al. 2012). This study specifically 
supported the over-dominance model since heterozygotes would have higher fitness 
in wild environment when Vitamin K is inadequate. Here, we not only estimated the 
relative fitness ratio for three genotypes of Vkorc1 gene, we also showed the genetic 
evidence for the balancing selection model. Directional selection is the commonly 
assumed and tested model, but the heterozygote advantage selection is believed to be 
acting on a small portion of loci and short-lived (Hedrick 2012). As we are exploring 
the general role of balancing selection in shaping the genome, there is argument that 
over-dominant alleles might be more common than we previously thought and play 
important roles in adaptation (Cochran et al., in progress). 
2.4.2. The effect of mutation age on sweep pattern 
There is no absolute cut between new mutation and the standing variation. 
Instead, it could be viewed as a continuous changing trend. “Old” standing variation 
that has existed in the population with long history would have weak effect on 
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flanking regions after selection. The younger age of the variation, the stronger effect 
of sweep (Figure 2.10). And if it is a de novo mutation after selection, it will affect a 
widest region surrounding it. Here a new mutation in certain population could be 
either a new ‘born’ or a variation introduced by migration. 
2.4.3. Linkage disequilibrium under balancing selection 
In this first SNP based analysis, directional selection on Y139C caused 
pronounced LD blocks surrounding the selected site, as was expected based on theory 
(Kim and Nielsen 2004; Stephan, Song, and Langley 2006) and based on previous 
studies on the same rat populations using microsatellites (Kohn, Pelz, and Wayne 
2000). Balancing selection, however, is not expected to cause this much LD 
(Charlesworth 2006). However, if the selection coefficient underlying balancing 
selection is high, such as it is in this study system, the simulations conducted here 
revealed that strong LD pattern can result from over-dominance (Figure 2.2A).  
The age of the Y139C mutation is unknown, but the rapid evolution of 
resistance as mediated by this mutation raised speculations as to the age of this 
mutation; i.e. whether the mutation pre-dated the introduction of warfarin selection. 
Unless better sampling of rats from their ancestral areas on Asia is done, and museum 
samples are analyzed, this issue remains a subject of speculation. However, by 
comparing the observed levels of LD with the simulated levels of change of LD over 
generations it is possible to discern the age of the mutation to some degree. 
Specifically, by assuming a range of recombination rates and selection coefficients 
the LD change over time can be modeled using forward-time simulations (Figure 
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2.12). Following this approach our estimations were consistent with a selection model 
that posits balancing selection n an overdominant Y139C mutation that occurred, or 
arrived in form of a migrant, at about 1965-1973. This estimate matches up well with 
the documented first occurrence of resistance in Europe (population and agriculture 
1986).  
2.4.4. The initial allele frequencies of linked neutral alleles strongly affect 
the expected selective sweep 
The selection intensity, time scale, and levels of recombination strongly affect 
the power to detect selective sweeps (Nielsen et al. 2005). In this study we considered 
numerous models and parameter settings to compare the expected signature of 
selective sweeps associated with warfarin resistance with those observed.  
Amongst the numerous factors that affect the signature of selection on genes 
and their neighboring loci, of these, the initial frequency of alleles at linked sites here 
was shown to impact analyses and expected outcomes in a most profound fashion.  
Similarly, the impact the ‘age’ of the adaptive allele has, and thus the ‘age’ of 
the neutral alleles linked to it, profoundly affected the outcomes of the simulated 
selection scenarios. We showed here for simulated data and for the observed data 
collected from a warfarin susceptible population (LH) that SNPs linked to ‘young’ 
low frequency alleles display drastic patterns of genetic hitchhiking; much unlike ‘old’ 
high frequency SNP alleles that have been on the same have as the wild type allele at 
the selected locus (Figure 2.13 and Figure 2.14).  
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2.4.5. Conclusion 
In this study, we established the association between the Y139C mutation in 
Vkorc1 and warfarin resistance.  We further provided estimates deduced from the 
observed polymorphism data at and around the locus and from simulations that 
revealed that the Y139C mutation is an overdominant mutation under balancing 
selection that has entered our study area as a new mutation (1/2Ne) after the 1950s. 
Whether this means that the mutation arose de novo or arrived in from of an 
immigrant resistant rats cannot be established given the sampling and data. However, 
our simulations indicated that the mutation is unlikely very old (here as modeled as 
more than 700 generations) as this would have unlikely resulted in the pronounced 
selective sweep patterns we have observed and modeled. Nevertheless, solutions to 
this question require more empirical data. This study is the first to confirm the 
proposed classical example of balancing selection mode on the warfarin resistance 
gene by using molecular population genetic data and forward-time simulations 
covering the resistance causing Y139C amino-acid change as well as linked neutral 
SNP data. Our work is of significance in that it documents that ‘classic selective 
sweeps’ appear to less common in natural population than it was assumed (Pritchard, 
Pickrell, and Coop 2010; Hernandez et al. 2011). Similarly, even though the selection 
for warfarin resistance in rats has become a classical example of selection on a simple 
adaptive trait we showed that it is difficult, yet possible, to discern some of the details 
regarding the precise selective regime on that gene and mutation. Given some of the 
complexities encountered during this study, and others described in the following 
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chapters, we remain cautious in terms of the ability to interpret genome-scans for 
adaptive variants in an overly simplistic fashion.  
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Chapter 3 
Network-guided GWAS reveals a polygenic 
architecture of warfarin resistance in the 
Norway rat 
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Abstract  
Over decades, genome wide association studies (GWAS) have successfully 
identified markers associated with human disease or, in rare instances adaptive traits 
in natural populations of humans, plants or animals. A recent trend in the biomedical 
sciences is to improve traditional GWAS by incorporating gene-gene interaction 
network data. The power of this approach lies in the a priori knowledge that genes 
interact, and thus, the traditional approach to correct for multiple testing becomes 
obsolete or, less relevant. Here we use NetGWAS, as well as a Google PageRank 
algorithm that is modified as part of this thesis, to combine genotype-phenotype 
association measures with genetic network information to detect candidate genes 
underlying warfarin resistance in the Norway rat. Under this framework for analysis 
of genome-wide single nucleotide polymorphism (SNP) association genes that show 
significant levels of association under traditional analysis conditions are given high 
ranks if SNPs tagging genes that are neighbors in the gene-gene interaction network 
have high statistical support during the association study also. As gene scores are 
initially based on traditional measures for marker-trait association, new algorithms 
that consider gene-gene interaction network information adjust the original level of 
association based on known or suspected genetic interactions. Here we collected 
genome-wide SNP data for wild warfarin resistant Norway rats (Rattus norvegicus) 
from Germany with aim to investigate whether any other genomic regions than the 
vitamin K epoxide reductase subunit 1 gene (Vkorc1) in the rat genome display 
significant association with warfarin resistance, as was measured in our study by a 
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physiological blood clotting response test (BCR). Notably, warfarin resistance once 
was thought of as a simple Mendelian trait.  However, here by assaying SNP 
polymorphisms across the rat genome we conducted a NetGWAS and identified 87 
SNPs tagging genes that displayed significant association with the warfarin resistance 
trait. Thus, this study indicated that warfarin resistance has a polygenic architecture. 
Using our approach Vkorc1 was significantly prioritized and attained the highest rank, 
as was expected and as we interpret as evidence for the power of our approach. 
However, we identified other genes whose annotations reveal compelling hints to 
previously unknown functions or pathways, many of which are in fact connected to 
the Vkorc1 driven blood coagulation and bone developmental pathways, as well as 
biochemical reactions that take place in the endoplasmic reticulum where, in the case 
of hepatic cells, the vitamin K cycle proteins presumably are located. The population 
genomic analysis of a warfarin resistant population NW and a non-resistant 
population LH provided further support for some of these candidate genes. Notably, 
evidence for selection on candidate gene regions was found, indicating that the 
identified regions are not artifacts of population structure and drift alone. For 
example, we found elevated levels of linkage disequilibrium (LD) that are consistent 
with selective sweeps associated with these SNPs. Warfarin resistance in the Norway 
rat, once thought to be a classical example of a simple adaptive trait appears to be of a 
more complex architecture. Thus, other studies of natural populations likely will have 
to anticipate more complex genetic architectures also than is generally assumed, but 
as is shown in this chapter these can be reduced to some degree by adopting a 
NetGWAS approach.   
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3.1. Introduction 
One important goal of genome-wide association studies (GWAS) is to dissect 
the genetic architecture underlying complex diseases in humans (Consortium 2007; 
Stranger, Stahl, and Raj 2011). To date (Dec, 2012), over 1,400 GWAS have 
identified around 8,000 SNPs related to human diseases and other traits since the first 
published GWA study in 2005 (Lucia A. et al.).  
GWAS have been applied to search the ample human genome variation data 
for adaptive loci in humans (Hancock et al. 2010; Brown 2012). More recently and if 
the genomic tools were available, approaches reminicient of human GWAS have bee 
applied to plants and animals to identify genes underlying adaptive traits (Parker et al. 
2009; Brachi, Morris, and Borevitz 2011).  
As foreseen 15 years ago (Risch and Merikangas 1996), large scale 
association analyses have revolutionized the identification of complex diseases and 
traits. In most studies, however, a large number of variants are tested for their 
association with a phenotype individually, one-by-one. This results in major issues 
with significance testing in that a large number of associations between SNPs and 
trait could be false-positives. Mostly this issue has been addressed by developing 
methods to adjust P-values for multiple testing.  
However, the value of utilizing results from molecular studies obtained in the 
laboratory has been recognized and increasingly implemented in GWAS in that genes 
are not assessed for their significance in isolation any longer but are evaluated with 
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regard to their connection to sets of genes that interact in gene-gene interaction 
networks (Cordell 2009).  
Generally, there are two ways to consider such presumably ‘known’ gene-
gene interaction information. First, one could incorporate known gene-gene 
interaction information to facilitate the identification of trait-associated sets of genes 
during GWAS (Morrison et al. 2005; Akula et al. 2011; Winter et al. 2012). Second, 
one could detect statistical interactions without applying any prior biological 
knowledge during GWAS and then, a posteriori, interpret statistically significant 
associations in light of known gene-gene interactions (Cordell 2002; Liu et al. 2011).  
In this study we employed the first of these two strategies by combining a 
GWAS study with prior gene-gene interaction network information to prioritize the 
selection of candidate genes that are associated with warfarin resistance in the 
Norway rat. We explore if this NetGWAS approach holds promise in the study of 
natural populations as we note on the increasingly refined gene-gene interaction 
networks that are now available for many model species (Barabasi and Oltvai 2004; 
Barabasi, Gulbahce, and Loscalzo 2011).  
Google’s PageRank algorithm (Page et al. 1999), which helped to establish 
Google’s success, has been successfully adapted to GO (Gene Ontology) network 
analysis (Morrison et al. 2005) and the analysis of gene-transcriptional networks 
(Winter et al. 2012). These successful adoption of the Google search algorithm in 
biological studies motivated us to perform similar such modification as suggested in 
the programming environments called GeneRank (Morrison et al. 2005) and NetRank 
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(Winter et al. 2012). These approaches couple SNP-trait association measures with 
gene-gene interactions that are mined from databases. This switch from an a 
posteriori evaluation of candidate genes to the implementation of algorithms that 
consider gene-gene interaction networks a priori is called NetGWAS.   
Google’s PageRank assigns a webpage a high rank if all the pages linked to it 
also have high ranks (Page et al. 1999). Similarly, genes with information on other 
genes that interact with it, and any information on associations with a phenotype, 
could be added to the ranking of candidate SNPs during GWAS. In such NetGWAS, 
the trait-association measure is assigned to each node in form of a gene score, and 
such gene scores are allowed to spread further depending on the network topology. 
Gene ranks are obtained by solving a convergence matrix of the ranking iteration. 
One desirable feature inherent in the algorithm is that highly relevant genes are 
prioritized and genes considered as noise in the particular biological context studied 
are given lower priorities. Thus, the approach might limit the ability to discover novel 
pathways as priority is given to known gene-gene interactions while rarely 
documented or unknown interactions are given a low priority. However, this 
approach might enable to at least focus on the systematic dissection of the genetics 
underlying a few seemingly complex traits. This would constitute main progress as 
the current state-of-the art analyses generally result in long lists of candidate genes 
that are virtually impossible to interpret with regard to the complex selection regime 
encountered by populations in nature. 
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In this study we applied NetGWAS to identify candidate genes involved in the 
resistance to the anticoagulant rodenticide warfarin in wild Norway rats (Rattus 
norvegicus). Warfarin causes lethal bleeding by impairing the recycling of vitamin K 
hydroquinone, which is essential for the gamma-carboxylation of blood coagulation 
factors and other vitamin K dependent proteins (c.f. Appendix 8, Figure 5.2) (Presnell 
and Stafford 2002; Stafford 2005).  
Specifically, warfarin inhibits the activity of the vitamin K 2,3-epoxide 
reductase protein complex (VKOR) located in the endoplasmatic reticulum of hepatic 
cells, and one of the two subunits of this component is encoded by a vitamin K 
epoxide reductase subcomponent 1 (Vkorc1) gene (Presnell and Stafford 2002; Pelz et 
al. 2005; Stafford 2005).  
Introduced in the 1950s, warfarin was a potent compound to control rat 
populations for 10-15 years, but in a surprisingly rapid manner resistance towards 
warfarin has become prevalent in Europe (Boyle 1960; Lund 1964; population and 
agriculture 1986) and US (Jackson and Kaukeinen 1972). Previous studies have 
identified Vkorc1 as the primary gene that confers resistance, most notably by a 
Y139C substitution and possibly by other variations on the gene depending on the 
resistant populations and species under study (Rost et al. 2004; Pelz et al. 2005). The 
Y139C amino acid change at the amino acid sequence position 139 is a result of a 
non-synonymous mutation from A to G in exon 3. The mutation reduces the basal in 
vitro VKOR activity by ~50% (Pelz et al. 2005; Rost et al. 2009), but protect the 
VKOR from inhibition by warfarin.  
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We sampled Norway rats from an area in northwestern Germany (Kohn, Pelz, 
and Wayne 2000; Kohn, Pelz, and Wayne 2003) where the Y139C mutation has 
spread and causes widespread resistance to warfarin in free-living rat populations. 
Data on warfarin resistance were available for the majorty of rats from previous 
studies that reported these (in form of the binary traits resistant/susceptible) as 
obtained from blood clotting response (BCR) tests (Kohn, Pelz, and Wayne 2003). 
Warfarin is also the most popular oral antithrombotic drug used to reduce the 
incidence and risk of heart attack, stroke or thrombosis in humans (Gage et al. 2003; 
Geisen et al. 2005). Though being widely prescribed for about 60 years, warfairn 
remains a difficult drug to manage because of its narrow therapeutic window and 
dramatically varying dosages dependent on genetics, diet and environments (Kamali 
2006). Few genes VKORC1, CYP2C9, CYP4F2 have been established as dose 
predictors for individual patients. So far, the identified genetic factors predict ~40% 
of dose variance, and non-genetic factors (age, sex, weight, etc.) explain ~15% (Rost 
et al. 2004; Takeuchi et al. 2009). GGCX, EPHX1 and other genes have been reported 
with controversial results from different studies in different populations (Wadelius et 
al. 2005; Pautas et al. 2009; Takeuchi et al. 2009). Nonetheless, incorporating genetic 
information greatly improved the warfarin dosage estimation and dramatically 
reduced health care costs (~ 1 billion annually, source: AEI-Brookings joint center for 
regulatory studies). It is now more commonplace to inform the warfarin dosing with 
the help of genetic information (Avery et al. 2011; UI-Health 2012).  
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Though recent genome scans in humans argued that there is no further need to 
add other genes than VKORC1, CYP2C9 and CYP4F2 to the list in near future, the 
45% unexplained genetic variance in warfarin dosing does remains a puzzle (Cooper 
et al. 2008; Takeuchi et al. 2009). As warfarin becomes a poster child for the future of 
personalized medicine more genetic information might be crucial to more accurately 
assess the warfarin dosing requirements before prescription. 
In rats Vkorc1 is the only gene with solid evidence that documents its role in 
warfarin resistance. However, in this study we propose, and test, the hypothesis that 
persistent selection for warfarin resistance over many decades should have co-
selected additional loci that either enhance the resistance trait, or, loci that act as 
modifiers in some other role (Figure 1.3). Moreover, preliminary investigations in our 
laboratory reported on rats that were warfarin-resistant according to BCR testing but 
without the known resistance mutation on Vkorc1. Finally, as indicated above, in 
humans more than the Vkorc1 is involved in warfarin drug metabolism. Thus, the 
genetic architecture of warfarin resistance in the Norway rat likely is more complex 
than is currently assumed.  
 Warfarin resistance in rats is both advantageous and detrimental, depending 
on the presence of the poison in the environment. A substantial fitness cost of 
resistance incurs in form of vitamin K deficiency, sporadic hemorrhage, arterial 
calcification and reduced growth/reproductive rates as observed in previous studies 
(Markussen et al. 2003; Pelz et al. 2005; Jacob et al. 2012). Thus, the study of 
warfarin resistant rats might reveal interesting facets of an adaption in that both the 
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beneficial alleles as well as detrimental alleles might be detected, and their functional 
connections be revealed.  
In this study, we aim to identify candidate genes involved in warfarin 
resistance using i) traditional GWAS, and ii) NetGWAS. First, we perform 
association tests at the level of single nucleotide polymorphisms (SNPs) collected on 
a microarray platform covering the rat genome. Then we map SNPs to genes and 
compute gene scores based on association measures. These association measures and 
gene scores will be evaluated in conjunction with gene-gene interaction network 
information as part of NetGWAS. The gene-gene interaction network is built based 
on the interaction information from STRING (functional protein association 
networks) database (Jensen et al. 2009). The candidate list will be evaluated in terms 
of the functions of genes and sets of interacting genes by using GO (Gene Ontology) 
and KEGG (Kyoto Encyclopedia of Genes and Genomes) annotations (Kanehisa and 
Goto 2000; Consortium 2008). Finally, we conduct a population genomic scan for 
extended haplotypes and linkage disequilibrium (LD) by comparing a resistant 
population NW with a nonresistant population LH. 
3.2. Materials and Methods 
3.2.1. Rat samples assayed on the SNP array 
29 rats (17 males) of a laboratory strain (NW samples) were derived from 
wild rats sampled from an area with reported anticoagulant resistance in northwestern 
Germany (Kohn, Pelz, and Wayne 2000; Kohn, Pelz, and Wayne 2003). 21 of them 
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were resistant to warfarin according to BCR (blood clotting response) tests (Kohn, 
Pelz, and Wayne 2000; Kohn, Pelz, and Wayne 2003). We obtained 12 rats (9 
males/3 females) from a non-resistant population LH (Location: LUDWIGSHAFEN) 
about 300km away from this resistance area (Appendix 1).  
3.2.2. Genotype data 
Genomic DNA of 41 rats was isolated from liver tissues using the classical 
phenol:chloroform extraction method. Genome scale SNP data of the rat samples 
were collected using the rat 10K array purchased from Affymetrix 
(http://www.affymetrix.com). DNA samples (each one with > 4ug in approximately 
30 ul of 1X TE buffer) were sent to Baylor Genomic & RNA Profiling Core 
(http://www.bcm.edu/garp/) and Vanderbilt University for Quality control tests. The 
genome sciences resources microarray center at Vanderbilt University 
(http://array.mc.vanderbilt.edu/) conducted the genotyping experiment on our behalf. 
The genotypes were generated based on intensity files following data normalization 
and quality control using GTGS (Affymetrix GeneChip Targeted Analysis Software).  
Genotypes were assigned based on the degree of the data from each assay 
belongs to a certain genotype cluster identified cross samples. Nine samples failed 
during genotyping as was judged by a call rate of less than 95%. Thus 20 NW 
samples and 12 LH samples were available for analyses. With 10,847 SNP sites from 
the Rat 10k array, after filtering 477 SNPs with failed genotype calls, we obtained 
3,053 non-informative SNPs in wild rats, and 7,317 informative SNPs for rats from 
NW and LH population (including 54 SNPs with unknown Chromosome location).  
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We performed the following association tests and population genomic tests on 
all of the 7,317 informative SNPs and also on the dataset after filtering out SNPs with 
MAF (minor allele frequency)  < 5% (6,506 sites). As results of both approaches are 
similar, we included all 7,317 SNPs such that we would not discard potentially 
interesting genes (Gorlov et al. 2008). 
3.2.3. Genome-wide association analysis (GWAS) 
The workflow of the genomic association analysis is depicted in Figure 3.1. 
First we performed the association analysis on the genotype data of informative SNPs 
using both genotype-phenotype chi-square test and Bayesian association analysis. The 
list of candidate SNPs was obtained following this traditional GWAS approach. Then, 
we mapped all SNPs on genes, and computed gene scores based on the association 
strength. Third, we combined the association information with the genetic networks 
to identify candidate genes based on the computed gene ranks. The network analysis 
and the traditional SNP association tests were complementary to each other. The 
analysis of function/pathway annotation was done based on Gene Ontology/KEGG. 
3.2.3.1. Genotype-phenotype association test  
For NW samples, association between warfarin resistance and genotype for 
each SNP was tested in PLINK (Purcell et al. 2007). A 2×2×K Cochran-Mantel-
Haenszel (CMH) test was performed to control for the potential confounding factor 
sex (Kohn, Price, and Pelz 2008). Holm-Bonferroni step-down adjusted P-values, 
Sidak step-down adjusted P-values, Benjamini&Hochberg step-up FDR control, and 
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Benjamini&Yekutieli step-up FDR controls were computed. The HOLM corrected P-
values were used to identify candidate SNPs under the null hypothesis H0 of no causal 
SNPs are present in the data.  
 
Figure 3.1 – The workflow of network-guided genomic association analysis. 
3.2.3.2. Imputation-based Bayesian association mapping  
We implemented the imputation-based association test for all rats and NW 
samples using software BimBam, using multi-marker LD model and a Bayesian 
regression approach (Scheet and Stephens 2006; Servin and Stephens 2007; Guan and 
Stephens 2008). The Bayesian regression method provided a Bayes Factor (BF) 
measuring the strength of genotype-phenotype association, and also generated a P-
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value after permutation. First, with the integrated approach to perform imputation and 
computing Bayes Factors, we calculated BF1 for each SNP using prior D2 from 
(Servin and Stephens 2007) and averaging over σa (additive effect) = 0.1, 0.2, 0.4 and 
σd (dominance effect) = σa /4 as suggested (Servin and Stephens 2007; Stephens and 
Balding 2009). We also computed BF2 using σd  = σa to increase the weight on 
dominance model. The genome wide pattern of association was plotted with –log10 
(P-values), log10 (BF1) and log10 (BF2) in R (Figure 3.6). We selected 82 SNPs with 
Holm adjusted P-values <= 0.05 or log10 (BF1)  >= 1 or log10 (BF2)  >=1 for future 
comparison.  
3.2.3.3. SNP-gene mapping and gene score 
We downloaded the Rattus norvegicus gene information of the NCBI build 4 
(RGSC v3.4) from NCBI ftp (ftp://ftp.ncbi.nih.gov/, accessed March 2012). With the 
library file provided by Affymetrix Rat 10k array, we could assign SNPs to genes 
using the best SNP strategy with an choice of gene boundaries of ±50 kb to capture 
any potentially regulatory regions. SNPs could be assigned to multiple genes and 
these ambiguities were considered when evaluating significant SNPs at the later 
stages of the analyses. The boundaries of ±50 kb has been used in another gene-based 
association test software VEGAS (Liu et al. 2010). We also used the boundary choice 
of ±200 kb. We summarized the frequency distribution of the distance in megabases 
between SNPs and the nearest genes (Figure 3.2). 
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Figure 3.2 – The distribution of distance between SNPs and the nearest genes in 
log(bp). 
According to the ‘best SNP strategy’, the association score of each gene was 
inherited from the SNPs with the highest Bayesian Factor that map within the genes, 
which measured the association strength. BF1 and BF2 were computed separately to 
provide a measure of significance under different genetic models. We did not 
compute traditional P-values of for association tests since these are lacking the power 
when measuring association strengths. To this end, we prepared the gene score files 
with either BF1 or BF2 measures each calculated for the gene boundaries of ±50 kb 
or ±200 kb to be used for the subsequent network-based ranking conducted. We 
removed the genes surrounding Vkorc1 that were assigned with the resistance 
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mutation on Vkorc1 since the flanking genes are known to be hitchhikers that map in 
the 30 Mb-spanning selective sweep region (c.f. Chapter 2).  
3.2.4. Network-guided GWAS (NetGWAS) by a modified Google’s 
PageRank algorithm 
3.2.4.1. Genetic network 
Incorporating the information of genetic interactions would facilitate the 
identification of candidate genes and functionally related additional genes. In gene-
gene interaction networks each gene is considered as a node and the gene-gene 
interaction is considered as an edge. Here we considered an undirected such genetic 
network, in which the information was retrieved from the STRING database (v9.0) 
(http://string-db.org/, accessed July 2012). The downloaded Rattus norvegicus 
protein-protein interaction data contain information from 7 channels: neighborhood, 
gene fusion, coocurrence, coexpression, experiments, database and textmining. To 
incorporate the protein-protein interactions and potential functional relationships, we 
selected the links with scores ≥ 150 from experiments, database or textmining as 
suggested by the authors of the database. Then we converted the proteins into their 
corresponding gene names to obtain gene-gene relationships. We matched the genes 
from the gene score files with the gene-gene interaction information and built two 
networks. Network1 contains 4,846 genes from the above SNP-gene mapping result 
with ±50 kb boundaries, and 50,095 edges between genes. Network2 contains 9,382 
genes from the above SNP-gene mapping result with ±200 kb boundaries, and 
160,567 edges between genes. The Network2 used wider gene boundaries and thus 
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included more genes that match up with our SNP data, but Network2 might contain 
more false positive gene-interactions and noise due to cross-platform annotation 
issues. Thus we compared the results from both network analyses later. The 
distribution of degree of the gene-gene interaction network is plotted in Figure 3.3.
 
Figure 3.3 – The distribution of degree in the gene-gene interaction network 
3.2.4.2. The modified Google’s PageRank algorithm   
 Our NetGWAS combines the genotype-phenotype association information 
with the genetic network information to identify candidate genes by computing gene 
ranks. This network-ranking algorithm is adapted from the PageRank algorithm, 
which is key to ensure search quality of Google by giving users the desired 
information (Page et al. 1999). PageRank determines the significance of a page by the 
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importance of all the pages that link to that page. Similarly, in biological networks, 
the rank of a gene could be computed iteratively based on other genes that interact 
with it as well as based on their association with external traits. Here, we used a 
modified Google PageRank algorithm similar to one that has been used in gene 
expression analysis (Morrison et al. 2005; Winter et al. 2012) (Page et al. 1999): 
 
 
  Equation 3.1 – A modified Google’s PageRank algorithm. 
Where  is the rank score of gene i after m iterations;  is the score of gene 
i, here we used the association strength measured by Bayesian factor (BF1 and BF2 
computed separately), but could be extended to any measure of interest; A denotes an 
adjacency matrix representing the gene network, in which Aij = Aji = 1 if gene i 
interact with gene j, otherwise Aij = Aji = 0; N is the number of nodes in the network; 
degj is the degree of gene j, which represents the number of interactions of gene j. d is 
a scalar parameter called damping factor, when d = 0, the impact of one node cannot 
be spread to others; whereas d = 1 means full influence from the network. The 
ranking vector R could be obtained by solving the linear system that equivalent to the 
convergence of iteration equation (1) (Page et al. 1999; Morrison et al. 2005; Winter 
et al. 2012): 
    
Equation 3.2 – The convergence of Equation 3.1 
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Where I is the identity matrix; D = diag(degi).  
The choice of the damping factor d affects the ranking results. The Google 
damping factor of 0.85 might be higher than the suited setting for biological 
networks, since most genetic networks are much more sparse than the WorldWide 
Web (Clune, Mouret, and Lipson 2013). We tried two settings: first, d = 0.3 as 
evaluated in a previous study of transcriptional network (Winter et al. 2012) and 
second, we calculated the dynamic damping factor ddfi for each node in our network 
according to Fu et al’s suggestion (Fu, Lin, and Tsai 2006): 
 
   Equation 3.3 – Dynamic damping factor. 
Fu et al. suggested Equation 3.3 to dynamically use a damping factor in the 
ranking process (Fu, Lin, and Tsai 2006). However, applying the varying damping 
factor of different nodes is not expected to result in a solution of the eigenvector R for 
our undirected network. Thus, we calculated the average ddf across all nodes and 
used it as the damping factor d in Equation 3.2. We used MATLAB scripts to conduct 
the network rankings. 
For each network (Network1 with ±50 kb boundaries and Network2 with 
±200 kb boundaries) we obtained four files of gene rank score based on the calculated 
gene scores, BF1 and BF2, and by applying damping factors of 0.3 or the average ddf.  
! 
ddf =
degi
degi
j |Aij=1
"
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3.2.4.3. Evaluation of ranking results 
To evaluate the gene ranking results, we compared the top 50 genes selected 
under four different scenarios:  
1) Gene score only. When d = 0, Equation 3.2 becomes R = S, i.e. gene ranks 
are only based on the assigned gene scores, which are the Bayes Factors. 
2) Equal score. When d = 1, Equation 3.2 becomes , i.e. gene 
ranks are only based on network topology, which equates to an approach where the 
equal score is assigned to every gene. 
3) Randomized gene scores. To investigate whether some genes with 
randomly assigned scores could end up being selected as top 50 candidates, we 
randomly shuffled the association measures (BF2) among the genes in Network1 and 
Network2 10,000 times. We kept the network topology and then obtained 10,000 files 
of genes ranks based on such randomly assigned gene scores. The random probability 
for each gene score was calculated as the frequency of each gene (and gene score) 
selected as one of the top 50 candidate genes after 10,000 randomizations. Then the 
top 50 genes with highest random probabilities were selected for comparison. These 
random probabilities were also used for the following correction process. 
4) Real gene rank score. The gene rank scores obtained as described above but 
modified to reflect the combined information from association analyses as well as 
network information in NetGWAS. 
A comparison of results is shown in Figure 3.4B and C. 
! 
(I " ATD"1)R = 0
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Figure 3.4 – The evaluation  and correction of gene ranking results. 
3.2.4.4. Correction methods applied to the gene ranking 
As suggested by the above evaluation steps of genes, there are some genes to 
be expected in the data that have inflated high rank scores merely by virtue of 
network topology, rather than due to the biologically meaningful relevance to the trait 
under study. Thus, we preformed gene rank correction steps using the random 
probabilities calculated and by applying the two damping factors d=0.3 and ddf. First, 
we corrected the gene rank scores (vector R’) by considering their random 
probabilities (RanProb): 
         
! 
R'= R(1"RanProb)
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   Equation 3.4 – Correct gene rank scores. 
For example, Vkorc1, which has a low random probability, was ranked as a 
top candidate gene even after correction; whereas a gene with high random 
probability would be corrected to lower ranks. 
Furthermore, we obtained gene rank scores based on the two damping factors: 
d=0.3 and ddf as suggested (Fu, Lin, and Tsai 2006; Winter et al. 2012). We also saw 
that the calculated average ddf is usually one order of magnitude smaller than d = 0.3. 
As mentioned earlier, the higher the damping factor the stronger is the effect of 
network topology on the final ranks of candidate genes. Without enough prior 
knowledge of the most suitable damping factor, at later stages of the candidate gene 
evaluation we closely examined those genes with big discrepancies in the rank scores 
obtained after application of the two damping factors. Especially some inflating 
effects of network topology could lead to a situation where genes with high rank 
score at d=0.3 can have low rank scores at ddf. As a complementary correction 
measure we used the random probabilities computed for each gene and its gene score 
after converting rank scores into ranks. We considered cases where Rankddf – Rankd0.3 
> 100 as a large discrepancy worth investigating in more detail when evaluating 
candidate genes. Taking Network1 (±50 kb boundaries) and using BF1 as an example, 
there were 14 out of 50 top candidate genes that were also selected from the equal 
score case, i.e. only considering the network topology (Figure 3.4B). The correction 
process (using random probabilities and differences in damping factors) then removed 
9 genes; if we applied stricter criteria by removing the genes whose Rankddf – Rankd0.3 
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> 50, there were only 3 genes remaining in the intersection with the equal score case. 
Similarly, taking Network2 using BF1 as an example, 12 top genes, which also were 
be selected from the equal score case, were reduced to 1 gene after correction with 
Rankddf – Rankd0.3 > 100 and were all removed after correction with Rankddf – Rankd0.3 
> 50. 
File combination and candidate gene selection 
As mentioned earlier, for each network we used two gene scores BF1 or BF2; 
and considering each gene score, we obtained the rank scores using two damping 
factors d=0.3 or the average ddf.  In the case of BF1 calculations in our Network1 
analysis we first corrected the gene rank scores by Equation 3.4 and then we removed 
the genes whose Rankddf – Rankd0.3 > 50. Subsequently we selected the top 50 genes 
from each file and pooled them together. Similarly for the BF2 calculations in our 
Network1 analysis we obtained the gene lists with corrected ranks after filtering out 
genes with large disagreements between the analyses done that applied the two 
different damping factors. We further pooled the gene lists from two gene scores 
(BF1 and BF2) and from two networks (Network1 and Network2) to yield the final 
list of 87 candidate genes (Appendix 4). The evaluation, correction and combination 
process is recorded in Figure 3.4D and E. 
Besides combining the candidate genes from 8 (2×2×2) ranking files 
(supporting score: +1 if present for each file), we also checked whether the genes 
could be selected as top 50 based only on their Bayesian association scores 
(supporting score: +1 if present, for each gene score type BF1 or BF2), or whether 
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they were selected because of network topology (supporting score: -1 if present, for 
each network). Thus for each gene, we assessed whether they have multiple 
supporting evidences from different sources by summing up the supporting scores. 
We did this such that we have a large list of genes to work with when adding 
additional evidence (gene expression and population genomic data) and to be able to 
statistically evaluate groups of genes. We note that we will follow up on individual 
genes with additional genotyping and detailed analyses. 
To investigate the interactions among the 87 candidate genes we drew a sub-
network using the R package igraph (http://igraph.sourceforge.net/index.html) (Figure 
3.7A). The bigger nodes correspond to genes with higher supporting scores. Some 
genes form a main cluster centered about Vkorc1 (red nodes and edges). Some 
isolated candidate genes (blue nodes) were re-connected (blue edges) with the 
clusters if they are physically located near (< 5 Mb) the genes in network clusters. 
Orange nodes and edges represent small clusters with at least two interacting genes in 
network, which are separate from the main Vkorc1 cluster in network.  
The initial SNP association test suggested 82 candidate SNPs. Here we 
assigned these SNPs to above identified candidate genes based on their physical 
location using a < 2 Mb threshold (Appendix 4). Some candidate SNPs that cannot be 
assigned unambiguously to annotated genes are kept for future reference. 
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3.2.4.5. Function/Pathway evaluation 
To evaluate the functions of candidate genes and the pathways they are 
involved in we performed GO (Gene Ontology) and KEGG (Kyoto Encyclopedia of 
Genes and Genomes) pathway analysis as implemented in DAVID 
(http://david.abcc.ncifcrf.gov, accessed Dec 2012). We submitted a background gene 
list with 9,382 genes from the larger dataset that emerged from the Network2 analysis 
and a candidate gene list (87 genes). The GO Fat category (particularly relevant to the 
vitamin K cycle) was disabled to avoid the overshadowing of specific functional 
terms such broadest of functional terms. KEGG and protein domain information 
(InterPro, PIR, SMART) were included in the analysis. The functional chart obtained 
listed 89 categories annotated from GO, KEGG or Protein Domain databases and the 
clustering report grouped similar annotations together, resulting in 37 clusters. After 
removing the functional clusters with enrichment P-values > 0.05, we obtained 19 
clusters (Appendix 5).  
We generated a GO network to facilitate the interpretation of functional 
relationships among genes discerned. In this GO network, nodes are genes, and two 
genes are connected by an edge if they have share similar functions (Figure 3.7B). 
Node size represents the supporting score for each gene. To examine the functional 
enrichment of each gene we also depicted the network in form of a heatmap where 
each cell represents the highest enrichment score of the category in each cluster for 
that gene (Figure 3.8). Genes are sorted based on their physical distribution along 
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chromosomes, and the left side bar uses the same color to represent chromosomal 
proximity (< 5 Mb) of genes in the network.  
3.2.5. Population genomics  
For the population genetic analysis of the SNP data we inferred haplotypes 
using fastPHASE while imputing missing genotypes (Scheet and Stephens 2006). 
3.2.5.1. Haplotype structure 
We computed two measures of haplotype identity: iHS and XP-EHH; both of 
them are based on Extended Haplotype Homozygosity (EHH). EHH estimated the 
probability of two randomly chosen haplotypes as being identical over a distance of X 
Mb to the locus under consideration (Sabeti et al. 2002). By definition, EHH depends 
on the choice of the relative distance to the locus. The integrated EHH statistic (iHS), 
is a standardized measure of EHH at a given locus of the ancestral allele relative to 
the derived allele (Voight et al. 2006). Thus large negative iHS scores suggest derived 
alleles under selection or the genetic hitchhiking of the loci. In contrast, large positive 
iHS scores indicate the presence of ancestral alleles. Treating each SNP as core SNP 
in turn, iHS summed over both directions of the EHH curve until 0.05 is reached for 
each site. Here we set the major allele frequencies observed in the non-resistant 
population LH as the frequency of the ancestral alleles (prior to warfarin selection) 
rather than determining ancestral and derived alleles based on outgroups (different 
species). The calculation and standardization of iHS are done with PERL scripts 
provided in WHAMM (Voight et al. 2006).  
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We also computed the XP-EHH statistic, which measures the cross population 
allele frequency differences between populations as the natural log of the ratio of iHS 
between two populations (Sabeti 2007), i.e. is a measure of population differentiation. 
The deviation from XP-EHH = 0 between resistant population NW and the non-
resistant population LH can be interpreted in light of warfarin selection because 
population LH is fully warfarin susceptible whereas population NW is highly 
resistant and known to have been exposed to warfarin as part of experimental rodent 
control research. Limited by the SNP density of the Rat 10K array the resolution of 
these two measures of haplotype structure are accordingly limited. We assigned XP-
EHH to the candidate regions (Appendix 4) and evaluated their values in light of the 
support they lend to our NetGWAS results. As a positive control we investigated the 
region on chromosome 1 where Vkorc1 maps and both statistics provided clear 
evidence for selection at this region. 
3.2.5.2. Linkage disequilibrium (LD)  
We calculated the pairwise r-square values of SNPs and used haploview 
(Barrett et al. 2005) to assess LD blocks along each chromosome. Some of the 
candidate regions that featured large LD blocks are highlighted in Appendix 4. To 
study the rate of decay of LD with chromosomal distance we plotted the pairwise r-
square values against distance in megabases separating any two SNPs for the whole 
genome data collected for the NW population (Figure 3.5). 
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Figure 3.5 – Pairwise r-square against the distance between SNPs. 
For the highlighted candidate regions with LD blocks in Appendix 4, we 
plotted the LD matrix of NW and LH samples using a modified R package snp.plotter 
(Luna and Nicodemus 2007). First, for the sweep region associated with the known 
resistant gene Vkorc1 (172-202 Mb on chromosome 1), we surprisingly noticed that 
the LD blocks of NW non-resistant rats are stronger than resistant rats (Figure 3.9A 
and B). To understand this non-intuitive finding we performed forward-time 
population genetic simulations (see below for the parameter settings) for the Vkorc1 
sweep region using Python scripts in the environment of simuPOP (Peng and Kimmel 
2005; Peng, Amos, and Kimmel 2007). We found that the LD blocks obtained for the 
sample of resistant rats in the population NW and for the corresponding sample of 
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non-resistant rats of the simulated population were plotted and compared (Figure 
3.9C). For other interesting regions with LD block signals we plotted the pairwise r-
square for rats collected from populations NW and LH, as well as for non-resistant 
resistant rats from population NW (Figure 3.9D-G). The comparisons between them 
potentially reveal the action of selection.  
Forward-time simulation settings. We followed the parameter settings used 
during the simulation study described in Chapter 2. Briefly, population size was set as 
1,000 diploid randomly mating individuals, and a recombination rate r = 2 × 10-3 per 
megabase per generation. Simulations were run to represent 100 generations 
corresponding to the time frame of 1965-1998 as estimated in Chapter 2. SNP sites: 
100 SNPs located surrounding the Y139C mutation in Vkorc1 (30 Mb) with their 
initial allele frequencies set according to the values in the control population LH. As 
suggested (c.f. Chapter 2), we assumed the adaptive variation on Vkorc1 gene as a 
new mutation under balancing selection model. SNPs surrounding Vkorc1 were 
hitchhiked with the adaptive variation. The selection coefficient s was 0.3 (estimated 
based on time-series data) with t = 0.1 as the fitness cost for the mutant homozygotes. 
The penetrance model for the adaptive SNP in Vkorc1 was estimated as 0.069, 0.947 
and 0.983 for wild homozygotes, heterozygotes and mutant homozygotes respectively. 
At the last generation, we obtained the genotype data for all the 100 SNPs and plotted 
their LD matrix for resistant and non-resistant samples respectively using the LD 
measure r-square. 
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3.3. Results 
3.3.1. GWAS identifies candidate SNPs 
As shown in Figure 3.1, genomic association analysis was first performed on 
7317 informative SNPs. Then SNPs were mapped on genes, and gene scores are the 
association strengths of the assigned best SNPs. With a network perspective, we 
combined the association information with genetic networks to identify candidate 
genes by the computed gene ranks. Complementary to the traditional GWAS, the 
network-guided GWAS is a gene-based identification approach considering prior 
knowledge of gene-gene interactions and SNP association.  
3.3.1.1. 82 top candidate SNPs detected based on association tests  
29 rats from a resistant population NW and 12 rats from a non-resistant 
population LH were sampled from northwestern German and collected for rat 10k 
SNP array experiments (c.f. Methods and Materials). For the resistant population 
NW, when we performed the genotype-phenotype association test, an inflation factor 
λ = 1.17 showed some evidence for inflation of chi-squared tests (we don’t pool NW 
and the non-resistant population LH together for association test because the high 
inflation factor of 2.9 implied the existence of population structure). So we do 
genomic correction and look at the genomic control adjusted significance value (GC) 
and the significance value corrected for multiple testing such as the step-down 
Bonferroni (HOLM) values. There are 31 SNPs with GC significance values < 0.05. 
After corrections for multiple testing only one SNP (Y139C) on the known resistant 
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gene Vkorc1 significantly associated with warfarin resistance (Figure 3.6A). The 
Bonferroni adjustment might be too conservative with the null hypothesis of no 
causal SNPs expected. Especially when we corrected for multiple testing based on 
genomic controlled values, even the known resistance SNP on Vkorc1 gene showed 
no association.  
Alternatively, Bayesian association analysis computed Bayesian Factor  (BF) 
to measure association strength, which is similar to a likelihood ratio (Servin and 
Stephens 2007; Stephens and Balding 2009). The larger BF means stronger support 
for association (H1) against no association (H0). Thus log10 (BF) = 0 indicates not able 
to discriminate H1 from H0 (Stephens and Balding 2009). BF1 was computed 
assuming additive model and BF2 was assuming dominance model during the 
Bayesian analysis. Without prior knowledge of the genetic model for most regions, 
these two measures (BF1 and BF2) are considered together. Including the known 
resistance mutation (Y139C) on Vkorc1, there were only 3 SNPs with log10 (BF1)  > 
2 and 8 SNPs with log10 (BF2)  > 2 (Figure 3.6B and C). We selected 82 SNPs (data 
not shown) with the log10 (BF1) ≥ 1 or log10 (BF2) ≥ 1 for future comparison with the 
results of a network-guided GWAS approach. Among the 82 SNPs, 15 SNPs are 
located in coding region. Two regions at chromosome 3 (157-158 Mb) and 
chromosome 5 (54-56 Mb) contain ≥ 3 SNPs. 
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Figure 3.6 – The genomic association signals (Manhattan plot). (A) The log10P-values 
of genotype-phenotype chi-square test (controlling for sex). (B) and (C) The log10BF1 
and log10BF2 (Bayes Factors calculated in Bayesian association analysis assuming 
additive model and dominance model respectively). 
3.3.1.2. SNP-Gene mapping and gene score 
We move from SNP level to gene level by assigning SNPs to genes and 
computed the gene score based on the highest Bayesian Factor (BF) of SNP for each 
gene. As shown in Table 3.1 and Figure 3.2, about 1/3 (2,893 SNPs) of the 7,317 
SNPs were located within genes, and 913 SNPs were in coding region. The ±50 kb 
boundaries as used in VEGAS (Liu et al. 2010) to capture surrounding regulatory 
regions were used during the mapping process. We also tried a wider gene boundaries 
of ±200 kb, which include more genes as well as potential noises. As one SNP could 
be assigned to multiple genes, we obtained 9,375 genes with scores using the ±50 kb 
boundaries and 19,775 genes with scores using the ±200 kb boundaries. The analysis 
results from these two gene score files would be combined later. 
Table 3.1 – Statistics of SNP-gene distance (X). 
All 
SNPs 
Within 
gene 
(X=0 Kb) 
0<X<1 
Kb 
1<X <10 
Kb 
10<X<100 
Kb 
0.1<X<1 
Mb ≥1 Mb 
7317 2893 253 826 1825 1455 11 
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3.3.2. NetGWAS identifies candidate genes by gene ranking based on a 
modified Google’s PageRank algorithm 
Genes are interacting with each other and the interactions are essential for 
performing and maintaining certain functions. With a network perspective, we could 
expand the traditional GWAS from isolated genes to interacting networks. We 
introduce NetGWAS, a modified Google PageRank algorithm, to combine genetic 
network information with gene-trait association measures. The PageRank algorithm, 
which basically ranks the importance of a webpage by the importance of other pages 
that link to it, is the key for the search quality of Google.  PageRank have been 
successfully adapted to Gene Ontology network (Morrison et al. 2005) and 
transcriptional network (Winter et al. 2012), facilitating the identification of gene 
markers.  
Here using NetGWAS, we integrate the information of phenotype association 
into genes as their features, which could spread in a gene-gene interaction network. 
Similar to the way of ranking webpages, genes interacting with more genes that are 
associated with resistance are given high ranks. Viewing in another direction, the 
association strength of one gene would spread to its neighbors and beyond depending 
on the network topology.  NetGWAS naturally integrate association measures as gene 
features spreading in the network; thus this algorithm not only prioritizes genes 
associated with resistance but also reveals functional related genes missing in the 
initial association analysis due to low SNP density. 
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3.3.2.1. Gene-gene interaction (GGI) network 
 The gene-gene interaction (GGI) networks are based on the protein-protein 
interaction and text-mining information provided by the STRING database 
(http://string-db.org/). After filtering interactions with score ≤ 150 as suggested 
344,481 interactions of 15,378 proteins remained for analysis. We matched proteins 
to genes, and then built two networks based on the genes from the gene score files 
with ±50 kb and ±200 kb boundaries. Thus Network1 analysis was based on 4,846 
genes and 50,095 interactions and, since wider gene boundaries were applied when 
assigning SNPs to genes during analysis Network2 a larger number of genes (9,382) 
and interactions (160,567) were available for analysis. The network degrees were 
found to follow a scale-free distribution (Figure 3.3). 
3.3.2.2. Gene ranking 
Gene ranks are obtained by solving a linear system that on one side represents 
the gene-gene interaction network and on the other side represent the calculated gene 
scores (c.f. Methods and Materials). Besides network topology the damping factor d 
is a parameter defined to describe how far the association measures or other gene 
features would spread in the network. Google uses a damping factor of 0.85 for web 
searches. In biological networks, however, the damping factors should be set lower 
because genetic networks are sparse (Clune, Mouret, and Lipson 2013). We used d = 
0.3 as suggested in a previous study of transcriptional networks (Winter et al. 2012). 
Also, we tried to calculate a dynamic damping factor ddfi for each node in our 
network according to Fu et al’s suggestion (Fu, Lin, and Tsai 2006) and used the 
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average ddf as the damping factor for the whole network. For our analysis Network1 
(±50 kb boundaries) the average ddf is 0.03 and for the analysis Network 2 (±200 kb 
boundaries) average ddf is 0.02. Thus for Network1 and Network2, respectively, we 
obtained four files containing gene ranks based on BF1 and BF2 as gene scores 
computed using d = 0.3 or ddf as damping factors.  
3.3.2.3. Evaluation and correction of gene ranking results 
Based on the gene ranking results we investigated how different the results 
would be compared to those obtained based on the association strength measures 
calculated without considering any network information. Furthermore, there might be 
situations where some candidate genes are given high ranks because of their 
popularity (high degree) in the network instead of any association with warfarin 
resistance. If this were the case, then these genes would have high ranks under certain 
network topologies regardless of their gene scores. Thus, we evaluated the NetGWAS 
by comparing the ranking results under four different scenarios: (1) Only based on 
gene score; (2) Only based on network; (3) Randomized gene score; (4) Real gene 
ranking (c.f. Materials and Methods for details, Figure 3.4A). Taking BF1 in analysis 
Network1 as an example we found that the top 50 genes selected from the above four 
approaches display overlap (Figure 3.4B). For example, 21 genes selected based on 
both the gene association score (1) and gene ranking (4) emerged as candidate genes. 
However, 14 candidate genes from real gene ranking (4) analysis emerged also from 
the analysis based on equal scores (4) for all genes in the network, and thus should be 
treated with caution. Especially 11 of these 14 genes have high random probabilities 
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of being selected as top 50 in networks even when randomly shuffled gene scores (3) 
were assigned to them. This observation thus reminds us of the necessity of correcting 
the ranking results, foremost in light of the network topology. 
As suggested by the above analyses there are some genes with inflated high 
rank scores due to network topology rather than trait relevance. Therefore we used 
random probabilities of being selected as top 50 genes with randomly shuffled gene 
scores and the difference between the two damping factors to correct the gene rank 
scores. As mentioned earlier, we obtained two files (with two damping factors: d=0.3 
and ddf) for Network1 and BF1. Correction was applied to ranking results from each 
file, and then we selected the top 50 genes from the two files and pooled them 
together (Figure 3.4D). A similar correction process was applied to each gene score 
measure and each network before we pooled the lists from different analyses together 
to form a final list with 87 candidate genes (Figure 3.4E). In the process of combining 
candidate genes, we assessed whether genes had multiple supporting evidences from 
different sources by supporting scores (c.f. Methods and Materials, Appendix 4). 
3.3.2.4. Candidate genes identified from GGI network 
Comparison between the traditional GWAS results of candidate SNPs, 75 of 
the 87 candidate genes had top candidate SNPs nearby. Most (72 genes) of the SNP-
gene distances are < 0.2 Mb and 16 genes contain the SNPs. 37 SNPs could not be 
matched to an annotated gene. Though most of these were with log10BF around 1-1.4, 
only one SNP (S695137) on chromosome 16 carried a relatively high association 
score (log10BF2 > 2).  
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Once we grouped the 87 candidate genes by their physical locations (within a 
5 Mb distance) we observed 41 candidate regions. Considering the potential effect of 
a selective sweep on physically linked and proximal genes we highlighted those 
regions with multiple candidate genes located within them (Appendix 4). We 
observed that 48 candidate genes cluster in 10 regions with each cluster containing ≥ 
3 genes. Conceivably, one or more genes located in each cluster are the causal genes 
under warfarin selection while the others appear as associated SNPs solely due to 
genetic hitchhiking effect. 
As the primary resistance gene (Rost et al. 2004; Pelz et al. 2005), Vkorc1 was 
ranked 1st in all the ranking files. Moreover, with high Bayesian association scores 
(log10BF > 4) and absence from the equal score ranking results, Vkorc1 gained the 
highest supporting scores (12) calculated from the summary of results obtained from 
multiple sources. Did not observe a large region of candidate genes around Vkorc1 
here since we already manually removed these hitchhikers surrounding Vkorc1 to 
decrease the noise in the data. Among the 87 candidate genes, there are 8 genes with 
the same supporting scores (12) as Vkorc1 and a total of 45 genes with supporting 
scores > 5. Consideration of their Bayesian association scores resulted in are 3 genes 
with log10BF1 > 2 and 17 genes with log10BF2 > 2, in addition to Vkorc1. 
The degrees of nodes, representing the number of network neighbors 
connecting any gene, are listed in Appendix 4. In the Network1 analyses the average 
degree of these 87 candidate genes is 29.8, which is somewhat higher than the mean 
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value of 21 computed for the entire network. In analysis Network2, the average 
degree of 58 candidate genes is 61, compared to 34 for the whole network.  
Prior to the correction of the ranking results the average degree for the 
selected candidate genes was 83 and 155 for Network1 and Network 2 respectively. 
This indicates that indeed some candidate genes were selected due to their popularity 
(high degree) in the network, which may not necessarily reflect their relevance to 
warfarin resistance. However, after correction, most such inflated rankings appear to 
have been reduced appropriately. For example, previously selected Akt1 has high 
node degree and high random probability; now is absent from the candidate gene list 
after correction. 
 We expect that recent and intense selection on adaptive variants would occur 
on genes with moderate degree, since hub genes with many neighbors tend to be 
conservative to changes and isolated genes with too few neighbors can hardly affect 
fitness. Vkorc1 gene has moderate node degree of 9 neighbors in Network1 and 12 
neighbors in Network2. Thus, this recently evolved mutation is predicted to have 
moderate number of effects on other genes but clearly has the potential to result in a 
multi-genic response to selection as well as the manifestation of a pleiotropic fitness 
cost by affecting important pathways (c.f. Chapter 2).  
Incorporating network information for genomic association analyses tends to 
identify genes and their neighbors that are connected in the network if they also have 
relatively high association strengths.  
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B. 
 
Figure 3.7 – The GGI network and GO for candidate genes. (A) GGI network. Nodes: 
genes; edges: gene interactions. Node size represents the support score of each gene. 
Genes (red nodes) belong to the cluster of interacted genes (red edges) centered with 
Vkorc1; isolated genes (blue nodes) and the genes belonging to other small clusters 
(orange nodes) are connected with the Vkorc1 cluster by chromosomal proximity 
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(blue edges). (B) GO network. With the same color code for nodes, here the edges 
indicate that genes share similar functions based on function annotation analysis. 
Here we examined whether these 87 candidate genes form clusters by building 
a sub GGI network showing the interactions among candidate genes. A main cluster 
centered about Vkorc1 indicates that most candidate genes in fact could interact with 
the main resistance gene (Figure 3.7A, red nodes and edges). Bigger nodes are genes 
with higher supporting scores. Among the 40 genes in the main cluster, there are 12 
genes that are directly connected with Vkorc1 (Ptgs2, Cyp4f1, Mgp, Calu, Ppig, Tdo2, 
Ggcx, Tpmt, F2, Bglap, Orm1, RT1-S3). Separate from the main Vkorc1 cluster, there 
are 34 isolated genes in terms of network interactions and 13 genes form 5 small but 
separate clusters.  
However, if we also considered the physical location of candidate genes by 
connecting them in the network if the map within a 5 Mb chromosomal distance (blue 
edges), some isolated genes (blue nodes) and small clusters of genes (orange nodes) 
were then re-connected to the main Vkorc1 cluster (Figure 3.7A). Only10 isolated 
genes remained separate from the main cluster, 5 of them located in 2 chromosomal 
regions. This representation allows us to explore the relationships among candidate 
genes in two dimensions: network interaction and chromosomal proximity. Further it 
enables us to distinguish those genes that may be of functional relevance in our study 
context from genes that merely are hitchhikers of nearby selective sweeps in 
candidate gene regions. For example, region 153 – 158 Mb at Chromosome 3 is 
composed of 9 candidate genes, and some of them reveal relatively strong association 
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signals. However, there is no prior knowledge about warfarin resistance and these 
genes. In Figure 3.7A we saw 5 genes (Mybl2, Cse1l, Ift52, Sgk2, Arfgef2) that are 
connected to the Vkorc1 network cluster, and another 4 genes are just their physical 
neighbors. This observation connected this region on Chromosome 3 to the main 
Vkorc1 cluster in network, and thus increases our knowledge about the potential 
candidate genes. 
Overall, we obtained a ‘warfarin resistance module’ that mainly was 
composed of 40 candidate genes related to the vitamin K pathway, and some other 
candidate genes that are in chromosomal proximity to them (Figure 3.7A). This 
observation is consistent with the human ‘disease module’ which connects certain 
disease with a well-defined neighborhood of the interactome (Barabasi, Gulbahce, 
and Loscalzo 2011). 
3.3.2.5. Candidate genes share similar functions 
To evaluate the functions of the candidate genes, the GO (Gene Ontology) and 
KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway analyses were 
performed in DAVID (http://david.abcc.ncifcrf.gov). For each of the functional 
(GO/pathway/protein domain) categories associated with candidate genes, the 
enrichment score was obtained by comparing candidate genes with the background 
gene list. Functional categories were grouped into 37 clusters by functional similarity. 
Keeping the clusters with at least one functional category with enrichment P-values ≤ 
0.05, we obtained 19 functional clusters (Appendix 5).  
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To further explore their functional relationships, we built a GO network for 
candidate genes in which genes are connected if they share similar functions. As 
shown in Figure 3.7B, this GO network is densely connected (in average, each gene 
share function with 33 genes), which further implies the high functional relevance 
among candidate genes. More specifically, 40 candidate genes share at least one 
functional category with Vkorc1 (GO/pathway/domain). To compare these results 
with the sub GGI network built from the list of candidate genes (Figure 3.7A), we 
used the same color codes for genes in this GO network. Most genes belong to the 
Vkorc1 GGI network cluster (red) and constitute a dense cloud of high functional 
similarity (Figure 3.7B). 
3.3.2.6. Summary of top candidate genes 
In Table 3.2, we showed the top candidate genes with supporting score > 5 (all 
of the 87 candidate genes and more details on them are provided as Appendix 4). For 
each gene, we provide the top two functional terms. We also depicted the functional 
enrichment of genes across different functional clusters after assigning each gene 
with the highest enrichment score of the functional category in each cluster (Figure 
3.8).  
Vkorc1 is a known warfarin resistant gene and our approaches consistently 
ranked the gene 1st during both traditional GWAS and NetGWAS. According to 
Figure 3.8, Vkorc1 is involved in 5 functional clusters (sorted from high to low 
enrichment scores): c6 - regulation of blood coagulation, c13 - positive regulation of 
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multicellular organismal process, c18-endoplasmic reticulum, c11 - response to 
organic substance and endogenous stimulus, c9 - disulfide bond. 
Nine genes located in between 153-158 Mb on chromosome 3 exhibited 
relatively strong signals in terms of Bayesian association scores and supporting scores 
based on multiple ranking results (Appendix 4). Prex1 in this region has the highest 
gene score (log10BF2 = 2.97) other than Vkorc1. But based on Figure 3.7A, Prex1 
was not connected to the Vkorc1 cluster in the sub GGI network. Other two genes 
(Ift52 and Mybl2) that map around 4 Mb away from Prex1 also carry relatively high 
gene scores (2.42) and high supporting scores (12). Moreover, they are connected 
with the Vkorc1 functional cluster in the network (Figure 3.7A). Thus this region is of 
great interest for further exploration, and we can start such explorations by examining 
the Ift52 and Mybl2 genes. 
Another region located on chromosome 19 from 49.5-49.8 Mb caught our 
attention since 8 genes in this region have relatively high supporting scores. The two 
genes with the support score of 12 are involved in fatty acid metabolic process and 
growth factor activity. In this region, only one gene Mbtps1 seems to connect with the 
Vkorc1 cluster in the sub GGI network (Figure 3.7A). As shown in Table 3.2, Mbtps1 
shares the function of “endoplasmic reticulum” with other 5 genes including Bche, 
Calu, Ggcx and Cyp4f1. 
 
Table 3.2 – Top candidate genes based on gene ranking (NetGWAS of SNP array I). 
Gene SupportScore 
Can
SNP Chr 
GeneStart 
(Mb) 
GS 
(logBF) NetDegree Function or GeneName 
Parva 11 2 1 170 1.70 26 membrane 
Xylt1 6 2 1 176 1.36 12 regulation of response to external stimulus;endoplasmic reticulum 
Vkorc1 12 1 1 187 6.22 12 
regulation of blood coagulation; positive regulation of multicellular 
process 
Fgfr2 6 1 1 189 1.91 192 bone development; positive regulation of cell proliferation. (FGFBP2) 
Bche 12 1 2 164 1.74 85 endoplasmic reticulum lumen;response to endogenous stimulus 
Tdo2 7 0 2 174 0.12 323 oxidoreductase 
Bglap 7 1 2 180 0.05 274 gamma-carboxyglutamic acid; bone mineralization 
Wdr3 6 2 2 195 1.75 30 WD repeat domain 3 
Unc5c 7 1 2 240 1.30 10 disulfide bond;extracellular 
Bmpr1b 10 1 2 240 1.30 48 regulation of bone mineralization; reproductive developmental process 
Ppig 8 0 3 52 0.19 55 intracellular organelle lumen 
F2 8 1 3 76 0.21 105 gamma-carboxyglutamic acid; regulation of blood coagulation 
Rin2 12 1 3 134 2.44 9 Ras and Rab interactor 2 
Nat5 12 1 3 135 2.44 8 N-acetyltransferase activity 
Sfrs6 6 1 3 154 2.42 48 serine/arginine-rich splicing factor 6 
L3mbtl 6 1 3 154 2.42 1 intracellular organelle lumen 
Sgk2 6 1 3 154 2.42 11 phosphorus metabolic process 
Ift52 12 1 3 154 2.42 14 intraflagellar transport 52 homolog 
Mybl2 12 1 3 154 2.42 45 myeloblastosis oncogene-like 2 
Prex1 12 3 3 158 2.97 21 phospholipid binding 
Cse1l 11 3 3 158 1.28 51 CSE1 chromosome segregation 1-like 
Calu 8 0 4 56 0.56 51 endoplasmic reticulum lumen;cytoplasmic membrane-bounded vesicle 
RGD1565690 6 1 4 88 2.07 5 GPRIN family member 3 
Ggcx 8 0 4 106 0.23 24 disulfide bond;endoplasmic reticulum 
Mgp 8 0 4 174 -0.03 118 gamma-carboxyglutamic acid; bone mineralization 
Gne 6 1 5 61 1.30 37 glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase 
Tex10 11 1 5 65 1.75 4 testis expressed 10 
 SupportScore: genes’ support score based on multiple ranking results. Bold gene names are genes with highest support scores. 
CanSNP: the number of matched candidate SNPs from traditional GWAS. 
Chr and GeneStart (Mb): genes’ position on chromosome. 
GS(logBF): gene score based on Bayes Factor (max(log10BF1, log10BF2) here). 
NetDegree: the number of other genes connected to each gene in network (Network2 here).Function or GeneName: the description of GO terms (KEGG or 
protein domain category if no GO) within the cluster with the top two enrichment score for each gene; 
 
Tmeff1 6 1 5 65 1.75 47 domain:EGF-like; disulfide bond 
Rock2 7 2 6 41 1.27 84 Rho-associated coiled-coil containing protein kinase 2 
Ptprn2 6 1 6 144 1.25 45 membrane-bounded vesicle; cytoplasmic membrane-bounded vesicle 
Cyp4f1 8 0 7 14 0.30 39 endoplasmic reticulum; membrane 
Tbx3 10 1 12 38 1.41 25 skeletal system development; reproductive developmental process 
F5 10 1 13 80 1.36 52 cytoplasmic vesicle part;wound healing 
Slc19a2 8 1 13 80 1.36 10 integral to membrane 
Fhit 9 2 15 17 1.37 161 fragile histidine triad 
Tpmt 8 0 17 24 0.14 20 integral to membrane 
Hsbp1 6 1 19 50 2.20 7 heat shock factor binding protein 1 
Necab2 6 1 19 50 2.20 1 N-terminal EF-hand calcium binding protein 2 
Mlycd 12 1 19 50 2.20 34 fatty acid metabolic process 
Osgin1 12 1 19 50 2.20 5 growth factor activity 
Mbtps1 6 1 19 50 2.20 140 endoplasmic reticulum;Golgi apparatus part 
Hsdl1 6 1 19 50 2.20 1 oxidation reduction 
Lrrc50 6 1 19 50 2.20 6 cell morphogenesis 
Taf1c 6 1 19 50 2.20 57 intracellular organelle lumen 
Tff1 8 1 20 10 1.37 54 secreted;growth factor activity 
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Figure 3.8 – The enrichment anaysis of functional categories. Left sidebar use color 
to separate candidate genes from different regions. 
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Bche carries the highest support score of 12 as Vkorc1. Calu and Ggcx are the 
genes involved in vitamin K cycle. Warfarin inhibits VKOR (encoded by Vkorc1) 
activity, and thereby impairs the recycling of vitamin K hydroquinone, which is an 
essential cofactor for gamma-carboxylation of downstream vitamin K dependent proteins 
(Presnell and Stafford 2002; Pelz et al. 2005; Stafford 2005). 
Ggcx, which encodes the gamma-glutamyl-carboxylase complex (GGCX), is the 
other important cofactor in the gamma-carboxylation system (Markussen et al. 2007b). 
Calu has been shown to regulate the vitamin K-dependent gamma-carboxylation system 
(Markussen et al. 2007b) and competes with warfarin for the binding-site in the VKOR 
complex (Markussen et al. 2007a). Cyp4f1 gene belongs to the cytochrome P450 gene 
family; most CYP450 gene members encode enzymes functions in metabolism of small 
molecules and xenobiotic compounds (Thomas 2007; Pautas et al. 2009). In addition to 
VKORC1, the other two gene markers (CYP2C9 and CYP4F2) used in human for dosage 
prediction are also members of this family (Rost et al. 2004; Takeuchi et al. 2009). 
CYP2C9 metabolizes the S-form warfarin, and CYP4F2 is believed to catalyse 
hydroxylation of vitamin K1 (McDonald et al. 2009). In the rat, Cyp4f1 gene is the 
orthologous gene to CYP4F2 in human. 
As shown in Table 3.2 and Appendix 4, some vitamin K dependent proteins were 
selected out as candidate genes (also c.f. Appendix 8, Figure 5.2), such as F2, F5, Bglap 
and Mgp. Both F2 and F5 are blood coagulation factors activated via gamma-
carboxylation system, which thus are directly affected by VKOR activity and warfarin 
(Stafford 2005). Some other vitamin K dependent proteins Bglap (bone gamma-
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carboxyglutamic acid-containing protein) and Mgp (matrix gla protein, calcification 
inhibitor) play roles in vessel calcification and bone mineralization (Suttie 1993; 
Danziger 2008). A previous study did observed arterial calcification in resistant rats with 
reduced activity of VKOR (Kohn, Price, and Pelz 2008). Thus, it is interesting to 
encounter these vitamin K dependent genes and other such genes (Bmpr1b and Fgfr2) 
involved in bone development as candidate genes related to warfarin resistance in this 
NetGWAS. Fgfr2 (fibroblast growth factor receptor 2) is 2 Mb away from Vkorc1 on 
Chromosome1, so it might be hard to distinguish true association from false association 
due to the selective sweep at Vkorc1. Interestingly, a recent genomic scan in humans for 
warfarin dose related genetic variants revealed FGFBP2 (fibroblast growth factor binding 
protein 2) gene has a relatively high genotype-dose association in addition to VKORC1 
and CYP2C9 (Cooper et al. 2008). This finding reminds us of the potential importance of 
Fgfr2 gene even though it might be under the sweep effect on the resistance gene Vkorc1. 
We noticed that Bmpr1b is also related to reproductive development, which might be a 
coincidence or an interesting lead as resistant rats have reduced reproduction and growth 
rates. Previous studies also suggested that the effect of MGP on calcification is 
determined by the relative amounts of MGP and the bone morphogenetic protein-2 
(BMP-2) (Zebboudj, Shin, and Bostrom 2003). Here we observed the gene Bmpr1b in our 
candidate list and the gene is a bone morphogenetic protein receptor. 
In addition, there is one more region at 60 - 65 Mb on chromosome 5 covering 
multiple (6) genes (Appendix 4). In this region, the Tex10 gene has a high support score, 
and it is a testis-expressed gene, which suggests us to further explore its role in sex 
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difference related to anticoagulant resistance, as male rats seem to be more sensitive to 
rodenticides (Kohn and Pelz 1999).  
We noticed that some candidate genes have low gene scores (with logBF < 1). 
They were prioritized, however, based on their interactions with genes associated with 
warfarin resistance. For example, the Orm1 gene has a low (logBF1 = 0.02) association 
strength measured by Bayes Factor but it is interesting to retain it here in the candidate 
list because a previous study on warfarin pharmacokinetics revealed that warfarin is 
bound to the proteins encoded by ORM1 and ORM2 during its transportation from 
stomach to liver in human (c.f. Appendix 8, Figure 5.2) (Wadelius et al. 2007). These 
genes would probably be missed in the traditional GWA study without network 
information, especially when SNP density is low.  
3.3.3. Population genomic analysis supports 6-8 out of candidate regions 
Selection would leave differentiated genetic signatures between populations under 
different environments. Here we compared the population genetic signals of the resistant 
population NW with the non-resistant population LH. Limited by the low density of SNP 
data, we used these signals as supporting evidence for above candidate gene regions. 
3.3.3.1. Measures of haplotype structure detect recent selection  
Extended haplotype homozygosity (EHH) has first been developed to detect 
recent selection by assessing the decay of LD along the chromosome (Sabeti et al. 2002). 
Then other two measures of haplotype structure were developed based on it. By 
comparing the integrated EHH between ancestral and derived alleles, large positive or 
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negative iHS score indicate unusually long haplotype carrying ancestral or derived alleles 
respectively (Voight et al. 2006). We calculated iHS scores and found 27 SNP with |iHS| 
> 2 in the NW population; 17 of them could be matched to 8 candidate regions (Appendix 
4). However, iHS could not be calculated around the known resistant gene Vkorc1 
because of low SNP density. We also computed the cross population EHH (XP-EHH), 
which is the natural log of the ratio between the iHS score from LH and NW population 
(Sabeti 2007). Large negative XP-EHH thus suggests selection in the NW population. In 
total, we found 12 SNPs with XP-EHH < -2; but only 2 of them could be matched to 
candidate regions (Appendix 4). One peak of both the iHS and XP-EHH measures is the 
chromosome 12: 34 – 38 Mb region, including the Tbx3 gene, which is involved in 
reproductive developmental process and mediated by bone morphogenetic protein (BMP) 
signals (Chen et al. 2009). 
3.3.3.2. Blocks of linkage disequilibrium reveal signals of selection 
To check the pattern of LD decay over distance, we plotted the r-square values 
along chromosomes in both the NW and LH populations (Figure 3.5).  
Selection usually creates LD blocks different from the background, thus regions 
carrying adaptive genetic variants should be detectable by searching for LD blocks. In the 
software Haploview (Barrett et al. 2005) we compared LD patterns using the pairwise r-
square matrix of each chromosome for both the NW and LH populations. LD blocks at 6 
regions were found and marked besides the candidate gene regions (Appendix 4). There 
are 3 LD blocks (Chr1: 249 Mb, Chr6: 72 Mb and Chr12: 21Mb) that were recognized in 
Haploview but that cannot be matched with any of candidate gene regions, which might 
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be interesting or simply due to demographic effects. Below we focus on LD block 
regions where candidate genes map, and these are the Vkorc1 region, Ggcx gene, Tex10 
gene region and the region on chromosome 3: 153-158 Mb that have support from LD 
analysis. 
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Figure 3.9 – The linkage disequilibrium blocks in resistant population NW and non- 
resistant population LH (A and D); LD blocks in resistant and susceptible samples within 
NW population (B and E). Simulated LD pattern in resistant and non-resistant rats (C). 
First, for the known resistance gene Vkorc1, LD blocks surrounding it (172-202 
Mb on Chr1) were observed in the resistant population NW but not in the control 
population LH (Figure 3.9A). But surprisingly we also found that the NW non-resistant 
rats have stronger signals of LD blocks than resistant rats (Figure 3.9B). 
To assess whether this observation is merely a special pattern in NW population 
or a generally useful signal, we performed forward simulations with the selection 
coefficient s = 0.3 as well as other parameters as estimated in a study of Vkorc1 sweep 
patterns (c.f. Chapter 2). After 100 generations we plotted the pairwise LD based on 
simulated data within resistant and non-resistant rats respectively. We did observe that 
LD signals of non-resistant rats are stronger than in resistant rats in the simulated 
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population after selection (Figure 3.9C). The differences of LD signals between resistant 
and susceptible rats were not as strong as we observed in Figure 3.9B, since 1,000 rats in 
population were allowed with random mating in the simulation, which might be a larger 
population size than the true effective population sizes of isolated demes of free-living 
rats. 
For other candidate regions, such as the region at Chr3 from 141 to169 Mb, we 
compared the LD blocks between the NW and LH populations, and also between the NW 
resistant rats and the NW non-resistant rats. Similar to with the pattern observed for the 
Vkorc1 region, in terms of the LD signals, we observed that: NW(susceptible) > NW(all) 
> NW(resistant) > LH (Figure 3.9D and E). This finding implies that selection has acted 
on this region; again, and it suggests that susceptible samples in a population that 
underwent selection would provide useful signals for detecting adaptive variations. The 
LD patterns were used as complementary source of information used to detect candidate 
genes. For example, though no candidate genes were identified on chromosome 1: 240-
259 Mb region, there are LD block signals; this region covers some cytochrome P450 
genes: Cyp2c22, Cyp2c23 and Cyp2c11. Cyp2c11 (cytochrome P450, subfamily 2, 
polypeptide 11) is the most possible ortholog of the human biomarker gene CYP2C9 
(Appendix 4). And Cyp2c22 (cytochrome P450, family 2, subfamily c, polypeptide 22) is 
closely clustered with the CYP2C9 group in the phylogenetic tree (Thomas 2007). 
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3.4. Discussion 
3.4.1. GWAS – Bayes factors measure association strength 
With the null hypothesis H0 of no association, there are several advantages of the 
imputation based Bayesian statistical method. First, by computing the Bayes Factor (the 
ratio of probability under H1 and probability under H0) for each SNP, Bayesian formula 
“posterior odds = prior odds × BF” naturally integrated information across SNPs (Servin 
and Stephens 2007); thus yield more reliable results. Moreover, the Bayes Factor, as the 
likelihood ratio between H1 and H0, could assess the association strength. This feature 
makes the Bayes Factor as a good measure of association, which is used as gene score in 
the Network-guided GWAS analyses.  
Second, P-values obtained from the standard association test are affected by 
factors such as the size of tests and MAF (minor allele frequency) (Stephens and Balding 
2009). But removing low-MAF SNPs would introduce the risk of excluding meaningful 
associations. Besides, the methods to account for multiple testing, such as Bonferroni 
correction, assume that no true associations exist in the genome, which is not a 
reasonable in practice because as in our case study we ‘knew’ a priori of at least one 
significant association and numerous others due to genetic hitchhiking. Thus, P-values 
have limited value to detect true associations. Using Bayes Factor, the problem raised in 
multiple testing is alleviated (Stephens and Balding 2009). 
Third, taking advantage of the linkage disequilibrium (LD) among nearby SNPs, 
unmeasured genotypes could be estimated (“imputed”). And the imputation process 
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naturally controlled for the confounding factor of LD among nearby SNPs, and thus is 
expected to have increased our power to detect associations (Servin and Stephens 2007).  
We applied two genetic models to compute Bayes Factors: BF1 with the additive 
model (σd (dominance effect) = σa (additive effect) / 4 as suggested (Servin and Stephens 
2007; Manna, Martin, and Lenormand 2011) and BF2 with the dominance model (σd = 
σa). As reported in the study of the Vkorc1 sweep region (Chapter 2), Vkorc1 is under 
over-dominance selection (c.f. Chapter 2). During the Bayesian association analysis, 
different selection models yielded different Bayes Factors; for Vkorc1 the over-
dominance model had the strongest signal. Thus, here for the genome scan, we 
considered the dominance model in addition to the general additive model. 
3.4.2. NetGWAS facilitates candidate identification 
There are several measures that can be used to quantify the role of genes in the 
network: 1) Degree centrality simply counts the number of neighbor genes connected to 
one node; 2) Closeness centrality is the inverse of a gene’s farness, which is the sum of 
its shortest path distance to all other nodes; 3) Betweenness centrality is the probability of 
one gene occurring on a randomly chosen shortest path between two randomly chosen 
nodes; 4) Eigenvector centrality is a measure of a gene’s influence by considering both 
the quantity and quality of its neighbors because not all connection are equal in the 
context of a phenotype (Davis et al. 2010). Google’s PageRank algorithm computes the 
eigenvector as page ranks based on the number of pages linked to it and the ranks of 
these (Page et al. 1999).  
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Previous studies have successfully modified and applied the PageRank algorithm 
to Gene Ontology network analysis and transcriptional network analysis (Morrison et al. 
2005; Winter et al. 2012). Here we adapted it to an analysis of a gene-gene interaction 
network to expand the traditional search for candidate genes as implemented by GWAS. 
This algorithm naturally integrates association measures as gene features that are allowed 
to spread in the network. The gene ranks are then computed as eigenvector by resolving a 
linear system of network topology and gene scores. Thus, computed gene ranks are not 
only dependent on the network topology but also are determined by gene scores (here: 
association measures). There is another network-based method called Network Interface 
Miner for Multigenic Interactions (NIMMI), which first computes gene ranks solely 
based on network topology, and then using the Liptak-Stouffer formula to combine gene 
ranks with z-scores converted from association P-values (Akula et al. 2011). This 
combination, however, may not be a true integration of the trait/phenotype association 
into genetic networks. 
Google PageRank set the damping factor as 0.85, which is not suitable for much 
more sparse biological networks. Previous studies have used damping factor d = 0.3~0.95 
(Morrison et al. 2005; Winter et al. 2012). We tried d = 0.3, evaluated as a good choice in 
transcriptional network (Winter et al. 2012). We also computed a dynamic damping 
factor for each node as suggested (Fu, Lin, and Tsai 2006) and used the average value ddf 
as damping factor for the whole network. The ddf for Network1 is 0.03 and ddf for 
Network2 is 0.02, which again reflected the sparse interaction in GGI network. We 
combined the rank results from both d = 0.3 and ddf to increase the reliability.  
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3.4.2.1. Limitation of the gene ranking 
It is important to be aware of some limitations of network-based ranking 
approach. First, there are biases of the genetic interaction information (Barabasi, 
Gulbahce, and Loscalzo 2011). Some widely studies genes have more connections, 
whereas some new identified genes have less or none. Second, some genes will be given 
high rank due to network topology rather than their association with trait. We justified 
this situation by correcting the gene ranks using random shuffled gene score. Third, if 
SNPs are located at intergenic region (> 200 kb to the nearest gene), these SNPs cannot 
be mapped on genes, thus the following network analyses cannot be conducted. 
Therefore, we kept the candidate SNPs selected from the traditional GWAS approach that 
cannot be assigned to candidate genes for future reference (data not shown). 
Nevertheless, network-based gene ranking not only prioritized genes with strong 
association signals, and also expanded our search for candidate genes in case that some 
genes are missing initially because of low SNP density. As the improvement of function 
annotation and protein-protein interaction identification, the quality of genetic network 
information will increase, and thus the power of network-based approach. 
3.4.3. Population genomic analysis supports 6-8 candidate regions 
3.4.3.1. Measures of haplotype structure require higher SNP density 
Population genomics signals are valuable for detecting adaptive variations among 
populations under different environments (Hernandez et al. 2011). Composite-likelihood 
ratio test based on genetic polymorphism has been commonly used to look for complete 
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sweeps and haplotype-based methods have been developed to discover ongoing sweeps 
(Kim and Stephan 2002; Sabeti 2007). The two measures of haplotype structure, iHS and 
XP-EHH, have been successfully used in previous studies (Voight et al. 2006; Sabeti 
2007). In our situation of rat 10k array, however, the resolution of these haplotype-based 
measures are limited because of the low SNP density. Along the genome, we only 
obtained 501 iHS scores for the resistant population NW and 129 XP-EHH scores 
between NW and the non-resistant population LH. We assigned the iHS and XP-EHH to 
the candidate regions (Appendix 4) as supporting evidence rather than signals for 
detection. 
3.4.3.2. Linkage disequilibrium (LD) signals selective sweep 
LD blocks are important features for detecting adaptive variations (c.f. Figure 
2.2A) (Kohn, Pelz, and Wayne 2000; Kim and Nielsen 2004). Here by splitting NW 
population that was under warfarin selection into two subgroups with different 
phenotypes, we surprisingly found that LD signals in susceptible samples are stronger 
than in resistant samples. By simulation and true data analyses, we showed that LD of 
susceptible rats could provide strong signals of selection. In general, this recognition 
reminds us to consider susceptible samples in experimental design and analyses. 
3.4.3.3. Conclusions 
With the aim to understand the genetic architecture of adaptation towards 
anticoagulant drug warfarin, we performed genomic scan for genotype-phenotype 
association signals. Based on traditional GWAS approach, we listed 82 SNPs with 
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relatively high association strength; two regions (chromosome 3: 157-158 Mb and 
chromosome 5: 54-56 Mb) with ≥ 3 candidate SNPs were detected. Modified Google’s 
PageRank algorithm combines network information and gene-trait association to identify 
candidate genes by computing gene ranks. Among 87 identified candidate genes, 48 
genes were clustered in 10 regions. Population genomic analysis found supports for 10 
candidate regions based on haplotype structure measure and 6 blocks of linkage 
disequilibrium. Considering the gene-gene interaction and chromosomal proximity, we 
found that most candidate genes are directly or indirectly connected to vitamin K 
pathway, forming a ‘warfarin resistance module’ centered about the resistance gene 
Vkorc1. This picture depicts the genetic architecture of multiple genes involved in 
warfarin related pathways, which could be viewed as a single selective event having 
resulted in a multigenic response, but with a focus on sets of interacting genes.  
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Chapter 4 
Polygenic adaptation at the gene expression 
level to warfarin selection in the Norway rat  
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Abstract 
Genome-wide expression profiling potentially can reveals signals of adaptation 
that are manifest at the level of gene expression. In a wild-derived strain of Norway rats, 
we study the warfarin related expression changes across the genome. With the 
experimental design that contrasts resistant and susceptible phenotypes, each of these 
warfarin induced and non-inducted and represented by both sexes, here we built weighted 
co-expression networks and identified 591 candidate genes that displayed significant 
expression variations related to warfarin resistance phenotype (as determined by blood 
clotting response tests, BCR), warfarin resistance genotype (Y139C mutation in Vkorc1 
as determined by DNA analyses) and warfarin exposure as measured by injections of 
sublethal doses of the anticoagulant. These candidate genes formed 21 clusters. By 
comparing with previously identified candidate genes from a NetGWAS (Chapter 3), we 
identified 7 regions of clustered genes with support from both the NetGWAS analysis of 
SNP array data and the co-expression analysis conducted on RNA microarray data. 
Interestingly, although the mutation in the resistance gene Vkorc1 is an amino-acid 
change with no known effects on gene expression, the region where the Vkorc1 gene 
maps on chromosome 1 was identified as one of the 21 clusters. This is explained by high 
levels of cis-regulatory genetic polymorphisms underlying gene expression variation in 
wild populations of Norway rats, and their genetic hitchhiking with the Y139C mutation. 
This finding shows the promise to identify other regions with genes directly or indirectly 
affected by warfarin based on the genetic hitchhiking of SNPs that cause gene expression 
changes. Here we detected such cis-eQTLs by associating results of a genome wide 
single nucleotide polymorphism (SNP) analysis with an analysis of gene expression 
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profiles to obtain a list of genes that appear to form parts of the complex genetic 
architecture of warfarin resistance in the Norway rat. 
4.1. Introduction 
Gene expression is often considered as an important “intermediate level” 
connecting genotype with phenotype. Recent genome wide association studies of human 
complex diseases revealed many trait associated non-coding variations, which might be 
functional in gene regulation (Gilad, Rifkin, and Pritchard 2008). Gene expression 
analyses are applied to a wide range of medical research directions and thereby have 
greatly facilitated the identification of biomarkers and the elucidation of the genetic 
mutations causing diseases (Schadt et al. 2005).  
From the evolutionary biological perspective, gene expression regulation is an 
important mode of adaptation. For example, polymorphisms in 5’ upstream sites of the 
lactase gene regulate gene expression and contribute to the ability of human adults to 
digest milk; and in another system regulatory variation at the blood coagulation factor 
VII was reported for human populations under selection (Hahn et al. 2004; Tishkoff et al. 
2007; Kudaravalli et al. 2009). Analyses of gene expression profiles have made 
progresses in understanding the genetic basis of adaptation in human populations, 
especially when recently associated with genetic variation data (Morley et al. 2004; 
Dixon et al. 2007; Stranger et al. 2007; Gilad, Rifkin, and Pritchard 2008; Kudaravalli et 
al. 2009). In both biomedical research and evolutionary biology a key question in need of 
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empirical data refers to the number and type of genes (genetic architecture) involved in 
the expression of phenotypic trait; be it a disease or an adaptive trait.  
Previous analyses of differentially expressed genes have identified numerous 
diseases-associated candidate genes and biomarkers, individually and independently 
(Jafari and Azuaje 2006; Maertzdorf et al. 2011). However, working interactively rather 
than in isolation, genes act in concert to constitute expression and regulatory networks, 
which are translated (in response to cellular and extracellular cues) into phenotypes 
(Wittkopp 2007). Therefore, a network-based analysis approach appears to be a natural 
choice for the analysis of gene expression data. In fact, a co-expression network with 
genes as nodes and expression similarities as edges is inherent in microarray data. In such 
networks the highly connected clusters of genes with similar expression profiles stand out 
and thus can be identified individually, and analyzed as modules, in terms of their 
association with a traits value (Langfelder and Horvath 2008).  
Second, incorporating known genetic interaction information can help further 
refinements of candidate gene lists. As in Chapter 3 here a modified version of Google’s 
PageRank algorithm is explored for its use in gene ranking; i.e. by considering each 
gene’s relevance to the traits and based on its interacting neighbors in network (Morrison 
et al. 2005; Winter et al. 2012). As exhibited during Google’s searches PageRank returns 
user desired pages by ranking them based on the ranks of other pages linked to them 
(Page et al. 1999). With similar logic applied to genomic analyses the genes that are be 
given a high rank are those whose neighbors in a gene-gene interaction network also have 
high ranks. Here, such ranks are initially determined by the gene expression-trait 
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association that is used as the relevance measure, and then such ranks are computed 
iteratively by considering all the genes and their network positions and trait associations.  
Using this algorithm genes highly relevant to the trait under study are prioritized. The 
biological network is constructed based upon any type of genetic interaction information, 
such as protein-protein interaction, gene-chemical interactions, or transcriptional co-
expression network.   
Here we examined gene expression data collected for a warfarin resistant Norway 
rat (Rattus norvegicus) strain and analyzed the data for correlations with the resistance 
phenotypes and genotypes and exposure to the anticoagulant rodenticide warfarin (Hans-
Joachim, Detlef, and Gerhard 1995; Kohn, Pelz, and Wayne 2000).  
Warfarin caused fatal hemorrhage in susceptible rats as they fail to recycle 
vitamin K from vitamin K 2,3-epoxide. Specifically, warfarin inhibits the activity of the 
vitamin K 2,3-epoxide reductase complex (VKOR), which is encoded by Vkorc1 (Li et al. 
2004; Rost et al. 2004). It thus impairs the vitamin K cycle as well as the following post-
translational modification process of multiple vitamin K dependent proteins needed for 
proper levels of activated blood-coagulation factors (Presnell and Stafford 2002; Stafford 
2005).  
The use of warfarin since 1950s has imposed intense selective pressure on rat 
populations (Endler 1985; Gillespie 1991; Kohn, Pelz, and Wayne 2000). However, 
resistance to warfarin in rat populations has been reported from numerous locations of the 
world (Boyle 1960; Lund 1964; Jackson and Kaukeinen 1972; population and agriculture 
1986). The resistance phenotype can be measured by blood clotting response (BCR) tests 
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(Kohn, Pelz, and Wayne 2000). Genetically, the resistance trait in European rats is 
primarily determined by the Y139C mutation on the third exon of Vkorc1 (Kohn, Pelz, 
and Wayne 2003; Rost et al. 2009).  
In humans, warfarin is widely used as an antithrombotic drugs in the prophylaxis 
and treatment of recurrent stroke, deep vein thrombosis and heart valve prosthesis 
(Wadelius et al. 2007). However the proper dosing of the drug is a troublesome affair 
(Kamali 2006). Two genes, VKORC1 and CYP2C9 (and enzyme that metabolizes the S-
enantiomer of warfarin) are approved by the Federal Drug Administration (FDA) as 
genetic biomarkers. The combined analysis in human subjects can explain ~30% and 
~10% of warfarin dosage variance, respectively (Rost et al. 2004; Takeuchi et al. 2009). 
Recently, CYP4F2, which metabolizes vitamin K1, has been reported to influence 
warfarin dosing also, but to a smaller degree than the other two genes that are used as 
biomarkers in personalized medicine (Takeuchi et al. 2009). Examination of other 
candidate genes thought to be involved in warfarin dependent pathways failed to yield 
new candidate genes that merit further analyses in human study cohorts (Wadelius et al. 
2007). Another genome-wide scan for genetic variants that might influence warfarin 
dosing yielded no further genes either (Cooper et al. 2008). Some genes such as GGCX, 
EPHX1 have been reported with controversial association results from different studies in 
different populations (Wadelius et al. 2005; Pautas et al. 2009; Takeuchi et al. 2009). But 
so far only ~55 % of warfarin dose variance can be jointly explained by known genetic 
and non-genetic factors such as sex, weight, age, etc.; leaving another ~45% of the 
variance around proper warfarin drug dosing in humans unexplained (Cooper et al. 2008).  
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In this study, we aim to identify candidate genes that differ in their gene 
expression patterns (collected for the liver tissue) with regard to warfarin exposure, 
warfarin resistance genotype, and sex. First we built co-expression networks in 4 
different comparisons considering resistance phenotype and warfarin treatment. By 
correlating expression profiles to warfarin-related traits in the co-expression network, we 
identified network modules and the candidate genes that form them. Further we 
combined expression-trait correlation measures with genetic network information 
(including data collected from published gene-gene interaction networks and a gene-
chemical interaction network). To evaluate any functional relationships among genes we 
conducted functional analyses and pathway annotations. Finally, we compared the results 
of this study of gene expression analysis with our previous network-guided genomic 
variation analysis (c.f. Chapter 3) and detected a strongly supported set of genes that are 
part of eQTL (expression quantitative trait loci). As in Chapter 3, this thesis chapter 4 
further supports the hypothesis that warfarin resistance has complex genetic 
underpinnings, with many of these underlying genetic factors being a target of natural 
selection. 
4.2. Materials and Methods 
4.2.1. Design of microarray study 
This study investigates two parameters for their effects on gene expression in the 
liver of rats (Figure 4.1A). Wild-derived lab-reared rats were resistant to the 
anticoagulant warfarin owing to a non-synonymous mutation in the Vkorc1 gene 
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(Y139C). The microarray experiment was designed for us to investigate the influence of 
warfarin treatment and warfarin-resistance phenotype on gene expression. 
4.2.2. Rat strains 
This study was conducted on rats sampled from an area in Northwestern 
Germany. Rats from this area carry a non-synonymous mutation in the Vkorc1 gene from 
A to G, resulting in the tyrosine to cysteine (Y to C) amino-acid change at position 139 in 
exon 3. This amino-acid change results in a 47% reduction of the basal in vitro VKOR 
activity (Pelz et al. 2005; Rost et al. 2009). The Vkorc1 genotypes are designated as G/G 
(homozygous mutant), G/A (heterozygous mutant) and A/A (wildtype). The strain 
examined is resistant to the anticoagulant warfarin if Vkorc1 carry the genotype of G/G or 
G/A, i.e. the mutation is dominant with respect to warfarin resistance (but is of 
incomplete penetrance, c.f. Table 2.1). 
 Rats, named as NW rats, were trapped in the field and were kept in the laboratory 
for 12-17 months, or rats were born by wild-caught rats in the laboratory (age was 
recorded in Supplementary Table 1 of (Kohn, Price, and Pelz 2008)). Rats were kept in 
Macrolon® cages on shavings from saw mills with tap water and standard lab food 
(altromin® 1324) ad lib. The diet contained 3 mg/kg Vitamin K3. The Institutional 
Animal Care and Use Committee approved the study. 
 The warfarin resistant (R) and warfarin-susceptible (S) phenotypes were 
distinguished by using a blood clotting response test (BCR) that measured percent clotting 
activities (PCA) after injection of a diagnostic dose of warfarin (c.f. Rodenticide 
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Resistance Action Committee 2003, a reappraisal of blood clotting response tests for 
anticoagulant resistance and a proposal for a standardized BCR test methodology: 
Technical Monograph, Crop Life International). Male and female rats were induced with 
7mg/kg or 8.5mg/kg warfarin, respectively, by intraperitoneal injection, which 
corresponds to 4 multiples of the ED50 in susceptible rats. This treatment unlikely 
explains the systematic differences among genotypes described in the results section as all 
genotypes were subjected to it. The presence of the A to G mutation at position 139 in 
exon 3 of the Vkorc1 gene was confirmed by PCR. 
4.2.3. Tissue processing 
 Liver is used as the tissue of choice because it is the organ where warfarin is 
metabolized (Thijssen 1995; Wallin et al. 2001), VKOR is located (Wallin et al. 2001; 
Rieder et al. 2005; Oldenburg et al. 2006), and important detoxification pathways are 
located (Runge-Morris et al. 1998; Raftogianis, Wood, and Weinshilboum 1999; 
Beckmann-Knopp et al. 2000; Tabrett and Coughtrie 2003; Wang et al. 2004; Wang, 
Zhao, and Dudoit 2006). Vitamin K cycle activity is traditionally measured from hepatic 
tissues and the VKOR is thought to reside in the liver microsomal membrane. Liver 
tissues are stored in RNALATER (Ambion Inc.) at -20C and shipped from Germany to 
Houston.  
 Total RNA was isolated from the liver of rats for array work. RNA quality 
control, labeling and hybridization of the RNA to the AFFYMETRIX rat genome 
ARRAY 230 2.0 were done by a commercial laboratory in Houston (SEQWRIGHT, 
http://www.seqwright.com/). The procedures to assay gene expression followed 
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recommendations by the supplier of arrays (http://www.affymetrix.com/). Quality control 
(QC) of whole RNA was done on an Agilent 2100 Bioanalyzer RNA LabChip.  
4.2.4. Microarray data and pre-processing (Figure 4.1B) 
 
 
Resistant Susceptible 
Warfarin 
Induction 6 4 Comp1 
No induction 7 6 Comp2 
Comp4 Comp3 
!"#
NW  
A. Experiment design: grouped by phenotype and warfarin treatment 
Comp1 
c. Co-expression modules identification 
Data pre-processing 
Comp2 Comp3 Comp4 
d. Detect modules and genes associated with 
resistance phenotype or warfarin treatment 
The combination of 
four comparisons 
Target genes 
eHitchhikers detected based 
on expression pattern 
clustered target genes 
a. Microarray data of 23 wild-derived rats 
b. Construct 4 gene co-expression networks 
according to the experimental design 
WGCNA in R 
WGCNA in R 0.2
0
.4
0
.6
0
.8
1
.0
Cluster Dendrogram
hclust (*, "average")
as.dist(dissTOM)
H
e
ig
h
t
Dynamic Tree Cut
Merged dynamic
-1
-0.5
0
0.5
1
S
E
X
P
H
E
N
O
T
Y
P
E
G
E
N
O
T
Y
P
E
MElightpink
MEcoral2
MEgreenyellow
MElightskyblue3
MEpalevioletred2
MElightblue3
MEslateblue1
MEdarkseagreen4
MElightskyblue4
MElightpink2
MEdarkmagenta
MEdeeppink
0.29
(0.4)
-0.7
(0.03)
-0.55
(0.1)
0.42
(0.2)
-0.63
(0.05)
-0.6
(0.07)
0.42
(0.2)
-0.71
(0.02)
-0.64
(0.04)
0.67
(0.03)
0.64
(0.05)
0.66
(0.04)
0.29
(0.4)
0.65
(0.04)
0.69
(0.03)
0.21
(0.6)
0.65
(0.04)
0.5
(0.1)
0.37
(0.3)
0.65
(0.04)
0.65
(0.04)
-0.0076
(1)
0.75
(0.01)
0.64
(0.05)
0.1
(0.8)
0.85
(0.002)
0.71
(0.02)
-0.024
(0.9)
0.81
(0.005)
0.86
(0.002)
-0.46
(0.2)
-0.74
(0.02)
-0.74
(0.01)
-0.11
(0.8)
-0.77
(0.009)
-0.61
(0.06)
B. Co-expression network analysis 
e. Gene ranking in genetic network 
GGI network 
(STRING database) 
CTD network 
(CTD database) 
Gene-trait 
correlation 
measures Modified Google’s 
PageRank algorithm 
GGI gene 
rank score 
CTD gene 
rank score 
f. Gene ontology or 
Pathway analysis 
NetGWAS of SNP array: 
87 candidate genes; 
cis-eQTL analysis 
 165 
 
Figure 4.1 – The experiment design (A) and workflow (B) of network-guided expression 
analysis. Flowchart indicates the main steps of identifying candidate genes related to 
warfarin in rat co-expression networks. 
  
 Expression data of rat liver for 24 warfarin-resistant and warfarin-susceptible rats (14 
males and 10 females) were obtained from Affymetrix arrays based on the platform of 
Affymetrix GeneChip Rat Genome 230 2.0. Corresponding rat genome information 
(NCBI build 4) was retrieved from UCSC Table Browser (http://genome.ucsc.edu/cgi-
bin/hgTables, accessed July 2010). Traits like sex, warfarin treatment and resistance 
phenotype were considered during each of the analyses (Table 4.1). 
 Table 4.1 – Microarray design and sample infromation. 
Rat ArrayID Induction Sex Phenotype Genotype Comp1 Comp2 Comp3 Comp4 
5783 B67 N M S A A   CON CON   
5991 B68 N F S A A   CON CON   
5989 B69 Y M S A A CON   TRE   
5994 B70 Y F S A A CON   TRE   
5738 C30 N M R G G   TRE   CON 
5791 C31 N F R G G   TRE   CON 
5766 C32 N M R G A   TRE   CON 
5909 C33 N F S A A   CON CON   
5744 C34 Y M R G G TRE     TRE 
5750 C35 Y F R G G TRE     TRE 
5761 C36 Y M S A A CON   TRE   
5801 C38 N M R G A   TRE   CON 
5658 C39 N M R G G   TRE   CON 
5758 C40 N F R G G   TRE   CON 
5768 C41 N F R G A   TRE   CON 
5907 C42 N M S A A   CON CON   
5784 C43 N M S A A   CON CON   
5910 C44 N F S A A   CON CON   
5751 C45 Y M R G G TRE     TRE 
5745 C46 Y M R G G TRE     TRE 
5760 C47 Y F R G G TRE     TRE 
5678 C49 Y M R G A TRE   TRE 
5731 C50 Y M S A A CON  TRE  
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Induction (Y/N) refers to warfarin induction Yes or No;  
Sex (M/F) refers to Male or Female;  
Phenotype (R/S) refers to Resistance to warfarin or Susceptible to warfarin;  
Genotype refers to the nonsynonymous mutation Y139C of Vkorc1 gene.  
Four comparisons (Comp1, Comp2, Comp3 and Comp4) are designed to detect modules and 
genes associated with phenotype and induction of warfarin. TRE-treatment, CON-control. 
 
 Data background correction, normalization, probe specific background correction 
and summarization were conducted using the Affy software version 1.18.2 (Gautier et al. 
2004) and the gcRMA version 2.12.1 (Wu et al. 2004) package in R (Ihaka and 
Gentleman 1996). Probes were matched to genes using the Rat230_2 annotation file 
(release 32, 06/09/11) obtained from Affymetrix (http://www.affymetrix.com/). After 
quality control examination, we removed one outlier female array C37 (sample 5675), 
resulting in 23 arrays of 31,099 probes. PCA analysis verified that the biological 
variables (warfarin induction, sex, and genotype) were indeed dominating the variation in 
expression, but the extend to which the gene expression over the rat genome was affected 
was unexpected given that Vkorc1 Y139C mutation is a coding mutation and apparently 
is the main genetic factor underlying resistance. Such analyses enable an exclusion of the 
effect of experimental issues, such as variation of expression results owing to sampling, 
extraction procedures, or even shipping of samples between laboratories. 
To reduce false positive rates of gene identification we filtered out low quality 
data based on the Affymetrix detection calls provided alongside CEL files. First, for each 
probe set the detection call (Absent (A), Present (P) or Marginal (M)) was calculated 
using Wilcoxon signed rank test (mas5calls in affy package) to measure the significance 
level (P-values) of signal intensities of the perfect match probes compared to the signal 
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intensities obtained for the mismatch probes.  As suggested (McClintick and Edenberg 
2006), we filtered out probe sets with ‘Absent’ or ‘Marginal’ call in at least 25% of the 
samples treated with or without warfarin respectively. After data processing 15,531 
probes remained. 
Finally, we excluded the control probes with the prefix AFFX in probe labels. In 
sum, here we report on the analyses of 23 arrays and 15,480 probes each. Expression data 
are deposited to the Gene Expression Omnibus (GEO) database 
(http://www.ncbi.nlm.nih.gov/geo/). 
4.2.5. Traditional analysis of gene expression using PADE 
 Basic statistical identification of differentially expressed genes used the 
AFFYMETRIX SOFTWARE MAS5 perfect match (PM) and mismatch (MM) probe analysis 
after application of REDI (REDUCTION OF INVARIANT PROBES) ANALYSIS. REDI was 
used to address issues with the reliability of expression analyses that were traced back to 
the sequence variation in the AFFYMETRIX probes on the array. The probes (not the entire 
probe set/transcript) are eliminated if they exceed a threshold level of noise, i.e. those that 
do not correspond to the expression level inferred from the majority of the other probes 
representing the transcript. We employed the algorithm by EXPRESSION.COM, DURHAM, 
NC, USA; http://www.expressionanalysis.com/) to identify and exclude poorly 
performing probes from analysis. In this two-step approach poorly performing perfect 
match (PM) probes were removed.  
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 We used the feature TWO-GROUP COMPARISONS WITH PERMUTATION ANALYSIS 
FOR DIFFERENTIAL EXPRESSION (PADE, EXPRESSION.COM, DURHAM, NC, USA) to detect 
changes in expression between groups with different phenotype and warfarin treatment. 
 Permutation based analyses enable estimation of the probability of falsely 
detecting differential expression, i.e. False Discovery Rates (FDR). We estimate the 
number of genes that is affected by an experimental treatment using the FDR as a guide. 
The FDR should be interpreted as the fraction of expected false positives in a given set of 
genes, without making statements which genes are the false positives. However, PADE 
attempts to do just that by permutation analysis that generates thousands of smaller 
subsets of genes and isolating those that among thousands of such small sets of genes 
consistently stand out. In short, we will use the FDA predominantly to qualify our 
statements regarding the genome wide response to warfarin induction. FDR graphs 
(Figure 4.2) are used to obtain the number of significant genes given a particular FDR 
and provide a (delta) cutoff value used to isolate significant genes. 
Comparisons considering warfarin treatment and resistance phenotype were 
analyzed in PADE. The differentially expressed genes identified from two comparisons 
using the corresponding delta cutoff (delta ≥ 1.2 in resistant vs. susceptible phenotype 
comparison; delta ≥ 0.4 in warfarin induction vs. non-induction comparison) were 
combined and used for future validation. We also selected 101 differentially expressed 
genes using P-value (≤0.05) from two comparisons (intersection) and compared these 
results with the co-expression network analysis results. 
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A. Comparison between resistant vs. susceptible rats.  
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B. Comparison between warfarin induction vs. noninduction. 
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Figure 4.2 - False discovery rate plots suggest cutoff for differentially expressed genes. 
(A) Comparison between resistant vs. susceptible rats. (B) Comparison between warfarin 
induction (treated with warfarin) vs. non-induction. 
4.2.6. Co-expression network and weighted correlation analysis 
By constructing a co-expression network (Figure 4.1B) based on the rats 
microarray data using R package WGCNA (Langfelder and Horvath 2008), we aim to 
identify candidate genes responding to warfarin induction and resistant/susceptible 
phenotype. In co-expression network, each gene is a node and the edge between genes 
represents their expression similarity. 
First, data cleaning: we removed genes with too many missing values with the 
default settings and verbose = 3.  
Second, network construction: We built co-expression network by calculating the 
co-expression similarity Sij = | cor(gi, gj) |  between gene pairs and adjacency (connection 
strength) matrix aij = sβij with β chosen as the lowest integer resulting in network with 
approximate scale-free topology (linear regression model fitting signed R2 between 
degree distribution log(p(k)) and average degree log(k) ≥ 0.9 (in Comp1 β = 9 reaches 
plateau at 0.8). This criterion of soft threshold β was applied to ensure co-expression 
network property satisfying scale-free architecture (Ghazalpour et al. 2006). Contrary to 
unweighted network with absolute value 0 (no co-expression) and 1 (perfect co-
expression) determined by “hard” threshold, here our weighted correlation with soft 
threshold preserves the continuous nature of the gene expression data.  
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Third, module detection: we used unsupervised hierarchical clustering method to 
identify clusters of densely interconnected genes, i.e. modules, with a minimum module 
size equals 30 probes (Langfelder and Horvath 2008; Ivliev, Rudneva, and Sergeeva 
2010). For each model, the eigengene was identified as the first principal component of 
the expression matrix. Then modules with very similar expression profiles were merged 
based on the correlation between eigengenes.  
Fourth, after identifying characteristic profile (eigengene) for each module, we 
look for modules significantly associated with external trait (resistance phenotype or 
warfarin induction) by calculating module significance (MS) based on the correlation of 
eigengene profiles and external traits. Specifically, two correlation measures were 
computed by Pearson correlation and Logistic regression respectively. The modules that 
significantly correlated with traits were shown in Figure 4.3. Meanwhile, for each probes, 
gene-trait association significance (GS) was also calculated as either the Pearson 
correlation coefficient or the pseudo r-squared of Logistic regression. These correlation 
measures of gene-trait association were also used as gene scores for the following gene 
ranking analyses. A fuzzy measure of membership of each gene in each module was also 
calculated. In addition, for each gene, we computed the overall network connectivity 
(Kall) as the sum of connection strengths with all other genes, i.e. node degree. To 
describe gene-module structure, we also calculated intramodular network connectivity 
(Kin) and outmodular connectivity (Kout) as well as the difference (Kdif = Kin – Kout) of 
each gene across modules. The connectivity measures for each module were averaged 
across genes within the module. 
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Following this process, we constructed 4 co-expression networks for following 
comparisons (Figure 4.1A): 
Comp1: detect genes associated with resistant or susceptible phenotype when 
exposed to warfarin (10 samples of 15081 probes, softPower β = 9);  
Comp2: detect genes show basal transcriptional difference between resistance and 
susceptible phenotype without warfarin induction (13 samples of 15125 probes, 
softPower β = 6);  
Comp3: detect genes responding to warfarin administration in susceptible rats (10 
samples of 15020 probes, softPower β = 7);  
Comp4: detect genes responding to warfarin administration in resistant rats (13 
samples of 15171 probes, softPower β = 9). 
The slight differences of probes numbers among comparisons were due to the 
initial data cleaning of missing values. The combination of above four comparisons 
(Figure 4.1B) helps us identify candidate genes of warfarin, as well as their surrounding 
neighbors affected by the potential causal genes.     
First, candidate genes were expected to show differential transcriptional patterns 
between resistant and susceptible rats (Comp1 or Comp2); and also these genes would 
respond to warfarin induction either in susceptible rats or in resistant rats (Comp3 or 
Comp2). 
 Target = (Comp1  Comp2)  (Comp3  Comp4) 
Equation 4.1 – The combination scheme for identifying candidate genes. 
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Genes affected by target genes because of their physical closeness to targets might 
also show different expression patterns between resistant and susceptible rats despite of 
warfarin induction; these genes, however, would not respond to warfarin administration 
in neither resistant nor susceptible rats. Similar to hitchhiked variants under selective 
sweep effect, these genes were called ehitchhikers here: 
  
Equation 4.2 – The combination scheme for identifying ehitchhikers. 
 We first selected candidate genes from each comparison with the criteria 
that the gene itself and the module it belongs to are significantly associated with traits (P-
value ≤ 0.05). The modules significantly correlated with traits in each comparison were 
shown in Figure 4.3. Then we applied above combination schema (Equation 4.1 and 
Equation 4.2) to all the comparisons and obtained a list of candidate genes (Appendix 6) 
and ehitchhikers (data not shown). Note that here the candidate genes and ehitchhikers 
are independently defined based on their expression correlation with phenotype. 
Several regions with clustered candidate genes were noticed, which might be the 
signals of highly related target genes in the region. Thus we defined regions of clustered 
gene as more than 5 genes located in a region with neighbor genes’ distance smaller than 
2mb (listed in Table 4.2 and Appendix 6). We plotted target genes along the genome 
(Figure 4.6), from which signals of candidate targets’ clusters (dense black bars) could be 
observed.  
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4.2.7. Gene ranking using known genetic interaction information 
Above analyses were based on co-expression networks. In this section, we 
combined prior knowledge of network information with the expression-trait correlation 
measure to refine the candidate list. As introduced in Chapter 3, the modified Google’s 
PageRank algorithm was applied to two types of networks for gene ranking. 
4.2.7.1. Gene-gene interaction (GGI) network 
In GGI network, each gene is a node, and the edge between genes represents their 
protein-protein interaction or other type of interactions. We downloaded the interaction 
information from STRING (functional protein association networks) database 
(http://string.embl.de/, accessed July 2012) (Jensen et al. 2009), which include protein 
links from diverse channels: neighborhood, gene fusion, occurrence, co-expression, 
experiments, database and text mining. We only retrieved the protein interactions 
experimentally derived or from databases of physical interactions or biological pathways 
or based on text-mining with the threshold of confidence score ≥ 150 applying to each 
channel. The remaining information contains 15376 proteins and 344481 interactions. 
Then we converted proteins into corresponding genes and matched them with the genes 
from microarray data in each comparison. Within each GGI network for each comparison 
(Table 4.4), we applied the modified PageRank algorithm (c.f. Chapter 3: NetGWAS) to 
compute the gene ranks. 
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4.2.7.2. CTD (Comparative Toxicogenomics Database) network 
We built CTD networks with warfarin related gene-gene interactions from CTD 
database (http://ctdbase.org, accessed Aug 2012). First, we downloaded the chemical 
vocabulary, 34 chemicals of them are warfarin related or the upper categories in the 
hierarchical classification system. Then, we found 46 genes interacting with above 34 
chemicals from the downloaded rat chemical-gene interaction data. Also from the 
chemical-gene interaction data, we generated gene-gene interactions if genes are 
interacting with same chemicals. The interaction strength between two genes equals to 
their interacting chemicals. We kept the gene-gene interactions with one gene name on 
the list of 46 warfarin related genes, resulting in 69760 interactions. After that, we 
matched the genes available from microarray data in each comparison and built 
corresponding CTD network (Table 4.4). 
Using the modified PageRank algorithm, we obtained gene rank files from both 
GGI and CTD network for each comparison. Then we assigned the gene rank scores to 
the selected candidate genes (Appendix 6). Then for each gene, according to Equation 4.1, 
we selected the higher rank score between Comp1 and Comp2, also the higher rank score 
between Comp3 and Comp4, then averaged them to get the final rankscore for candidate 
target. The rank scores from GGI and CTD network were listed besides candidate genes 
as reference. The 21 clusters of candidate genes were shown in Table 4.2 with average 
rank scores for each cluster. 
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4.2.8. Candidate genes for Function/Pathway evaluation 
To evaluate the candidate genes’ function, we performed GO (Gene-Ontology) 
and KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway analysis in DAVID 
(http://david.abcc.ncifcrf.gov, accessed Aug 2012). We submitted a background gene list 
with all genes available from microarray data and a candidate gene list with 163 selected 
genes. The GO Fat category was chosen to avoid the overshadowing of broadest terms on 
more specific terms. KEGG and protein domain information (InterPro, PIR, SMART) 
were also included. 149 functional categories (of the 157 DAVID IDs corresponding to 
candidate targets) from GO, KEGG or Protein Domains databases were grouped into 45 
function clusters. Their detailed information and corresponding genes were listed in 
Appendix 7. After removing the categories with the enrichment P-values > 0.05, we 
obtained 19 function clusters composed of 80 categories. We depicted the enrichment of 
genes in each functional cluster with the highest enrichment score of the functional 
category in that cluster for each gene (Figure 4.6). 
4.2.9. cis-eQTL (quantitative trait loci) analysis 
As suggested by Kudaravalli et al. (Kudaravalli et al. 2009), we tried to identify 
SNPs (single nucleotide polymorphisms) that are associated with gene expression 
profiles. cis-eQTL were defined as SNPs that located on a gene with boundaries of ± 
100kb to transcription start and end, which significantly associate with expression 
profiles. Though without direct evidence of true cis-acting regulation, these SNPs were 
refer to as cis-eQTL since they might regulate expression levels of their corresponding 
genes (Kudaravalli et al. 2009).  
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Genotype data of 10847 SNPs were obtained based on Rat 10k array for the same 
24 NW wild-derived rat samples (c.f. Chapter 3). 14 samples had both expression and 
SNP array data. Genotypes of SNP were codes into 0, 1, 2. The association between 
genotype and expression profile were tested using standard linear regression. Multiple 
SNPs could be mapped to one gene with multiple probes; in this case, the association of 
each SNP-probe pair was calculated. We consider SNPs with P-value ≤ 0.05 as cis-
eQTLs and also selected a smaller set of SNPs with significance level threshold ≤ 10-4 as 
suggested (Kudaravalli et al. 2009).  
 With the identified cis-eQTL, we tested whether they were enriched in the 
candidate genes using hypergeometric test in R. Here the candidate gene list we tested 
includes the 591 candidate genes based on expression network analysis (Appendix 6), 
101 or 55 differentially expressed genes using traditional expression analysis (data not 
shown), and 87 candidate genes based on SNP array analysis (c.f. Chapter 3). The 
significance levels were recorded in Table 4.5. 
4.3. Results 
With the goal of identifying genes related to warfarin, we designed four 
comparisons based on 23 rat (Rattus norvegicus) samples (Figure 4.1) and collected their 
RNA expression data on Affymetrix microarrays. What we label as Comp1 and Comp2 
are the comparisons aimed to detect genes differentially expressed between resistant and 
susceptible rats and with or without warfarin induction, respectively. On the other hand, 
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Comp3 and Comp4 intended to identify genes that are differentially expressed with or 
without warfarin induction in either susceptible rats or resistant rats, respectively.  
Co-expression networks of different comparisons were then built to detect 
candidate genes that are related to warfarin in terms of Vkorc1 genotype, warfarin 
resistance phenotypes as measured by the BCR method, and sex. We incorporated gene-
gene interaction and gene-chemical interaction information to facilitate the candidate 
identification using a modified Google’s PageRank algorithm. The combination of co-
expression network and prior knowledge on genetic network location and interactions of 
genes enabled us to prioritize candidate genes whose expression changes showed 
associations with the experimental variables studied here. 
4.3.1. A co-expression network identifies ~600 candidate genes 
The co-expression networks were built based on rat microarray data. Nodes are 
genes, and edges between them are the transformed expression similarity: connection 
strength = | similarity |β with β as the chosen soft threshold (see methods and materials). 
The connection strength of the network preserves the continuous nature of co-expression 
data, and the results of network analyses are robust to the choice of β (Ghazalpour et al. 
2006). We built four co-expression networks according to the designed comparisons and 
intended to combine the results from them to detect candidate genes (Figure 4.1). 
4.3.1.1. Modules were detected in the co-expression network 
Co-expressed genes tend to involve in similar functions/pathways (van Noort, 
Snel, and Huynen 2003). Co-expression networks could be clustered into modules, which 
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respond to environmental change as a whole in terms of expression profiles. Thus, 
detecting modules and correlating them with external traits would facilitate the 
identification of candidate genes, whose expression changes might be related to traits. For 
each comparison, we identified modules with highly connected genes using hierarchical 
clustering. Modules were represented by different colors, and their properties were 
recorded but not shown here. For example, in Comp1 (resistant vs. susceptible rats with 
warfarin induction), module sizes ranged from 30 to 2,659; with an average size of 198 
probes. Their overall connectivity (Kall, node degrees) ranged from 37 to 341 nodes 
across different modules, which is lower than the average Kall ~ 95 seen for the total 
network. We calculated two other measures of network cluster structure: intramodular 
connectivity (Kin) and outmodular connectivity (Kout). In Comp1, the average Kin and Kout 
across modules are 20 and 75, respectively. 
4.3.1.2. Modules significantly associated with traits 
To assess the trait relevance of each module, we calculated the module 
significance (MS), which measured the correlation between traits and expression profiles 
of each gene in each module (see Methods and Materials). Figure 4.3 showed the 
modules that significantly correlate with traits in the four comparisons Comp1-4. In 
Comp1, the module most relevant to resistance was called lightskyblue4 (MS=0.85, P-
value=0.002, with Kin=65.9, Kout=189.5, module size=840). The known resistance gene 
Vkorc1 was located in the module called lightpink (MS=-0.7, P-value=0.03, with 
Kin=56.2, Kout=122.2, module size=645).  
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A. Comp1 (R vs. S rats with induction) B. Comp2 (R vs. S rats without induction) 
C. Comp3 (warfarin treatment in S rats) D. Comp4 (warfarin treatment in R rats) 
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Figure 4.3 – Modules correlated with warfarin treatment and phenotype in the 
coexpression network. Modules (named by colors) are highly connected gene clustered 
identified in co-expression network in each comparison. Correlation coefficients of trait-
module correlation (and the P-values) are shown. 
Overall, there were 12 modules correlated with resistance phenotype with 
warfarin induction; while without warfarin induction, there were 15 modules correlated 
with the warfarin resistance phenotype in Comp2. In Comp3, only 5 modules 
significantly correlated with warfarin treatment in susceptible rats; whereas in Comp4, 13 
modules were associated with warfarin treatment in resistant rats. 
4.3.1.3. About 600 genes emerged from co-expression network analyses 
Previous studies suggested anticoagulant rodenticide resistance might be 
attributed to expression changes of a few genes, such as those that belong the cytochrome 
P450 family (Markussen et al. 2008b). With the goal of detecting genes whose expression 
changes are related to the experimental variables considered here, we expected that target 
genes not only associate with resistance phenotype (Comp1 or Comp2) but also to 
warfarin induction (Comp3 or Comp4) (Equation 4.1). Thus, we first tried to select genes 
that are differentially expressed between resistant and susceptible rats (Comp1  
Comp2); then we chose genes that are differentially expressed between the groups of rats 
that underwent warfarin induction and those that did not (Comp3  Comp4). After that, 
we intersected results to obtain a list of 719 probes, corresponding to 591 candidate genes 
(118 probes could not be matched to genes (Appendix 6). We expect to have false 
positive associations in this dataset.  
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Genes that map in the chromosomal neighborhood of genes that directly interact 
with warfarin induction might exhibit similar expression profiles as genes that are 
associated with the warfarin resistance genotype/phenotype  (Comp1  Comp2) because 
of the hitchhiking effect. However, such genes, called ehitchhikers, would not respond to 
warfarin treatment ( ). With this logic in mind (Equation 4.2) we 
identified 1,328 candidate ehitchhikers that were not directly related to the experimental 
variables genotype, phenotype, and induction; sex being non relevant in this context. 
The candidate genes were selected not only based on their gene-trait association 
significances (GS), but they also must be located within the interaction network modules 
(MS) that were found to correlate with the experimental variables genotype, phenotype, 
and warfarin induction (Appendix 6). The known resistance gene Vkorc1 did not emerge 
as significant data point (Comp1: lightpink module, P-value=0.486; Comp2: coral3 
module, P-value=0.865; Comp3: tan2 module, P-value=0.064; Comp4: pink4 module, P-
value=0.557). This is not surprising since the known Y139C variation confers resistance 
in form of a non-synonymous protein coding mutation (Rost et al. 2009). On the other 
hand, a suspected ehitchhiker, Sult1a1 (unpublished data) with polymorphisms in its 5’ 
upstream region was on the ehitchhiker list (Comp1: lightskyblue4 module, P-
value=0.025; not significant in Comp3 and Comp4). 
Table 4.2 – Candidate regions of clustered target genes in the rat genome. 
Regions Chr Position (Mb) GGIRank CTDRank 
Gene 
no. 
Start & End 
Genes 
Candidates 
(Chapter 3) 
1 1 82 - 86 4 7 10 Cyp2t1; Gpi  
2 1 185 - 187 1 4 8 Tufm; Pycard Vkorc1 
3 1 201 - 213 8 1 22 Psmd13; Prpf19  
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4 1 247 - 252 11 17 6 Slc25a28; Taf5  
5 2 178 - 182 7 8 6 Rps3a; Snapap Bglap 
6 3 154 - 158 13 17 6 Fitm2; Ddx27 154 - 158 
7 5 136 – 140 4 8 6 Mast2; Ppcs  
8 7 8 – 13 8 17 13 Zfp347; Cyp4f6 Cyp4f1 
9 7 67 – 69 20 20 5 Cdk4; Hrsp12  
10 7 113 – 116 2 2 12 Ly6e; Cdc42ep1  
11 7 137 – 140 15 2 5 Tuba1b; RGD1359310  
12 8 46 – 48 15 5 6 Oaf; Sidt2  
13 8 112 – 115 8 21 6 Rassf1; Lrrfip2  
14 10 70 – 73 21 5 5 Tmem132e; Usp32  
15 10 106 – 110 6 13 10 Galk1; Sectm1b  
16 11 82 – 83 2 13 6 Chrd; Klhl24  
17 12 33 – 37 13 13 5 Setd8; Plbd2 Clip1 
18 14 84 – 87 15 8 7 Tcn2; Ccm2  
19 16 17 – 20 11 8 8 Mbl1; Atp14a1  
20 19 49 – 53 19 16 6 Mlycd; Tcf25 Mlycd 
21 20 1 – 3 15 8 5 Znrd1; RT1-CE5 RT1-S3 
 
Chr: chromosome. 
GGIRank: the rank based on average gene rank score from GGI network for each gene region. 
CTDRank: the rank based on average gene rank score from CTD network for each gene region. 
Start & End Genes: the start and end genes within each candidate region. 
Candidate genesfromGWAS: candidate genes detected in rat SNP array I (GWAS) located in the 
same candidate regions identified here from microarray data. 
  
 From the list of candidate genes (Appendix 6), we noticed that 8 candidate genes 
clustered (Figure 4.6A, bold red in Appendix 6) at the region of 185 -187 Mb on 
chromosome 1, which should be under the selective sweep effect of resistance gene 
Vkorc1 (Kohn, Pelz, and Wayne 2000)(c.f. Chapter 2). We noted that although the 
resistance variant Y139C in Vkorc1 is a non-synonymous mutation with no consequences 
on the expression profile of Vkorc1, the selective sweep associated with the warfarin 
selection on Vkorc1 generated a broad genomic window in which numerous gene 
expression differences were assoiated with the experimental variables. Thus, we 
predicted that many genomic regions with spatially clustered gene expression differences 
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might indicate the location of either an adaptive gene expression change or the presence 
of another type of selected mutation (e.g. non-synonymous) within this region.  
Thus we searched the data for regions of clustered candidate genes along the 
genome (Table 4.2; for gene information c.f. Appendix 6). On chromosome 1, there are 
three additional such regions of clustered candidate genes: 82 – 86 Mb, 201 – 213 Mb 
and 247 – 252 Mb. Additional candidate regions were found on other chromosomes, 
including a 178 – 182 Mb region on chromosome 2, 154 – 158 Mb region on 
chromosome 3 and an 8 – 13 Mb spanning region on chromosome 7, to mention some of 
these (c.f. Figure 4.4). In addition to the Vkorc1 region there are 20 additional such 
regions with clustered candidate genes in the genome of the rat (dense black bars 
highlighted with red squares in Figure 4.6B) that are of interest with regard to our 
experimental variables studied; notable warfarin induction and warfarin resistance 
genotype.  
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Figure 4.4 – 591 candidate target genes with warfarin related expression signals form 21 
clusters along the genome. (A) the resistance gene Vkorc1 locates in the 185-187 Mb 
region on chromosome 1 with 8 clustered candidate genes. (B) Regions of clustered 
genes are highlighted red, and regions with supports from SNP array analysis (Chapter 3) 
are marked with box of different colors (color code as in Figure 4.7), with region ID (as 
in Table 4.2) and corresponding candidate genes from SNP array analysis labelled beside.  
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4.3.1.4.  Candidate genes have high connectivity in the co-expression network 
We are interested in understanding the effect of network position has on the 
association of genes in our study context. Hub genes have higher connectivity that the 
average gene in the co-expression network, and thus, might have stronger effects on the 
trait (Ghazalpour et al. 2006; Benfey and Mitchell-Olds 2008; Barabasi, Gulbahce, and 
Loscalzo 2011). We calculated network connectivity (Kall, i.e. node degree), intramodular 
connectivity (Kin) and outmodular network connectivity (Kout) for each gene. In Table 4.4 
we compare the average connectivity of trait-associated modules with the average 
connectivity of all modules in the co-expression networks. We observed that the former 
are generally larger than the latter. Moreover, we saw that the average connectivity 
values of trait-associated genes are higher than the background values. These 
observations indicate that hub genes in co-expression networks play important roles in 
mediating the adaption to warfarin as mediated by gene regulatory evolution.  
Table 4.3 – Connectivity in co-expression network. 
Comp1 Comp2 Comp3 Comp4  
Kall Kin Kout Kall Kin Kout Kall Kin Kout Kall Kin Kout 
All modules 95 20 75 121 12 108 80 16 64 86 13 73 
Trait-
associated 
modules 
138 30 109 124 14 111 89 13 76 105 13 92 
All genes 175 65 110 151 33 117 141 60 81 121 32 89 
Trait-
associated 
genes 
255 87 168 181 44 137 184 83 101 143 39 104 
 
Comp1: Resistant vs. Susceptible with warfarin induction; Comp2: Resistant vs. Susceptible 
without warfarin induction; Comp3: Warfarin Induction vs. Non-induction in Susceptible rats; 
Comp4: Warfarin Induction vs. Non-induction in Resistant rats. See Materials and Methods and 
Table1 for detailed experimental design in above four comparisons.  
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Kall: average total network connectivity; Kin: average intramodular network connectivity; Kout: 
average outmodular network connectivity. 
All modules or genes: the average connectivity for all modules or genes. 
Trait-associated modulesor genes: the average connectivity for modules or genes that correlate 
with traits (P-value < 0.05). 
 
 
 
Figure 4.5 – Gene-trait relevance (GS) correlate with intramodular connectivity (Kin). 
The modules with high correlation with resistance or warfarin induction in each of the 
four co-expression networks are shown here. Other modules were not shown. 
A. Comp1 (R vs. S rats with induction) B. Comp2 (R vs. S rats without induction) 
C. Comp3 (warfarin treatment in S rats) D. Comp4 (warfarin treatment in R rats) 
K
in 
K
in Kin 
K
in 
 189 
 
 More specifically, we found that intramodular connectivity Kin significantly 
correlates with the relevance of genes to traits, such as can be seen from the lightpink 
module in Comp1, which contained the Vkorc1 gene (Spearman correlation=0.57, P-
value=1.7×10-60). Within most trait-related modules genes with higher gene-trait 
relevance scores tend to have higher intramodular connectivity (Figure 4.5), which 
suggest that hub genes in co-expression network might have higher relevance to the 
resistance phenotype and/or warfarin treatment. 
4.3.2. Gene-gene interaction information facilitates candidate identification 
4.3.2.1. Gene ranking algorithm 
The modified PageRank algorithm integrated gene-trait correlation measures into 
genetic network and gave high rank scores to genes if their interacting genes also had 
high rank scores (see Methods and Materials). It effectively prioritized genes highly 
relevant to traits, and would help decrease false positive signals. Thus we assigned gene 
ranks to the selected candidate genes to refine candidate list. Besides network topology, 
damping factor d is a user-defined parameter that would affect gene ranks, for it describes 
how far a gene feature would spread in the network (Fu, Lin, and Tsai 2006; Winter et al. 
2012b). Google used 0.85 as the damping factor for web searches. In biological network, 
however, the damping factors should be lower since most genetic networks are much 
more sparse (Clune, Mouret, and Lipson 2013).  We estimated dynamic damping factor 
ddfi for each node in our network according to Fu et al’s suggestion (Fu, Lin, and Tsai 
2006) and used the average ddf as the damping factor for the whole network.  
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4.3.2.2. Properties of GGI network 
First, we computed gene rank scores in gene-gene interaction (GGI) networks 
based on the information of protein-protein interaction and text-mining from STRING 
database (http://string-db.org/). We built four GGI networks according to the designed 
comparisons (Figure 4.1). The number of nodes and edges of GGI network for each 
comparison are summarized in Table 4.4. There is no much difference among GGI 
networks of different comparisons; the slight difference of gene numbers were due to the 
initial data cleaning process of microarray data.  
Table 4.4 – Network statistics of GGI (gene interaction network) and CTD (comparative 
toxicogenomic database) network. 
 
Nodes: genes. Edges: gene interactions. 
 
4.3.2.3. CTD network 
We also computed gene rank scores in CTD networks, which were built from a 
chemical-gene interaction database (Comparative Toxicogenomic Database, 
http://ctdbase.org/). Based on the rat chemical-gene interaction data we first retrieved 
warfarin related genes, and then their interactions with other genes if they were 
interacting with the same chemicals. The resulting warfarin related gene-gene interaction 
network data generated 4 CTD networks corresponding to 4 comparisons (Table 4.4).  
Comp1 Comp2 Comp3 Comp4 Statistics 
(N) Nodes Edges Nodes Edges Nodes Edges Nodes Edges 
GGI 6573 109785 6617 111328 6568 109636 6616 111085 
CTD 7474 203668 7516 205098 7477 203808 7513 204841 
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In each network and comparison we obtained gene rank scores from both GGI 
and CTD networks, and then assigned them to our candidate genes. The GGI and CTD 
ranks for the 21 regions of clustered candidate genes after averaging rank scores within 
each region are shown in Table 4.2. Region 2 includes the known resistance gene Vkorc1, 
which has highest GGI rank; although Vkorc1 itself didn't show trait related expression 
changes. Region 3 was ranked 1st when using the CTD data, and covers 10 Mb (201 – 
213 Mb) on chromosome 1. 
4.3.3. Candidate genes across different chromosomal regions share similar 
functions 
 To evaluate the functions of the 163 candidate genes from the clustered regions 
(Figure 4.6, Table 4.2), the GO (Gene-Ontology) and KEGG (Kyoto Encyclopedia of 
Genes and Genomes) pathway analyses were performed in DAVID 
(http://david.abcc.ncifcrf.gov). We obtained 149 function categories 
(GO/pathway/protein domain) and their enrichment score by comparing candidate genes 
from 21 clustered regions with the overall background gene list. Keeping the categories 
with enrichment P-values ≤ 0.05, 84 categories corresponding to 95 genes were grouped 
into 19 function clusters, each carrying genes sharing similar functions (Figure 4.6, 
Appendix 7). 
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Figure 4.6 – Heatmap of candidate genes’ enrichment across functional clusters. 
Candidate target genes form 21 clusters along the genome. Function clusters are 
identified based on gene ontology and pathway analysis. Genes sharing similar functions 
are distributed at different regions along the genome. 
4.3.4. Candidate genes in clustered regions are connected in gene-gene 
interaction networks 
 Among the 591 genes with detected warfarin-related expression signals, 163 genes 
are clustered into 21 chromosomal regions along the genome (Figure 4.6B). Based on 
Gene Ontology annotation analysis, we noticed some genes from different chromosomal 
regions share similar functions (Figure 4.6). This observation inspired the questions of 
what are the relationships among these 163 candidate genes? It is expected that one or 
two genes in each region would be directly affected by warfarin, and other genes in the 
same region with expression changes are physically linked to these ‘causal’ genes. Here 
we depicted the gene interactions among these 163 candidate genes in 21 genomic 
regions based on the gene-gene interaction data downloaded from the STRING database. 
Nodes in Figure 4.7A are genes. Two genes are connected using red line if they are 
interacting with each other; and the names are shown for these genes. If there is no 
interaction between two genes, but they are located in the same chromosomal region, 
they are connected using gray lines. And the genes with only chromosomal proximity 
connections with others were indicated with small gray nodes without name shown.  
Corresponding to the 21 chromosomal regions, we observed 21 clusters of 163 
genes in Figure 4.7A (the number besides each cluster represents the region ID as in 
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Table 4.2). We saw that most (20) clusters are connected except one is isolated. 
Consistent with our expectation, most connections are made through one or two genes in 
each region/cluster. The region Vkorc1 located in (region 2, red) has three genes 
interacting with other genes. As mentioned above, Vkorc1 itself has no expression signals; 
but the expression profiles of other genes in this region were probably affected by its 
sweep effect.  
Another two regions (region 3 and region 8) gained our attention that they have 
multiple genes (8 and 7) connected to other clusters in terms of gene interaction. Region 
3 is located at chromosome 1 (201-213 Mb), which is right next to the sweep region of 
Vkorc1. But it is too early to say the expression changes of these genes are warfarin 
relevant. Region 8 is at chromosome 7 (8-13 Mb, orange), which is also detected in 
previous SNP array analysis (Chapter 2).  
From the NetGWAS analysis of rat SNP array data, we have identified 87 candidate 
genes (Appendix 4, c.f. Chapter 3). We compared these 87 candidate genes detected 
based on genetic variations with the 163 genes with expression signals related to warfarin 
(Appendix 6). 7 chromosomal regions with supports from both SNP array and expression 
analyses were highlighted along the chromosomes (Figure 4.6B), as well as in gene 
interaction networks using the same color code (Figure 4.7A).  
26 candidate genes from SNP array and 49 target genes with expression signals 
are located in these 7 regions. So we pooled these genes and drew gene interaction 
network specifically for them (Figure 4.7B). As in Figure 4.7A, nodes are genes; region 
ID is labeled beside each cluster with the same color code. Two genes are connected 
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using red line if they are interacting with each other (big nodes with gene name shown); 
two genes are connected using gray line if they are in the same chromosomal region. 
Genes only share chromosomal proximity with others are small gray nodes.  
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Figure 4.7 – (A) Gene-gene interactions among 163 target genes clustered in 21 regions 
along the genome. (B) Gene-gene interactions among 73 genes in 7 regions supported by 
both SNP array and Microarray analysis. Node: gene. Red line: gene-gene interaction. 
Gray line: genes in the same chromosomal region. Gene names are not shown for genes 
that don’t interact with others. Region ID is labeled besides. 
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6 out of 7 regions are connected and as expected Vkorc1 region is the center. 
Vkorc1 is interacting with Cyp4f1 gene in region 8, Bglap gene in region 5 and RT1-S3 
gene in region 21. Cyp4f1 gene belongs to cytochrome P450 gene family, in which most 
members were found to be drug-metabolizing enzymes (Thomas 2007). Moreover, 
Cyp4f1 is the ortholog of CYP4F2 gene in human, which recently has been identified to 
be associated with warfarin dosage variance (Pautas et al. 2009; Takeuchi et al. 2009). 
Bglap gene encodes a vitamin K dependent protein that is involved in vessel 
calcification and bone mineralization (Suttie 1993; Danziger 2008). As we will mention 
in Chapter 6, we detected that Bglap gene is associated with both arterial calcification 
and warfarin resistance. Thus it might be a good starting point to investigate the fitness 
costs of warfarin resistance in terms of arterial calcification (Kohn, Price, and Pelz 2008). 
The region 6 at chromosome 3 (154-158 Mb) was observed with relatively high 
association with warfarin resistance in SNP array analysis (Chapter 3), and was also 
detected with expression signals. But which gene in this region is related to warfarin was 
a puzzle to us. Here we saw that region 6 is connected with the Fgfr2 gene, which is a 
fibroblast growth factor receptor and is 2 Mb away from Vkorc1 on Chromosome1. 
Within this distance, Fgfr2 should be under the sweep effect of Vkorc1; the potential 
hitchhiked variant in Fgfr2 and its interaction with region 6 might be one explanation for 
the detected association signals at region 6. But it is also possible that Fgfr2 and genes in 
region 6 are functional relevant to warfarin resistance, since Fgfr2 plays important roles 
in embryonic development and tissue repair, especially for bone and blood vessels. 
Moreover, in human a fibroblast growth factor binding protein gene (FGFBP2) exhibited 
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relatively high association with warfarin dose (Cooper et al. 2008). Considering the 
fitness cost of reduced growth rate in resistant rats and the ‘blood-thinning’ effect of 
warfarin, this Fgfr2 gene might provide another path for us to explore the connections 
with warfarin.  
 The region 6 and region 8 are both connected to region 20 by gene Mbtps1 
(membrane-bound transcription factor peptidase, site 1). It might be another interesting 
gene for further examination.  
4.3.5. Summary of top candidate genes 
All the candidate genes were shown in Appendix 6. Table 4.2 listed the 21 
candidate regions with clustered targets (163 genes) along the genome. Figure 4.7A 
depicted the gene-gene interactions among these 163 genes. 95 genes of them were 
grouped into 19 function clusters based on function annotation analysis, with their 
enrichment scores across function clusters shown in Figure 4.6. Here the functional 
sharing pattern is different from the pattern of similar functions sharing among candidate 
genes identified from the genomic variant data (c.f. Chapter 3). Genes located within the 
same candidate regions don’t necessarily share similar functions; they are detected as 
their expression changes associated with warfarin related traits. 
The five genes at region 2 (185 – 187 Mb on chromosome 1), where the resistance 
gene Vkorc1 locates, exhibited different function profiles. However, enrichment of 
similar function clusters was observed across different chromosomal regions. For 
example, 12 out of 21 candidate regions carry genes with function categories in cluster 4, 
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which are related to regulation of defense response and membrane coat (Appendix 7). 
Function categories in cluster 3 shared by genes in 11 candidate regions, are annotated as 
translation elongation and protein biosynthesis. 
In human, in addition to VKORC1, there are two genes identified as predictors for 
warfarin dosage: CYP2C9 and CYP4F2; both of them belong to cytochrome P450 gene 
family (Rost et al. 2004; Takeuchi et al. 2009). Most members in this family have been 
recognized as drug-metabolizing enzymes (Thomas 2007). More specifically, some 
P450s in the Cyp2c, Cyp2e and Cyp3a family have been detected with differentiated 
expression related to anticoagulant resistance (Imaoka, Hashizume, and Funae 2005; 
Markussen et al. 2008b; Markussen et al. 2008a). We noticed there are two P450 genes 
Cyp2t1 and Cyp4f6 that map in regions with label 1 and 3 on chromosome 1 and region 8 
on chromosome 7, respectively. These share functional attributes including the oxidation-
reduction cycling with Vkorc1 and ion binding with other P450 genes.  
As shown in Figure 4.6 and Table 4.2, the P450 gene Cyp4f1, detected as a candidate 
gene from NetGWAS (Chapter 2), also maps on chromosome 7 region 8, close to the 
Cyp4f6 gene. CYP4F2 gene is a vitamin K1 oxidase (McDonald et al. 2009). A 
comparison study between human and rat showed that both CYP4F2 in human and its 
ortholog Cyp4f1 in rat produced 19/20-HETE (hydroxyeicosatetraenoic acids) (Imaoka, 
Hashizume, and Funae 2005). As the region on chromosome 1where Vkorc1 is located, 
the region of 8 – 13 Mb on chromosome 7 containing Cyp4f6 and Cyp4f1 genes are 
interesting for further examination based on signals from both expression and SNP array 
studies.  
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In addition, we observed strong SNP-resistance association signals at the region 
of 154 – 158 Mb on chromosome 3. And here the microarray analysis revealed 
expression signals at this region again (region 6), which can hardly be observed by 
chance. As shown in Figure 4.7B, genes in this region are interacting with the Fgfr2 gene, 
which is under the sweep effect of Vkorc1 or it might be functional relevant. The next 
challenge for us would be locating the potential causal gene in this area.  
Overall, other than the known resistance gene Vkorc1, we listed 20 regions with clustered 
candidate genes from microarray analysis; 7 of them are paralleled with supporting 
evidences from NetGWAS of SNP array (Figure 4.6, Figure 4.7). The candidate genes in 
Table 4.2 suggest a starting list for further exploration. 
4.3.6. Traditional analysis identifies differentially expressed genes 
Before conducting gene co-expression network analysis, we performed traditional 
gene expression analysis to detect genes differentially expressed between two phenotypes 
(resistant vs. susceptible) and warfarin treatment (induction vs. non-induction). Applying 
cutoffs of delta values suggested by permutation based estimation of false discovery rates 
(FDR) (Figure 4.2), we obtained 55 differentially expressed genes considering either 
resistance phenotype or warfarin induction (data not shown). 9 of 55 differentially 
expressed genes were on our candidate target list identified from co-expression analysis; 
16 of them were located in the regions of clustered candidate targets. But without the co-
expression analysis results, this list of 55 genes itself gave us limited information about 
the potential candidate genes.  
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We also obtained another list of differentially expressed genes (101 genes, data 
not shown) considering both resistance phenotype and warfarin induction using P-value ≤ 
0.05 as a threshold. 26 of 101 differentially expressed genes matched with our candidate 
target genes; 19 of them were located in the clustered gene regions. Though these 
differentially expressed genes identified using traditional approach didn’t provide clear 
hint about candidate genes for next validation, they are kept for comparison purpose with 
the co-expression network analysis results. 
4.3.7. cis-eQTLs (quantitative trait loci) are enriched in candidate genes 
Gene expression variation is abundant in species from yeast to human, and plays 
important role in connecting genotypic variation to phenotypic variation (Morley et al. 
2004; Gilad, Rifkin, and Pritchard 2008). How would the nucleotide change affect 
phenotype by modifying gene expression profiles? By expression quantitative trait loci 
(eQTL) mapping, we could identify genetic factors involved in gene regulation. As eQTL 
studies have demonstrated its promise in human biomedical and adaptation research since 
2004 (Morley et al. 2004; Schadt et al. 2005; Gilad, Rifkin, and Pritchard 2008; Veyrieras 
et al. 2008; Kudaravalli et al. 2009), we try to detect expression associated genetic 
variations by examining both the SNP array (c.f. Chapter 3) and microarray data of the 
wild-derived NW rats. It has been suggested that eQTLs are targets of recent positive 
selection in human (Kudaravalli et al. 2009). Here in rat populations under strong 
selection of warfarin, we expect to observe enrichment for eQTLs in our candidate genes 
rather than the genetic background.   
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We tried to identify cis-eQTLs that the SNPs are located within 100 kb of the 
gene, and also are associated with gene expression profiles based on standard regression 
test (Kudaravalli et al. 2009). With a threshold of P-value ≤ 0.05, we gained 506 SNPs as 
cis-eQTLs, which correspond to 550 genes. In addition, we selected a smaller set of SNPs 
(19 eQTLs) with significance level threshold ≤ 10-4 as suggested (Kudaravalli et al. 
2009).  
 With the identified cis-eQTL, we tested whether they were enriched in our 
identified candidate genes. Here we considered several candidate gene list, including the 
591 candidate genes based on expression network analysis (Appendix 6), 101 or 55 
differentially expressed genes using traditional expression analysis (data not shown), and 
87 candidate genes based on SNP array analysis (c.f. Chapter 3). As expected, eQTLs are 
indeed enriched (P-values ≤ 0.01) in both the 87 candidate genes from SNP array and 591 
candidate genes from expression analysis (Table 4.5). But they are not overrepresented in 
the 55 differentially expressed genes identified using traditional approach. These 
enrichment results are consistent with our hypothesis that warfarin selection lead to more 
expression variations, thus support our identified candidate genes. 
Table 4.5 – cis-eQTL enrichment test in candidate genes 
 Expression analysis (Microarray) NetGWAS(SNParray) 
Tested gene 
list 
591 
targetsα 
101 differentially 
expressed genesβ 
55 differentially 
expressed genesβ 
87 candidate genes 
(c.f. Chapter 3) 
eQTL No. 36 7 4 8 
P-value (=hits 
of eQTL) 0.001 0.049 0.099 0.011 
P-value (>hits 
of eQTL) 0.002 0.036 0.058 0.005 
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α candidate target gene list based on expression network analysis. 
β differentially expressed gene list based on traditional expression analysis. 
4.4. Discussion 
Natural selection is the key of Darwin’s explanation of biodiversity and 
adaptation. What is actually being selected at the molecular level? One is amino acid 
change of protein sequences, and another is the expression levels’ or patterns’ alteration. 
Though positive selection on coding region has been intensely studied, the adaptive 
expression changes have been paid less attention. Using rat resistance toward 
anticoagulant drug warfarin, we demonstrated that there is a huge response of expression 
variations (~ 600 candidate genes) related to warfarin. The candidate genes form 21 
clustered regions along the genome, ranging from 5-22 genes with average of 8 genes in 
each cluster. These candidate clusters implies the existence of ‘true’ warfarin related 
genes and the potential hitchhiking effects on their flanking regions. In addition, our 
study suggested that the strategy of network-guided approach should be useful for 
complex systems, like complex diseases in human. 
4.4.1. Building gene co-expression network is an effective way to detect trait 
relevant expression variations 
Although our microarray dataset is incomplete and error-prone, it provides us an 
access to genomic changes embedded in expression variations response to warfarin 
stimuli. To understand the source of expression variations, networks with thousands of 
interacting genes that orchestrate expression need to be considered (Wittkopp 2007). The 
success of using genetic network to predict genes involved in specific pathways for either 
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unicellular organisms or animals has been demonstrated before (Lee et al. 2008). Here we 
constructed genome-wide co-expression networks, but aimed to identify genes 
specifically related to warfarin selection.  
Modularity is an innate property of many genetic networks and a major 
contributor to organisms’ evolvability (Clune, Mouret, and Lipson 2013). Highly 
connected co-expressed modules could be consistent with co-regulated genes related to 
certain function or adaptive to certain environmental change (Ghazalpour et al. 2006; 
Wittkopp 2007). Similar to the engineering concept, modularity maintains integrity, 
security and reliability. It might be evolved because of common challenges in rapidly 
changing environments or as a byproduct of selection reducing costs of connections in 
genetic network (Clune, Mouret, and Lipson 2013). Here we detected modules of genes 
with similar expression profiles that are associated with warfarin treatment or resistance 
phenotype. 
Network connectivity predicts gene essentiality. Gene essentiality is a general but 
important parameter, which would not only aid in targeting candidate genes in warfarin 
selection. It was reported that gene connectivity of probabilistic network could predict 
gene essentiality in yeast, worm and mouse (Lee et al. 2008). In our analysis, the positive 
correlation between intramodular connectivity of genes and their extents to trait 
association supported this idea in co-expression network (Figure 4.5). 
The rats’ expression data and gene connectivity measures in co-expression 
network are accessible to the community for interests in other pathways or diseases. 
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The interactions between genes would help identify signals which otherwise 
might be missed using traditional single-locus analysis, especially for those loci with 
moderate or small single-locus effect on phenotype (Liu et al. 2010). 
4.4.2. CYP450 genes are not overrepresented in candidate genes involved in 
warfarin resistance 
Previously, Markussen et al reported that cytochrome P450 genes play important 
role in 4-hydroxycoumarin-based anticoagulant resistance by examining their hepatic 
expression profiles upon bromadiolone administration (Markussen et al. 2003). 
Cytochrome 9450 gene family usually includes 50-80 genes and human genome contains 
~ 60 genes. Genes in this superfamily that encode enzymes to metabolize known 
endogenous substrates are phylogenetically stable; and other unstable genes function in 
detoxification of xenobiotic compouds (Thomas 2007). Here we find that, in statistical 
terms, the CYP450 genes are not overrepresented in our candidate gene list 
(hypergeometric test, P-value of more than 2 CYP450 genes as candidate genes is 0.900). 
And the study on the long-term evolutionary stability of CYP450 genes found that sites of 
selection in these xenobiotic related genes are mostly associated with changes in protein 
structure rather than modification in expression regulatory regions (Thomas 2007). Thus, 
the importance of CYP450 genes in expression variation induced by anticoagulant drugs 
as previously inferred would be more like a result of the experimental setup, where only 
these have been assayed and thus, necessarily some will emerge. But we still cannot rule 
out the possibility that CYP450 genes did play key role in expression variation associated 
with bromadiolone, which is a second-generation rodenticide, belonging to 4-
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hydroxycourmarin compounds. Further examination based on expression data with 
bromadiolone treatment is needed to understand the genetic architecture (c.f. Future 
direction in Chapter 6). 
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Chapter 5 
Calu and other candidate genes are associated 
with warfarin resistance in wild Norway rats 
as revealed by population structure analysis 
and NetGWAS 
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Abstract 
 Drift plays important role in human population because of strong demographic 
effects, thus adaptive signals might be obscure across different populations. However, we 
expect to find candidate genes with discernible adaptive signals in rat populations since 
they have experienced strong selection of warfarin. We performed the network-guided 
GWAS of the rat 10k SNP array data (SNP array II) in multiple wild rat populations. 46 
samples were chosen from genetically homogeneous virtual populations inferred by 
population structure analysis of ~ 600 rats. Following the NetGWA analysis, genes with 
multiple supporting evidences across populations were reported as top candidates. We 
have collected the genotype data for one candidate gene Calu (Calumenin) in ~ 600 rats, 
and observed significant associations with warfarin resistance in 7 natural populations, 
compared to the observation of significant associations in 13 natural populations for 
Vkorc1 gene. The significant associations for Calu and Vkorc1 gene remain in inferred 
virtual populations. Given Calu’s regulation role in the vitamin K-dependent 
carboxylation pathway, the observed association in multiple natural populations suggests 
Calu is another warfarin-related gene merited further investigation. The result also 
provides foundation for examining the effect of gene interactions on adaptive 
consequences. 
5.1. Introduction 
We have obtained a list of candidate genes based on GWAS (c.f. Chapter 3) and 
gene expression analysis (c.f. Chapter 4). However, both the SNP array and microarray 
 209 
 
data were collected from samples of a wild-derived population NW. To evaluate the 
candidate list and to search for additional candidate genes in natural populations, we 
collect more genotype data of wild rat samples based on the same SNP array, and for 
distinguishing purpose we called it SNP array II.  
In these wild populations, how to choose samples for SNP array experiment is a 
problem. We have sampled ~ 700 rats from 19 farms in a resistant area at north-western 
Germany (Figure 5.1). Usually the population is naturally determined by the geographical 
origin of samples. But rats from different farms are not necessarily genetically 
differentiated; on the other hand individuals from the same location could be genetically 
structured due to unidentified barriers to gene flow (Evanno, Regnaut, and Goudet 2005). 
With this recognition in mind, we analyzed the population structure for the ~ 700 rats 
before we selecting samples for SNP array experiment and genomic association analysis.  
We collected genotype data of microsatellites and presumably neutral SNPs for 
~700 rats. Population structure analysis is implemented in two commonly used softwares: 
STRUCTURE and INSTRUCT. It is always a challenge to decide the optimal number of 
clusters (K) when identifying genetically homogeneous groups of individuals. We used 
different criterions to the best of our knowledge to detect K, which would be a useful 
reference for future population structure studies. 
The following GWAS and network-guided GWAS were conducted the same as 
described in Chapter 3. Combining genetic variation data and expression data in multiple 
populations, we refined the candidate gene list and summarized them for further 
validation. We have already collected genotype data and conducted association tests for 
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one candidate gene Calu in multiple natural populations, which shows the relationship of 
Calu and warfarin resistance, and is also the foundation for future gene interaction 
analysis.  
5.2. Materials and Methods 
5.2.1. Rat (R. norvegicus) samples 
742 wild Rattus norvegicus samples were sampled from 36 farms located in 
north-western Germany with reported anticoagulant resistance (Kohn, Pelz, and Wayne 
2000; Kohn, Pelz, and Wayne 2003). Farms with small sample size (< 10) were 
disregarded from further analysis, resulting in 691 rats from 19 farms (Appendix 1). We 
used the abbreviation names for 5 populations (WU-pop24, KB-pop11, TH-pop23&16, 
SP-pop20, LH-pop4f (a control population from non-resistant area)) as mentioned in 
previous study (Kohn, Pelz, and Wayne 2000). Other populations were called by their 
farm numbers as used in previous study (Kohn, Pelz, and Wayne 2003). 618 samples of 
above 691 rats were assigned with warfarin resistant/susceptible phenotypes, which were 
physiologically determined with a blood clotting response (BCR) test (Thijssen 1995; 
Kohn, Pelz, and Wayne 2000; Kohn, Pelz, and Wayne 2003). For other three second-
generation rodenticides, we also obtained the bromadiolone and the coumatetralyl 
resistant/susceptible phenotype depending on the BCR test (Thijssen 1995; Kohn, Pelz, 
and Wayne 2000; Kohn, Pelz, and Wayne 2003). The resistant level R% for each 
population is calculated using the number of resistant samples divided by the number of 
samples with warfarin related phenotype tested. 
 211 
 
5.2.2. Microsatellites and SNP data for structure analysis 
We randomly selected 8 SNPs on the intergenic region of the rat genome. 4 of 
them were located in the gene desert region (the nearest gene were 1 Mb away).  
First, we conducted PCR and sequencing to obtain the genotypes of 10 samples 
for each SNP. The primers covering the identified SNP sites (product length: 1000-1200 
bp) (Appendix 2) were designed in Primer3 (http://frodo.wi.mit.edu/primer3, access May 
2012). For each DNA sample, a final reaction volume of 13.5 µl buffer with 1.5 µl 
genomic DNA was prepared for PCR. In general, PCR was preformed with an initial 
denaturation of 94°C (2.5 minutes), followed by 33 cycles of denaturation at 94°C (0.5 
minutes), annealing at 57.5°C (40 seconds), and extension at 72°C (1 minute). The final 
extension was conducted at 72°C (5 minutes). For the primer dimmer cleanup, we added 
3.5 µl ExoSAP-IT to 7 µl PCR product, and incubated at 37°C for 15 minutes and then 
inactivated ExoSAP-IT at 80°C for 15 minutes. PCR product was sent for both forward 
and reverse sequencing using ABI 3730 xl sequencer (DEWALCH, Houston, TX). The 
sequenced contig were assembled and edited using Phred/Phrap/Consed 
(http://www.phrap.org/) (Ewing et al. 1998; Gordon, Abajian, and Green 1998).  
With 10 reference genotypes for each SNP, we genotyped the 691 rat samples 
from 19 natural populations by High Resolution Melting (HRM) test (Wittwer et al. 
2003). The HRM PCR Kit was purchased from QIAGEN (http://www.qiagen.com, 
access Jun 2012). The primers covering the identified SNP sites (product length: 100-130 
bp) for HRM genotyping (Appendix 2) were designed in Primer3 
(http://frodo.wi.mit.edu/primer3, access May 2012). For each rat DNA sample, 0.65 ul 
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genomic DNA was added to reaction volume of 10 ul, which includes 5 ul HRM PCR 
Master Mix, 2.95 ul RNase-free water and 1.4 ul primer Mix. The HRM analyses were 
conducted on the Rotor-Gene Q, with an initial PCR activation of 95°C for 5 min, 
followed by 40 cycles of denaturation at 95°C for 10 seconds, annealing and extension at 
55°C for 30 seconds; the following HRM were performed in a temperature range from 
75°C-90°C with 0.1°C increments at each step. The temperature range for SNP S696656 
is from 67°C-82°C as its Tm is around 75°C. The genotypes for each rat sample were 
called using two combined clustering methods with 10 reference genotypes in R (Team 
2012). As recommended by (Reja et al. 2010), we carried out the linear discriminant 
analysis (LDA) to cluster unknown samples into groups after learning the features of 
known genotypes using the R package MASS (Venables and Ripley 2002). The two 
approaches were different in the curve scaling and normalization methods (simple scaling 
of the fluorescence rate from 0 to 100 and also the Levenberg-Marquardt method) 
(D.W.Marquardt 1963). 
We combined the genotype data of 8 SNPs and 5 microsatellites from previous 
study (Kohn, Pelz, and Wayne 2003) for the population structure analysis. 5 neutral 
microsatellite loci: D2Rat31, D10Rat6, D13Rat18, D14Rat15, and D17Rat38 were 
distributed on rat chromosomes 2, 10, 13, 14 and 17 respectively. Samples from LH 
population were excluded since they were sampled from a non-resistant area about 300 
km away from the main resistant area, resulting genotype data for 603 rat samples. 
 213 
 
5.2.3. Structure analysis 
Based on the SNP and microsatellites data of 603 rats sampled from 18 farms, we 
analyzed the population structure using two Bayesian methods: Structure 2.3.3 (Pritchard, 
Stephens, and Donnelly 2000) and INSTRUCT (Gao, Williamson, and Bustamante 
2007).  
Parameter setting: In Structure the parameter settings were as follows:  
1. Admixture model was applied since our rat samples may have mixed ancestry 
among different populations (Non-admixture model was tested and gave similar results).  
2. Correlated allele frequency model was chosen with the assumption that 
frequencies of neutral loci are likely to be similar among different populations 
(independent allele frequency was tested and gave less convergent Ln Pr(X|K)).  
3. Without given pre-defined population information, population structure was 
inferred from genetic information. (Estimation with pre-defined population information 
(given by the farm location that each sample was sampling from) resulted in large 
fluctuate values of α (1.7-0.5), which indicates poor separating populations).  
4. Lambda, the parameter of the distribution of allelic frequencies, was set to 1 as 
suggested. 
5. Burn-in iterations of 10,000 followed by 10,000 MCMC (Markov Chain Monte 
Carlo) repetitions were set as recommended (Pritchard, Stephens, and Donnelly 2000). 
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In INSTRUCT, we ran 5 independent chains of 200000 iterations with 100000 
burn-in iterations. 
Choosing optimal K: To appropriately specify the optimal number of the 
estimated cluster (K), we ran K = 1 to 18 (the number of sampled locations) and repeat 20 
runs for each K in STRUCTURE AND 5 chains in INSTRUCT. We examined several 
criterions to choose the optimal K. 1) the posterior probability Ln Pr(X|K) (Pritchard, 
Stephens, and Donnelly 2000). Optimal K was selected when posterior probabilities Ln 
Pr(X|K) converged for larger K and the dirichlet parameter α for the degree of admixture 
settled down to be plateaus. 2) Evanno et al. developed another statistic, the second order 
rate of change of Ln Pr(X|K) weighted by the variance - delta K. The peak of delta K was 
used for detecting the true K (Evanno, Regnaut, and Goudet 2005). The analysis was 
implemented using Structure Harvester (Earl and vonHoldt). 3) We also estimated the 
delta FST (similar to delta K) and the average maximum correlation coefficient for each K 
using CorrSieve in R to assess the optimal K (Cockram et al. 2008; Campana et al. 2011). 
4) We calculated the average pairwise Euclidian distance between matrices of predicted 
allelic frequencies using R scripts with the algorithm described by (Camus-Kulandaivelu 
et al. 2006). Then with the distance matrix we built the Neighbor-Joining tree using the R 
package ape. The NJ tree would also help decide the suitable K.  
With the chosen K, we performed the permutation in CLUMPP (Jakobsson and 
Rosenberg 2007) to minimizing the inconsistency across replicates resulting from ‘label 
switching’ or ‘genuine multimodality’. The resulted individual membership Q matrix 
were visualized using DISTRUCT (Rosenberg 2004). 
 215 
 
We calculated a similarity index to combine the virtual population grouping 
results from STRUCTURE and INSTRUCT as described by (Saïdou et al. 2009). 534 
samples with agreement of population membership between STRUCTURE and 
INSTRUCT were kept for further analysis. And here we called the assigned population 
membership based on structure analysis as virtual populations.  
5.2.4. Select samples for rat 10k SNP array 
We selected 46 samples based on their natural and virtual population (VP) 
structure, considering both K=3 and K=6. VP3.X represents the virtual population group 
number X according to K=3; similarly VP6.X represents the virtual population group 
number X according to K=6. For SNP array experiment, 18 samples from pop20, 20 
samples form WU, 5 samples from TH and 3 samples from other 3 populations were 
mainly belong to VP3.1 and VP3.3, or VP6.1, VP6.3 and VP6.6. 
The population structure of all populations and the above 46 samples for SNP 
array experiment were shown in Figure 5.1. 
5.2.5. Analysis of SNP array data 
Genomic DNA of 46 rats were isolated using the classical phenol:chloroform 
extraction method from liver tissues. Genome scale SNP data of the rat samples were 
collected using the rat 10K array purchased from Affymetrix (c.f. Chapter 3. Methods 
and Materials). Quality control tests were performed by Baylor Genomic & RNA 
Profiling Core and Vanderbilt University for us. The microarray center at Vanderbilt 
University conducted the genotyping experiment on our behalf. The genotypes were 
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called following data normalization and quality control using GTGS (Affymetrix 
GeneChip Targeted Analysis Software). With 10847 SNP sites from Rat 10k array, 
filtering out 493 failed SNP sites and 3594 non-informative SNPs, we obtained 6760 
informative SNPs for 46 wild rats. We performed the association tests and population 
genomic tests on all the 6760 informative SNPs. 
We followed the same procedure as describe in Chapter 3 to analyze the SNP 
array data. First, conducted the traditional GWAS using P-values and Bayes Factors as 
genotype-phenotype association measures. Then mapped SNPs to genes, and computed 
gene ranking in gene interaction network based on STRING database (http://string-
db.org/, accessed July 2012). The modified PageRank algorithm was used for calculating 
gene ranks. Considering the effect of network topology, we corrected the gene ranks by 
random rank scores (c.f. Figure 3.4). The top ranked genes were selected for function 
annotation analysis. This is a validation of previous identified candidate genes and also a 
new discovery process. 
5.2.6. SNP discovery, genotyping and association tests for Calu gene 
8 primer pairs of Calu gene covering the 7 exon regions as well as the flanking 
intronic regions were designed to amplify about 1kb sequence of each region. To evaluate 
the potential hitchhiking effect of warfarin resistance, we also detected the SNPs on the 
intergenic flanking region of Calu gene. All the primer pairs were designed using 
Primer3 (http://frodo.wi.mit.edu/primer3, access May 2011) and are available in 
Appendix 2. 
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32 rat samples in the wild-derived laboratory strain (NW) were first look at as a 
standard dataset for SNP discovery. For each rat DNA sample, a final reaction volume of 
13.5 µl buffer with 1.5 µl genomic DNA was prepared for PCR. In general, PCR was 
preformed with an initial denaturation of 94°C (2.5 minutes), followed by 33 cycles of 
denaturation at 94°C (0.5 minutes), annealing at 57.5°C (40 seconds), and extension at 
72°C (1 minute). The final extension was conducted at 72°C (5 minutes). For the primer 
dimmer cleanup, we added 3.5 µl ExoSAP-IT to 7 µl PCR product, and incubated at 37°C 
for 15 minutes and then inactivated ExoSAP-IT at 80°C for 15 minutes. PCR product was 
sent for both forward and reverse sequencing using ABI 3730 xl sequencer (DEWALCH, 
Houston, TX). Using GenBank sequence NC_005103.2 of Calu as the reference gene, 
SNP sites were identified using Polyphred (Nickerson, Tobe, and Taylor 1997) after 
contig assembly and editing in Phred/Phrap/Consed (http://www.phrap.org/) (Ewing et al. 
1998; Gordon, Abajian, and Green 1998).  
With the discovered SNP site Calu_56228735 on Calu gene and the site 
Calu_S1_56038243 on the flanking intergenic region (Table 5.5), we genotyped all the 
691 rat samples from 19 natural populations by High Resolution Melting (HRM) test 
(Wittwer et al. 2003). The HRM PCR Kit was purchased from QIAGEN 
(http://www.qiagen.com, access Sep 2011). The primers covering the identified SNP sites 
for HRM genotyping (Appendix 2) were designed in Primer3 
(http://frodo.wi.mit.edu/primer3, access May 2011). For each rat DNA sample, 0.65 ul 
genomic DNA was added to reaction volume of 10 ul, which includes 5 ul HRM PCR 
Master Mix, 2.95 ul RNase-free water and 1.4 ul primer Mix. The HRM analyses were 
conducted on the Rotor-Gene Q, with an initial PCR activation of 95°C for 5 min, 
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followed by 40 cycles of denaturation at 95°C for 10 seconds, annealing and extension at 
55°C for 30 seconds; the following HRM were performed in a temperature range from 
75°C-90°C with 0.1°C increments at each step. The genotypes for each rat sample were 
identified with the threshold of confidence percentage > 85% (White, Hall, and Cross 
2007) in the HRM analysis of comparison to 6 reference genes with known genotypes.  
Genotype-phenotype association test (Table 5.6) between phenotype and SNP 
sites of Calu gene as well as flanking region for 618 rat samples was conducted for each 
natural and inferred virtual population (based on the population structure analysis) in 
PLINK (http://pngu.mgh.harvard.edu/purcell/plink/) (Purcell et al. 2007). Simple Chi-
square test of allele model was computed. To control the effect of sex as a potential 
confounding factor, the Cochran-Mantel-Haenszel (CMH) test was also applied. The 
phenotype-genotype association of the SNP site Y139C on Vkorc1 gene was used as a 
reference. 
5.2.7. Linkage disequilibrium between Vkorc1 and Calu 
  For each natural and inferred virtual population, linkage disequilibrium (LD) 
among the SNPs inVkorc1, Calu gene and Calu_S1 in intergenic reigon were calculated 
in PLINK (Purcell et al. 2007) using the measure of squared r, which represents the 
correlation between two loci (Table 5.7). 
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5.3. Results 
Inferring population structure is a critical step before performing association 
analyses. Otherwise, spurious associations would be detected, which might be due to the 
population admixture or demographic history (Mezmouk et al. 2011). We first collected 
genotype data of microsatellites and presumably neutral SNPs for ~700 rats. The 
genotypes were called based on high resolution melting (HRM) genotyping data using 
two combined clustering methods in R. Based on the genotype data of neutral sites, we 
examined the population structure for 618 wild rats of 19 farms from a resistant area in 
Germany (Figure 5.1A) (Kohn, Pelz, and Wayne 2000; Kohn, Pelz, and Wayne 2003). 
Samples were assigned to inferred virtual populations based on the STRUCTURE and 
INSTRUCT population membership assignment. Then considering both the natural 
population and virtual population structure, we selected 46 wild rats for SNP array 
experiment and performed the genome wide association study to detect and validate 
candidate genes involved in warfarin resistance. 
5.3.1. Population structure analysis inferred 3 virtual populations with 
genetically homogeneous individuals  
We implemented Bayesian method in STRUCTURE to cluster individuals by 
minimizing the within cluster linkage disequilibrium and keeping Hardy-Weinberg 
equilibrium (Pritchard, Stephens, and Donnelly 2000). Besides, we also performed the 
analysis in INSTRUCT allowing inbreeding model and without the assumption of Hardy-
Weinberg equilibrium. A network clustering approach (NetView) was recently developed 
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to detect population structure; its performance needs more evaluation (Neuditschko, 
Khatkar, and Raadsma 2010). 
First, we ran the cluster number from 1 to 19 to choose the optimal cluster value 
K. Determining the optimal number of clusters of genetically homogeneous individuals is 
always a challenge. Here we used 7 different criterions to detect K: 1) the posterior 
probability of the data Ln Pr(X|K)for each given K; 2) the second order rate of change of 
Ln Pr(X|K) – delta K; 3) the average maximum correlation coefficients; 4) the Neighbor-
Joining tree; 5) the deviance information criterion (DIC) for INSTRUCT results; 6) the 
second order rate of change of FST – delta FST for STRUCTURE results; 7) the value of 
dirichlet parameter alpha for STRUCTURE results. See Appendix 9 for detailed 
information about the support of K for each measure. We collected these different 
measures (to the best of our knowledge) to detect K, which would be a useful guide for 
further and other population structure studies. 
Overall (Table 5.1), 5 measures suggested optimal K=3, and 6 measures 
supported the optimal K = 6. From the NJ tree, we see only with K=6, the lines were 
clearly clustered (Appendix 9). This situation implies K=3 is suitable and there might be 
hierarchical structures. For following analysis, we chose K=3. 
Table 5.1 – Choosing optimal K in population structure analysis 
Criteria STRUCTURE INSTRUCT 
LnPr(X|K) 6 6 
ΔK 3 3 
AverMaxCorr 6 3 
NJ tree 6 NA 
DIC NA 6 
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ΔFST 3 3 
alpha 6 NA 
See Appendix 9 for details about choosing K based on different criteria. 
Figure 5.1B demonstrated the population structure and the statistics for each 
natural population in the resistant area in Germany. We chose 46 rat samples from 3 
natural populations and 3 virtual populations. As shown in Figure 5.1C, VP1 is composed 
of samples from two natural populations: WU and TH; whereas VP2 and VP3 contain 
samples all from population 20. Then in this case, we could perform GWAS in either 
natural populations or virtual populations. 
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Figure 5.1 – Maps of wild rats with population structure information. A. Wild rats were 
sampled from a resistant area at northwestern Germany. Non-resistant rats in LH 
population were sampled 300 km away. B. The inferred genetically homogeneous 
population structure for 19 natural populations. C. The population structure for 46 
samples selected for SNP array II experiment. 
5.3.2. GWAS identified 8 top candidate SNPs in natural populations 
We didn’t pool samples from SNP array I and SNP array II together for the 
genomic association test because of the high inflation factor (λ = 2.64). Even within SNP 
array II, there was high inflation factor (λ = 2.33) indicating the existence of population 
structure, which is expected since SNP array II is composed of samples from 3 natural 
populations. Considering population structure and sample size, for these SNP array II 
samples, we tested genomic association in two groups: virtual population 3.1 (28 
samples, VP3.1 composed of WU and TH samples) and pop20 (5 VP3.2 and 13 VP3.3 
samples). The inflation factor in VP3.1 is still high (λ = 2.13), but in pop20 is relatively 
low (λ = 1.26). Nevertheless, these inflation factors suggest the necessity of genomic 
correction. 
Vkorc1 gene is still significantly associated with warfarin resistance phenotype in 
both VP3.1 (P-value = 1.7×10-4) and pop20 (P-value = 4.3×10-3), but surprisingly not 
after corrected for multiple tests (HOLM P-value = 1). There are 54 SNPs in VP3.1 with 
significance level smaller than Vkorc1’s P-value and 8 SNPs are significantly associated 
with resistance phenotype after multiple correction (P-value < 0.05) (Table 5.2). In 
pop20, there are 23 SNPs with significance level smaller than Vkorc1’s, but none of them 
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are still significant after multiple correction. There is no overlap of the 54 SNPs in VP3.1 
and the 23 SNPs in pop20.  
Comparing with the 82 top associated SNPs from SNP array I (c.f. Chapter 3), 
there is one SNP (S425367) at chromosome 16 (position: 4663834 bp) detected as top 
SNP based on both SNP array I and array II data. There are two genes within 0.5 Mb 
distance to this SNP: LOC100360666 and Cacna2d3 (calcium channel, voltage-
dependent, alpha 2/delta subunit 3). Interestingly, another calcium-channel gene 
CACNA1C (calcium channel, voltage-dependent, L type, alpha 1C subunit) was noticed 
previously in a human genomic scan for warfarin dose associated genetic variants 
(Cooper et al. 2008). The rat orthologs Cacna1c gene and Cacna2d3 gene are directly 
interacting according to STRING database (http://string-db.org). And one of the 8 SNPs 
significantly associated with resistance after multiple correction, SNP (S423237, Table 
5.2) at chromosome 4 (position: 14219587 bp) is also near a calcium-channel gene 
Cacna2d1 (calcium channel, voltage-dependent, alpha2/delta subunit 1). Another SNP 
(S422784) among these 8 SNPs is located in a gene Fhit (fragile histidine triad), which 
has been identified as a candidate gene in NetGWAS based on SNP array I (Appendix 4). 
Table 5.2 – Top associated SNPs from GWAS based on SNP array II data 
SNP Chromosome Position (Mb) P-value HOLM_Pvalue 
S422784 15 17 3.55e-7 0.002 
S423237 4 14 3.94e-7 0.003 
S697166 1 105 5.75e-7 0.004 
S693878 1 152 1.61e-6 0.010 
S423282 1 86 2.74e-6 0.018 
S693984 3 22 3.59e-6 0.023 
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S692698 4 60 5.39e-6 0.035 
S695878 15 102 5.44e-6 0.035 
  
P-value: uncorrected P-value of genomic association test.  
HOLM Pvalue: P-value after multiple correction using HOLM method. 
5.3.3.  NetGWAS identified Vkorc1 and other candidate genes 
After applying the modified PageRank algorithm to the SNP array II data, we 
obtained 159 candidate genes and 143 candidate genes from VP3.1 and pop20 
respectively. Looking at these candidate genes, we found some of them are from the same 
chromosomal region. So if we group these candidate genes into a cluster when there are 
more 4 genes within 2 Mb distance from each other, we obtained 13 clusters in VP3.1 
and 12 clusters in pop20. A region at chromosome 7 (114-116 Mb) containing 27 
candidate genes detected in VP3.1 gained our attention. There is an Apol3 gene 
(apolipoprotein L, 3) maybe functional related. As in human, vitamin K1 is taken along 
with the dietary fat, which is then cleared by APOE gene (apolipoprotein E) (Wadelius et 
al. 2007). 
If applying the same grouping criteria to previous SNP array I results, we got 7 
clusters. And there are 21 regions of clustered genes from the microarray analysis (Table 
4.2). We compared these regions with above gene clusters in VP3.1 and pop20. The 
regions of gene clusters identified from both microarray and VP3.1 or pop20 might be 
relatively important because they are replicates from different populations (Table 5.3). In 
addition, there are 3 regions (Chr1: 184-187, Chr12: 32-37 and Chr20: 1-5 Mb) repeatedly 
appeared. Obviously Vkorc1 is located in the first region. In chromosome 12: 32-37 Mb 
region, there is a Tbx3 (T-box 3) gene, which is involved in reproductive developmental 
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process. Interestingly, it might be indirectly interacting with the vitamin K dependent 
protein - bone matrix protein MGP because Tbx3 is mediated by bone morphogenetic 
protein (BMP) signals and MGP modulates BMP-2 activity (Zebboudj, Shin, and 
Bostrom 2003; Chen et al. 2009). 
We also specifically compared these candidate genes with previously identified 
87 candidate genes from SNP array I and candidate targets from microarray (Table 5.3). 
We saw Vkorc1 is shown in all populations as expected. Ggcx gene was identified from 
both SNP array I and VP3.1, which is involved in vitamin K pathway to activate vitamin 
K dependent proteins. But previous tests of its association with warfarin dose in human 
reported controversial results (Wadelius et al. 2005; Cha et al. 2007; Wadelius et al. 
2007), so it is our chance to test the Ggcx gene in rat populations. Gene Fhit might be of 
interest as it has been identified as candidate genes based on SNP array I and II data, plus 
the SNP (S422784) in it is significantly associated with resistance phenotype (Table 5.2). 
Other gene names are not familiar in terms of known vitamin K pathway genes, but might 
be useful for future examination. 
Table 5.3 - Comparison of candidate gene list between SNP array I and II and microarray 
Comparison Candidate genes 
SNPArrayI  
vs. Microarray Vkorc1, Bglap, Ift52, Mybl2, Cyp4f1, Tbx3, Mlycd, Osgin1, RT1-S3 
SNPArrayI  
vs. VP3.1 Vkorc1, Tuft1, Ggcx, Rock2, Fhit, Tpmt 
SNPArrayI  
vs. pop20 Vkorc1 
VP3.1  
vs. pop20 
Gsg1l, LOC100360815, Vkorc1, Hdc, Myh9, Megf11, Rab11a, Tbc1d5, 
Ncam2, Abcc5, Clph, Csn3, LOC494224, Odam, Csn1s2b, Csn1s2a 
Comparison Regions of clustered candidate genes (Mb) 
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SNPArrayI  
vs. Microaray 
Chr1: 185-187; Chr2: 178-182; Chr3: 153-158;  
Chr4: 9-13; Chr12: 33-38; Chr19: 49-53; Chr20: 1- 3 
Microarray 
vs.VP3.1  Chr1: 82-86; Chr1: 184-187; Chr7: 113-116 
Microarray  
vs. pop20 Chr1: 184-187; Chr11: 82-83; Chr12: 32-37; Chr20: 1-5 
VP3.1  
vs. pop20 Chr1: 185-187; Chr14: 21 
 
5.3.4. Summary of candidate genes combining NetGWAS of two SNP array 
data and gene expression analysis 
 Combining the results of SNP array I, SNP array II and microarray analysis, we listed 
some candidate genes for further validation (Table 5.4). Vkorc1 gene has been 
reconfirmed in three populations by association tests. In microarray analysis, although the 
adaptive mutation in Vkorc1 changes protein structure rather than modifying expression 
profiles, the genes in flanking region exhibited warfarin-related expression signals 
(Figure 4.6A) due to the effect of selective sweep (c.f. Chapter 2). Thus Vkorc1 could be 
detected based on both variation and expression signals. 
 Cyp4f1 gene gains support from both SNP array I and microarray analysis. It is one of 
the ortholog gene of human CYP4F2 gene, which has been identified as a warfarin dose 
predictor explaining ~1.5% dose variance in patients (Pautas et al. 2009; Takeuchi et al. 
2009). In vitro metabolic experiments showed that CYP4F2 gene is a vitamin K1 oxidase, 
and the V433M allele in CYP4F2 result in a reduced enzyme activity, thus an elevated 
level of hepatic vitamin K, which requires more warfarin dose to elicit the same 
anticoagulant response (McDonald et al. 2009). Phylogenetic analysis also indicated that 
CYP4F genes are subject to positive selection (Thomas 2007). These information suggest 
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Cyp4f1 gene might be involved in warfarin resistance in rats, thus would be of interest for 
further validation. However, as recognized before, CYP450 genes duplicate a lot and 
enzymes function in xenobiotic substrates tend to form clusters (Thomas 2007). Based on 
GenBank annotation, we saw that closely near Cyp4f1 gene is a Cyp4f6 gene. And ~0.3 
Mb away, there are two genes Cyp4f40 and Cyp4f4, which is actually another rat ortholog 
of CYP4F2 gene. Expanding to 0.6 mb, there are 4 more CYP450 genes. This situation 
and the rapid evolutionary rate of xenobiotic related CYP450 genes pose the challenge of 
discerning the ‘true’ warfarin related gene, because it is difficult to assign one-to-one 
ortholog for these genes. 
Table 5.4 – Summary of candidate genes or regions 
Genes or 
Regions 
(Mb) 
Chr Pos (Mb) 
Human 
ortholog Function 
SNP 
arrayI 
(NW) 
Micro
array 
(NW) 
SNP 
arrayII 
(VP3.1) 
SNP 
arrayII 
(pop20) 
82-86 1 82-86 - -  ✓ ✓  
Vkorc1 1 187 VKORC1 regulation of blood coagulation ✓ ✓ ✓ ✓ 
Fgfr2 1 189 FGFR2 bone development, FGFBP2 ✓ ✓   
Bglap 2 180 BGLAP bone mineralization ✓ ✓   
Ift52 
(153-158) 3 154 IFT52 
intraflagellar 
transport 52 
homolog 
✓ ✓   
Mybl2 
(153-158) 3 154 MYBL2 
myeloblastosis 
oncogene-like 2 ✓ ✓   
Calu 4 56 CALU regulate vitamin K cycle ✓   ✓ 
Ggcx 4 106 GGCX gamma-carboxylation ✓  ✓  
Cyp4f1 7 14 CYP4F2 cytochrome P 450 gene family ✓ ✓   
113-116 7 113-116 - 
Apol3 
apolipoprotein, 
APOE 
 ✓ ✓  
82-83 11 82-83 - -  ✓  ✓ 
Tbx3 
(32-37) 12 38 TBX3 
reproductive 
development ✓ ✓  ✓ 
21-21 14 21 - -   ✓ ✓ 
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 Bglap gene, encoding a vitamin K dependent protein that affects vessel calcification 
and bone mineralization (Suttie 1993; Danziger 2008), is ascertained from both SNP 
array and microarray study. More interestingly, our preliminary test of genomic 
association with arterial calcification phenotype indicated that 4 SNPs near Bglap gene 
are significant associated with both arterial calcification and warfarin resistance 
phenotypes (c.f. Chapter 6, Future directions). Considered previously observed arterial 
calcification of homozygote resistant rats (Kohn, Price, and Pelz 2008), Bglap gene might 
open a door for us to explore the mechanisms of one of the fitness costs associated with 
warfarin resistance besides the reduced growth and reproductive rate (Jacob et al. 2012). 
The other two vitamin K dependent proteins (Gas-6 and Mgp) with the function of 
protecting vasculature, however, were not detected in our study (Danziger 2008). In vitro 
experiment showed that MGP’s effect on calcification also relies on its relative amounts 
with the bone morphogenetic protein BMP-2 (Zebboudj, Shin, and Bostrom 2003). In this 
complicate scenario, it is hard to predict what we would observe for Mgp gene. 
The region of 154-158 Mb on chromosome 3 exhibited relatively strong 
association signals as well as expression signals. However, there are 9 genes in this 
region; which one would be the potential causal gene? At first, the Prex1 gene carried the 
Fhit 15 16 FHIT  ✓  ✓  
Cacna2d3 16 4 CACNA2D3 
calcium channel 
protein, CACNA1C ✓  ✓  
Mlycd 
(49-53) 19 50 MLYCD 
fatty acid 
metabolic process ✓ ✓   
Osgin1 
(49-53) 19 50 OSGIN1 
growth factor 
activity ✓ ✓   
RT1 
(1-5) 20 2 HLA-E 
histocompatibility 
complex gene ✓ ✓  ✓ 
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strongest associated SNP seemed to be an interesting one. I have conducted SNP 
discovery and genotyping for this gene in other wild populations, but didn’t find 
significant association with warfarin resistance. Based on the gene interaction network 
analysis (Figure 3.7A), the Prex1 gene was not connected to the main Vkorc1 cluster in 
the GGI subnetwork of candidate genes. Instead, other two genes (Ift52 and Mybl2) in 
this region carried relatively high association scores and also connected to Vkorc1 cluster 
in terms of gene interaction, thus might be worthy of further examination. Moreover, 
genes in this region interact with the Fgfr2 gene (involved in embryonic development and 
tissue repair) in Vkorc1 sweep region, which suggests us another path to explore the 
association with warfarin resistance for this region.  
There are 3 other genes Tbx3, Mlycd and RT1-S3, with supports from expression 
and genomic variation analysis. Especially Tbx3 gene was identified from two SNP array 
and the microarray data. We suspect that Tbx3 gene might be indirectly interacting with 
the vitamin K dependent protein - bone matrix protein (MGP) via the bone 
morphogenetic protein (BMP-2) (Zebboudj, Shin, and Bostrom 2003; Chen et al. 2009). 
And the functional enrichment analysis (Table 3.2) showed that Tbx3 gene is involved in 
reproductive developmental process, which is an interesting coincidence that resistant 
rats were observed to have fitness costs of both arterial calcification and reduced 
reproductive rate (Smith, Townsend, and Smith 1991; Pelz et al. 2005; Kohn, Price, and 
Pelz 2008; Rost et al. 2009). Though lack of enough knowledge of their relationship with 
warfarin, these genes should be paid attention to in future analysis.  
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As we mentioned above, Ggcx, Fhit and Cacna2d3 genes were identified based 
on SNP array data from two populations. Ggcx gene were examined as a candidate gene 
related to warfarin before but was not fully confirmed in replication studies (Wadelius et 
al. 2005; Cha et al. 2007; Wadelius et al. 2007). Cacna2d3 is potentially interesting 
because there is another calcium-channel gene CACNA1C carried the best novel SNP in a 
GWAS of warfarin dose in human (Cooper et al. 2008). Another gene Fgfr2 (fibroblast 
growth factor receptor 2), shown to be involved in bone development (Table 3.2), also 
have supporting evidence from human: the genomic scan revealed FGFBP2 (fibroblast 
growth factor binding protein 2) gene has a relatively high genotype-dose association in 
addition to VKORC1 and CYP2C9 in human (Cooper et al. 2008). 
There are two regions are supported by microarray and SNP array II data in 
VP3.1. One region is at chromosome 1: 82-86 Mb. Another region is at chromosome 7: 
114-116 Mb, containing 27 candidate genes. There is an Apol3 gene (apolipoprotein L, 3) 
in this region. And in human, another APOE gene (apolipoprotein E) is responsible for 
the transportation of vitamin K1 from upper gastrointestinal tract to liver. In addition, 
there is a region at chromosome 14 around 21 Mb carrying replicate signals from VP3.1 
and pop20. 6 genes in this region need more literature search for function relevance. 
According to the traditional candidate approach, it is intuitive to examine the rat 
ortholog of the human CYP2C9 gene, which is the secondary warfarin dose biomarker 
just behind VKORC1. Human CYP2C9 gene and its rat ortholog Cyp2c11 were found 
under positive selection based on phylogenetic analysis (Thomas 2007). I did a small-
scale SNP discovery for rat Cyp2c11 gene, but didn’t find significant association with 
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warfarin resistance. More replication experiments are needed to assess the role of 
Cyp2c11 gene in rat resistance. 
5.3.5. Candidate gene Calu was associated with warfarin resistance in 
multiple wild populations 
As we are listing these top candidate genes for further evaluation, we actually 
already collected genotype data of another candidate gene Calu in multiple wild 
populations. Calumenin gene (Calu), located at chromosome 4: 56 Mb, has been 
identified as a candidate in SNP array I analysis (c.f. Chapter 3) with relatively high 
support score, but without high association strength in the wild-derived NW populations. 
In pop20 (SNP array II), three genes located at the same chromosomal region were 
detected as candidate genes. As previous studies showed that Calu regulate the vitamin 
K-dependent gamma-carboxylation system (Markussen et al. 2007b) and compete with 
warfarin for the binding-site in the VKOR complex (Markussen et al. 2007a), we 
performed SNP discovery for Calu gene and collected genotype data.    
Using 8 primer pairs covering 7 exon regions on the Calu gene, we found 4 SNPs 
located on 5’ region, 1 SNP on the first intron, 1 SNP, a 26bp deletion and a 2bp insertion 
on the 5th intron, 3 SNPs on the 6th exon (Table 5.5). For the SNP site Calu_56228735 
located on the first intron, we collected the genotype information using HRM for all the 
rats from the 19 natural populations and used it in the association test. The intergenic 
SNP site Calu_S1_56038243 was also genotyped as a linked locus to Calu gene (0.2 
upstream). 
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Table 5.5 – Characterization of SNP variants in Calu gene and flanking region 
Bold SNP IDs are the SNPs used in the following association tests. 
As the main resistance gene, Vkorc1 showed significant associations (P < 0.031) 
with the resistant phenotype in NW and 13 natural populations (Table 5.6). Represented 
by the SNP Calu_56228735, Calu gene exhibited significant association (P < 0.02) in 7 
populations and marginal association (P = 0.08) in NW population. The intergenic SNP 
site Calu_S1_56038243 (call it Calu_S1 from now on) located 0.2 Mb upstream to the 
Calu gene also showed significant associations (P <= 0.017) in 7 populations. This 
observation indicates Calu is associated with warfarin resistance and the flanking region 
was also affected by warfarin selection due to potential hitchhiking effect.  
There are 5 populations missing Vkorc1 association signals. In Pop6, Pop10 and 
Pop25, there are too few susceptible rats (≤ 2); in pop15, only 1 rat out of 6 is resistant. 
Besides the small number of non-resistant rats in above 3 populations, these non-resistant 
rats actually carry the Y139C mutation in Vkorc1 gene. It might be due to some 
misclassification of BCR (blood clotting response) test, or implies the effect of other 
Genes Position  SNP ID Location Variation 
Vkorc1 Chr1:187177048 Vkorc1_187177048 Vkorc1 1st exon A->G 
Calu 5’ region Chr4:56038243 Calu_S1_56038243 Calu upstream intergenic C->G 
Calu Chr4:56228407 Calu_56228407 Calu 5' intergenic C->G 
Calu Chr4:56228527 Calu_56228527 Calu 5' intergenic G->T 
Calu Chr4:56228578 Calu_56228578 Calu 5' intergenic C->T 
Calu Chr4:56228735 Calu_56228735 Calu 1st intron A->G 
Calu Chr4:56251705 Calu_56251705 Calu 5th intron C->A 
Calu Chr4:56251821 Calu_56251821 Calu 5th intron 26bp deletion 
Calu Chr4:56252081 Calu_56252081 Calu 5th intron 2bp insertion 
Calu Chr4:56252174 Calu_56252174 Calu 6th exon 1->2 
Calu Chr4:56252656 Calu_56252656 Calu 6th exon G->A 
Calu Chr4:56252715 Calu_56252715 Calu 6th exon G->A 
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genes on warfarin resistance. In the SP population with moderate resistant level (33%), 
we noticed the absence of phenotype-genotype association for Vkorc1 gene, which can 
hardly be explained by sample size (7 resistant and 14 non-resistant rats). In SP 
population, all the samples (except one sample 3452), even the 6 resistant rats, are 
homozygotes of the Vkorc1 non-resistance allele A. This observation suggests other 
genes may contribute to wafarin resistance, and is one motivation for us to do genomic 
scan for additional warfarin related genes. And here we detected significant association in 
this SP population at the Calu_S1 locus, which merits further investigation. The 
significant association for both Vkorc1 and Calu gene are maintained in the inferred 
virtual populations. 
Table 5.6 – Warfarin resistance association tests for Calu in multiple wild populations. 
Pop N R(N) S(N) R% Vkorc1 Calu_S1 Calu 
NW 32 20 10 69% 2.6e-7* 0.110 0.080 
WU 73 51 4 93% 9.0e-5* 0.000* 0.017* 
KB 70 54 11 83% 1.5e-4* 0.465 0.780 
SP 23 7 14 33% 0.273 0.002* 0.251 
TH 56 4 51 7% 0.001* 0.932 0.768 
Pop4 52 43 3 94% 0.008* 0.252 0.008* 
Pop17 53 44 7 86% 1.4e-6* 0.010* 0.756 
Pop28 37 30 5 86% 0.028* 0.011* 0.015* 
Pop5 20 14 5 74% 0.004* 0.767 0.020* 
Pop19 56 32 17 65% 3.1e-8* 0.000* 0.011* 
Pop13 42 23 13 64% 1.5e-5* 0.257 0.266 
Pop20 27 16 10 62% 0.000* 0.017* 0.012* 
Pop14 19 7 9 44% 0.001* 0.007* 0.008* 
Pop15 10 1 5 17% 0.083 0.693 0.127 
Pop6 24 23 1 96% 0.103 0.711 0.106 
Pop12 25 20 1 95% 0.012* 0.307 0.763 
Pop10 42 36 2 95% 0.170 0.696 0.419 
Pop18 29 21 2 91% 0.031* 0.200 0.103 
Pop25 20 17 2 90% 0.278 0.071 0.156 
Virtual_pop1 158 122 20 77% 1.8e-10* 1.6e-3* 7.5e-7* 
Virtual _pop2 207 154 51 74% 2.5e-25* 6.7e-5* 4.7e-3* 
Virtual _pop3 210 129 77 61% 8.4e-34* 3.8e-9* 1.1e-8* 
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N: Sample size for each population. 
R(N) and S(N): the number of rat samples with the warfarin resistant (R) and susceptible (S) phenotype. 
R%: the warfarin resistant level, the number of resistant rats divided by the number of samples with 
warfarin phenotype. 
* are the significant P-values < the threshold of 0.05. 
 
5.3.6. Vkorc1 and Calu were in linkage disequilibrium 
Linkage disequilibrium (LD) described the non-random association of alleles 
between different SNP sites (Hartl and Clark 2007). For SNPs located on the same 
chromosome, LD would decrease with the increase of distance (Xiong and Guo 1997). 
Simultaneously, LD is also affected by recombination rate and population structure 
(Xiong and Guo 1997). Extended LD blocks of linked loci are usually considered to be 
signatures of selection (Chapter 2, Figure 2.2A) (Kohn, Pelz, and Wayne 2000; Kim and 
Nielsen 2004; Hohenlohe et al. 2011). Thus, we expected to detect strong LD signals at 
regions with potential adaptive variants in populations resistant to warfarin. Sometimes, 
however, LD might be maintained by functional interaction between SNP pairs even 
located on different chromosomes; reciprocally, strong LD between physically unlinked 
sites with biological significance would help identify functional relationship between the 
SNP pairs (Burmeister 1999; Slatkin 2008). 
Table 5.7 showed the LD between SNPs with the threshold of squared r >= 0.15. 
SNPs in the Calu gene are in LD with its upstream intergenic SNP Calu_S1, indicating 
the effect of selective sweep. Though distributed on different chromosomes, Vkorc1 is in 
LD with the Calu gene as well as its upstream intergenic SNP in multiple wild 
populations. These non-random associations between physically unlinked genes implied 
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their potential functional relatedness or they were under the same selection pressure (Liu 
et al. 2010). 
Table 5.7 – Linkage disequilibrium of Vkorc1 and Calu in multiple wild populations. 
Population SNPA Position_SNPA SNPB Position_SNPB LD (r-square) 
NW Vkorc1 Chr1: 187177049 Calu Chr4: 56228736 0.16 
NW Calu_S1 Chr4: 56038243 Calu Chr4: 56228736 0.48 
WU Calu_S1 Chr4: 56038243 Calu Chr4: 56228736 0.16 
Pop19 Vkorc1 Chr1: 187177049 Calu Chr4: 56228736 0.15 
Pop19 Vkorc1 Chr1: 187177049 Calu_S1 Chr4: 56038243 0.19 
Pop4 Vkorc1 Chr1: 187177049 Calu Chr4: 56228736 0.11 
Pop28 Vkorc1 Chr1: 187177049 Calu_S1 Chr4: 56038243 0.13 
Pop20 Vkorc1 Chr1: 187177049 Calu Chr4: 56228736 0.28 
Pop12 Vkorc1 Chr1: 187177049 Calu_S1 Chr4: 56038243 0.11 
Pop12 Calu_S1 Chr4: 56038243 Calu Chr4: 56228736 0.27 
Pop5 Vkorc1 Chr1: 187177049 Calu Chr4: 56228736 0.18 
Pop25 Vkorc1 Chr1: 187177049 Calu_S1 Chr4: 56038243 0.21 
Pop25 Calu_S1 Chr4: 56038243 Calu Chr4: 56228736 0.18 
Pop14 Vkorc1 Chr1: 187177049 Calu_S1 Chr4: 56038243 0.41 
Pop14 Vkorc1 Chr1: 187177049 Calu Chr4: 56228736 0.32 
Pop14 Calu_S1 Chr4: 56038243 Calu Chr4: 56228736 0.11 
 
5.4. Discussion 
Based on genomic variation and expression data, we performed network-guided 
analysis and obtained a list of candidate genes related to warfarin. Most of them are 
involved in or related to vitamin K pathway, and are connected to the resistance gene 
Vkorc1 in the gene-gene interaction network (Figure 3.7). Here we reviewed previously 
examined candidate genes considering the warfarin therapy in human, which are 
important reference for our and future study. 
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5.4.1. Short review of 31 previously studied candidate genes in human 
As the most popular oral anticoagulant for preventing thrombotic events, warfarin 
therapy is associated with risk of thrombosis or risk of bleeding, especially during the 
initial phase (Pavani et al. 2012).  
In human, VKORC1 and CYP2C9 established the warfarin dose prediction model 
coupled with other non-genetic factors (sex, age, weight, etc.). CYP4F2 and EPHX1 
genes are recently identified with small influence on warfarin dose (Pautas et al. 2009; 
Takeuchi et al. 2009). As shown in Figure 5.2, VKORC1 encode vitamin K epoxide 
reductase; -1639 G to A mutation (rs9923231) in the upstream promoter region produces 
less VKORC1, thus lower warfarin dose is needed for patients with the A allele. More 
nonsynonymous mutations in VKORC1 associated with warfarin sensitivity have been 
detected recently and complicate the dose optimization algorithms (Baniasadi et al. 2011; 
Pavani et al. 2012). CYP2C9 and CYP4F2 encode enzymes metabolizing S-warfarin and 
vitamin K1 respectively (McDonald et al. 2009). Patients with the variant alleles *2 
(R144C, rs1799853) and *3 (I359L, rs1057910) in CYP2C9 gene have greater risks of 
bleeding and need lower warfarin dose (Takeuchi et al. 2009). Whereas individuals with 
the V433M (rs2108622) allele in CYP4F2 gene require higher warfarin dose because the 
allele reduce enzyme capacity to metabolize vitamin K1 (McDonald et al. 2009).  
Though there remains ~40% unexplained variance of warfarin dose, neither 
candidate gene approach nor genomic scan identified new determinants of warfarin 
dosing (Wadelius et al. 2007; Takeuchi et al. 2009). About 30 candidate genes believed 
to be involved in vitamin K or warfarin interactive pathways were examined: PROC, 
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APOE, EPHX1, ORM1-ORM2, CALU and GGCX were associated with warfarin dose, 
but none except VKORC1 and CYP2C9 reach significance after multiple correction 
(Wadelius et al. 2007).  
 
Figure 5.2 – Overview of the interaction between warfarin and genes involved in vitamin 
K related pathway based on human studies. 
For future reference, we briefly introduced the genes involved in warfarin 
interactive pathways base on research in human (Wadelius et al. 2007) (Figure 5.2, 
Appendix 8). Warfarin inhibited VKOR (encoded by VKORC1) reductase activity, thus 
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impaired the recycling of vitamin K hydroquinone, which is an essential cofactor for the 
formation of functional vitamin K dependent proteins (mostly blood coagulation factors) 
by gamma-carboxylase, encoded by GGCX (Presnell and Stafford 2002; Pelz et al. 2005; 
Stafford 2005). Another Vitamin K epoxide reductase is encoded by EPHX1 gene, which 
was found to be associated with the maintenance dose of warfarin (Pautas et al. 2009). 
Calumenin, encoded by CALU gene, has been shown to regulate the vitamin K-dependent 
gamma-carboxylation system (Markussen et al. 2007b) and compete with warfarin for the 
binding-site in the VKOR complex (Markussen et al. 2007a). APOE (apolipoprotein E) 
and NQO1 (NAD(P)H dehydrogenase, quinone 1) gene encode apolipoprotein E and 
NAD(P)H dehydrogenase, which the potential to affect dietary vitamin K (Markussen et 
al. 2007b; Wadelius et al. 2007). 
As mentioned above, several vitamin K dependent proteins are converted into 
biologically active forms by the gamma-carboxylation process, which requies vitamin K 
hydroquinone as a cofactor. These genes are involved in blood coagulation and bone 
metabolism: F2 (coagulation factor II), F7 (coagulation factor VII), F9 (coagulation 
factor IX), F10 (coagulation factor X), PROC (protein C, inactivator of coagulation 
factors Va and VIIIa), PROS1 (protein S (alpha)), PROZ (protein Z, vitamin K-dependent 
plasma glycoprotein) and MGP (matrix Gla protein), BGLAP (bone gamma-
carboxyglutamate (gla) protein) (Suttie 1993; Stafford 2005; Danziger 2008). SERPINC1 
(serpin peptidase inhibitor, clade C (antithrombin), member 1) gene encoded a non-
vitamin K-dependent protein, which inhibits the Vitamin K dependent clotting factors 
(Wadelius et al. 2007).  
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Other vitamin K dependent proteins are involved in calcification process. The 
growth-arrest specific protein 6, encoded by GAS6, affects vascular smooth muscle cell 
movement and apoptosis (Yanagita 2004; Danziger 2008). MGP (bone matrix gla 
protein) is a vascular calcification inhibitor, interacting with bone morphogenetic protein 
BMP-2 (encoded by BMP2 gene, bone morphogenetic protein 2), which further mediate 
TBX genes (Zebboudj, Shin, and Bostrom 2003; Chen et al. 2009). BGLAP is also related 
to vessel calcification. Different from coagulant factors that are produced and 
carboxylated in liver, MGP and GAS6 are produced and carboxylated locally within 
vasculature (Danziger 2008). 
Cytochrome P450 enzymes metabolize warfarin in liver. CYP2C8 (cytochrome 
P450, family 2, subfamily C, polypeptide 8), especially CYP2C9 play important role in 
metabolizing the S-form of administered warfarin. CYP1A2 (cytochrome P450, family 1, 
subfamily A, polypeptide 2), CYP3A4 (cytochrome P450, family 3, subfamily A, 
polypeptide 4), CYP1A1 (cytochrome P450, family 1, subfamily A, polypeptide 1), 
CYP3A5 (cytochrome P450, family 3, subfamily A, polypeptide 5) were reported to 
metabolize the R-warfarin. An interestingly study on habitual caffeine consumption 
demonstrated that CYP1A2 gene was the primary enzyme involved in caffeine 
metabolism (Cornelis et al. 2011). Other genes like ORM1 (orosomucoid 1), ORM2 
(orosomucoid 2) and ABCB1 (ATP-binding cassette, sub-family B (MDR/TAP), member 
1) encoded proteins involved in warfarin transportation in or out of the liver. NR1I2 
(nuclear receptor subfamily 1, group I, member 2) and NR1I3 (nuclear receptor subfamily 
1, group I, member 3) encode proteins inducing CYP450 enzymes and ABCB1. 
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This brief introduction of vitamin K related genes in human is updated and could 
be used as a reference in candidate identification (Figure 5.2). 
5.4.2. Calu as a candidate gene associated with warfarin resistance 
Our genotype-phenotype association test result for Calu gene in multiple wild 
populations designated Calu as a candidate gene affected by warfarin. The observed 
significant associations for the Vkorc1, Calu and its linked loci in both natural and the 
inferred virtual populations (Table 5.6) suggest the observation are not due to population 
structure or could be randomly obtained. Though lack of clear functional explanation for 
the observed polymorphism on this gene, previous study recognized the regulation role of 
Calu gene on the vitamin K-dependent g-carboxylation pathway (Markussen et al. 
2007b). And the fact that Calu gene competitively bound the VKOR complex (encoded 
by the Vkorc1 gene) with warfarin suggested an alternative way for developing resistance 
other than the direct variation on Vkorc1 gene (Markussen et al. 2007a). The missing of 
association for Vkorc1 gene and the detected association for Calu gene in the SP 
population gained our attention. This observation suggested alternative paths to warfarin 
resistance, at least in some rats. Moreover, the non-random association (LD) between 
Vkorc1 and Calu reminds us of the potential role of Calu gene in warfarin-mediated 
pathways.  
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Chapter 6 
Conclusions and Future directions 
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6.1. Conclusions 
There is much hope to dissect the genetic architecture of adaptive traits in natural 
populations. However, as shown in this thesis, even in the case of what has been 
propagated as a classical system of a simple Mendelian adaptive trait the situation is more 
complex. Moreover, virtually all insights into the system date back to the 1970s and here 
it is for the first time that warfarin resistance in the rat is studied in the post genome era 
and with the knowledge of the warfarin resistance gene, Vkorc1, and the resistance 
causing mutation Y139C in hand.   
My thesis work revealed that the main warfarin resistance gene Vkorc1 set in the 
genetic background of rats from Germany likely is under strong (s~0.3) balancing 
selection; which confirms earlier inferences from field studies on phenotype frequencies 
but my work is novel in that it is the first population genetic analysis of the Vkorc1 gene. 
Moreover, resistance in my study area likely has evolved from a new, as opposed to 
standing, genetic variant in Vkorc1 (Y139C), which I inferred from forward time 
simulations that were most consistent with a starting frequency ~1/Ne of the resistance 
allele around the time when resistance appeared in the area. This new mutation could be a 
de novo mutation or carried by single (or few) migrants (Chapter 2).  
Beyond Vkorc1, we identified candidate genes related to warfarin resistance based 
on genomic variation data (Chapter 3) and microarray expression data (Chapter 4). A key 
innovation of my thesis is that I adopt a NetGWAS approach to analyze genomic data 
collected on wild populations. This approach has entered the area of complex disease 
gene mapping in the biomedical field, but has not been adopted by evolutionary 
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geneticists thus far. I show that while conventional association studies, or GWAS, hold 
much reduced potential to identify candidate genes related to warfarin resistance than 
does NetGWAS. A main reason for this is that adaptive loci in natural populations 
display strong haplotype structuring due to breeding structure and genetic hitchhiking; 
both leading to large numbers of false associations during single nucleotide 
polymorphism (SNP) genotyping and, interestingly and to my knowledge as not 
documented before, during gene expression analysis. The latter observation indicates that 
searches for adaptive trait loci in natural populations that have employed gene expression 
analyses potentially have dramatically overestimated the complexity of the genetic 
architecture of the adaptive trait under study, and/or potentially has misled interpretations 
of such results to the effect that the number of traits under selection was overestimated 
also.  My combined analysis of SNP association with warfarin resistance and gene 
expression data showed that despite massive numbers of associated SNPs it is possible to 
distinguish between true association and false association due to linkage (and other 
factors) by adopting a NetGWAS approach. Furthermore, I complemented my analyses 
by conducting a cis-eQTL (expression quantitative trait loci) mapping approach, which 
substantiated my results.  
Although we identified multiple candidate genes and selection signals on 
numerous chromosomes we were able to establish that analyzing these genes in a gene-
gene network can reduce this apparent complexity of the genetics of warfarin resistance. 
Specifically, we were able to show that candidate genes can be connected to each other 
and shown to be centered on the vitamin K pathway; thereby forming what we could call 
a ‘warfarin resistance module’ (Figure 3.7A). We performed further analyses of 
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identified candidate genes in wild populations. The genes that have passed analyses 
described in the chapters 3-5 are summarized in Chapter 5. These are considered high-
quality candidate genes that merit detailed further study. As a start, we collected 
genotype data and tested for the association of one such candidate gene, Calu, in 19 
natural populations of rats where warfarin resistance is common. We observed that Calu 
is significantly associated with warfarin resistance in seven populations.  It is interesting 
to note that any reference to the complexity of genetic architectures of adaptive traits 
appears to be manifest also in form of differences in the loci involved in different local 
populations. This would be analogous to genetic heterogeneity of human complex 
diseases. As such, I postulate a strong influence of genetic drift in shaping the complex 
genetics of adaptation to warfarin in our study area.   
This network-guided genomic study demonstrated the importance of ‘think 
globally’, i.e. the consideration of gene-gene interactions in genomic studies. The 
NetGWAS and co-expression network analysis conducted here and supplemented by 
population genomics were shown as a powerful approach for the identification of 
candidate genes underlying warfarin resistance in the Norway rat. The evidence for 
selection at many of the identified genomic regions indicates that these regions indeed are 
part of a recent event.  
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6.2. Future directions 
6.2.1. Is the Vkorc1-Calu interaction an example for the ‘soft’ selective sweep 
model underlying adaptation 
Adaptations result from the rise in frequencies and fixation of beneficial alleles. 
This can occur by selection on a new mutant or by selection from standing variants 
(Pritchard and Di Rienzo 2010).  As described by the ‘selective sweep’ model (c.f. 
Chapter 2), adjacent neutral alleles show similar evolutionary dynamics as the closely 
linked loci under selection (Kim and Stephan 2003). Traditionally, ‘hard sweep’ models 
refer to the situation that selection drives a new beneficial mutation to fixation rapidly, 
and genetic variants at linked sites are wiped out, thereby creating a large identical-by-
descent (IBD) region (Pritchard, Pickrell, and Coop 2010). Detecting sweep signals thus 
became an effective means to detect potentially adaptive genes e.g. in human populations 
that evolved to deal with high altitude or benefitted from milk consumption (Enattah et 
al. 2008; Yi et al. 2010).  
Recently, it has been advocated by the community that a polygenic, or ‘soft 
sweep’, model is might be more adequate to describe the process of genetic adaptation in 
natural populations than is the classical ‘hard sweep’ model (Pritchard and Di Rienzo 
2010; Pritchard, Pickrell, and Coop 2010; Hernandez et al. 2011). This soft sweep model 
predicts small frequency shifts across many loci, and thus, under such ‘polygenic 
adaptation’ the fixation of beneficial alleles and the large IBD regions are not predicted. 
This would render genomic searches for such soft sweeps more difficult than searches for 
hard sweeps. In addition, under the polygenic model multiple loci with new or pre-
 247 
 
existing beneficial alleles respond to the selection directly by affecting the phenotype 
(Pritchard, Pickrell, and Coop 2010), or indirectly by interacting with the loci that interact 
with the trait. The population genetics of such interacting genes have not been explored 
to date, but likely follow soft sweep models also. Our study system of warfarin resistant 
rats and the now identified set of genes provide a unique opportunity for us to examine 
the soft sweep models in more detail. 
Calu encodes an enzyme that binds to the VKOR complex. We have observed 
that Calu is associated with warfarin resistance and is in linkage disequilibrium with the 
resistance gene Vkorc1 (Table 5.6, Table 5.7). As shown in Chapter 2, selection on 
Vkorc1 created a sweep region spanning ~30 Mb around Vkorc1, which could be 
considered as a ‘hard sweep’ case except that the adaptive mutant is not fixed because of 
balancing selection. Calu, on the other hand, might be under a much weaker selection 
pressure and is part of a ‘soft sweep’ that is coupled with selection on Vkorc1 even 
though the two genes are located on different chromosomes. 
In addition, although the interferences between linked beneficial mutations have 
been noted and modeled in several studies (Kim and Stephan 2003; Illingworth and 
Mustonen 2011), genetic interactions between unlinked variants are not widely 
considered in population genetic theory. Now with the network perspective, we expect 
the gene-gene interactions between physically unlinked genes would potentially affect 
their evolutionary dynamics. Thus, both theoretical studies and empirical studies are 
needed that consider the population genetics of interacting genes underlying adaptive 
traits and the potential fitness cost associated with a soft sweep over numerous interacting 
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loci. We envision scenarios that merit exploration of the role of each gene in such groups 
of genes. For example, using the Vkorc1-Calu combination of genes one could 
distinguish between interactions of two genes that interact with warfarin (‘potential 
drivers’) as well as genes that merely hitchhike with these genes without direct 
contributions to the trait (hitchhikers). 
6.2.2. Genes involved in arterial calcification – a fitness cost of resistance 
The resistance mutation (Y139C) in Vkorc1 confers tremendous advantage to rats 
when exposed to warfarin, but it also brings some fitness costs with it in form of reduced 
VKOR activity and, as was reported for a strain from the U.K., reduced growth rate 
(Smith, Townsend, and Smith 1991; Pelz et al. 2005; Rost et al. 2009). In a previous 
study of the wild-derived NW population rats displayed a cardiovascular phenotype 
(Kohn, Price, and Pelz 2008). 
This emerging knowledge on the fitness cost of the adaptation to warfarin 
motivated us to search for genetic variants related to the phenotype of arterial 
calcification using our SNP array data. Provided that much evidence points to a higher 
cost of resistance in males than in females the role of sex-specific modifiers of the traits 
should be explored further. 
A preliminary genomic association test has revealed nine SNPs that are 
significantly associated with the combined set of traits warfarin resistance, arterial 
calcification and gender. One of these nine SNPs is located in the 5’ region of the Fgfr2 
gene (fibroblast growth factor receptor 2). This finding might indicate that this gene is 
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functionally related to our study variables, but the gene may be falsely associated with 
the traits because a selective sweep nearby at Vkorc1 resulted in SNP associations over 
distances spanning 2 Mb separating the Vkorc1 and Fgfr2. A previous GWAS on 
warfarin dose requirements in human patient cohorts observed that FGFBP2 (fibroblast 
growth factor binding protein 2) contributed to the relatively high genotype-dose 
associations seen. Just as we observed here this was supported in addition to associations 
of VKORC1 and CYP2C9 (Cooper et al. 2008), and other loci discussed in my thesis. 
Thus, further investigations into Fgfr2 association with resistance and a potential fitness 
cost are merited. 
In addition, we found that the Bglap gene is significantly associated with both 
warfarin resistance and arterial calcification. With the prior knowledge of the dependence 
of this gene on vitamin dependent gamma-carboxylation and its association with 
mineralization of the bone matrix (Pan and Price 1985) we propose that the association 
detected in my thesis represents its potential role in vascular calcification seen in warfarin 
resistant Y139C mutant rats. 
The Y139C mutation in Vkorc1 is associated with arterial calcification phenotype 
with significance level P-value = 5.23×10-5. We observed another SNP (S694261) with a 
significant P-value = 6.33×10-5 associated with arterial calcification. This SNP, located 
on chromosome 16 (position: 45349355 bp), is also associated with warfarin resistance 
before multiple correction (P-value = 0.021). There are 3 more SNPs in this region that 
exhibit such associations with both warfarin resistance and arterial calcification, however 
at lower levels of significance. Thus, an interesting question for future research refers to 
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the genes that map into this region. However, currently the resolutions of the SNP survey 
as well as the annotations of the region are too limited to resolve this question. As best as 
can be determined here there are two genes that map within 1mb of the S694261 SNP: 
LOC100363103 and LOC681082.  
These preliminary results revealed some interesting patterns associated with 
arterial calcification in rats, which might be induced by warfarin resistance and/or the 
exposure to warfarin. More comprehensive investigation including the network-guided 
analysis would help us understand the fitness costs of warfarin resistance in more detail, 
and could shed light on warfarin therapy in patients with chronic kidney disease given 
their high risk of vascular calcification. 
6.2.3. Genetic architecture of resistance to second-generation anticoagulant 
rodenticides 
Warfarin, a 4-hydroxycoumarin-based compound, is the first generation 
anticoagulant rodenticide. After rats resistant to warfarin had been found, other derivative 
of 4-hydroxycoumarin including coumatetralyl, bromadiolone, and difenacoum were 
introduced as rodent control compounds. We have obtained the phenotype data of rats 
resistant to some second-generation anticoagulant rodenticides (Kohn, Pelz, and Wayne 
2003).  For bromadiolone, we saw that Vkorc1 gene and the flanking neutral alleles show 
significant associations (P <= 0.055) with the resistance phenotype in 4 natural 
populations. Calu and an upstream intergenic SNP are associated with the bromadiolone 
resistant phenotype in 3 natural populations. Interesting patterns of association were 
observed in the SP population, where all samples in this population are susceptible to 
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bromadiolone and resistance to warfarin was observed even though the Y139C mutation, 
or other Vkorc1 mutations were not found. Thus, the observed resistance to warfarin in 
this population SP might be due to different mechanism. In addition, females were found 
to be more tolerant to second-generation anticoagulants than are males, and a previous 
study reported that sex is a factor affecting underlying resistance to bromadiolone (Kohn 
and Pelz 1999). Thus, we expect that the genetic architecture of resistance to 
bromadiolone is not limited to the known single resistance gene Vkorc1. 
For the anticoagulant coumatetralyl we observed genotype-phenotype 
associations for Vkorc1 and surrounding neutral SNPs in 4 natural populations, but none 
such association was observed for Calu and linked sites. Association of SNPs with 
difenacoum was not tested here because too few rats in the available sample are resistant 
to it. Resistance to this anticoagulant remains relatively sparse, e.g. as shown during a 
recent survey conducted in Belgium (Baert K 2012). 
More detailed investigations of the genetics underlying resistance to second-
generation anticogulant rodenticides are required. For example, previous studies have 
claimed that cytochrome P450 genes play an important role in bromadiolone resistance 
(Markussen et al. 2008a; Markussen et al. 2008b). Our study of warfarin resistance, 
however, did not support a statistical overrepresentation of cytochrome P450 genes. 
Thus, the role of cytochrome P450 genes in mediating bromadiolone resistance, as 
opposed to warfarin resistance, deserves further study.  
Two additional areas of interest refer to the better quantification of the fitness 
costs of warfarin resistance and the specific genetic pathways that are pleiotropic; i.e. tat 
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can be shown to confer resistance but also can be shown to underlie detrimental traits. 
Finally, the fact that resistance has evolved from first- to second-generation 
anticogulants, called ‘resistance hierarchy’, poses a potential clue as to how adaptation 
progresses in nature (Pelz, Hänisch2, and Lauenstein 1995). Conceivably, in this system 
it is possible to infer in more detail how a set of mutations result in an adaptation to one 
environmental factor and to pre-adaptation to similar such factors. 
6.2.4. The importance of adopting a gene-gene interaction network 
perspective 
We have demonstrated the importance of adopting a gene-gene interaction 
network perspective when conducting GWAS and analyses of gene expression. As is 
shown in Figure 3.1, instead of identifying individual SNPs, under this framework SNPs 
are mapped to genes, and genes are mapped onto genetic networks prior to computing 
gene ranks. Besides the advantages of identification of individual genes that are 
associated with a trait this gene-gene interaction network perspective is helpful also in the 
context of the study of the genetic architecture underlying adaptive traits in that we were 
able to show that selection for warfarin resistance resulted in the association of clusters of 
highly connected genes with the trait. It might be feasible to adopt and modify 
approaches currently explored in the biomedical research field, where tools and 
algorithms aiming to test for associations between subnetworks with patient survival data 
have been developed (Li et al. 2012).  
 
 253 
 
References 
Adams, N., and R. Boice. 1983. A longitudinal study of dominance in an outdoor colony 
of domestic rats. Journal of Comparative Psychology 97:24-33. 
Akula, N., A. Baranova, D. Seto et al. 2011. A network-based approach to prioritize 
results from genome-wide association studies. PLoS ONE 6:e24220-e24220. 
Avery, P. J., A. Jorgensen, A. K. Hamberg, M. Wadelius, M. Pirmohamed, and F. 
Kamali. 2011. A proposal for an individualized pharmacogenetics-based warfarin 
initiation dose regimen for patients commencing anticoagulation therapy. Clin 
Pharmacol Ther 90:701-706. 
Axelsson, E., A. Ratnakumar, M.-L. Arendt, K. Maqbool, M. T. Webster, M. Perloski, O. 
Liberg, J. M. Arnemo, Ö. Hedhammar, and K. Lindblad-Toh. 2013. The genomic 
signature of dog domestication reveals adaptation to a starch-rich diet. Nature. 
Baert K, S. J. 2012. Distribution of anticoagulant resistance in the brown rat in Belgium. 
Belgian Journal of Zoology 142:39-48. 
Baniasadi, S., S. Beizaee, B. Kazemi, N. Behzadnia, B. Shafaghi, M. Bandehpour, and F. 
Fahimi. 2011. Novel VKORC1 mutations associated with warfarin sensitivity. 
Cardiovascular Therapeutics 29:e1-e5. 
Barabasi, A.-L., N. Gulbahce, and J. Loscalzo. 2011. Network medicine: a network-based 
approach to human disease. Nat Rev Genet 12:56-68. 
Barabasi, A.-L., and Z. n. N. Oltvai. 2004. Network biology: understanding the cell's 
functional organization. Nature Reviews Genetics 5:101-113. 
Barrett, J. C., B. Fry, J. Maller, and M. J. Daly. 2005. Haploview: analysis and 
visualization of LD and haplotype maps. Bioinformatics 21:263-265. 
Barrett, R. D., and D. Schluter. 2008. Adaptation from standing genetic variation. Trends 
Ecol Evol 23:38-44. 
Barrett, R. D. H., and H. E. Hoekstra. 2011. Molecular spandrels: tests of adaptation at 
the genetic level. Nat Rev Genet 12:767-780. 
Beckmann-Knopp, S., S. Rietbrock, R. Weyhenmeyer, R. H. Bocker, K. T. Beckurts, W. 
Lang, M. Hunz, and U. Fuhr. 2000. Inhibitory effects of silibinin on cytochrome 
P-450 enzymes in human liver microsomes. Pharmacol Toxicol 86:250-256. 
Benfey, P. N., and T. Mitchell-Olds. 2008. From genotype to phenotype: systems biology 
meets natural variation. Science 320:495-497. 
 254 
 
Bollback, J. P., T. L. York, and R. Nielsen. 2008. Estimation of 2Nes From Temporal 
Allele Frequency Data. Genetics 179:497-502. 
Boyle, C. M. 1960. Case of apparent resistance of Rattus norvegicus Berkenhout to 
anticoagulant poisons. Nature 188:517-517. 
Brachi, B., G. P. Morris, and J. O. Borevitz. 2011. Genome-wide association studies in 
plants: the missing heritability is in the field. Genome Biol 12:232. 
Brown, E. A. 2012. Genetic explorations of recent human metabolic adaptations: 
hypotheses and evidence. Biol Rev Camb Philos Soc 87:838-855. 
Burmeister, M. 1999. Basic concepts in the study of diseases with complex genetics. Biol 
Psychiatry 45:522-532. 
Campana, M. G., H. V. Hunt, H. Jones, and J. White. 2011. CorrSieve: software for 
summarizing and evaluating Structure output. Molecular Ecology Resources 
11:349-352. 
Camus-Kulandaivelu, L. t., J.-B. Veyrieras, B. Gouesnard, A. Charcosset, and D. 
Manicacci. 2006. Evaluating the reliability of outputs in case of relatedness 
between individuals. 
Carvajal-Rodriguez, A. 2008. Simulation of genomes: a review. Current Genomics 
9:155-159. 
Cha, P.-C., T. Mushiroda, A. Takahashi, S. Saito, H. Shimomura, T. Suzuki, N. 
Kamatani, and Y. Nakamura. 2007. High-resolution SNP and haplotype maps of 
the human gamma-glutamyl carboxylase gene (GGCX) and association study 
between polymorphisms in GGCX and the warfarin maintenance dose 
requirement of the Japanese population. Journal of Human Genetics 52:856-864. 
Charlesworth, D. 2006. Balancing selection and its effects on sequences in nearby 
genome regions. PLoS Genet 2. 
Chen, Y.-L., B. Liu, Z.-N. Zhou, R.-Y. Hu, C. Fei, Z.-H. Xie, and X. Ding. 2009. Smad6 
inhibits the transcriptional activity of Tbx6 by mediating its degradation. The 
Journal of Biological Chemistry 284:23481-23490. 
Clune, J., J.-B. Mouret, and H. Lipson. 2013. The evolutionary origins of modularity. 
Proceedings of the Royal Society B: Biological Sciences 280. 
Cockram, J., J. White, F. J. Leigh, V. J. Lea, E. Chiapparino, D. A. Laurie, I. J. Mackay, 
W. Powell, and D. M. O'Sullivan. 2008. Association mapping of partitioning loci 
in barley. BMC Genetics 9:16-16. 
 255 
 
Consortium, T. G. O. 2008. The Gene Ontology project in 2008. Nucleic Acids Research 
36:D440-D444. 
Consortium, T. I. H. 2005. A haplotype map of the human genome. Nature 437:1299-
1320. 
Consortium, T. W. T. C. C. 2007. Genome-wide association study of 14,000 cases of 
seven common diseases and 3,000 shared controls. Nature 447:661-678. 
Cooper, G. M., J. A. Johnson, T. Y. Langaee et al. 2008. A genome-wide scan for 
common genetic variants with a large influence on warfarin maintenance dose. 
Blood 112:1022-1027. 
Cordell, H. J. 2009. Detecting gene-gene interactions that underlie human diseases. Nat 
Rev Genet 10:392-404. 
Cordell, H. J. 2002. Epistasis: what it means, what it doesn't mean, and statistical 
methods to detect it in humans. Hum Mol Genet 11:2463-2468. 
Cornelis, M. C., K. L. Monda, K. Yu et al. 2011. Genome-wide meta-analysis identifies 
regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine 
consumption. PLoS Genet 7:e1002033-e1002033. 
Coyne, J. 2009. Why evolution is true. Oxford University Press. 
Crawford, D. C., T. Bhangale, N. Li, G. Hellenthal, M. J. Rieder, D. A. Nickerson, and 
M. Stephens. 2004. Evidence for substantial fine-scale variation in recombination 
rates across the human genome. Nat Genet 36:700-706. 
D.W.Marquardt. 1963. An algorithm for least-squares estimation of nonlinear parameters. 
J. Soc. Ind. Appl. Math 11:431-441. 
Danziger, J. 2008. Vitamin K-dependent proteins, warfarin, and vascular calcification. 
Clin J Am Soc Nephrol 3:1504-1510. 
Darwin, C. 1859. On the origin of species by means of natural selection, London. 
Davis, N. A., J. E. Crowe, Jr., N. M. Pajewski, and B. A. McKinney. 2010. Surfing a 
genetic association interaction network to identify modulators of antibody 
response to smallpox vaccine. Genes Immun 11:630-636. 
Dixon, A. L., L. Liang, M. F. Moffatt et al. 2007. A genome-wide association study of 
global gene expression. Nature Genetics 39:1202-1207. 
Earl, D., and B. vonHoldt. STRUCTURE HARVESTER: a website and program for 
visualizing STRUCTURE output and implementing the Evanno method. 
Conservation Genetics Resources 4:359-361. 
 256 
 
Ellegren, H., L. Smeds, R. Burri et al. 2012. The genomic landscape of species 
divergence in Ficedula flycatchers. Nature. 
Enattah, N. S., T. G. K. Jensen, M. Nielsen et al. 2008. Independent Introduction of two 
lactase-persistence alleles into human populations reflects different history of 
adaptation to milk culture. The American Journal of Human Genetics 82:57-72. 
Endler, J. A. 1985. Natural selection in the wild. Princeton Univ. Press, Princeton. 
Evanno, G., S. Regnaut, and J. Goudet. 2005. Detecting the number of clusters of 
individuals using the software structure: a simulation study. Molecular Ecology 
14:2611-2620. 
Ewing, B., L. Hillier, M. C. Wendl, and P. Green. 1998. Base-calling of automated 
sequencer traces using phred. I. Accuracy assessment. Genome Res 8:175-185. 
Fu, H.-H., D. K. J. Lin, and H.-T. Tsai. 2006. Damping factor in Google page ranking: 
Research Articles. Appl. Stoch. Model. Bus. Ind. 22:431-444. 
Gage, B. F., C. Eby, P. E. Milligan, G. A. Banet, J. R. Duncan, and H. L. McLeod. 2003. 
Use of pharmacogenetics and clinical factors to predict the maintenance dose of 
warfarin. Thrombosis and Haemostasis. 
Gao, H., S. Williamson, and C. D. Bustamante. 2007. A markov chain monte carlo 
approach for joint inference of population structure and inbreeding rates from 
multilocus genotype data. Genetics 176:1635-1651. 
Gautier, L., L. Cope, B. M. Bolstad, and R. A. Irizarry. 2004. affy--analysis of 
Affymetrix GeneChip data at the probe level. Bioinformatics 20:307-315. 
Geisen, C., M. Watzka, K. Sittinger, M. Steffens, L. Daugela, E. Seifried, C. R. Müller, 
T. F. Wienker, and J. Oldenburg. 2005. VKORCI haplotypes and their impact on 
the inter-individual and inter-ethnical variability of oral anticoagulation. 
Thrombosis and Haemostasis. 
Ghazalpour, A., S. Doss, B. Zhang et al. 2006. Integrating genetic and network analysis 
to characterize genes related to mouse weight. PLoS Genet 2:e130. 
Gilad, Y., S. A. Rifkin, and J. K. Pritchard. 2008. Revealing the architecture of gene 
regulation: the promise of eQTL studies. Trends in Genetics 24:408-415. 
Gillespie, J. H. 1991. The causes of molecular evolution. Oxford Univ. Press, New York. 
Goodstadt, L., and C. P. Ponting. 2004. Vitamin K epoxide reductase: homology, active 
site and catalytic mechanism. Trends in Biochemical Sciences 29:289-292. 
 257 
 
Gordon, D., C. Abajian, and P. Green. 1998. Consed: a graphical tool for sequence 
finishing. Genome Res 8:195-202. 
Gorlov, I. P., O. Y. Gorlova, S. R. Sunyaev, M. R. Spitz, and C. I. Amos. 2008. Shifting 
paradigm of association studies: value of rare single-nucleotide polymorphisms. 
The American Journal of Human Genetics 82:100-112. 
Greaves, J. H., and P. Ayres. 1969. Linkages between genes for coat colour and 
resistance to warfarin in Rattus norvegicus. Nature 224:284-285. 
Greaves, J. H., R. Redfern, P. B. Ayres, and J. E. Gill. 1977. Warfarin resistance: a 
balanced polymorphism in the Norway rat. Genetics Research 30:257-263. 
Guan, Y., and M. Stephens. 2008. Practical issues in imputation-based association 
mapping. PLoS Genetics 4:e1000279-e1000279. 
Hahn, M. W., M. V. Rockman, N. Soranzo, D. B. Goldstein, and G. A. Wray. 2004. 
Population genetic and phylogenetic evidence for positive selection on regulatory 
mutations at the factor VII locus in humans. Genetics 167:867-877. 
Hancock, A. M., G. Alkorta-Aranburu, D. B. Witonsky, and A. D. Rienzo. 2010. 
Adaptations to new environments in humans: the role of subtle allele frequency 
shifts. Philosophical Transactions of the Royal Society B: Biological Sciences 
365:2459-2468. 
Hans-Joachim, P., H. n. Detlef, and L. Gerhard. 1995. Resistance to anticoagulant 
rodenticides in Germany and future strategies to control Rattus norvegicus. 
Pesticide Science 43:61-67. 
Harr, B., M. Kauer, and C. Schlötterer. 2002. Hitchhiking mapping: A population-based 
fine-mapping strategy for adaptive mutations in Drosophila melanogaster. 
Proceedings of the National Academy of Sciences 99:12949-12954. 
Hartl, D. L., and A. G. Clark. 2007. Principles of population genetics. Sinauer Associates, 
Inc. 
Hedrick, P. W. 2012. What is the evidence for heterozygote advantage selection? Trends 
in Ecology & Evolution 27:698-704. 
Hernandez, R. D., J. L. Kelley, E. Elyashiv, S. C. Melton, A. Auton, G. McVean, P. 
Genomes, G. Sella, and M. Przeworski. 2011. Classic selective sweeps were rare 
in recent human evolution. Science 331:920-924. 
Hoban, S., G. Bertorelle, and O. E. Gaggiotti. 2012. Computer simulations: tools for 
population and evolutionary genetics. Nature Reviews Genetics 13:110-122. 
 258 
 
Hohenlohe, P. A., S. Bassham, M. Currey, and W. A. Cresko. 2011. Extensive linkage 
disequilibrium and parallel adaptive divergence across threespine stickleback 
genomes. Philosophical Transactions of the Royal Society B: Biological Sciences 
367:395-408. 
Hohenlohe, P. A., S. Bassham, P. D. Etter, N. Stiffler, E. A. Johnson, and W. A. Cresko. 
2010. Population genomics of parallel adaptation in threespine stickleback using 
sequenced RAD tags. PLoS Genet 6. 
Hudson, R. R. 2002. Generating samples under a Wright-Fisher neutral model of genetic 
variation. Bioinformatics 18:337-338. 
Hurst, L. D. 2009. Genetics and the understanding of selection. Nature Reviews Genetics 
10:83-93. 
Ihaka, R., and R. Gentleman. 1996. R: a language for data analysis and graphics. Journal 
of Computational and Graphical Statistics 5:299-314. 
Illingworth, C. J. R., and V. Mustonen. 2011. Distinguishing driver and passenger 
mutations in an evolutionary history categorized by interference. Genetics 
189:989-1000. 
Imaoka, S., T. Hashizume, and Y. Funae. 2005. Localization of rat cytochrome P450 in 
various tissues and comparison of arachidonic acid metabolism by rat P450 with 
that by human P450 orthologs. Drug Metabolism and Pharmacokinetics 20:478-
484. 
Ivaskevicius, V., E. Jusciute, M. Steffens, C. Geisen, P. Hanfland, T. F. Wienker, E. 
Seifried, and J. Oldenburg. 2005. gammaAla82Gly represents a common 
fibrinogen gamma-chain variant in Caucasians. Blood Coagulation & 
Fibrinolysis: An International Journal in Haemostasis and Thrombosis 16:205-
208. 
Ivliev, A. E., V. A. Rudneva, and M. G. Sergeeva. 2010. Applicability of coexpression 
networks analysis to anticancer drug targets discovery. Molecular Biology 
44:366-374. 
IWPC. Warfarin Dosing. http://warfarindosing.org. 
Jackson, W. B., and D. Kaukeinen. 1972. Resistance of wild Norway rats in north 
Carolina to warfarin rodenticide. Science 176:1343-1344. 
Jacob, J., S. Endepols, H.-J. Pelz, E. Kampling, T. G. Cooper, C. H. Yeung, K. Redmann, 
and S. Schlatt. 2012. Vitamin K requirement and reproduction in bromadiolone-
resistant Norway rats. Pest Management Science 68:378-385. 
 259 
 
Jafari, P., and F. Azuaje. 2006. An assessment of recently published gene expression data 
analyses: reporting experimental design and statistical factors. BMC Medical 
Informatics and Decision Making 6. 
Jakobsson, M., and N. A. Rosenberg. 2007. CLUMPP: a cluster matching and 
permutation program for dealing with label switching and multimodality in 
analysis of population structure. Bioinformatics 23:1801-1806. 
Jensen, L. J., M. Kuhn, M. Stark et al. 2009. STRING 8--a global view on proteins and 
their functional interactions in 630 organisms. Nucleic Acids Res 37:D412-416. 
Jensen-Seaman, M. I., T. S. Furey, B. A. Payseur, Y. Lu, K. M. Roskin, C.-F. Chen, M. 
A. Thomas, D. Haussler, and H. J. Jacob. 2004. Comparative recombination rates 
in the rat, mouse, and human genomes. Genome Research 14:528-538. 
Johannsen, W. 1911. The genotype conception of heredity. The American Naturalist 
45:129-159. 
Kamali, F. 2006. Genetic influences on the response to warfarin. Current Opinion in 
Hematology 13:357-361. 
Kanehisa, M., and S. Goto. 2000. KEGG: Kyoto Encyclopedia of Genes and Genomes. 
Nucleic Acids Res 28:27 - 30. 
Kim, Y., and R. Nielsen. 2004. Linkage disequilibrium as a signature of selective sweeps. 
Genetics 167:1513-1524. 
Kim, Y., and W. Stephan. 2002. Detecting a local signature of genetic hitchhiking along a 
recombining chromosome. Genetics 160:765-777. 
Kim, Y., and W. Stephan. 2003. Selective sweeps in the presence of interference among 
partially linked loci. Genetics 164:389-398. 
Kim, Y., and T. Wiehe. 2009. Simulation of DNA sequence evolution under models of 
recent directional selection. Briefings in Bioinformatics 10:84-96. 
Kohn, M. H., and H.-J. Pelz. 2000. A gene-anchored map position of the rat warfarin-
resistance locus, Rw, and its orthologs in mice and humans. Blood 96:1996-1998. 
Kohn, M. H., and H.-J. Pelz. 1999. Genomic assignment of the warfarin resistance locus, 
Rw, in the rat. Mammalian Genome 10:696-698. 
Kohn, M. H., H. J. Pelz, and R. K. Wayne. 2003. Locus-specific genetic differentiation at 
Rw among warfarin-resistant rat (Rattus norvegicus) populations. Genetics 
164:1055-1070. 
 260 
 
Kohn, M. H., H. J. Pelz, and R. K. Wayne. 2000. Natural selection mapping of the 
warfarin-resistance gene. Proc Natl Acad Sci U S A 97:7911-7915. 
Kohn, M. H., R. E. Price, and H.-J. Pelz. 2008. A cardiovascular phenotype in warfarin-
resistant Vkorc1 mutant rats. Artery research 2:138-147. 
Kudaravalli, S., J. B. Veyrieras, B. E. Stranger, E. T. Dermitzakis, and J. K. Pritchard. 
2009. Gene expression levels are a target of recent natural selection in the human 
genome. Mol Biol Evol 26:649-658. 
LaFramboise, T. 2009. Single nucleotide polymorphism arrays: a decade of biological, 
computational and technological advances. Nucleic Acids Research 37:4181-
4193. 
Langfelder, P., and S. Horvath. 2008. WGCNA: an R package for weighted correlation 
network analysis. BMC Bioinformatics 9:559. 
Larkin, M. A., G. Blackshields, N. P. Brown et al. 2007. Clustal W and Clustal X version 
2.0. Bioinformatics 23:2947-2948. 
Lee, I., B. Lehner, C. Crombie, W. Wong, A. G. Fraser, and E. M. Marcotte. 2008. A 
single gene network accurately predicts phenotypic effects of gene perturbation in 
Caenorhabditis elegans. Nat Genet 40:181-188. 
Li, J., P. Roebuck, S. Grünewald, and H. Liang. 2012. SurvNet: a web server for 
identifying network-based biomarkers that most correlate with patient survival 
data. Nucleic Acids Research 40:W123-W126. 
Li, T., C. Y. Chang, D. Y. Jin, P. J. Lin, A. Khvorova, and D. W. Stafford. 2004. 
Identification of the gene for vitamin K epoxide reductase. Nature 427:541-544. 
Linnen, C. R., Y.-P. Poh, B. K. Peterson, R. D. H. Barrett, J. G. Larson, J. D. Jensen, and 
H. E. Hoekstra. 2013. Adaptive evolution of multiple traits through multiple 
mutations at a single gene. Science 339:1312-1316. 
Liu, J. Z., A. F. McRae, D. R. Nyholt et al. 2010. A versatile gene-based test for genome-
wide association studies. Am J Hum Genet 87:139-145. 
Liu, Y., H. Xu, S. Chen et al. 2011. Genome-wide interaction-based association analysis 
identified multiple new susceptibility Loci for common diseases. PLoS Genet 
7:e1001338. 
Long, M., and L. Zhang. 2012. Why rodent pseudogenes refuse to retire. Genome 
Biology 13. 
Lucia A., H., M. J, M. J, J. HA, H. PN, K. AK, and M. TA. A catalog of published 
genome-wide association studies. http://www.genome.gov/gwastudies/. 
 261 
 
Ludwig, A., M. Pruvost, M. Reissmann et al. 2009. Coat color variation at the beginning 
of horse domestication. Science 324:485-485. 
Luna, A., and K. K. Nicodemus. 2007. snp.plotter: an R-based SNP/haplotype association 
and linkage disequilibrium plotting package. Bioinformatics 23:774-776. 
Lund, M. 1964. Resistance to warfarin in the common rat. Nature 203:778-778. 
Maertzdorf, J., D. Repsilber, S. K. Parida, K. Stanley, T. Roberts, G. Black, G. Walzl, 
and S. H. E. Kaufmann. 2011. Human gene expression profiles of susceptibility 
and resistance in tuberculosis. Genes Immun 12:15-22. 
Manna, F., G. Martin, and T. Lenormand. 2011. Fitness landscapes: an alternative theory 
for the dominance of mutation. Genetics 189:923-937. 
Markussen, M. D., A.-C. Heiberg, C. Alsbo, P. S. Nielsen, S. Kauppinen, and M. 
Kristensen. 2007a. Involvement of hepatic xenobiotic related genes in 
bromadiolone resistance in wild Norway rats, Rattus norvegicus (Berk.). Pesticide 
Biochemistry and Physiology 88:284-295. 
Markussen, M. D., A. C. Heiberg, M. Fredholm, and M. Kristensen. 2007b. 
Characterization of bromadiolone resistance in a danish strain of Norway rats, 
Rattus norvegicus, by hepatic gene expression profiling of genes involved in 
vitamin K-dependent gamma-carboxylation. J Biochem Mol Toxicol 21:373-381. 
Markussen, M. D. K., A.-C. Heiberg, M. Fredholm, and M. Kristensen. 2008a. 
Differential expression of cytochrome P450 genes between bromadiolone-
resistant and anticoagulant-susceptible Norway rats: a possible role for 
pharmacokinetics in bromadiolone resistance. Pest Management Science 64:239-
248. 
Markussen, M. D. K., A.-C. Heiberg, M. Fredholm, and M. Kristensen. 2008b. 
Identification of cytochrome P450 differentiated expression related to 
developmental stages in bromadiolone resistance in rats (Rattus norvegicus). 
Pesticide Biochemistry and Physiology 91:147-152. 
Markussen, M. D. K., A.-C. Heiberg, R. Nielsen, and H. Leirs. 2003. Vitamin K 
requirement in Danish anticoagulant-resistant Norway rats (Rattus norvegicus). 
Pest Management Science 59:913-920. 
McClintick, J. N., and H. J. Edenberg. 2006. Effects of filtering by Present call on 
analysis of microarray experiments. BMC Bioinformatics 7:49. 
McDonald, M. G., M. J. Rieder, M. Nakano, C. K. Hsia, and A. E. Rettie. 2009. CYP4F2 
Is a vitamin K1 oxidase: an explanation for altered warfarin dose in carriers of the 
V433M variant. Molecular Pharmacology 75:1337-1346. 
 262 
 
Mezmouk, S., P. Dubreuil, M. Bosio, L. Décousset, A. Charcosset, S. Praud, and B. 
Mangin. 2011. Effect of population structure corrections on the results of 
association mapping tests in complex maize diversity panels. TAG. Theoretical 
and Applied Genetics. Theoretische Und Angewandte Genetik 122:1149-1160. 
Morley, M., C. M. Molony, T. M. Weber, J. L. Devlin, K. G. Ewens, R. S. Spielman, and 
V. G. Cheung. 2004. Genetic analysis of genome-wide variation in human gene 
expression. Nature 430:743-747. 
Morrison, J. L., R. Breitling, D. J. Higham, and D. R. Gilbert. 2005. GeneRank: Using 
search engine technology for the analysis of microarray experiments. BMC 
Bioinformatics 6:233-233. 
Neuditschko, M., M. S. Khatkar, and H. W. Raadsma. 2010. NetView: a high-definition 
network-visualization approach to detect fine-scale population structures from 
genome-wide patterns of variation. PLoS ONE 7. 
Nickerson, D. A., V. O. Tobe, and S. L. Taylor. 1997. PolyPhred: automating the 
detection and genotyping of single nucleotide substitutions using fluorescence-
based resequencing. Nucleic Acids Res 25:2745-2751. 
Nielsen, R., S. Williamson, Y. Kim, M. J. Hubisz, A. G. Clark, and C. Bustamante. 2005. 
Genomic scans for selective sweeps using SNP data. Genome Res 15:1566-1575. 
Ogata, H., S. Goto, K. Sato, W. Fujibuchi, H. Bono, and M. Kanehisa. 1999. KEGG: 
Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Research 27:29-34. 
Oldenburg, J., C. G. Bevans, C. R. Muller, and M. Watzka. 2006. Vitamin K epoxide 
reductase complex subunit 1 (VKORC1): the key protein of the vitamin K cycle. 
Antioxid Redox Signal 8:347-353. 
Orr, H. A. 2005. The genetic theory of adaptation: a brief history. Nature Reviews 
Genetics 6:119-127. 
Orr, H. A., and S. Irving. 1997. The genetics of adaptation: the genetic basis of resistance 
to wasp parasitism in Drosophila melanogaster. Evolution 51:1877-1885. 
Page, L., S. Brin, R. Motwani, and T. Winograd. 1999. The PageRank citation ranking: 
bringing order to the web. 
Pan, L. C., and P. A. Price. 1985. The propeptide of rat bone gamma-carboxyglutamic 
acid protein shares homology with other vitamin K-dependent protein precursors. 
Proc Natl Acad Sci U S A 82:6109-6113. 
Parker, H. G., B. M. VonHoldt, P. Quignon et al. 2009. An expressed fgf4 retrogene is 
associated with breed-defining chondrodysplasia in domestic dogs. Science 
325:995-998. 
 263 
 
Partridge, G. G. 1979. Relative fitness of genotypes in a population of Rattus norvegicus 
polymorphic for warfarin resistance. Heredity 43:239-246. 
Partridge, G. G. 1980. The vitamin K requirements of wild brown rats (Rattus 
norvegicus) resistant to warfarin. Comparative Biochemistry and Physiology Part 
A: Physiology 66:83-87. 
Pautas, E., C. Moreau, I. Gouin-Thibault et al. 2009. Genetic factors (VKORC1, CYP2C9, 
EPHX1, and CYP4F2) are predictor variables for warfarin response in very 
elderly, frail inpatients. Clin Pharmacol Ther 87:57-64. 
Pavani, A., S. M. Naushad, Y. Rupasree, T. R. Kumar, A. R. Malempati, R. K. Pinjala, R. 
C. Mishra, and V. K. Kutala. 2012. Optimization of warfarin dose by population-
specific pharmacogenomic algorithm. The Pharmacogenomics Journal 12:306-
311. 
Pelz, H.-J., D. Hänisch2, and G. Lauenstein. 1995. Resistance to anticoagulant 
rodenticides in Germany and future strategies to control Rattus norvegicus. 
Pesticide Science 43:61-67. 
Pelz, H.-J., S. Rost, M. Hünerberg et al. 2005. The genetic basis of resistance to 
anticoagulants in rodents. Genetics 170:1839-1847. 
Peng, B., C. I. Amos, and M. Kimmel. 2007. Forward-time simulations of human 
populations with complex diseases. PLoS Genet 3:e47. 
Peng, B., and M. Kimmel. 2005. simuPOP: a forward-time population genetics 
simulation environment. Bioinformatics 21:3686-3687. 
population, C. o. s. f. t. m. o. p. r. p., and B. o. agriculture. 1986. Pesticide Resistance. 
National Academy Press. 
Presnell, S. R., and D. W. Stafford. 2002. The vitamin K-dependent carboxylase. Journal 
of Thrombosis and Haemostasis 87:937-946. 
Pritchard, J. K., and A. Di Rienzo. 2010. Adaptation – not by sweeps alone. Nat Rev 
Genet 11:665-667. 
Pritchard, J. K., J. K. Pickrell, and G. Coop. 2010. The genetics of human adaptation: 
hard sweeps, soft sweeps, and polygenic adaptation. Current Biology 20:R208-
R215-R208-R215. 
Pritchard, J. K., M. Stephens, and P. Donnelly. 2000. Inference of population structure 
using multilocus genotype data. Genetics 155:945-959. 
Purcell, S., B. Neale, K. Todd-Brown et al. 2007. PLINK: a tool set for whole-genome 
association and population-based linkage analyses. Am J Hum Genet 81:559-575. 
 264 
 
Radwan, J., and W. Ç. Babik. 2012. The genomics of adaptation. Proceedings of the 
Royal Society B: Biological Sciences. 
Raftogianis, R. B., T. C. Wood, and R. M. Weinshilboum. 1999. Human phenol 
sulfotransferases SULT1A2 and SULT1A1: genetic polymorphisms, allozyme 
properties, and human liver genotype-phenotype correlations. Biochem 
Pharmacol 58:605-616. 
Reja, V., A. Kwok, G. Stone, L. Yang, A. Missel, C. Menzel, and B. Bassam. 2010. 
ScreenClust: Advanced statistical software for supervised and unsupervised high 
resolution melting (HRM) analysis. Methods 50:S10-S14. 
Rieder, M. J., A. P. Reiner, B. F. Gage, D. A. Nickerson, C. S. Eby, H. L. McLeod, D. K. 
Blough, K. E. Thummel, D. L. Veenstra, and A. E. Rettie. 2005. Effect of 
VKORC1 haplotypes on transcriptional regulation and warfarin dose. N Engl J 
Med 352:2285-2293. 
Risch, N., and K. Merikangas. 1996. The future of genetic studies of complex human 
diseases. Science 273:1516-1517. 
Ronquist, F., and J. P. Huelsenbeck. 2003. MrBayes 3: Bayesian phylogenetic inference 
under mixed models. Bioinformatics 19:1572-1574. 
Rosenberg, N. A. 2004. distruct: a program for the graphical display of population 
structure. Molecular Ecology Notes 4:137-138. 
Rost, S., A. Fregin, V. Ivaskevicius et al. 2004. Mutations in VKORC1 cause warfarin 
resistance and multiple coagulation factor deficiency type 2. Nature 427:537-541. 
Rost, S., H.-J. Pelz, S. Menzel, A. D. MacNicoll, V. Leon, K.-J. Song, T. Jaekel, J. 
Oldenburg, and C. R. Muller. 2009. Novel mutations in the VKORC1 gene of wild 
rats and mice - a response to 50 years of selection pressure by warfarin? BMC 
Genetics 10:4-4. 
Runge-Morris, M., K. Rose, C. N. Falany, and T. A. Kocarek. 1998. Differential 
regulation of individual sulfotransferase isoforms by phenobarbital in male rat 
liver. Drug Metab Dispos 26:795-801. 
Sabeti, e. a. 2007. Genome-wide detection and characterization of positive selection in 
human populations. Nature 449:913-918. 
Sabeti, P. C., D. E. Reich, J. M. Higgins et al. 2002. Detecting recent positive selection in 
the human genome from haplotype structure. Nature 419:832-837. 
Saïdou, A.-A., C. Mariac, V. Luong, J.-L. Pham, G. Bezançon, and Y. Vigouroux. 2009. 
Association studies identify natural variation at PHYC linked to flowering time 
and morphological variation in Pearl Millet. Genetics 182:899-910. 
 265 
 
Schadt, E. E., J. Lamb, X. Yang et al. 2005. An integrative genomics approach to infer 
causal associations between gene expression and disease. Nat Genet 37:710-717. 
Scheet, P., and M. Stephens. 2006. A fast and flexible statistical model for large-scale 
population genotype data: applications to inferring missing genotypes and 
haplotypic phase. American Journal of Human Genetics 78:629-644. 
Schlenke, T. A., and D. J. Begun. 2004. Strong selective sweep associated with a 
transposon insertion in Drosophila Simulans. Proceedings of the National 
Academy of Sciences of the United States of America 101:1626-1631. 
Servin, B., and M. Stephens. 2007. Imputation-based analysis of association studies: 
candidate regions and quantitative traits. PLoS Genetics 3:e114-e114. 
Slatkin, M. 2008. Linkage disequilibrium--understanding the evolutionary past and 
mapping the medical future. Nat Rev Genet 9:477-485. 
Smith, J. M., and J. Haigh. 1974. The hitch-hiking effect of a favourable gene. Genetical 
Research 23:23-35. 
Smith, P., M. Berdoy, R. H. Smith, and D. W. Macdonald. 1993. A new aspect of 
warfarin resistance in wild rats: benefits in the absence of poison. Functional 
Ecology 7:190-194. 
Smith, P., M. G. Townsend, and R. H. Smith. 1991. A cost of resistance in the brown rat? 
Reduced growth rate in warfarin-resistant lines. Functional Ecology 5:441-447. 
Stafford, D. W. 2005. The vitamin K cycle. Journal of Thrombosis and Haemostasis 
3:1873-1878. 
Stephan, W., Y. S. Song, and C. H. Langley. 2006. The hitchhiking effect on linkage 
disequilibrium between linked neutral loci. Genetics 172:2647-2663. 
Stephens, M., and D. J. Balding. 2009. Bayesian statistical methods for genetic 
association studies. Nat Rev Genet 10:681-690. 
Stephens, M., and N. Li. 2003. Modeling linkage disequilibrium and identifying 
recombination hotspots using single-nucleotide polymorphism data. Genetics 
165:2213-2233. 
Stephens, M., and P. Scheet. 2005. Accounting for decay of linkage disequilibrium in 
haplotype inference and missing-data imputation. American Journal of Human 
Genetics 76:449-462. 
Stephens, M., N. J. Smith, and P. Donnelly. 2001. A new statistical method for haplotype 
reconstruction from population data. American Journal of Human Genetics 
68:978-989. 
 266 
 
Stranger, B. E., A. C. Nica, M. S. Forrest et al. 2007. Population genomics of human 
gene expression. Nature Genetics 39:1217-1224. 
Stranger, B. E., E. A. Stahl, and T. Raj. 2011. Progress and promise of genome-wide 
association studies for human complex trait genetics. Genetics 187:367-383. 
Suttie, J. W. 1993. Synthesis of vitamin K-dependent proteins. FASEB J. 7:445-452. 
Tabrett, C. A., and M. W. Coughtrie. 2003. Phenol sulfotransferase 1A1 activity in 
human liver: kinetic properties, interindividual variation and re-evaluation of the 
suitability of 4-nitrophenol as a probe substrate. Biochem Pharmacol 66:2089-
2097. 
Takeuchi, F., R. McGinnis, S. Bourgeois et al. 2009. A genome-wide association study 
confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of 
warfarin dose. PLoS Genet 5:e1000433. 
Team, R. D. C. 2012. R: A language and environment for statistical computing. 
Thijssen, H. H. W. 1995. Warfarin-based rodenticides : mode of action and mechanism of 
resistance. Pesticide Science:73-78. 
Thomas, J. H. 2007. Rapid birth-death evolution specific to xenobiotic Cytochrome P450 
genes in vertebrates. PLoS Genet 3. 
Tishkoff, S. A., F. A. Reed, A. Ranciaro et al. 2007. Convergent adaptation of human 
lactase persistence in Africa and Europe. Nat Genet 39:31-40. 
UI-Health. 2012. A team approach to warfarin pharmacogenetics. Pharmacy Practice 
News 39. 
van Noort, V., B. Snel, and M. A. Huynen. 2003. Predicting gene function by conserved 
co-expression. Trends in Genetics 19:238-242. 
Venables, W. N., and B. D. Ripley. 2002. Modern applied statistics with S. Springer, 
New York. 
Veyrieras, J.-B., S. Kudaravalli, S. Y. Kim, E. T. Dermitzakis, Y. Gilad, M. Stephens, 
and J. K. Pritchard. 2008. High-resolution mapping of expression-QTLs yields 
insight into human gene regulation. PLoS Genet 4:e1000214-e1000214. 
Voight, B. F., S. Kudaravalli, X. Wen, and J. K. Pritchard. 2006. A map of recent positive 
selection in the human genome. PLoS Biol 4:e72. 
Wadelius, M., L. Y. Chen, K. Downes et al. 2005. Common VKORC1 and GGCX 
polymorphisms associated with warfarin dose. Pharmacogenomics J 5:262-270. 
 267 
 
Wadelius, M., L. Y. Chen, N. Eriksson, S. Bumpstead, J. Ghori, C. Wadelius, D. Bentley, 
R. McGinnis, and P. Deloukas. 2007. Association of warfarin dose with genes 
involved in its action and metabolism. Human Genetics 121:23-34. 
Wadelius, M., L. Y. Chen, J. D. Lindh, N. Eriksson, M. J. R. Ghori, S. Bumpstead, L. 
Holm, R. McGinnis, A. Rane, and P. Deloukas. 2009. The largest prospective 
warfarin-treated cohort supports genetic forecasting. Blood 113:784-792. 
Wajih, N., D. C. Sane, S. M. Hutson, and R. Wallin. 2004. The inhibitory effect of 
calumenin on the vitamin K-dependent gamma-carboxylation system. 
Characterization of the system in normal and warfarin-resistant rats. J Biol Chem 
279:25276-25283. 
Wallace, M. E., and F. M. MacSwiney. 1979. An inherited mild middle-aged adiposity in 
wild mice. The Journal of Hygiene 82:309-317. 
Wallin, R., S. M. Hutson, D. Cain, A. Sweatt, and D. C. Sane. 2001. A molecular 
mechanism for genetic warfarin resistance in the rat. FASEB J. 15:2542-2544. 
Wang, B., Y.-B. Zhang, F. Zhang et al. 2011. On the origin of Tibetans and their genetic 
basis in adapting high-altitude environments. PLoS ONE 6. 
Wang, Y., U. Wimmer, P. Lichtlen et al. 2004. Metal-responsive transcription factor-1 
(MTF-1) is essential for embryonic liver development and heavy metal 
detoxification in the adult liver. FASEB J 18:1071-1079. 
Wang, Y., L. P. Zhao, and S. Dudoit. 2006. A fine-scale linkage-disequilibrium measure 
based on length of haplotype sharing. American Journal of Human Genetics 
78:615-628. 
White, H. E., V. J. Hall, and N. C. P. Cross. 2007. Methylation-sensitive high-resolution 
melting-curve analysis of the SNRPN Gene as a diagnostic screen for Prader-Willi 
and Angelman syndromes. Clin Chem 53:1960-1962. 
Winter, C., G. Kristiansen, S. Kersting et al. 2012. Google goes cancer: improving 
outcome prediction for cancer patients by network-based ranking of marker 
genes. PLoS Comput Biol 8:e1002511. 
Wittkopp, P. J. 2007. Variable gene expression in eukaryotes: a network perspective. 
Journal of Experimental Biology 210:1567-1575. 
Wittwer, C. T., G. H. Reed, C. N. Gundry, J. G. Vandersteen, and R. J. Pryor. 2003. 
High-resolution genotyping by amplicon melting analysis using LCGreen. Clin 
Chem 49:853-860. 
 268 
 
Wu, Z., R. Irizarry, R. Gentleman, F. Martinez-Murillo, and F. Spencer. 2004. A model-
based background adjustment for oligonucleotide expression arrays. Journal of the 
American Statistical Association 99:909. 
Xiong, M., and S. W. Guo. 1997. Fine-scale genetic mapping based on linkage 
disequilibrium: theory and applications. American Journal of Human Genetics 
60:1513-1531. 
Yanagita, M. 2004. Gas6, warfarin, and kidney diseases. Journal of Clinical and 
Experimental Nephrology 8:304-309. 
Yi, X., Y. Liang, E. Huerta-Sanchez et al. 2010. Sequencing of 50 human exomes reveals 
adaptation to high altitude. Science 329:75-78. 
Zebboudj, A. F., V. Shin, and K. Bostrom. 2003. Matrix GLA protein and BMP-2 
regulate osteoinduction in calcifying vascular cells. Journal of Cellular 
Biochemistry 90:756-765. 
 
 
 269 
 
Appendix  
Appendix 1 – Population and sample information. 
Farm 
No. Farm Name 
Sample 
size  R&S(N) R(N) R(%) 
Rc/Rc+
(N) 
Rb/Rb+(N
) 
Rd/Rd+
(N) 
Abbre
vation  
- NW 29 29 20 68.9% - - - NW  
4f LUDWIGSHAFEN 13 13 0 0% 9 0 0 LH  
24 WANNING-UPGANG 73 55 51 92.7% 56 51 43 WU 
11 KORTENBUSCH 70 65 54 83.1% 30 51 39 KB 
21 SCHULTE-SPECHTEL 23 21 7 33.3% 3 14 0 SP 
23&16 THISSEN & NARMANN 56 55 4 7.3% 17 7 2 TH 
19 PIEPER 56 49 32 65.3% 28 33 23  
17 NIEHOFF 53 51 44 86.3% 44 42 37  
4 BEUCK 52 46 43 93.5% 21 37 31  
10 KLEVERTH 42 38 36 94.7% 23 32 28  
13 LEPPMANN 42 36 23 63.9% 27 25 19  
28 WESTLINNING 37 35 30 85.7% 20 29 21  
18 NOTTELMANN 29 23 21 91.3% 8 19 15  
20 SCHULTE-EVERDING 27 26 16 61.5% 14 15 14  
12 KOSTERS-BORKMAN 25 21 20 95.2% 8 17 17  
6 GUNNIGMANN 24 24 23 95.8% 11 20 16  
5 GROSSE-HOLZ 20 19 14 73.7% 0 15 13  
25 VERNAUER 20 19 17 89.5% 13 15 12  
14 LOOZ 19 16 7 43.8% 3 12 4  
15 LUTTGE-HOLZ 10 6 1 16.7% 0 3 0  
30 DUISENBURG/ EMSLA 9 9 7 77.8% 9 7 5  
26 WAULIGMANN 6 6 6 100% 2 6 6  
29 BRAMHAR 6 6 4 66.7% 5 4 2  
3 BAYER-EMMERICH 5 4 1 25.0% 0 3 1  
32 LAHDEN 4 4 1 25.0% 2 2 0  
2 ASBECK/ SCHOPPINGEN 3 3 3 100% 0 3 1  
3f MAGDEBURG/ZOO 3 3 1 33.3% 0 0 0  
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1 ALTENAU 2 2 2 100% 2 2 2  
8 HOLTKAMP 2 2 2 100% 2 2 2  
27 WEHLING 2 2 2 100% 2 2 2  
33 LUTCKE/ GIEVENBECK 2 2 1 50.0% 1 1 1  
2f KREIS SOEST 2 2 2 100% 2 2 2  
7 HAMM-UENTROP 1 0 0 NA 1 0 0  
9 KLEMANN 1 1 0 0% 1 0 0  
22 SENDENHORST 1 1 1 100% 0 1 1  
31 HAARANNEN/ FURST 1 1 1 100% 0 0 0  
5f JANSSEN/ SOLTBORG 1 1 0 0% 1 0 0  
 
Populations (N > 10) were highlighted bold. NW: wild-derived; LH: non-resistant population. 
R&S(N) The number of rat samples with the warfarin resistant/susceptible phenotype.  
R(N):  The number of rat samples with the warfarin resistant phenotype. 
R(%)  The warfarin resistant level: R(N) divided by R&S(N).  
Coumatetralyl, bromadiolone and difenacoum are anticoagulant rodenticides.   
Rc/Rc+(N) The number of rats with the coumatetralyl resistant/susceptible phenotype.  
Rb/Rb+(N) The number of rats with the bromadiolone resistant/susceptible phenotype.  
Rd/Rd+(N) The number of rat samples with the difenacoum resistant/susceptible phenotype.  
 
Appendix 2 – Designed primers for PCR and High resolution melting genotyping. 
I. Polymerase chain reaction (PCR) 
Primer for SNP Chr:Pos PCR Forward PCR Reservse 
rs105465027 5:47202315 CACGACGTTGTAAAACGACTTACAAACAAGTCGGCCAAG 
GGATAACAATTTCACACAGGCA
CGAGAGAGTACAGAGCCATTT 
rs105163021 4:138458155 CACGACGTTGTAAAACGACACACACACCTCTACCACACCA 
GGATAACAATTTCACACAGGCA
TGACCTTGAGGAGGATGC 
rs105210758 2:7301927 CACGACGTTGTAAAACGACAGAAGCAAAACCCAATGAACA 
GGATAACAATTTCACACAGGTG
GTGTTGCCTGTGTCCTAA 
rs197161785 1:11546996 CACGACGTTGTAAAACGACCCTCCTCTTCACGCAACTTT 
GGATAACAATTTCACACAGGTT
TGGTGCTTTCCCCAGTAA 
Primers for SNP discovery PCR Forward PCR Reservse 
Rn_Calu_5’ intergenic region CACGACGTTGTAAAACGACAAATGTTCCTTTGGCCTCCT 
GGATAACAATTTCACACAGGCT
TGGATCGGGAAAATGAAA 
Rn_Calu_5’ exon1 CACGACGTTGTAAAACGACAGAAGTGTGAAAGACCAACGTG 
GGATAACAATTTCACACAGGAG
AACAAGGACGTGCGAAAC 
Rn_Calu_5’ intron1 CACGACGTTGTAAAACGACCCTAGAGAATCCCCCACACA 
GGATAACAATTTCACACAGGAA
GGAGGAAGGAGGTGGAAA 
Rn_Calu_5’ exon2 CACGACGTTGTAAAACGACGACCTGTGTTATGGGGCAAG 
GGATAACAATTTCACACAGGAT
CCCCAACCCCTTCCTACT 
Rn_Calu_5’ exon3 CACGACGTTGTAAAACGACGCTTTGCTGGTTTGCCTTAC 
GGATAACAATTTCACACAGGAG
GACTTCAGCTCCCCCTTC 
Rn_Calu_5’ exon4&5 CACGACGTTGTAAAACGACGGTTAGAGATGAGCGGAGGTT 
GGATAACAATTTCACACAGGAA
GGTGTGTGCATGTATGAGTG 
Rn_Calu_5’ exon6 CACGACGTTGTAAAACGACTCCCTGTCTGTGGAGATGTG 
GGATAACAATTTCACACAGGGG
CCTCTGCATGGTCATAGT 
Rn_Calu_5’ exon7 CACGACGTTGTAAAACGACGCTCACCAAGGAGGAGATTG 
GGATAACAATTTCACACAGGGG
TGCCCAAATCGTTTATCT 
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II. High resolution melting (HRM) genotyping  
Primer for Chr:Pos HRM Forward HRM Reservse 
Rn_Vkorc1_Y139C 1:187177049 TGTCTGTCGCTGGTTCTCTGT AGGGCTTTTTGACCTTGTGTT 
Rn_Calu_56228735 4:56228735 CTGTCGGCCTTGTTCTCTATTC CGGGCTACAACCCTTTCC 
Rn_Calu_56038243 4:56038243 TCAGCCCAGAGTAAGGATGC GGGAGGGTAAGAGTCCTGGT 
rs105465027 5:47202315 CCGGGAAAGGGAATAACAAT AGGAGCCACTTGAACAAACG 
rs105163021 4:138458155 AGCCACATGCTTTCTCAAAT GCCCCTTGAGAGTACAGCAA 
rs105210758 2:7301927 ATTGGCAAAATGAACCATTACAC TCCTAAAGTTCCTATTTTCAGTCCA 
rs197161785 1:11546996 CTCCTCTTCACGCAACTTTCTC AGGCCCCTGAAGTGAATTTTAT 
S422152 6:136715130 ATGTGCTACCCGAGTCTTCCT GCTGTGTGGCCTTAAATAGCA 
S693558 5:30306799 CAAGAGCTGGTTTGAGACAACA TGAAAACAATCATGGGCAAA 
S694902 4:63592604 AGAATGTCCCTGTGTGATTG GCTTCACCAAACATCCCAGT 
S696656 10:19930191 GCTGTGAGGGGAAACAAGAA GCACCAATCTCCATCCACTT 
Chr:Pos indicates the position of the SNP site on chromosome based on NCBI build 4. 
Appendix 3 – Genotype-phenotype association tests of Vkorc1 and surrounding 
region for NW samples (Figure 2.2). 
SNP Pos Assoc_P-value log10(BF1) log10(BF2) log10(BF3) LH_linkfreq 
NW_linkfre
q(original) 
NW_linkfreq
(recovered) 
S422912 172020573 4.03E-1 -0.076 -0.043 -0.055 0.792 0.725 0.745 
S424296 172021329 8.23E-2 0.361 0.411 0.671 0.708 0.875 0.819 
S425392 172199898 4.03E-1 -0.072 -0.045 0.013 0.708 0.725 0.745 
S425775 172504303 1.21E-1 0.42 0.383 0.763 0.750 0.900 0.855 
S426319 172577432 1.21E-1 0.373 0.356 0.756 0.750 0.900 0.855 
S422189 172998518 4.29E-2 0.659 0.702 1.215 0.667 0.850 0.782 
S693423 173147475 1.03E-1 -0.039 0.028 0.081 0.958 0.800 0.854 
S425346 173398184 2.03E-2 0.8 1.037 1.609 0.500 0.800 0.710 
S693021 173583296 3.11E-1 -0.067 -0.077 -0.196 0.909 0.800 0.819 
S692583 173785040 7.57E-1 -0.038 -0.08 -0.186 0.667 0.750 0.747 
S426162 174129878 3.11E-1 -0.074 -0.084 -0.173 0.583 0.800 0.819 
S426183 174184945 4.86E-1 -0.068 -0.091 -0.266 0.667 0.816 0.825 
S423031 174238208 6.72E-1 -0.038 -0.064 -0.235 0.583 0.763 0.766 
S422569 174412169 2.68E-1 -0.069 -0.067 -0.119 0.708 0.825 0.855 
S422184 174592784 2.31E-1 0.215 0.203 0.341 0.500 0.925 0.891 
S424830 174638055 6.57E-1 0.018 0.048 -0.022 0.417 0.900 0.884 
S423531 174804498 3.19E-1 -0.061 -0.026 -0.073 0.900 0.763 0.798 
S694817 174957949 3.71E-1 0.101 0.138 0.164 0.900 0.969 0.991 
S422107 175233123 1.15E-1 0.167 0.115 0.345 0.542 0.600 0.531 
S421541 175536967 2.38E-1 0.17 0.19 0.344 0.958 0.950 0.927 
S424580 175619519 6.78E-3 0.886 1.245 1.892 0.250 0.775 0.673 
S693438 175677908 6.78E-3 1.029 1.277 1.881 0.250 0.775 0.673 
S421567 175944948 6.13E-1 -0.077 -0.032 -0.052 0.625 0.725 0.742 
S426628 176403842 5.13E-1 0.134 0.138 0.236 0.900 0.975 0.964 
S693441 176588782 1.45E-2 0.198 0.361 0.292 0.833 0.650 0.748 
S692235 176761645 1.32E-1 -0.057 0.118 0.41 0.773 0.789 0.842 
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S421516 177843913 2.31E-1 0.191 0.211 0.34 0.708 0.925 0.891 
S696928 179327802 1 0.062 0.071 0.125 0.708 1.000 1.000 
S426284 179862388 3.23E-3 0.412 0.382 0.557 0.727 0.700 0.820 
S424953 180822160 1.02E-2 -0.02 0.096 0.264 0.900 0.900 0.964 
S421720 181012647 7.34E-3 0.444 0.525 0.892 0.125 0.725 0.630 
S423104 181287248 4.38E-1 0.009 -0.077 -0.331 0.100 0.450 0.484 
S422575 181494720 3.17E-1 0.109 0.137 0.258 0.750 0.975 0.964 
S420883 181818332 9.65E-2 0.153 0.294 0.422 0.900 0.725 0.658 
S692233 182078913 9.65E-2 0.185 0.284 0.532 0.875 0.725 0.658 
S424697 182145797 3.29E-2 0.386 0.569 0.864 0.167 0.325 0.415 
S693902 183065176 2.61E-1 0.025 0.106 0.162 0.958 0.800 0.766 
S421196 184360555 2.00E-1 -0.002 0.03 -0.012 0.792 0.700 0.760 
S425055 184935644 1.50E-1 -0.03 0.01 0.067 0.750 0.842 0.893 
S423171 184995554 5.13E-1 0.082 0.14 0.231 0.833 0.975 0.964 
S694795 185341704 1.72E-1 0.258 0.286 0.42 0.750 0.925 0.891 
S421721 185633136 1.93E-2 0.013 0.252 0.441 0.667 0.850 0.921 
Sult1a1_ 
185832744 185832744 1.44E-2 0.38 0.546 0.941 0.591 0.879 0.928 
S421034 185853325 5.13E-1 0.17 0.141 0.234 0.909 0.975 0.964 
S425356 186055581 1.93E-2 -0.001 0.172 0.444 0.833 0.850 0.921 
S693022 186370915 5.03E-3 0.134 0.291 0.776 0.708 0.875 0.957 
Spn_ 
186389319 186389319 1.48E-2 0.301 0.452 0.837 0.682 0.914 0.957 
Spn_ 
186389641 186389641 4.60E-1 -0.008 -0.015 -0.053 0.864 0.983 0.977 
S426028 186535990 1 -0.03 -0.011 -0.083 0.958 1.000 1.000 
S693918 186703048 1.93E-2 0.055 0.164 0.427 0.625 0.850 0.921 
Vkorc1_ 
187177049 187177049 1.18E-6 4.158 6.222 8.235 0.000 0.483 0.636 
Bckdk_ 
187189027 187189027 4.60E-1 -0.008 -0.015 -0.053 0.900 0.983 0.977 
Tgfb1i1_ 
187506367 187506367 5.88E-4 0.835 1.318 2.12 0.818 0.914 0.973 
Tgfb1i1_ 
187506630 187506630 5.88E-4 0.835 1.318 2.12 0.818 0.914 0.973 
Tgfb1i1_ 
187506650 187506650 5.88E-4 0.835 1.318 2.12 0.818 0.914 0.973 
S421312 187528619 1.34E-1 0.499 0.644 1.018 0.900 0.917 0.873 
S691557 187787779 1.81E-1 0.007 0.101 0.333 0.636 0.750 0.804 
Bag3_ 
187802465 187802465 1.80E-3 0.484 0.777 1.393 0.818 0.931 0.980 
Bag3_ 
187802630 187802630 1.80E-3 0.484 0.777 1.393 0.818 0.931 0.980 
Bag3_ 
187802733 187802733 1.80E-3 0.484 0.777 1.393 0.818 0.931 0.980 
Bag3_ 
187802803 187802803 1.80E-3 0.484 0.777 1.393 0.818 0.931 0.980 
Bag3_ 
187802804 187802804 2.16E-1 0.091 0.111 0.144 0.636 0.724 0.760 
Bag3_ 
187802864 187802864 5.88E-4 0.835 1.318 2.12 0.818 0.914 0.973 
S424424 187947190 1 0.067 0.082 0.142 0.875 1.000 1.000 
Ppapdc1a_
188588783 188588783 1.48E-2 0.301 0.452 0.837 0.909 0.914 0.955 
Ppapdc1a_
188588940 188588940 1.48E-2 0.301 0.452 0.837 0.900 0.914 0.955 
Ppapdc1a_
188588959 188588959 1.48E-2 0.301 0.452 0.837 0.900 0.914 0.955 
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SNP  The SNP ID. For SNPs from 10K Affymetrix array, we used the Assay ID; for SNPs genotyped by ourselves, we used the gene name and the physical position on chromosome 1 
Pos The physical position of each SNP on chromosome 1 
Assoc_P-value The unadjusted P values calculated using Cochran-Mantel-Haenszel (CMH) test controlling for the potential confounding factor sex 
log10(BF1) The log10 values of the Bayes Factor 1 using codominant genetic model 
log10(BF2) The log10 values of the Bayes Factor 2 using dominant genetic model 
log10(BF3) The log10 values of the Bayes Factor 3 using overdominant genetic model 
LH_linkfreq The frequency of the allele initially linked to Vkorc1's mutation in LH population 
NW_linkfreq(original) The frequency of the allele initially linked to Vkorc1's mutation for NW samples 
NW_linkfreq(recovered) The frequency of the allele initially linked to Vkorc1's mutation in the recovered NW population 
Ppapdc1a_
188589203 188589203 6.84E-4 1.251 1.129 1.539 0.091 0.603 0.709 
Ppapdc1a_
188589271 188589271 1.44E-2 0.457 0.375 0.506 0.227 0.517 0.596 
Ppapdc1a_
188589288 188589288 1 -0.005 -0.011 -0.028 0.955 1.000 1.000 
S693024 188627443 1 -0.054 -0.064 -0.182 0.650 1.000 1.000 
S695593 189396078 7.10E-4 1.758 1.782 2.393 0.083 0.375 0.516 
S692253 190281302 1 0.064 0.083 0.15 0.958 1.000 1.000 
S424949 191240400 7.71E-3 0.904 0.868 1.251 0.125 0.300 0.407 
S692250 191697937 7.14E-3 0.256 0.126 0.32 0.150 0.600 0.702 
S693026 191854465 2.47E-2 0.001 0.205 0.509 0.208 0.579 0.647 
S422227 192027314 3.17E-1 -0.026 -0.038 -0.124 0.875 0.975 0.993 
S692209 192027314 3.17E-1 -0.018 -0.05 -0.111 0.875 0.975 0.993 
S694323 192700265 1 0.048 0.073 0.14 0.792 1.000 1.000 
S425868 193218073 1.02E-2 -0.037 0.11 0.301 0.900 0.900 0.964 
S422139 193248816 2.20E-2 0.206 0.231 0.422 0.364 0.650 0.743 
S422001 193421868 3.17E-1 0.109 0.126 0.196 0.900 0.975 0.964 
S693895 194505012 6.49E-1 0.008 -0.076 -0.013 0.583 0.632 0.605 
S692595 194673191 8.41E-1 -0.074 -0.122 -0.383 0.417 0.625 0.622 
S423289 195132894 1 0.041 0.076 0.155 0.958 1.000 1.000 
S693428 195273115 1.35E-3 0.328 0.202 0.34 0.773 0.563 0.690 
S424902 196018672 3.42E-1 0.177 0.213 0.355 0.875 0.950 0.927 
S424023 196204823 5.13E-1 0.092 0.119 0.209 0.900 0.975 0.964 
S694816 196572137 7.20E-3 0.392 0.326 0.519 0.500 0.694 0.594 
S422355 197212851 8.66E-2 0.346 0.351 0.722 0.875 0.900 0.855 
S422488 197533634 1.82E-2 0.197 0.232 0.546 0.455 0.639 0.734 
S422095 197862317 7.30E-1 -0.059 -0.05 -0.099 0.708 0.625 0.628 
S425251 197922583 1.48E-1 0.227 0.264 0.417 0.773 0.825 0.774 
S425620 198161874 1.48E-1 0.274 0.261 0.346 0.833 0.825 0.774 
S693884 199166234 7.84E-3 0.892 1.064 1.555 0.792 0.325 0.443 
S423722 199384293 3.42E-1 0.22 0.189 0.272 0.375 0.950 0.927 
S423093 199652599 1.94E-1 0.105 0.113 0.174 0.350 0.550 0.487 
S422067 199983879 2.21E-3 1.016 0.903 1.423 0.900 0.425 0.559 
S693421 200884723 1 0.069 0.06 0.095 0.875 0.725 0.710 
S423813 201127302 6.12E-1 -0.02 -0.058 -0.181 0.958 1.000 1.000 
Appendix 4 – Candidate genes identified from SNP array I (Chapter 3). 
Gene Candidate SNPs Chr 
Gene 
Start 
Gene 
End Region 
Support 
Score 
GeneScore 
(Log10BF1) 
GeneScore 
(Log10BF2) 
NodeDegree 
(Net1) 
NodeDegree 
(Net2) 
LD 
blocks 
iHS  
(XP-EHH) 
Npas1 S693005 1 76719188 76738565 1 5 1.29 1.69 NA 18   
Ap2s1 S693005 1 77069125 77081190 1 5 1.29 1.69 12 25   
Parva S424447: S426027 1 170232441 170387843 2 11 1.29 1.70 13 26 LD1 2.0 
Tead1 S424447: S426027 1 170557393 170695818 2 5 1.29 1.70 17 28 LD1 2.0 
Xylt1 S424580: S693438 1 175687360 175802134 3 6 1.13 1.36 7 12 LD1 2.0 
Vkorc1 Vkorc1_ 187177049 1 187175098 187179262 4 12 4.16 6.22 9 12 LD1  
Fgfr2 S695593 1 189482977 189589279 4 6 1.64 1.91 NA 192 LD1  
Bche S424818 2 164329613 164427994 5 12 1.30 1.74 50 85   
Tdo2 NA 2 173594018 173611833 6 7 0.07 0.12 182 323   
Bglap S423241 2 180482313 180483290 7 7 0.05 0.00 152 274  2.6 
Fdps S423241 2 181168903 181177792 7 1 0.61 0.69 16 29  2.6 
Tuft1 NA 2 189595502 189641602 8 1 0.61 0.89 7 14   
Wdr3 S425777: S426471 2 195093948 195116591 9 6 1.15 1.75 17 30  3.0 
F3 S424133: S425042 2 218371050 218382644 10 3 1.03 1.77 NA 100   
Abcd3 S424133: S425042 2 218396081 218432176 10 3 1.03 1.77 NA 43   
Bcar3 S424133: S425042 2 219075206 219188344 10 5 1.04 1.37 14 21   
Unc5c S425671 2 239568542 239721231 11 7 1.30 1.25 7 10  2.1 
Bmpr1b S425671 2 239727570 239777074 11 10 1.30 1.25 21 48  2.1 
Ppig NA 3 51866989 51895890 12 8 0.08 0.19 36 55 LD2 2.5 
Olr672 S424398: S424527 3 73233335 73234249 13 5 1.12 1.31 1 1   
Olr673 S424398: S424527 3 73309447 73310382 13 5 1.12 1.31 1 1   
Olr674 S424398: S424527 3 73318353 73319288 13 5 1.12 1.31 1 1   
F2 S424527 3 76005320 76018603 13 8 0.18 0.21 58 105   
Shf S422383 3 109129839 109149342 14 5 1.11 1.44 9 18   
Ascc3l1 S425673 3 114708625 114738537 15 5 1.03 1.31 48 86   
Ciao1 S425673 3 114740677 114746203 15 5 1.03 1.31 17 29   
Tmem1
27 S425673 3 114746454 114759246 15 4 1.03 1.31 5 8   
Stard7 S425673 3 114768201 114795440 15 4 1.03 1.31 2 4   
Rin2 S421464 3 134307538 134503915 16 12 2.06 2.44 6 9   
Nat5 S421464 3 134522185 134537185 16 12 2.06 2.44 3 8   
Sfrs6 S423582 3 153795483 153799024 17 6 1.72 2.42 NA 48 LD3  
L3mbtl S423582 3 153811334 153836990 17 6 1.72 2.42 NA 1 LD3  
Sgk2 S423582 3 153849825 153890111 17 6 1.72 2.42 NA 11 LD3  
Ift52 S423582 3 153893164 153917594 17 12 1.72 2.42 9 14 LD3  
Mybl2 S423582 3 153925908 153954323 17 12 1.72 2.42 21 45 LD3  
Prex1 
S424732: 
S424154: 
S423483 
3 157693897 157863943 17 12 2.24 2.97 10 21 LD3  
Arfgef2 
S424732: 
S424154: 
S423483 
3 157967942 158051358 17 5 1.06 1.28 10 17 LD3  
Cse1l 
S424732: 
S424154: 
S423483 
3 158061678 158100065 17 11 1.06 1.28 27 51 LD3  
Stau1 
S424732: 
S424154: 
S423483 
3 158101209 158147105 17 5 1.06 1.28 21 40 LD3  
Calu NA 4 56228617 56256117 18 8 0.47 0.56 35 51   
RGD15
65690 S424027 4 88376454 88378742 19 6 1.71 2.07 4 5   
Ggcx NA 4 105719323 105735190 20 8 0.23 0.17 15 24 LD4  
Mgp NA 4 173910585 173913947 21 8 -0.07 -0.03 58 118   
Clta S422841 5 60484404 60502432 22 5 1.13 1.30 61 103 LD5  
Gne S422841 5 60506174 60546285 22 6 1.13 1.30 20 37 LD5  
Tex10 S694477 5 65118575 65165336 22 11 1.50 1.75 4 4 LD5  
RGD13
08165 S694477 5 65226927 65249757 22 5 1.50 1.75 NA 4 LD5  
Tmeff1 S694477 5 65271278 65357295 22 6 1.50 1.75 NA 47 LD5  
Murc S694477 5 65357777 65365621 22 5 1.50 1.75 NA 3 LD5  
Akap2 S422312 5 75814965 75855490 23 2 0.79 1.38 4 14   
Orm1 NA 5 80325042 80328194 24 4 0.02 0.00 NA 112   
Rock2 S426589: S421572 6 40581249 40672854 25 7 1.27 1.19 49 84  2.4 
Rnf144
a S425096 6 43957013 44073940 25 2 1.03 1.07 2 3  2.4 
Rsad2 S425096 6 44101919 44113911 25 3 1.03 1.07 14 28  2.4 
Cmpk2 S425096 6 44128537 44139346 25 3 1.03 1.07 23 32  2.4 
Tgfb3 S423641 6 110173444 110195215 26 5 1.00 1.30 70 122   
RGD15
65705 S692740 6 143566620 143657319 27 2 1.19 1.25 NA 2   
Ptprn2 S692740 6 143787884 144549042 27 6 1.19 1.25 28 45   
Cyp4f1 NA 7 13589664 13600856 28 8 0.25 0.30 26 39   
RGD15
66296 S424184 8 64149487 64350969 29 4 1.10 1.19 2 2  2.8 
Trerf1 S421824 9 9092501 9136587 30 3 1.02 1.28 21 40   
Clip1 S420886 12 34049773 34155526 31 2 0.65 1.29 51 99  2.8  (-4.85) 
Diablo S420886 12 34196347 34209619 31 2 0.65 1.29 35 52  2.8  (-4.85) 
Tbx3 S694643 12 38155494 38166670 31 10 1.16 1.41 12 25  2.8  (-4.85) 
Ptgs2 NA 13 64427288 64433974 32 4 0.18 0.21 NA 366   
Sell S425490 13 79827342 79845296 33 3 1.18 1.36 NA 146   
Selp S425490 13 79896091 79922180 33 4 1.18 1.36 NA 110   
F5 S425490 13 79923988 79997285 33 10 1.18 1.36 26 52   
Slc19a2 S425490 13 80017780 80031776 33 8 1.18 1.36 7 10   
Qdpr S422251 14 70741985 70755600 34 4 1.05 1.17 37 64   
Fhit S426143: S694236 15 16518688 17329184 35 9 1.07 1.37 94 161   
Tpmt NA 17 23695915 23714386 36 8 0.14 0.12 14 20   
Hbegf S420920: S693837 18 29143567 29153944 37 1 0.99 1.35 NA 151 LD6  
Sra1 S420920: S693837 18 29306556 29309783 37 3 0.99 1.35 27 50 LD6  
Gnal NA 18 63595606 63735803 38 1 0.03 0.02 257 634   
Hsbp1 S422804 19 49589565 49594599 39 6 1.77 2.20 NA 7   
Necab2 S422804 19 49629595 49718718 39 6 1.77 2.20 NA 1   
Mlycd S422804 19 49637190 49653015 39 12 1.77 2.20 16 34   
Osgin1 S422804 19 49682142 49690478 39 12 1.77 2.20 4 5   
Mbtps1 S422804 19 49751424 49802700 39 6 1.77 2.20 85 140   
Hsdl1 S422804 19 49807249 49814030 39 6 1.77 2.20 1 1   
Lrrc50 S422804 19 49821884 49842233 39 6 1.77 2.20 2 6   
Taf1c S422804 19 49842372 49848891 39 6 1.77 2.20 37 57   
RT1-S3 NA 20 2815988 2818484 40 4 0.01 0.17 NA 276  (-3.21) 
Tff3 S421700 20 9469888 9474605 41 2 1.18 1.37 26 35   
Tff2 S421700 20 9492352 9510558 41 5 1.18 1.37 15 26   
Tff1 S421700 20 9526674 9530534 41 8 1.18 1.37 35 54   
 
CandidateSNPs: the candidate SNPs selected based on traditional GWAS matched to gene if within 2 Mb distance. 
Chr and GeneStart, GeneEnd (Mb): genes’ position on chromosome. 
Region: candidate genes form clusters along the genome. 
SupportScore: assess how well a gene is supported by multiple ranking files from different network and settings. 
NodeDegree: the number of other genes connected to each gene in network (Network1 and Network2). 
GeneScore(Log10BF): gene score based on Bayes Factor (Log10BF1 or Log10BF2). 
LDblocks: the Linakge Disequilibrium detected in Haploview 
iHS(XP-EHH): the integrated extended haplotype homozygosity (EHH) in NW population and (the cross population EHH between NW and LH population).  
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Appendix 5 – Functional annoation analyses of candidate genes from SNP array I 
(Chapter 3). 
Annotation Cluster 1 Enrichment Score: 2.77   
Term Count PValue Genes Fold Bonferroni 
IPR017994:P-type trefoil, 
chordata 3 0.000 TFF2, TFF3, TFF1 97.97 0.05 
IPR017957:P-type trefoil, 
conserved site 3 0.001 TFF2, TFF3, TFF1 73.47 0.09 
IPR000519:P-type trefoil 3 0.001 TFF2, TFF3, TFF1 73.47 0.09 
SM00018:PD 3 0.001 TFF2, TFF3, TFF1 63.51 0.03 
Annotation Cluster 2 Enrichment Score: 2.32   
carboxyglutamic acid 3 0.001 BGLAP, F2, MGP 72.57 0.08 
IPR000294:Gamma-
carboxyglutamic acid-rich 
(GLA) domain 
3 0.002 BGLAP, F2, MGP 41.99 0.28 
gamma-carboxyglutamic acid 3 0.002 BGLAP, F2, MGP 41.47 0.24 
domain:Gla 3 0.002 BGLAP, F2, MGP 40.36 0.30 
SM00069:GLA 3 0.003 BGLAP, F2, MGP 36.29 0.09 
calcium binding 3 0.034 BGLAP, F2, MGP 10.01 0.99 
Annotation Cluster 3 Enrichment Score: 2.12   
GO:0009611~response to 
wounding 11 0.000 
SELP, ORM1, PTGS2, F5, F3, F2, TGFB3, TFF3, 
HBEGF, TFF1, BMPR1B 4.12 0.19 
GO:0006954~inflammatory 
response 6 0.008 SELP, ORM1, PTGS2, F3, F2, BMPR1B 4.68 1.00 
GO:0006952~defense response 7 0.017 SELP, ORM1, PTGS2, F3, F2, RSAD2, BMPR1B 3.33 1.00 
Annotation Cluster 4 Enrichment Score: 2.11   
GO:0001503~ossification 6 0.001 FGFR2, BGLAP, PTGS2, TGFB3, MGP, RSAD2 8.77 0.37 
GO:0070167~regulation of 
biomineral formation 4 0.001 BGLAP, TGFB3, MGP, BMPR1B 21.84 0.47 
GO:0030500~regulation of 
bone mineralization 4 0.001 BGLAP, TGFB3, MGP, BMPR1B 21.84 0.47 
GO:0060348~bone 
development 6 0.001 FGFR2, BGLAP, PTGS2, TGFB3, MGP, RSAD2 7.78 0.56 
GO:0030278~regulation of 
ossification 5 0.001 BGLAP, TGFB3, MGP, RSAD2, BMPR1B 10.80 0.61 
GO:0001501~skeletal system 
development 8 0.001 
FGFR2, BGLAP, PTGS2, TBX3, TGFB3, MGP, 
RSAD2, BMPR1B 4.58 0.74 
GO:0031214~biomineral 
formation 3 0.015 FGFR2, BGLAP, PTGS2 15.56 1.00 
Annotation Cluster 5 Enrichment Score: 1.69   
domain:EGF-like 5 0.000 SELP, TMEFF1, PTGS2, SELL, HBEGF 29.43 0.00 
IPR006209:EGF 5 0.002 SELP, TMEFF1, PTGS2, SELL, HBEGF 8.75 0.31 
IPR000742:EGF-like, type 3 5 0.008 SELP, TMEFF1, PTGS2, SELL, HBEGF 6.12 0.73 
IPR006210:EGF-like 5 0.011 SELP, TMEFF1, PTGS2, SELL, HBEGF 5.70 0.82 
SM00181:EGF 5 0.016 SELP, TMEFF1, PTGS2, SELL, HBEGF 4.92 0.42 
IPR013032:EGF-like region, 
conserved site 5 0.025 SELP, TMEFF1, PTGS2, SELL, HBEGF 4.37 0.98 
Annotation Cluster 6 Enrichment Score: 1.59   
GO:0030193~regulation of 
blood coagulation 3 0.014 SELP, F2, VKORC1 16.38 1.00 
GO:0050818~regulation of 
coagulation 3 0.015 SELP, F2, VKORC1 15.56 1.00 
Annotation Cluster 7 Enrichment Score: 1.40   
GO:0042060~wound healing 7 0.001 F5, F3, F2, TGFB3, TFF3, HBEGF, TFF1 5.67 0.67 
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Annotation Cluster 8 Enrichment Score: 1.33   
GO:0044421~extracellular 
region part 12 0.006 
SELP, ORM1, BGLAP, F5, RGD1566296, BCHE, 
F3, TGFB3, MGP, TFF3, HBEGF, TFF1 2.50 0.66 
Annotation Cluster 9 Enrichment Score: 1.29   
GO:0009611~response to 
wounding 11 0.000 
SELP, ORM1, PTGS2, F5, F3, F2, TGFB3, TFF3, 
HBEGF, TFF1, BMPR1B 4.12 0.19 
GO:0042060~wound healing 7 0.001 F5, F3, F2, TGFB3, TFF3, HBEGF, TFF1 5.67 0.67 
disulfide bond 18 0.002 
GGCX, SELP, BGLAP, TMEFF1, PTGS2, SELL, 
TGFB3, MGP, ORM1, XYLT1, F3, F2, VKORC1, 
TFF2, TFF3, HBEGF, TFF1, UNC5C 
2.11 0.27 
disulfide bond 17 0.003 
GGCX, SELP, BGLAP, TMEFF1, PTGS2, SELL, 
TGFB3, MGP, ORM1, F3, F2, VKORC1, TFF2, 
TFF3, HBEGF, TFF1, UNC5C 
2.07 0.43 
signal 18 0.006 
SELP, BGLAP, TMEFF1, PTGS2, SELL, 
PTPRN2, TGFB3, MGP, RT1-S3, ORM1, F3, F2, 
TFF2, TFF3, HBEGF, TFF1, UNC5C, MBTPS1 
1.93 0.55 
GO:0044421~extracellular 
region part 12 0.006 
SELP, ORM1, BGLAP, F5, RGD1566296, BCHE, 
F3, TGFB3, MGP, TFF3, HBEGF, TFF1 2.50 0.66 
GO:0005615~extracellular 
space 10 0.006 
SELP, ORM1, BGLAP, F5, BCHE, F3, TGFB3, 
MGP, HBEGF, TFF1 2.87 0.66 
signal peptide 18 0.007 
SELP, BGLAP, TMEFF1, PTGS2, SELL, 
PTPRN2, TGFB3, MGP, RT1-S3, ORM1, F3, F2, 
TFF2, TFF3, HBEGF, TFF1, UNC5C, MBTPS1 
1.88 0.67 
GO:0005576~extracellular 
region 15 0.015 
SELP, BGLAP, TGFB3, MGP, CALU, ORM1, 
RGD1566296, F5, BCHE, F3, F2, TFF2, TFF3, 
HBEGF, TFF1 
1.95 0.92 
Annotation Cluster 10 Enrichment Score: 1.28   
GO:0001501~skeletal system 
development 8 0.001 
FGFR2, BGLAP, PTGS2, TBX3, TGFB3, MGP, 
RSAD2, BMPR1B 4.58 0.74 
Annotation Cluster 11 Enrichment Score: 1.05   
Term Count PValue Genes Fold Bonferroni 
GO:0001503~ossification 6 0.001 FGFR2, BGLAP, PTGS2, TGFB3, MGP, RSAD2 8.77 0.37 
GO:0060348~bone 
development 6 0.001 FGFR2, BGLAP, PTGS2, TGFB3, MGP, RSAD2 7.78 0.56 
GO:0010033~response to 
organic substance 11 0.049 
SELP, GNAL, PTGS2, SELL, XYLT1, BCHE, 
VKORC1, TGFB3, MGP, TFF3, TFF1 1.93 1.00 
Annotation Cluster 12 Enrichment Score: 1.01   
GO:0001501~skeletal system 
development 8 0.001 
FGFR2, BGLAP, PTGS2, TBX3, TGFB3, MGP, 
RSAD2, BMPR1B 4.58 0.74 
Annotation Cluster 13 Enrichment Score: 0.98   
GO:0001503~ossification 6 0.001 FGFR2, BGLAP, PTGS2, TGFB3, MGP, RSAD2 8.77 0.37 
GO:0060348~bone 
development 6 0.001 FGFR2, BGLAP, PTGS2, TGFB3, MGP, RSAD2 7.78 0.56 
GO:0001501~skeletal system 
development 8 0.001 
FGFR2, BGLAP, PTGS2, TBX3, TGFB3, MGP, 
RSAD2, BMPR1B 4.58 0.74 
GO:0051240~positive 
regulation of multicellular 
organismal process 
6 0.017 FGFR2, PTGS2, F2, VKORC1, TGFB3, BMPR1B 3.94 1.00 
Annotation Cluster 14 Enrichment Score: 0.96   
Term Count PValue Genes Fold Bonferroni 
GO:0008083~growth factor 
activity 5 0.009 TFF2, TGFB3, HBEGF, OSGIN1, TFF1 5.96 0.82 
Annotation Cluster 15 Enrichment Score: 0.81   
GO:0048661~positive 
regulation of smooth muscle 
cell proliferation 
3 0.041 FGFR2, PTGS2, HBEGF 9.15 1.00 
Annotation Cluster 16 Enrichment Score: 0.78   
GO:0031988~membrane-
bounded vesicle 9 0.022 
SELP, BGLAP, CLTA, F5, PTPRN2, AP2S1, 
TGFB3, TFF3, CALU 2.52 0.98 
GO:0044433~cytoplasmic 
vesicle part 5 0.025 SELP, CLTA, F5, AP2S1, TGFB3 4.37 0.99 
GO:0030141~secretory granule 5 0.046 SELP, F5, PTPRN2, TGFB3, TFF3 3.63 1.00 
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GO:0016023~cytoplasmic 
membrane-bounded vesicle 8 0.049 
SELP, CLTA, F5, PTPRN2, AP2S1, TGFB3, 
TFF3, CALU 2.34 1.00 
Annotation Cluster 18 Enrichment Score: 0.77   
Term Count PValue Genes Fold Bonferroni 
endoplasmic reticulum 7 0.039 GGCX, PTGS2, XYLT1, VKORC1, CYP4F1, RSAD2, MBTPS1 2.72 0.99 
GO:0005783~endoplasmic 
reticulum 10 0.042 
GGCX, PTGS2, XYLT1, BCHE, VKORC1, 
CYP4F1, MGP, RSAD2, MBTPS1, CALU 2.10 1.00 
Annotation Cluster 19 Enrichment Score: 0.68   
GO:0044433~cytoplasmic 
vesicle part 5 0.025 SELP, CLTA, F5, AP2S1, TGFB3 4.37 0.99 
GO:0016023~cytoplasmic 
membrane-bounded vesicle 8 0.049 
SELP, CLTA, F5, PTPRN2, AP2S1, TGFB3, 
TFF3, CALU 2.34 1.00 
GO:0031410~cytoplasmic 
vesicle 8 0.092 
SELP, CLTA, F5, PTPRN2, AP2S1, TGFB3, 
TFF3, CALU 2.02 1.00 
Annotation Cluster 20 Enrichment Score: 0.64   
Term Count PValue Genes Fold Bonferroni 
GO:0005788~endoplasmic 
reticulum lumen 3 0.038 PTGS2, BCHE, CALU 9.45 1.00 
 
Appendix 6 – Candidate genes with expression changes clustered in 21 regions along 
the genome (Chapter 4). 
Targets ClusteredRegions Chr GenePos ProbeID GGIRankScore CTDRankScore 
Cyp2t1 1 1 82228606 1368265_at NA 0.551 
Fbl 1 1 83271967 1388528_at 0.757 0.578 
Supt5h 1 1 83404787 1372094_at NA 0.623 
Zfp36 1 1 83486643 1387870_at 0.750 0.563 
Eif3k 1 1 84083646 1372735_at 0.752 0.329 
Tyrobp 1 1 85365371 1374730_at 0.870 0.655 
Tbcb 1 1 85490553 1371885_at 0.780 NA 
Rbm42 1 1 85692754 1371502_at 0.718 0.555 
Fxyd1 1 1 86095551 1369960_at 0.717 0.467 
Gpi 1 1 86658839 1371392_at 0.696 0.478 
Tufm 2 1 185631333 1371962_at NA 0.394 
Coro1a 2 1 185852742 1369964_at 0.850 0.671 
Aldoa 2 1 185970658 1367617_at 0.769 0.533 
Cdipt 2 1 186153278 1387900_at 0.843 0.597 
Znf553 2 1 186498827 1383260_at NA NA 
Znf771 2 1 186507474 1383260_at NA 0.531 
Dctpp1 2 1 186519957 1370308_at NA 0.528 
Pycard 2 1 187276089 1389873_at 0.802 0.625 
Psmd13 3 1 201044403 1371617_at 0.735 0.485 
Rplp2 3 1 201635581 1371340_at NA 0.377 
Ap2a2 3 1 201741585 1371493_at 0.616 0.435 
Ctsd 3 1 202619669 1367651_at 0.830 0.586 
Nadsyn1 3 1 204187196 1379472_at 0.619 0.438 
Cpt1a 3 1 205852746 1386946_at 0.655 10.770 
Cdk2ap2 3 1 206681430 1373901_at NA 0.564 
 281 
 
Pitpnm1 3 1 206684110 1389347_at 0.678 0.530 
Coro1b 3 1 206733359 1398769_at 0.812 0.637 
Ctsf 3 1 207469235 1373258_at NA 0.274 
Brms1 3 1 207661537 1373428_at 0.728 0.491 
Cfl1 3 1 208133876 1370184_at 0.759 0.610 
Fau 3 1 208695065 1371316_at NA 0.460 
Ehd1 3 1 209055078 1388623_at 0.676 0.501 
Sf1 3 1 209146177 1398339_at 0.746 0.498 
Prdx5 3 1 209583414 1367677_at 0.856 0.661 
Ppp1r14b 3 1 209648657 1389815_at NA 0.649 
Ubxn1 3 1 211540964 1373299_at 0.660 NA 
Mta2 3 1 211618426 1373103_at 0.685 0.521 
Tmem216 3 1 213037899 1382049_at NA 0.457 
Ddb1 3 1 213095276 1399162_a_at 0.812 0.492 
Prpf19 3 1 213390564 1398867_at NA 0.460 
Slc25a28 4 1 247159998 1392978_at 0.704 NA 
Bloc1s2 4 1 249086242 1398473_at 0.769 0.593 
Fbxw4 4 1 250746869 1373211_at 0.687 0.333 
Cuedc2 4 1 251546667 1376368_at NA NA 
Actr1a 4 1 251592429 1371741_at 0.679 0.397 
Taf5 4 1 252391049 1376050_at 0.724 0.563 
Rps3a 5 2 178092354 1367606_at 0.664 0.351 
Hdgf 5 2 179991032 1367817_at 0.810 0.523 
Scamp3 5 2 181249544 1370921_at NA 0.501 
Flad1 5 2 181598343 1373758_at 0.703 NA 
Il6ra 5 2 182078051 1386987_at NA 0.607 
Snapap 5 2 182762319 1376366_at 0.730 NA 
Fitm2 6 3 154375988 1394392_at NA 0.490 
Sdc4 6 3 155446138 1367721_at 0.723 0.616 
LOC685079 6 3 155482350 1367543_at 0.763 NA 
Pltp 6 3 155872122 1391435_at 0.707 0.545 
Slc13a3 6 3 156447894 1368047_at 0.641 0.320 
Ddx27 6 3 158165670 1385471_at 0.651 0.364 
Mast2 7 5 136573518 1388399_at 0.753 0.582 
LOC500532 7 5 137578017 1371721_at 0.851 NA 
Atp6v0b 7 5 138349548 1398930_at NA 0.426 
Ipo13 7 5 138359936 1367876_at 0.766 0.583 
Ebna1bp2 7 5 139095875 1388397_at 0.674 0.477 
Ppcs 7 5 140008436 1388756_at 0.698 0.427 
Zfp347 8 7 8938240 1368726_a_at 0.810 0.546 
Dohh 8 7 9806009 1372677_at 0.774 0.403 
Sgta 8 7 10137703 1388467_at 0.627 0.374 
Slc39a3 8 7 10160746 1377933_at 0.714 0.535 
Oaz1 8 7 10394495 1372241_at 0.759 0.461 
Ap3d1 8 7 10480810 1367549_a_at 0.731 0.357 
Mbd3 8 7 10824397 1371345_at NA 0.617 
Atp5d 8 7 11072820 1370278_at 0.655 0.486 
Sbno2 8 7 11117835 1392107_at 0.830 0.440 
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Wdr18 8 7 11253443 1375439_at 0.623 0.453 
Ppap2c 8 7 11694272 1388913_at 0.778 0.622 
Brd4 8 7 12772428 1372351_at 0.704 0.339 
Cyp4f6 8 7 13609103 1387916_at 0.627 0.431 
Cdk4 9 7 67016944 1369950_at NA 0.652 
Tspan31 9 7 67019197 1372739_at 0.612 0.463 
Sdc2 9 7 68290768 1382189_at 0.330 0.243 
Rpl30 9 7 69886763 1398774_at NA 0.517 
Hrsp12 9 7 69930466 1368060_at 0.720 0.429 
Ly6e 10 7 113151828 1388347_at 0.804 0.630 
Eef1d 10 7 113870559 1388134_at 0.731 0.499 
Puf60 10 7 114101195 1367464_at 0.782 NA 
LOC100362108 10 7 114264088 1376056_at 0.751 NA 
Oplah 10 7 114326739 1368091_at 0.721 0.491 
Exosc4 10 7 114374913 1371670_at 0.643 0.514 
Maf1 10 7 114402298 1371374_at 0.767 0.607 
Bop1 10 7 114500159 1392910_at 0.777 0.547 
Dgat1 10 7 114552056 1367915_at 0.735 0.579 
MGC94207 10 7 114766704 1372562_at NA NA 
Eif3d 10 7 115877161 1388568_at 0.836 0.524 
Cdc42ep1 10 7 116807762 1389157_at 0.836 0.641 
Tuba1b 11 7 137706856 1367579_a_at 0.801 0.619 
Tuba1a 11 7 137729408 1367579_a_at 0.805 0.640 
Tuba1c 11 7 137809847 1367579_a_at 0.801 0.626 
Gpd1 11 7 138458875 1371363_at 0.402 0.362 
RGD1359310 11 7 140029813 1372026_at 0.660 NA 
Oaf 12 8 46224862 1388425_at 0.609 0.483 
Mizf 12 8 47275524 1391849_at 0.690 NA 
Hmbs 12 8 47314235 1386983_at 0.773 0.608 
Slc37a4 12 8 47363896 1386960_at 0.668 0.585 
Fxyd2 12 8 48379075 1387799_at NA 0.499 
Sidt2 12 8 48909652 1388828_at 0.707 0.546 
Rassf1 13 8 112798863 1373989_at 0.699 0.334 
Ifrd2 13 8 112834734 1373068_at 0.694 0.464 
Slc38a3 13 8 112898379 1370824_at 0.630 0.499 
Map4 13 8 114354729 1373268_at 0.679 0.431 
Dhx30 13 8 114438390 1388595_at 0.857 0.587 
Lrrfip2 13 8 115509800 1379282_at 0.780 0.405 
Tmem132e 14 10 70584564 1384771_at NA NA 
Slfn2 14 10 71236408 1377916_at NA 0.614 
Ap2b1 14 10 71386233 1367704_at 0.727 0.549 
Ccl6 14 10 71659632 1389123_at 0.538 0.735 
Usp32 14 10 73256761 1373962_at 0.347 0.271 
Galk1 15 10 106116775 1389248_at 0.747 0.523 
H3f3b 15 10 106130318 1398888_at NA 0.527 
Prpsap1 15 10 106582382 1367750_at 0.827 0.709 
Rbm25 15 10 107711516 1392936_at 0.693 0.378 
Usp36 15 10 108264874 1374940_at NA 0.300 
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Lgals3bp 15 10 108388185 1387946_at 0.682 0.549 
Nploc4 15 10 109809121 1393244_at 0.753 0.518 
Hgs 15 10 109868142 1367840_at 0.667 0.359 
Thoc4 15 10 109984500 1374897_at 0.742 0.552 
Sectm1b 15 10 110271329 1376976_at 0.783 0.510 
Chrd 16 11 82401720 1380285_at 0.650 0.515 
Eif4g1 16 11 82452006 1388322_at NA 0.440 
Psmd2 16 11 82478179 1398858_at 0.831 0.496 
Abcf3 16 11 82570496 1371456_at 0.732 0.556 
Ap2m1 16 11 82585474 1398765_at 0.839 0.533 
Klhl24 16 11 83097219 1383110_at NA 0.425 
Setd8 17 12 33253847 1375928_at NA 0.464 
Clip1 17 12 34049773 1367993_at 0.632 0.489 
Orai1 17 12 34631272 1390031_at 0.733 0.567 
Pptc7 17 12 35445316 1388522_at NA 0.377 
Plbd2 17 12 37260666 1375173_at 0.734 0.540 
Tcn2 18 14 84579191 1367765_at 0.747 0.587 
Ewsr1 18 14 85730484 1389289_at 0.690 0.544 
Dbnl 18 14 86450408 1368274_at 0.701 0.543 
Ykt6 18 14 86619828 1372505_at 0.545 0.471 
Ddx56 18 14 86985895 1389389_at 0.769 0.508 
Purb 18 14 87231825 1374205_at 0.717 0.369 
Ccm2 18 14 87329085 1375282_at 0.642 0.490 
Mbl1 19 16 17591820 1387765_at 0.724 0.505 
LOC688495 19 16 17685244 1399080_at NA NA 
Cherp 19 16 17785631 1372705_at NA 0.428 
Fam125a 19 16 18726945 1388457_at 0.709 0.551 
Pgls 19 16 18791241 1374523_at 0.692 0.532 
LOC498606 19 16 19413529 1389156_at 0.687 NA 
Sf4 19 16 19835922 1376164_at 0.695 0.398 
Atp13a1 19 16 20100482 1371925_at 0.735 0.580 
Mlycd 20 19 49637190 1367638_at 0.690 0.412 
Cotl1 20 19 50096633 1388596_at 0.810 0.617 
Fbxo31 20 19 51823606 1372600_at NA 0.470 
Zc3h18 20 19 52654167 1391455_at NA 0.533 
Rpl13 20 19 53437633 1386858_at 0.697 0.583 
Tcf25 20 19 53700976 1391346_at 0.522 0.292 
Znrd1 21 20 1687850 1388590_at 0.705 0.548 
Rnf39 21 20 1697530 1368662_at 0.618 0.490 
Abcf1 21 20 2953601 1398876_at 0.766 0.569 
RGD1309543 21 20 3025507 1373262_at 0.824 NA 
RT1-CE5 21 20 3509597 1370972_x_at 0.545 0.413 
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Appendix 7 – Functional annotation analyses of candidate genes from microarray 
data (Chapter 4). 
Annotation Cluster 1 Enrichment Score: 2.89   
Term Count PValue Genes Fold Bonferroni 
GO:0043232~intracellular 
non-membrane-bounded 
organelle 
33 0.000 
ABCF1, TUFM, ALDOA, RPL13, RPLP2, ZNRD1, 
BOP1, FAM125A, RPL30, CDC42EP1, BLOC1S2, 
RPS3A, ACTR1A, FAU, DHX30, TUBA1A, TUBA1B, 
TUBA1C, DBNL, TAF5, HMBS, MBD3, COTL1, 
FBL, PURB, CORO1B, CORO1A, DDX56, MAST2, 
CFL1, CLIP1, MAP4, H3F3B, SLC13A3 
1.86 0.08 
GO:0043228~non-membrane-
bounded organelle 33 0.000 
ABCF1, TUFM, ALDOA, RPL13, RPLP2, ZNRD1, 
BOP1, FAM125A, RPL30, CDC42EP1, BLOC1S2, 
RPS3A, ACTR1A, FAU, DHX30, TUBA1A, TUBA1B, 
TUBA1C, DBNL, TAF5, HMBS, MBD3, COTL1, 
FBL, PURB, CORO1B, CORO1A, DDX56, MAST2, 
CFL1, CLIP1, MAP4, H3F3B, SLC13A3 
1.86 0.08 
GO:0005856~cytoskeleton 17 0.018 
ALDOA, DBNL, TAF5, COTL1, FAM125A, 
CORO1B, CORO1A, MAST2, CDC42EP1, 
BLOC1S2, ACTR1A, CFL1, MAP4, CLIP1, 
SLC13A3, TUBA1A, TUBA1B, TUBA1C 
1.86 0.98 
Annotation Cluster 2 Enrichment Score: 1.80   
domain:ADF-H 3 0.004 DBNL, CFL1, COTL1 31.05 0.66 
SM00102:ADF 3 0.005 DBNL, CFL1, COTL1 27.33 0.28 
IPR002108:Actin-binding, 
cofilin/tropomyosin type 3 0.005 DBNL, CFL1, COTL1 27.09 0.78 
actin-binding 5 0.059 CORO1B, DBNL, CORO1A, CFL1, COTL1 3.37 1.00 
Annotation Cluster 3 Enrichment Score: 1.39   
GO:0006414~translational 
elongation 7 0.000 
TUFM, RPL30, RPS3A, RPL13, RPLP2, FAU, 
EEF1D 8.03 0.22 
protein biosynthesis 7 0.008 TUFM, EIF3D, RPL30, RPL13, RPLP2, FAU, EEF1D 4.00 0.81 
rno03010:Ribosome 5 0.012 RPL30, RPS3A, RPL13, RPLP2, FAU 5.52 0.59 
GO:0044445~cytosolic part 5 0.021 BLOC1S2, RPS3A, RPL13, PRDX5, FAU 4.71 0.99 
GO:0030529~ribonucleoprote
in complex 11 0.025 
ABCF1, SF4, PRPF19, RPL30, RPS3A, RPL13, SF1, 
RPLP2, FAU, BOP1, FBL 2.22 1.00 
ribonucleoprotein 6 0.037 RPL30, RPS3A, RPL13, RPLP2, FAU, FBL 3.22 1.00 
GO:0006412~translation 9 0.041 ABCF1, TUFM, EIF3D, RPL30, RPS3A, RPL13, RPLP2, FAU, EEF1D 2.29 1.00 
Annotation Cluster 4 Enrichment Score: 1.30   
GO:0050690~regulation of 
defense response to virus by 
virus 
3 0.002 AP2A2, AP2B1, AP2M1 40.85 0.91 
GO:0030139~endocytic 
vesicle 5 0.003 AP2A2, AP2B1, CORO1A, EHD1, AP2M1 8.41 0.48 
IPR002553:Clathrin/coatomer 
adaptor, adaptin-like, N-
terminal 
3 0.003 AP2A2, AP2B1, AP3D1 34.83 0.59 
GO:0030666~endocytic 
vesicle membrane 4 0.004 AP2A2, AP2B1, CORO1A, AP2M1 12.07 0.62 
GO:0009898~internal side of 
plasma membrane 7 0.005 
AP2A2, AP2B1, HGS, SNAPAP, EHD1, YKT6, 
AP2M1 4.43 0.67 
IPR011989:Armadillo-like 
helical 5 0.006 AP2A2, AP2B1, DOHH, IPO13, AP3D1 6.66 0.86 
GO:0050688~regulation of 
defense response to virus 3 0.008 AP2A2, AP2B1, AP2M1 21.79 1.00 
GO:0030117~membrane coat 4 0.012 AP2A2, AP2B1, AP3D1, AP2M1 8.21 0.94 
GO:0048475~coated 
membrane 4 0.012 AP2A2, AP2B1, AP3D1, AP2M1 8.21 0.94 
GO:0030119~AP-type 
membrane coat adaptor 
complex 
3 0.017 AP2A2, AP2B1, AP2M1 14.66 0.98 
GO:0030131~clathrin adaptor 
complex 3 0.017 AP2A2, AP2B1, AP2M1 14.66 0.98 
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GO:0043900~regulation of 
multi-organism process 3 0.020 AP2A2, AP2B1, AP2M1 13.62 1.00 
rno04144:Endocytosis 7 0.020 FAM125A, AP2A2, AP2B1, RT1-CE5, HGS, EHD1, AP2M1 3.19 0.78 
GO:0002831~regulation of 
response to biotic stimulus 3 0.023 AP2A2, AP2B1, AP2M1 12.57 1.00 
GO:0008565~protein 
transporter activity 4 0.025 AP2A2, AP2B1, IPO13, AP3D1 6.35 1.00 
protein transport 8 0.028 PITPNM1, FAM125A, AP2A2, AP2B1, IPO13, HGS, YKT6, AP2M1 2.70 1.00 
GO:0015031~protein 
transport 11 0.028 
PITPNM1, FAM125A, AP2A2, SCAMP3, AP2B1, 
IPO13, CFL1, HGS, AP3D1, YKT6, AP2M1 2.18 1.00 
coated pit 3 0.029 AP2A2, AP2B1, AP2M1 11.13 1.00 
GO:0045184~establishment 
of protein localization 11 0.029 
PITPNM1, FAM125A, AP2A2, SCAMP3, AP2B1, 
IPO13, CFL1, HGS, AP3D1, YKT6, AP2M1 2.16 1.00 
GO:0005905~coated pit 3 0.034 AP2A2, AP2B1, AP2M1 10.26 1.00 
GO:0046907~intracellular 
transport 10 0.035 
AP2A2, AP2B1, IPO13, CFL1, HGS, AP3D1, 
THOC4, EHD1, YKT6, AP2M1 2.21 1.00 
GO:0030118~clathrin coat 3 0.036 AP2A2, AP2B1, AP2M1 9.93 1.00 
GO:0016192~vesicle-
mediated transport 9 0.046 
DBNL, AP2A2, AP2B1, CORO1A, AP3D1, SNAPAP, 
EHD1, YKT6, AP2M1 2.24 1.00 
GO:0006886~intracellular 
protein transport 7 0.046 AP2A2, AP2B1, IPO13, CFL1, HGS, AP3D1, AP2M1 2.67 1.00 
Annotation Cluster 5 Enrichment Score: 1.23   
GO:0006733~oxidoreduction 
coenzyme metabolic process 4 0.012 GPD1, PGLS, NADSYN1, FLAD1 8.38 1.00 
GO:0051186~cofactor 
metabolic process 6 0.037 GPD1, PGLS, MLYCD, HMBS, NADSYN1, FLAD1 3.24 1.00 
Annotation Cluster 6 Enrichment Score: 1.23   
GO:0048029~monosaccharid
e binding 5 0.002 ALDOA, MBL1, GPI, GALK1, PGLS 9.92 0.37 
GO:0019318~hexose 
metabolic process 7 0.011 
ALDOA, GPI, GPD1, GALK1, PGLS, SLC37A4, 
CPT1A 3.76 1.00 
GO:0005996~monosaccharid
e metabolic process 7 0.018 
ALDOA, GPI, GPD1, GALK1, PGLS, SLC37A4, 
CPT1A 3.32 1.00 
GO:0006006~glucose 
metabolic process 6 0.022 ALDOA, GPI, GPD1, PGLS, SLC37A4, CPT1A 3.71 1.00 
rno00030:Pentose phosphate 
pathway 3 0.027 ALDOA, GPI, PGLS 11.45 0.87 
GO:0044275~cellular 
carbohydrate catabolic 
process 
4 0.028 ALDOA, GPI, GPD1, PGLS 6.05 1.00 
GO:0046164~alcohol 
catabolic process 4 0.028 ALDOA, GPI, GPD1, PGLS 6.05 1.00 
GO:0030246~carbohydrate 
binding 8 0.044 
ALDOA, MBL1, GPI, GALK1, CDIPT, PGLS, 
HDGF, CHRD 2.45 1.00 
Annotation Cluster 7 Enrichment Score: 1.22   
repeat:WD 5 5 0.023 PRPF19, CORO1B, CORO1A, WDR18, BOP1 4.59 1.00 
repeat:WD 4 5 0.026 PRPF19, CORO1B, CORO1A, WDR18, BOP1 4.42 1.00 
repeat:WD 3 5 0.029 PRPF19, CORO1B, CORO1A, WDR18, BOP1 4.26 1.00 
repeat:WD 2 5 0.030 PRPF19, CORO1B, CORO1A, WDR18, BOP1 4.21 1.00 
repeat:WD 1 5 0.030 PRPF19, CORO1B, CORO1A, WDR18, BOP1 4.21 1.00 
Annotation Cluster 8 Enrichment Score: 1.14   
GO:0009165~nucleotide 
biosynthetic process 7 0.008 
ATP5D, ALDOA, ATP13A1, NADSYN1, FLAD1, 
PRPSAP1, ATP6V0B 3.95 1.00 
GO:0034404~nucleobase, 
nucleoside and nucleotide 
biosynthetic process 
7 0.010 ATP5D, ALDOA, ATP13A1, NADSYN1, FLAD1, PRPSAP1, ATP6V0B 3.81 1.00 
GO:0034654~nucleobase, 
nucleoside, nucleotide and 
nucleic acid biosynthetic 
process 
7 0.010 ATP5D, ALDOA, ATP13A1, NADSYN1, FLAD1, PRPSAP1, ATP6V0B 3.81 1.00 
GO:0044271~nitrogen 
compound biosynthetic  8 0.030 
ATP5D, ALDOA, ATP13A1, HMBS, NADSYN1, 
FLAD1, PRPSAP1, ATP6V0B 2.65 1.00 
Annotation Cluster 9 Enrichment Score: 1.06   
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GO:0042802~identical 
protein binding 12 0.026 
MBL1, GPD1, DBNL, CORO1A, DDX56, BLOC1S2, 
RASSF1, PYCARD, CLIP1, PRPSAP1, CPT1A, 
IL6RA 
2.10 1.00 
Annotation Cluster 10 Enrichment Score: 1.05   
GO:0016887~ATPase 
activity 8 0.015 
DDX27, ABCF1, ATP5D, FXYD2, ABCF3, DDX56, 
ATP13A1, DHX30 3.07 0.99 
GO:0042623~ATPase 
activity, coupled 6 0.044 DDX27, ATP5D, FXYD2, DDX56, ATP13A1, DHX30 3.09 1.00 
Annotation Cluster 11 Enrichment Score: 1.04   
GO:0006511~ubiquitin-
dependent protein catabolic 
process 
6 0.018 PSMD13, DDB1, PSMD2, FBXO31, USP36, USP32 3.94 1.00 
GO:0043632~modification-
dependent macromolecule 
catabolic process 
7 0.045 CUEDC2, PSMD13, DDB1, PSMD2, FBXO31, USP36, USP32 2.69 1.00 
GO:0019941~modification-
dependent protein catabolic 
process 
7 0.045 CUEDC2, PSMD13, DDB1, PSMD2, FBXO31, USP36, USP32 2.69 1.00 
Annotation Cluster 12 Enrichment Score: 1.03   
GO:0008092~cytoskeletal 
protein binding 10 0.013 
CORO1B, DBNL, CORO1A, MAST2, BLOC1S2, 
CFL1, CLIP1, SDC4, COTL1, SDC2 2.64 0.98 
cytoskeleton 9 0.014 CORO1B, DBNL, FAM125A, CORO1A, CDC42EP1, BLOC1S2, ACTR1A, CFL1, COTL1 2.80 0.95 
GO:0005856~cytoskeleton 17 0.018 
ALDOA, DBNL, TAF5, COTL1, FAM125A, 
CORO1B, CORO1A, MAST2, CDC42EP1, 
BLOC1S2, ACTR1A, CFL1, MAP4, CLIP1, 
SLC13A3, TUBA1A, TUBA1B, TUBA1C 
1.86 0.98 
Annotation Cluster 13 Enrichment Score: 0.98   
GO:0006639~acylglycerol 
metabolic process 4 0.014 CDIPT, DGAT1, SLC37A4, CPT1A 7.78 1.00 
GO:0006638~neutral lipid 
metabolic process 4 0.016 CDIPT, DGAT1, SLC37A4, CPT1A 7.51 1.00 
GO:0006662~glycerol ether 
metabolic process 4 0.016 CDIPT, DGAT1, SLC37A4, CPT1A 7.39 1.00 
GO:0018904~organic ether 
metabolic process 4 0.018 CDIPT, DGAT1, SLC37A4, CPT1A 7.14 1.00 
GO:0006006~glucose 
metabolic process 6 0.022 ALDOA, GPI, GPD1, PGLS, SLC37A4, CPT1A 3.71 1.00 
GO:0005624~membrane 
fraction 7 0.697 
GPI, DGAT1, CYP4F6, SLC37A4, SLC13A3, 
SNAPAP, CPT1A 1.00 1.00 
GO:0005626~insoluble 
fraction 7 0.745 
GPI, DGAT1, CYP4F6, SLC37A4, SLC13A3, 
SNAPAP, CPT1A 0.95 1.00 
Annotation Cluster 14 Enrichment Score: 0.92   
GO:0015630~microtubule 
cytoskeleton 9 0.028 
FAM125A, MAST2, BLOC1S2, ACTR1A, CLIP1, 
MAP4, SLC13A3, TUBA1A, TUBA1B, TUBA1C 2.48 1.00 
Annotation Cluster 16 Enrichment Score: 0.87   
GO:0016887~ATPase 
activity 8 0.015 
DDX27, ABCF1, ATP5D, FXYD2, ABCF3, DDX56, 
ATP13A1, DHX30 3.07 0.99 
GO:0042623~ATPase 
activity, coupled 6 0.044 DDX27, ATP5D, FXYD2, DDX56, ATP13A1, DHX30 3.09 1.00 
Annotation Cluster 19 Enrichment Score: 0.83   
GO:0006396~RNA 
processing 8 0.046 
ZFP36, SF4, PRPF19, DDX56, THOC4, BOP1, 
RBM25, FBL 2.42 1.00 
Annotation Cluster 20 Enrichment Score: 0.79   
GO:0006396~RNA 
processing 8 0.046 
ZFP36, SF4, PRPF19, DDX56, THOC4, BOP1, 
RBM25, FBL 2.42 1.00 
Annotation Cluster 21 Enrichment Score: 0.69   
GO:0006812~cation transport 10 0.035 ATP5D, ORAI1, FXYD2, SLC38A3, CORO1A, ATP13A1, SLC13A3, TCN2, SLC39A3, ATP6V0B 2.21 1.00 
Annotation Cluster 24 Enrichment Score: 0.51   
GO:0016887~ATPase 
activity 8 0.015 
DDX27, ABCF1, ATP5D, FXYD2, ABCF3, DDX56, 
ATP13A1, DHX30 3.07 0.99 
Annotation Cluster 30 Enrichment Score: 0.31   
GO:0030246~carbohydrate 
binding 8 0.044 
ALDOA, MBL1, GPI, GALK1, CDIPT, PGLS, 
HDGF, CHRD 2.45 1.00 
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Appendix 8 – Genes involved in warfarin interactive pathways in human. 
Genes Function Reference 
Genes reported to be connected to VKORC1 in STRING database 
VKORC1 Encodes a protein of the vitamin K 2,3-epoxide reductase complex (VKOR), explain 30% dose variance 
(Li et al. 2004; Rost et 
al. 2004) 
CYP2C9 Dose predictor CYP2C9 in human, explain ~ 10% dose variance (Takeuchi et al. 2009) 
CYP4F2 Genetic determinant of warfarin dose, explain ~1.5% dose variance (Takeuchi et al. 2009) 
EPHX1 Associated with the maintenance dose of warfarin in elderly populations (Pautas et al. 2009) 
CALU Encodes calumenin, inhibits both the GGCX and the VKOR; suggested to contribute to warfarin resistance by over-expression in north America (Wajih et al. 2004) 
GGCX Catalyzes the posttranslational modification of glutamate to gamma-carboxyglutamate (Gla) in vitamin K-dependent proteins 
(Markussen et al. 
2007b) 
NQO1 Encodes a warfarin sensitive NAD(P)H quinone dehydrogenase, involved in vitamin K reduction pathway, potentially reduce dietary vitamin K 
(Markussen et al. 
2007b) 
APOE Apolipoprotein E, clear Vitamin K1, absorbed along with dietary fat (Wadelius et al. 2007) 
Vitamin K dependent genes involved in blood coagulation 
F2 Blood coagulation factor II (thrombin) (Stafford 2005) 
F7 Blood coagulation factor VII (serum prothrombin conversion accelerator) (Stafford 2005) 
F9 Blood coagulation factor IX (Stafford 2005) 
F10 Blood coagulation factor X (Stafford 2005) 
PROS1 Vitamin K dependent protein S (Stafford 2005) 
PROC Vitamin K dependent anticoagulant protein C (Stafford 2005) 
PROZ Vitamin K dependent protein Z (Stafford 2005) 
SERPRINC1 inhibits the Vitamin K dependent clotting factors  
Vitamin K dependent genes involved in cell cycle regulation 
GAS6 Encodes a unique vitamin K-dependent autocrine growth factor for mesangial cell. Affect vascular smooth muscle cell movement and apoptosis. 
(Yanagita 2004; 
Danziger 2008) 
Vitamin K dependent genes involved in bone metabolism 
MGP 
Encodes vitamin K-dependent protein (matrix Gla), which prevents vascular 
calcification. Its effect on calcification is determined by the relative amounts of 
MGP and BMP-2. 
(Danziger 2008) 
(Zebboudj, Shin, and 
Bostrom 2003) 
BGLAP Vitamin K-dependent protein gamma-carboxyglutamyl (bone Gla) (Suttie 1993) 
AXL Receptor of GAS6 (Yanagita 2004) 
STAT3 A downstream signaling molecule of the GAS6/AXL pathway (Yanagita 2004) 
Other interesting genes 
FGG Combines with alpha and beta polypeptides to form the mature fibrinogen molecule, which is an important component of the coagulation cascade; 
(Ivaskevicius et al. 
2005) 
CYP1A2, 
CYP3A4, 
CYP1A1, 
CYP3A5 
CYP2C8 
Metabolize R-warfarin or S-warfarin (Wadelius et al. 2007). 
ORM1, 
ORM2 
ABCB1 
Warfarin transport in and out of the liver (Wadelius et al. 2007). 
CACNA1C Subunit of an L-type calcium channel that may be involved in bone metabolism and compensatory renal growth (Cooper et al. 2008) 
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